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Abstract 
This thesis is divided into four chapters.  
The first chapter comprises an introduction to the fasicularin family of marine alkaloids, and a review 
of previous total syntheses of the members of this class of compounds. This chapter also covers the 
previous work by Craig et al. on the synthesis of (±)-lepadiformine, and how this influenced our 
initial approach to the enantioselective synthesis of (–)-lepadiformine. 
The second chapter details the first part of our investigation into the synthesis of these compounds, 
including short reviews of diastereoselective aziridination protocols developed by Yoon et al. and 
Sharpless et al. This section includes the results of this investigation, and discusses the successes and 
failures of this approach. 
The third chapter concerns our revised second-generation strategy for the synthesis of                        
(–)-lepadiformine, and includes a review of the decarboxylative Claisen rearrangement, and 
diastereoselective variants thereof. This section also covers our results and discussion for this revised 
synthesis. 
The fourth chapter contains experimental details and characterisation data for all compounds 
synthesised.  
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Abbreviations 
9-BBN  9-Borabicyclo[3.3.1]nonane 
Ac  acetyl 
acac  acetylacetonate 
ADDP  1,1'-(azodicarbonyl)dipiperidine 
Ar  aryl 
Bn  benzyl 
Boc  tert-butyloxycarbonyl 
BSA  N,O-bis(trimethylsilyl)acetamide 
BTEAC benzyltriethylammonium chloride 
Bu  butyl 
cat.  catalytic 
Cbz  carboxybenzyl 
cod  1,5-cyclooctadiene 
CSA  camphorsulfonic acid 
Cy  cyclohexyl 
d  doublet 
dba  dibenzylideneacetone 
DBB  di-tert-butyl biphenylide 
DBU  1,8-Diazabicyclo[5.4.0]undec-7-ene 
DCC  dicyclohexylcarbodiimide 
DCE  dichloroethane 
dCr  decarboxylative Claisen rearrangement 
DEAD  diethyl azodicarboxylate 
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DIAD  di(isopropyl) azodicarboxylate 
DIBAL-H di-isobutyl-aluminium hydride 
DIC  di(isopropyl)carbodiimide 
DMAP  4-dimethylaminopyridine 
DME  dimethoxyethane 
DMF  dimethylformamide 
DMPU  1,3-Dimethyl-3,4,5,6-tetrahydro-2(1H)-pyrimidinone 
DMSO  dimethylsulfoxide 
DNA  deoxyribonucleic acid 
DPEN  diphenylethylenediamine 
dppf  1,1'-Bis(diphenylphosphino)ferrocene 
EDCI  1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide 
Eh  2-ethylhexanoate 
Et  ethyl 
h  hextet 
hept  heptet 
HFIP  hexafluoro-2-propanol 
HMDS  hexamethyldisilazide 
HOMO  highest occupied molecular orbital 
Hz  Hertz 
IR  infrared spectroscopy 
LDA  lithium diisopropylamide 
LUMO  lowest unoccupied molecular orbital 
m-CPBA meta-chloroperoxybenzoic acid 
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Me  methyl 
MOM  methoxymethyl ether 
Ms  methanesulfonyl 
MS  mass spectrometry 
Naphth  naphthyl 
NBS  N-bromosuccinamide 
NCS  N-chlorosuccinamide 
ND  neodecanoate 
NMO  N-methylmorpholine-N-oxide 
NMR  nuclear magnetic resonance spectroscopy 
Ns  4-nitrobenzenesulfonyl 
p  pentet 
PCC  pyridinium chlorochromate 
PDC  pyridinium dichromate 
PG  protecting group 
Ph  phenyl 
PMB  para-methoxybenzyl 
PPTS  pyridinium p-toluenesulfonate 
Pr  propyl 
PTAB  phenyltrimethylammonium tribromide 
Py  pyridine 
q  quartet 
rt  room temperature 
s  singlet 
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SES  2-trimethylsilylethanesulfonyl 
t  triplet 
TBAF  tetrabutylammonium fluoride 
TBDPS  tert-butyldiphenylsilyl 
TBS  tert-butyldimethylsilyl 
Tf  trifluoromethanesulfonyl 
TFA  trifluoroacetic acid 
TFAA  trifluoroacetic anhydride 
THF  tetrahydrofuran 
TIPS  tri(isopropyl)silyl 
TLC  thin layer chromatography 
TMEDA tetramethylethylene diamine 
TMS  trimethylsilyl 
TPAP  tetra(isopropyl)ammonium perruthenate 
Tris  2,4,6-tri(isopropyl)-benzenesulfonyl 
Ts  para-toluenesulfonyl 
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Stereochemical Notation 
It should be noted that the Maehr convention for indicating relative and absolute stereochemistry has 
been used throughout this report.
1
 Therefore, solid and broken lines are used to denote racemates, and 
solid and broken wedges denote absolute configuration. 
  
 
Chapter 1 
Introduction
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1.0.0 Isolation and structural assignment 
1.0.1 Cylindricine alkaloids 
The Fasicularin family of marine alkaloids is a class of compounds mostly comprising the 
cylindricine alkaloids, along with fasicularin and lepadiformine. The cylindricine alkaloids were first 
isolated in the early 1990s from the marine ascidian (sea squirt) Clavelina cylindrica in Tasmania by 
Blackman et al.
2–4
 Their structures were assigned by X-ray crystallography of the corresponding 
picrates, the majority of which are illustrated in Figure 1. 
 
Figure 1. The structures of the first five cylindricines. 
The most abundant compound isolated was cylindricine A 1. Cylindricine B 7 is the second most 
abundant, and is in equilibrium with 1 via an aziridinium intermediate 6 (Figure 2). This mode of 
isomerisation is common throughout the Fasicularin family, and contributes to the compounds’ 
interesting biological activity. 
 
Figure 2. Interconversion of cylindricines A and B. 
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The cylindricine alkaloids contain a cis-fused 1-azadecalin ring system; their preferred conformation, 
as shown above, was confirmed by X-ray crystallography and NMR analysis.
3
 Cylindricine B 7 
contains a cis-fused pyridoquinoline core, contrary to the cis-fused pyrroloquinoline motif found in 
the majority of the cylindricine alkaloids. At present, the absolute stereochemistry of these 
compounds is not definitively known. Optical rotations of the naturally occurring cylindricines were 
not taken at the time of isolation, and as such only the relative stereochemistry of these compounds 
can be proven.  
1.0.2 Fasicularin 
Structurally-related fasicularin 8 was isolated in 1997 in Pohnpei, Micronesia from the ascidian 
Neptheis fasicularis (Figure 3).
5
 
 
Figure 3. Structure of fasicularin. 
The structure shown above and its relative stereochemistry were determined by NMR and nOe 
experiments. Its structure is closely related to cylindricine B 7, containing a pyridoquinoline core 
structure. However, fasicularin displays a trans-fused 1-azadecalin structure. Again, as optical 
rotations of the naturally occurring enantiomers were not recorded, the absolute configuration of 
fasicularin is as yet unassigned.  
1.0.3 (–)-Lepadiformine 
Lepadiformine was isolated in 1994 by Biard et al. by HCl extraction of the marine tunicate Clavelina 
lepadiformis collected in Tunisia, and from Clavelina moluccensis collected near Djibouti.
6,7
 Its 
original structure was assumed to be zwitterionic, and it was believed to be part of the cylindricine 
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class of alkaloids, thereby having a cis-1-azadecalin core. Its actual structure, containing a 
trans-1-azadecalin in line with fasicularin, was assigned by total synthesis (Figure 4).
8–10
 
 
Figure 4. Originally proposed zwitterionic structure 9, and the actual structure of (–)-lepadiformine 10.  
X-ray crystallography studies of synthetic material have determined that the B-ring of                        
(–)-lepadiformine 10 exists in a boat conformation, thereby avoiding axial disposition of the hexyl 
side chain.  
1.0.4 Biological Activity 
This family of alkaloids has varying and interesting biological activities. The cylindricine class of 
compounds has limited biological activity, whereas studies of fasicularin and lepadiformine have 
proven more fruitful. Fasicularin has been shown to have biological activity against a DNA 
repair-deficient strain of yeast, and has been shown to have DNA-damaging activity via guanine base 
alkylation (Figure 5).
5,11
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Figure 5. Alkylation of guanine bases found in DNA strands by racemic fasicularin. 
It was presumed that fasicularin 8 underwent conversion to aziridinium ion 11 (via a similar 
mechanism to that of the interconversion of cylindricines A and B), which was sufficiently 
electrophilic to alkylate at N(7) of the guanine base to afford product 12. This mode of action is 
similar to the mechanism of action of several clinically used anticancer drugs (notably 
mechloroethamine, melphalan and chlorambucil), suggesting fasicularin may be a future candidate for 
a cancer therapeutic.
12–14
  
(–)-Lepadiformine has shown moderate in vitro cytotoxicity against nasopharynx carcinoma (throat 
cancer) and non-small-cell lung carcinoma.
6
 In vivo analysis of (–)-lepadiformine revealed it induces 
bradycardia and a transient fall in blood pressure.
7
 More recently, this compound and related 
lepadiformines B and C, were reported to block the cardiac muscle Kir channel, which is particularly 
rare.
15
 It was shown that the amine portion of the molecule binds to an intracellular site to cause the 
blocking of this channel, and the length of the aliphatic side chain affects the degree of blocking that 
takes place. With this in mind, it seems that this family of alkaloids may well prove to be useful in the 
biological arena in the future. 
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1.1.0 Previous total syntheses 
This class of alkaloids has attracted considerable attention from the synthetic community since its 
discovery in the mid-1990s. A selection of these investigations are detailed here. 
1.1.1  Syntheses of (±)-lepadiformine and (±)-fasicularin by Kibayashi et al. 
Kibayashi et al. were the first to report a total synthesis of racemic lepadiformine in 29 steps (longest 
linear sequence) and in 1.5 % overall yield.
8,9
 Their retrosynthetic analysis centred on an 
intramolecular acylnitroso-Diels–Alder cycloaddition of a substrate derived from hydroxamic acid 15 
(Figure 6). 
 
Figure 6. Retrosynthetic analysis of (±)-lepadiformine by Kibayashi et al. 
This approach was unusual in that it constituted only the second use of an exocyclic diene in an 
acylnitroso-Diels–Alder reaction; the first involved the formation of a fused 7/6 ring system, and was 
completed by Fuchs and Burkholder.
16,17
 A feature of this synthesis was the violation of the implicit 
rule of syn-tether specificity in an intramolecular [4 + 2] cycloaddition, resulting in anti-facial 
approach of the dienophile to form the requisite A/B trans-fused ring system of both 
(±)-lepadiformine and (±)-fasicularin (Figure 6). 
In general, the acylnitroso moiety approaches the dienophile portion from the same face as the anchor 
position of the tether, giving rise to syn-facial stereochemistry and therefore access to the cis-fused 
azadecalin core structure 19, which was the originally proposed stereochemistry of lepadiformine. 
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Despite this, initial molecular models suggested that the anti-facial transition state is more 
energetically favourable, and so Kibayashi et al. hoped to be able to tune this process to have access 
to both stereochemical outcomes (Figure 7). 
 
Figure 7. Selectivity in acylnitroso-Diels–Alder cycloadditions. 
 
Figure 8. Endo transition states for the intramolecular acylnitroso-Diels–Alder cycloaddition of hydroxamic acid 15. 
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The selectivity for trans-azadecalin formation can be rationalised in terms of the endo transition states 
above (Figure 8). Syn-facial transition state 21 experiences steric repulsion between the two illustrated 
ring methylene groups and the tethered side chain, thereby rendering it unfavourable. Transition state 
22 places the side chain in an unfavourable axial position. Anti-facial transition state 20, giving rise to 
trans stereochemistry in the product, is therefore the most favourable, orienting the side chain in an 
equatorial position and avoiding any unfavourable interactions with the ring. 
Hydroxamic acid 15 was prepared in 10 steps from ketone 16, and subjection of 15 to oxidative 
conditions using periodate resulted in the formation of trans- and cis-fused products 14 and 24 
respectively, in the following ratios (Scheme 1, Table 1). 
 
Scheme 1. Acylnitroso-Diels–Alder cycloaddition of 15. 
Entry Periodate Solvent Ratio of 14:24 Yield (%) 
1 Pr4NIO4 CHCl3 2.1:1 58 
2 Pr4NIO4 H2O:MeOH (5:1) 4.5:1 80 
3 Pr4NIO4 H2O:MeOH (5:1) 4.5:1 84 
4 Bu4NIO4 H2O:DMF (5:1) 4.7:1 75 
5 Bu4NIO4 H2O:DMSO (5:1 4.8:1 77 
Table 1. Conditions for cycloaddition of 15. All reactions carried out by treatment of hydroxamic acid 15 with the periodate 
at 0 °C for 30 – 45 min. 
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Use of CHCl3 as a solvent resulted in low diastereoselectivity (Table 1, Entry 1). Based on literature 
precedent, Kibayashi et al. attempted the reaction in aqueous media, and observed a considerable 
increase in selectivity for the desired trans-fused product.
18
 This is believed to be due to the 
hydrophobic effect, where a reactant encapsulated in a hydrophobic pocket surrounded by a 
hydrogen-bonding network of water molecules experiences a rate, yield and selectivity increase. 
In order to complete the synthesis of (±)-lepadiformine, 14 underwent several transformations to 
deliver advanced intermediate 30 (Scheme 2). 
 
Scheme 2. (i) H2, Pd–C, MeOH (95 %); (ii) Na(Hg), Na2HPO4, EtOH (90 %); (iii) MsCl, Et3N, DMAP (89 %); (iv) t-BuOK, 
THF, rt (91 %); (v) LiNH2BH3, THF then CbzCl, Na2CO3, CHCl3–H2O (63 %); (vi) (COCl)2, DMSO, Et3N,    –78  0 °C 
(81 %); (vii) C6H13MgBr, Et2O, 0 °C (84 %, 2:1 30:31);  (viii) p-NO2C6H4CO2H, Ph3P, DEAD; (ix) 10 % NaOH,      THF–
MeOH (90 % over 2 steps). 
Hydrogenation of 14 preceded reductive ring-opening and mesylation to afford 26. Ring closure, 
reductive amide cleavage and Cbz-protection ensued to deliver 28. Swern oxidation and introduction 
of the hexyl side chain using n-hexylmagnesium bromide gave alcohols 30 and 31 in a 2:1 ratio. The 
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undesired diastereomer 31 could be swiftly converted into the required alcohol via Mitsunobu 
inversion with p-nitrobenzoic acid and basic hydrolysis of the ester formed. 
The final stages of this synthesis were as follows (Scheme 3): 
 
Scheme 3. (i) H2, Pd–C, MeOH (84 %); (ii) Ph3P, CBr4, Et3N, rt (88 %); (iii) c. HCl, MeOH, rt then 5 % K2CO3 (96 %); 
(iv) 1 N HCl–MeOH. 
Removal of the Cbz group of 30 under hydrogenolytic conditions and Appel bromination brought 
about ring closure to afford 32. Simple MOM-deprotection delivered (±)-lepadiformine 13, which was 
converted into its HCl salt and the structure confirmed unequivocally by X-ray crystallography. This 
structure matched all of the spectroscopic analysis conducted on natural lepadiformine, and was the 
first insight into the unusal twist-boat conformation of the B-ring of lepadiformine, which is adopted 
to ensure the hexyl side chain adopts an equatorial orientation. 
Elaboration of trans-fused 14 to complete the synthesis of (±)-fasicularin proceeded as outlined below 
(Scheme 4). 
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Scheme 4. (i) H2, Pd–C, MeOH (95 %); (ii) c. HCl, MeOH, reflux (92 %); (iii) BnBr, NaH, Bu4NI, DMF, rt (95 %); 
(iv) Na(Hg), Na2HPO4, EtOH; (v) TBDPSCl, imidazole, DMF (92 %); (vi)  H2, Pd–C, MeOH (95 %); (vii) TsCl, Et3N, 
DMAP, CH2Cl2 (86 %); (viii) NaH, THF, reflux (99 %); (ix) LiNH2BH3, THF then CbzCl, Na2CO3, CHCl3–H2O (97 %); 
(x) (COCl)2, DMSO, Et3N, CH2Cl2, –78  0 °C (88 %); (xi) C6H13MgBr, Et2O, 0 °C then PCC, CH2Cl2 (99 %). 
Tricycle 14 was hydrogenated over palladium on carbon to afford 15, which subsequently underwent 
reductive N–O cleavage with sodium amalgam and protecting group modification to deliver tosylate 
34. Base-promoted ring closure, amide cleavage and Cbz-protection to alcohol 36 followed. Swern 
oxidation, interception of the resulting aldehyde by a Grignard reagent and finally reoxidation gave 
ketone 37.  
Ketone 37 underwent the following transformations to furnish (±)-fasicularin (Scheme 5, 6). 
 
Scheme 5. (i) Bu4NF, THF, rt (98 %); (ii) p-NO2C6H4CO2H, PPh3, DEAD, rt; (iii) 5 % NaOH, THF, rt (99 % over 2 steps). 
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Desilylation of 37, Mitsunobu inversion with p-nitrobenzoic acid and hydrolysis afforded alcohol 38, 
which then underwent reductive amination cyclisation and displacement of the hydroxyl group by a 
thiocyanate anion to give (±)-fasicularin (Scheme 6). 
 
Scheme 6. (i) H2, Pd–C, cyclohexane, rt (62 %, 5.2:1 39:40); (ii) HSCN, PPh3, DEAD, C6H6 (20 %). 
Hydrogenolysis over palladium on carbon brought about Cbz removal and subsequent reductive 
amination-cyclisation to afford tertiary amines 39 and 40 as a 5.2:1 mixture of diastereomers. 
Kibayashi et al. carried this step out in a variety of solvents, and found that an uncoordinating, 
unreactive solvent such as cyclohexane gave the best diastereoselectivity, whereas conventional 
alcoholic solvents gave rise to the preferred formation of the undesired diastereomer 40. They 
postulated that this was because cyclohexane is a much poorer competitor for binding sites on the 
catalytic surface than EtOH or MeOH, thus allowing the substrate alcohol to interact fully with the 
catalyst which leads to the preferred formation of 39.
19
 Finally, alcohol 39 underwent Mitsunobu 
substitution with thiocyanic acid, forming the natural product 8, the structure of which was confirmed 
by comparison with data from a naturally-obtained sample. 
The work of Kibayashi et al. on the synthesis of these alkaloids is interesting in that it involves the 
concomitant formation of two significant stereocentres during the acylnitroso-Diels–Alder 
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cycloaddition, and provides a good precedent for the application of this methodology to the synthesis 
of similar trans-fused 1-azadecalin-containing natural products. 
1.1.2 Synthesis of (±)- and (–)-lepadiformine by Weinreb et al. 
The first synthesis of the naturally occurring enantiomer of lepadiformine, (–)-lepadiformine, was 
completed by Weinreb et al. in 2002.
20
 This was the first point at which the stereochemistry of the 
lepadiformine alkaloids was proven, by comparison of synthetic samples with those obtained 
naturally. The synthesis makes use of a novel intramolecular spirocyclisation strategy of an 
N-acyliminium species with an allylsilane, allowing for the formation of both the A- and C-rings of 
the natural product in a single step, with the correct relative stereochemistry.  
Their synthesis of (±)-lepadiformine began with the metallation of commercially available 2-methyl-
1-pyrroline 41 with known (Z)-allylsilane iodide 42, which provided the substrate for the key 
spirocyclisation step (Scheme 7).  
 
Scheme 7. (i) LDA, THF, –78 °C  rt; (ii) o-NO2C6H4C(O)Cl, Et3N. 
The alkylation product 43 was obtained as a mixture of the two enamides shown, and was used 
without further purification in the cyclisation step, which involved treatment of 43 with TFA (Scheme 
8). 
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Scheme 8. (i) TFA, CH2Cl2, rt (57 % from pyrroline 41). 
The two enamides 43 were converted into the corresponding iminium species via treatment with TFA, 
and this intermediate was subsequently intercepted in an intramolecular Sakurai-type alkylation 
process. This transformation produced a single diastereomeric product 46, as confirmed by X-ray 
crystallography. It was suggested that transition state 44 was favoured due to the positioning of both 
the allylsilane and N-acyliminium groups quasi-equatorially, whereas suspected steric repulsion 
between the N-acyl group and the axial protons of the forming ring in transition state 45, would render 
this pathway much less favourable.  
Weinreb et al. intended to introduce the requisite hydroxymethyl group on the C-ring of the natural 
product using their amide oxidation methodology, which involves the formation of α-oxidised amides 
via cuprous ion-promoted decomposition of o-diazobenzamides.
21–23
 Thus, 46 was elaborated in the 
following way (Scheme 9). 
Chapter 1: Introduction  27 
 
 
 
Scheme 9. (i) NaBH4, Cu(acac)2, EtOH (95 %); (ii) NaNO2, HCl, CuCl, MeOH (81 %); (iii) 50, BF3•OEt2, CuBr•Me2S, 
Et2O, –78 °C  rt (87 %, 7:1 51:52); (iv) BF3•HOAc, CH2Cl2, rt; (v) 35 % H2O2, NaHCO3, MeOH, THF, Δ (95 % over 2 
steps). 
Reduction of nitro compound 46 to the corresponding aniline preceded exposure to sodium nitrite 
under acidic conditions with catalytic copper(I) chloride to effect amide oxidation in line with 
previously published methodology.
21–23
 Alkylation of the corresponding iminium ion with Grignard 
reagent 50 furnished allylsilanes 51 and 52 in a 7:1 ratio in favour of the desired stereochemistry. This 
selectivity is thought to arise from approach of the nucleophile from the less crowded face of the 
N-acyl iminium species. Finally, Tamao oxidation delivered alcohol 53, with the hydroxymethyl 
group correctly oriented for the natural product.
24
 
Weinreb et al. envisaged the formation of the B-ring of the natural product to proceed via a 
Mannich-type cyclisation, however several attempts using varying methods proved unsuccessful. 
Ultimately, a reductive amination–alkylation procedure was implemented (Scheme 10). 
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Scheme 10. (i) Rh(CO)2acac, CO/H2 (1:1), THF, P(OPh)3; (ii) MeOH, HCl, (MeO)3CH (81 % over 2 steps); (iii) 15 % 
LiOH, EtOH, H2O, Δ (99 %); (iv) BnBr, NaH, THF (75 %); (v) p-TsOH, Me2CO, H2O, Δ; (vi) HCl, MeOH, KCN, H2O, 
Me2CO (56 % over 2 steps). 
Rh-catalysed hydroformylation of alkene 53 and subsequent acetal formation delivered 54, which then 
underwent amide hydrolysis and benzylation to afford 55. Cyclocondensation of the liberated amine 
with the dimethyl acetal gave cyclic enamine 56. Several attempts were made to C-alkylate this 
enamine, although it proved to be rather unstable and no alkylation products were detected. Thus, 
α-cyano amine 57 was formed, shown here as the putative kinetic product. Upon standing, this 
compound slowly isomerizes to the thermodynamic product, which Weinreb et al. believed to be 
epimeric at the α-amino position. This hypothesis is in line with the propensity of these alkaloids to 
minimise steric repulsion by maintaining pseudo-equatorial disposition of the hexyl side chain in the 
natural product.
25
 
The final stages of this synthesis began with conversion once more of kinetic α-cyano amine 57 to the 
corresponding iminium ion, and C-alkylation of this species (Scheme 11). 
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Scheme 11. (i) C6H13MgBr, BF3•OEt2, THF, –20 °C  rt (67 % from acetal 55); (ii) Na/NH3, THF (83 %); (iii) Na/NH3, 
THF (100 %). 
Alkylations on similar ring systems to that shown above often occur in favour of axial approach of the 
nucleophile. Although a bias is shown here, Weinreb et al. postulated that the lower selectivity 
observed is due to an increasing diaxial interaction between the incoming nucleophile and the 
methylene in the β-position to the amine on the C-ring. Despite this lower selectivity, alkylation 
product 59 was obtained in good yield, and underwent slow conformational inversion to form the 
more thermodynamically stable B-ring conformer 60. This compound was subsequently debenzylated 
using sodium in ammonia to afford racemic lepadiformine 13. The minor alkylation product also 
undergoes conformational inversion to a more stable isomer 62, which can then undergo 
debenzylation to give epimeric lepadiformine 63. 
With this success, Weinreb et al. wished to extend the methodology developed here to the synthesis of 
the naturally occurring enantiomer of the natural product, (–)-lepadiformine (Scheme 12). 
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Scheme 12. (i) PhMe2SiCl, Li, CuCN, THF (92 %); (ii) KH, CbzCl, THF (96 %); (iii) t-BuLi, THF, Et2O, –78 °C  rt; 
(iv) BF3•2HOAc, CH2Cl2, –78 °C  rt (52 % over 2 steps). 
Bromide 64, derived from (S)-pyroglutamic acid, was converted into silane 65 which was 
subsequently protected as the Cbz amide 66. Lithium–iodine exchange of 67 with tert-butyllithium 
and alkylation produced hemiaminal 68, which without purification was subjected to Lewis acidic 
conditions to form iminium species 69. Allylsilane 69 then underwent intramolecular Sakurai-type 
alkylation to afford bicyclic structure 70 as a single diastereomer, the stereochemistry of which was 
proven by elaboration to (–)-lepadiformine. 
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The final stages of the synthesis proceeded smoothly (Scheme 13). 
 
Scheme 13. (i) BF3•2HOAc; (ii) NaHCO3, H2O2, MeOH/THF (89 % over 2 steps); (iii) Rh(CO)2acac, CO/H2, THF, 
P(OPh)3, 80 °C; (iv) MeOH/HCl, (MeO)3CH (90 % over 2 steps); (v) Na/NH3, t-BuOH, THF (94 %); (vi) BnBr, NaH, THF; 
(vii) p-TsOH, Me2CO, H2O, Δ; (viii) HCl, MeOH, KCN, H2O, Me2CO (3:1 d.r.); (ix) ) C6H13MgBr, BF3•OEt2, THF, –20 °C 
 rt; (x) Na/NH3, THF. 
Firstly, Tamao oxidation of silane 70 provided alcohol 71, which underwent Rh-catalysed 
hydroformylation and acetalisation to afford 72. N-deprotection, O-benzylation and cyclisation to 
cyclic enamine 74 followed, the product of which was subjected to acidic conditions in the presence 
of cyanide to form α-cyano amine 75. Weinreb et al. initially isolated α-cyano amine as the kinetic 
major product 75 in a 3:1 mixture, however leaving nitrile 75 to stand in solution brings about full 
conversion to the nitrile epimer. Finally, iminium ion formation and interception with a Grignard 
reagent gave the thermodynamic product 75, which after simple O-debenzylation delivered 
lepadiformine as a single enantiomer. The material produced was in direct agreement with naturally-
obtained samples. 
This synthesis from Weinreb et al. constituted the first conclusive proof of the absolute 
stereochemistry of naturally-occurring lepadiformine, as this synthetic material was the first to show 
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complete agreement with the data obtained from a natural sample. This work further highlights the 
importance of total synthesis in natural product structural determination. 
1.1.3 Formal total synthesis of (–)-lepadiformine by Kim et al. 
Kim et al. published a stereoselective formal total synthesis of (–)-lepadiformine in 2005, which 
constituted the synthesis of the Weinreb intermediate α-cyano amine 75.26 The synthesis of this key 
fragment centred around a diastereoselective Ireland–Claisen rearrangement (Figure 9).  
 
Figure 9. Retrosynthetic analysis of advanced (–)-lepadiformine fragment 75 by Kim et al. 
Key steps in their approach include the use of ring-closing metathesis to form the A-ring of the natural 
product, the substrate of which they believed could be accessed via cyclic amino acid 78. The 
stereochemistry of this compound was proposed to be installed using a diastereoselective         
Ireland–Claisen rearrangement, where the control of stereochemistry is influenced by both the enolate 
and transition state geometries.  
Similar to the work of Weinreb et al., this synthesis began with (S)-pyroglutamic acid (Scheme 14). 
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Scheme 14. (i) NaClO2, NaH2PO4, MeCN, t-BuOH, H2O, rt (98 %); (ii) 81, DCC, DMAP, CH2Cl2, rt (88 %). 
The synthesis began with a seven step protocol first devised by Ishida et al. to provide aldehyde 
83.
27,28
 This was followed by a Pinnick oxidation to afford acid 80, which was then esterified with 
known alcohol 81 using carbodiimide coupling reagents to deliver ester 79, which was the substrate 
for the crucial Ireland–Claisen rearrangement. Kim et al. hypothesised that they would need to form 
specifically the (Z)-silyl ketene acetal during the rearrangement for the correct stereochemistry to be 
installed. Eventually they discovered that treatment with LHMDS and TBSCl effected the 
transformation in good yield and diastereoselectivity (Scheme 15). 
 
Scheme 15. (i) LHMDS, TBSCl, THF, –78 °C  rt (79 %, 8:1 d.r.). 
The rearrangement shown above produced the required product in 8:1 d.r. The stereochemistry of the 
major product was confirmed through its conversion to α-cyano amine 75, which matched the data 
provided by Weinreb et al.
20
 It was postulated that some chelation control may have taken place in 
this process, with the Li cation coordinating to both the silyl ketene acetal oxygen and the oxygen of 
the Boc group, thereby encouraging (Z)-enolate formation and ultimately the correct stereochemistry 
in the major product.  
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Initial attempts to convert the tethered acid moiety into the homoallyl group required for ring-closing 
metathesis proved unsuccessful, and so Kim et al. instead turned their attention to homologation of 
the vinyl moiety (Scheme 16). 
 
Scheme 16. (i) MeI, K2CO3, acetone, Δ (93 %); (ii) 9-BBN, TlOEt, THF, 50 °C; (iii) vinyl bromide, Pd(dppf)Cl2, AsPh3, 
THF/DMF, 40 °C (73 % over 2 steps); (iv) LiAlH4, THF, 0 °C (91 %); (v) (COCl)2, DMSO, Et3N, CH2Cl2; (vi) CH3PPh3I, 
n-BuLi, THF (84 % over 2 steps). 
Esterification proceeded smoothly from acid 78 to afford methyl ester 85, which subsequently 
underwent hydroboration with 9-BBN to the corresponding alkyl borane. This species then partook in 
an in situ Suzuki–Miyaura reaction with vinyl bromide to install the requisite homoallyl 
functionality.
29
 Reduction with LiAlH4 followed, and the resulting alcohol underwent Swern 
oxidation and Wittig olefination to deliver ring-closing metathesis substrate 77. 
From 77, ring-closing metathesis and subsequent transformations proceeded smoothly to produce 
advanced lepadiformine intermediate 75 (Scheme 17). 
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Scheme 17. (i) Grubbs’ 2nd generation catalyst, CH2Cl2, 40 °C (98 %); (ii) H2, Pd–C, Et3N, MeOH (95 %); (iii) TBAF, THF, 
rt (96 %); (iv) Dess–Martin periodinane, CH2Cl2, rt (96 %); (v) p-TsOH, acetone/H2O, Δ; (vi) KCN, 1 N HCl, acetone/H2O, 
rt (70 % over 2 steps). 
Ring-closing metathesis using Grubbs’ 2nd generation catalyst proceeded smoothly to afford 76, which 
was then subjected to hydrogenative conditions. O-Desilylation and hydrogenation provided 87, 
which was then oxidised to the corresponding aldehyde using Dess–Martin periodinane. This 
aldehyde was converted into cyclic enamine 74 by treatment with p-TsOH at elevated temperature, 
which was, without isolation, converted into α-cyano amine 75 under conditions described previously 
by Weinreb et al.
20
 The data collected for 75 were in agreement with those published previously. 
This work is notable for its use of a Claisen rearrangement to form key stereocentres of a natural 
product target, and also is an interesting example of the use of ring-closing metathesis in the assembly 
of alkaloid ring motifs. 
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1.1.4 Synthesis of (–)-lepadiformine and the cylidricine alkaloids by Hsung et al. 
Hsung et al. conducted lengthy research into the synthesis of the fasicularin alkaloids, particularly 
both enantiomers of cylindricines C-E and both the putative (cis-1-azadecalin) and confirmed 
(trans-1-azadecalin) structures of (–)-lepadiformine.30–33 Their first foray into the synthesis of these 
alkaloids focussed on the synthesis of a common intermediate en route to both unnatural 
(+)-cylindricines C-E and naturally occurring (–)-lepadiformine (Figure 10). 
 
Figure 10. Common late stage intermediate in the retrosynthetic analyses of (+)-cylindricines C-E and (–)-lepadiformine. 
Hsung et al. postulated that both natural products could be accessed via intermediate 89. 
(+)-Cylindricines C-E were believed to be accessed via epimerisation of 89 at C(5), thereby installing 
the requisite cis-1-azadecalin framework. (–)-Lepadiformine 10 on the other hand, was thought to be 
accessible via deoxygenation at C(4) of 89. 
The synthesis of common intermediate 89 utilised a key aza-Prins reaction and Wharton 
rearrangement, and proceeded from known butyrolactam 91 (Scheme 18).
34–37
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Scheme 18. (i) 92, t-BuLi, THF (61 %); (ii) HCO2H:THF:PhMe (50:3:47), –10 °C; (iii) K2CO3, MeOH/H2O (64 % over 2 
steps). 
Butyrolactam 91 was treated with lithiated alkyl iodide 92 to afford amino ketone 93, which 
subsequently underwent aza-Prins cyclisation with formic acid, wherein the formate anion quenched 
the carbocation formed, to deliver formate ester 94. Hydrolysis of the formyl group under basic 
conditions gave allyl alcohol 95. 
Allyl alcohol 95 was elaborated via a Wharton rearrangement to install the requisite oxidation at C(4) 
of the natural product (Scheme 19). 
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Scheme 19. (i) m-CPBA, CH2Cl2, –10 °C  rt (94 %); SO3•Py, DMSO, Et3N (80 %); (iii) NH2NH2, MeOH, AcOH,           –
10 °C; (iv) AcOH (66 % over 2 steps); (v) MnO2, CH2Cl2 (90 %).  
Epoxidation of alcohol 95 and further oxidation of the hydroxyl moiety afforded epoxyketone 96. 
Condensation with excess hydrazine gave hydrazone 97, which without isolation was subjected to 
Wharton rearrangement conditions with AcOH to deliver allylic alcohol 98 as solely the trans 
geometric isomer. Further allylic oxidation with MnO2 provided 99. 
Hsung et al. next demonstrated a tuneable formation of the B-ring of the natural products (Scheme 20, 
Table 2). 
 
Scheme 20. (i) TFA:CH2Cl2 (1:1), –10 °C  rt (72 %); (ii) See Table 2. 
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Entry Reagent Solvent Temp Result 
1 silica gel - rt 89:100 1:1 
2 K2CO3 MeOH rt 89:100 1:0 
3 DBU PhMe rt 89:100 2:1 
Table 2. Conditions for the C(5) epimerisation of 89. 
Treatment of 99 with TFA brought about N-Boc removal and concomitant aza-Michael addition to 
afford tricycle 89, the twist-boat conformation of which was proven by the observation of an nOe 
interaction between the two pseudo-axial protons of the B-ring. Although this product was observed 
solely from treatment of 99 with TFA, subsequent exposure of 89 to silica gel or basic conditions 
gave rise to C(5) epimerisation to give structure 100, which is an advanced intermediate in the 
synthesis of (+)-cylindricines C-E. Thus, desilylation via conventional methods afforded 
(+)-cylindricine C, which could be further elaborated via Purdie methylation or acetylation  to 
(+)-cylindricines D and E (Scheme 21). 
 
Scheme 21. (i) TBAF, CH2Cl2, rt (91 %); (ii) MeI, Ag2O, MeCN, rt (45 %); (iii) DMAP, AcCl, Et3N, rt (50 %). 
The final stages of Hsung et al.’s (–)-lepadiformine synthesis required only the C(4)-deoxygenation of 
89. Although initial attempts, including Burgess- and Chugaev-type elimination processes with 
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subsequent hydrogenation, proved unsuccessful, the Barton–McCombie deoxygenation protocol 
provided (–)-lepadiformine in good yield (Scheme 22).38 
 
Scheme 22. (i) NaBH4, MeOH, rt; (ii) NaH, CS2, MeI, THF (72 % over 2 steps); (iii) AIBN, n-Bu3SnH, C6H6; (iv) TBAF, 
THF (79 % over 2 steps). 
Reduction and xanthate formation afforded 104, which then underwent deoxygenation under radical 
conditions, with subsequent desilylation to provide (–)-lepadiformine 10. 
Hsung et al. also completed a synthesis of the naturally occurring enantiomer (–)-cylindricine C 
utilising their aza-(3 + 3) annulation protocol; their retrosynthetic analysis for this approach is 
depicted in Figure 11. 
 
Figure 11. Retrosynthetic analysis of (–)-cylindricine C by Hsung et al. 
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The key aza-(3 + 3)-annulation step is exhibited in the transformation of 107 to 106, the substrate for 
which can be accessed from vinyloxazoline 109, which in turn is synthesised from L-serine. The 
beginning of this synthesis is outlined in Scheme 23. 
 
Scheme 23. (i) 9-BBN, THF, 0 °C  rt, then PdCl2(dppf)-CH2Cl2, K3PO4, 110, Δ; (ii) PPTS, MeOH, Δ (75 % over 2 steps); 
(iii) TBDPSCl, imidazole, CH2Cl2; (iv) DIBAL-H, CH2Cl2, –78 °C (81 % over 2 steps). 
Hydroboration of vinyloxazoline 109 produced a Suzuki–Miyaura coupling substrate, which was 
treated with a palladium catalyst and triflate 110 to afford ester 111. Acetonide hydrolysis, protection 
of the liberated alcohol and finally reduction of the ester moiety provided allylic alcohol 113.  
Five further steps were required to produce the substrate for the key aza-(3 + 3)-annulation step 
(Scheme 24). 
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Scheme 24. (i) Ac2O, pyridine; (ii) TFA, CH2Cl2, 0 °C; (iii) EtOH, pyridine, Δ (61 % over 3 steps); (iv) K2CO3, MeOH; 
(v) TPAP, NMO, 4 Å MS (85 % over 2 steps). 
Acetylation of alcohol 113 and Boc removal provided 108. This compound was treated with 
bromopyrone 114 under basic conditions to effect an aza-Michael addition to deliver secondary amine 
115, which after acetate hydrolysis and Ley oxidation afforded aldehyde 116. 
Aldehyde 116 was then subjected to optimised conditions for the key annulations step (Scheme 25). 
 
Scheme 25. (i) piperidinium acetate, Na2SO4, EtOAc, 150 °C, sealed tube (68 %, 9:1 d.r.). 
Substoichiometric piperidinium acetate served as the catalyst for vinyliminium ion formation, after 
which the aza-(3 + 3)-annulation proceeded smoothly in a sealed tube at elevated temperature, to 
produce dihydropyridine 117 as a 9:1 mixture of diastereomers, in favour of the stereochemistry 
shown above. The stereochemistry of this product was assigned unequivocally by X-ray 
crystallography at a later stage. 
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Re-oxidation of C(4) to the requisite ketone proved challenging, and Hsung et al. instead carried out a 
less direct protocol involving halohydrin formation (Scheme 26). 
 
Scheme 26. (i) NCS, t-BuOH:H2O (1:1), rt (76 %); (ii) TPAP, NMO, 4 Å MS, CH2Cl2; (iii) Zn/HOAc (65 % over 2 steps). 
Thus 117 was treated with excess N-chlorosuccinimide to afford chlorohydrin 118 as a mixture of 
diastereomers, which was then oxidised to the corresponding ketone. The tertiary chloride substituent 
was removed by treatment with Zn/HOAc to deliver ketone 119. 
At this point, Hsung et al. intended to make use of a reductive pyrone cleavage they had previously 
developed, however treatment with LiAlH4 under increased pressure hydrogenation conditions did not 
produce any of the desired product.
39
 An interesting protocol was therefore adopted (Scheme 27). 
 
Scheme 27. (i) 60 psi H2, 10 % Pd–C, EtOH; (ii) NaCNBH3, MeOH, HCl or HOAc (92 % over 2 steps), (iii) TBAF, THF 
(93 %). 
Hydrogenation of pyrone 119 afforded dihydropyrone 120 in a 2:1 ratio of diastereomers. It should be 
noted that prolonged exposure to these conditions gave rise to complete hydrogenation to the 
corresponding lactone. Subsequent hydride-promoted ring opening and concomitant decarboxylation 
of the intermediate α,β-unsaturated carboxylic acid, followed by O-desilylation provided Hsung et al. 
with α,β-unsaturated-γ-amino lactone 121.  
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Finally, an iridium-catalysed Stork–Crabtree directed hydrogenation was employed to produce          
(–)-cylindricine C.40,41 However, this method produced only the C(2)-epimer of the natural product. 
Instead, a hydroxyl-directed borohydride reduction of the enone was selected, and afforded               
(–)-cylindricine C with the hexyl side chain in the requisite equatorial disposition. These final 
transformations are outlined below (Scheme 28). 
 
Scheme 28. (i) Na(OAc)3BH, cat. HOAc, CDCl3, rt, 21 h then reflux, 40 min (83 %); (ii) 50 psi H2, Pd–C, EtOAc, 
Ir[cod(PCy3)Py]PF6, rt (53 %). 
Hsung et al.’s efforts in this field of synthesis have demonstrated the utility of their methodology in 
the synthesis of alkaloids, and have highlighted the advantage of being able to interconvert common 
late-stage intermediates of these alkaloids to complete divergent syntheses. 
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1.1.5 Synthesis of (+)-cylindricine C and formal total synthesis of (–)-lepadiformine by 
Shibasaki et al. 
Shibasaki et al. took a slightly different approach to the synthesis of this class of alkaloids, devising 
an expedient route to (+)-cylindricine C and a synthesis of an advanced (–)-lepadiformine 
intermediate from Hsung et al.’s synthesis.30,42 Their retrosynthetic analysis of (+)-cylindricine C is 
outlined below (Figure 12). 
 
Figure 12. Retrosynthetic analysis of (+)-cylindricine C by Shibasaki et al. 
Shibasaki et al. envisaged the concurrent formation of all three rings of the natural product from 
precursor 123, which would undergo imine formation, Mannich reaction and finally a Michael 
addition to close the third ring. This precursor was envisaged to arise from Michael addition of 124 to 
dienone 125.  
The synthesis began with the facile synthesis of dienone 125 (Scheme 29). 
 
Scheme 29. (i) CH3ONHCH3•HCl, EDCI, Et3N, CH2Cl2 (84 %); (ii) 128, t-BuLi, THF; (iii) vinylmagnesium bromide, THF 
(37 % over 2 steps). 
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Diacid 126 was converted into the corresponding Weinreb amide 127, which then underwent 
alkylation with both heptene iodide 128 and vinylmagnesium bromide, to afford the unsymmetrical 
dienone 125. 
The next stage of the synthesis concerned the addition of known glycine Schiff base 124 to dienone 
125 via a catalytic asymmetric Michael addition (Scheme 30). 
 
Scheme 30. (i) (S,S)-TaDiAS, Cs2CO3, 3-fluorotoluene, –40 °C (87 %, 82 % e.e.). 
After much optimisation, the Michael addition illustrated above was carried out in fluorotoluene, with 
Cs2CO3 as base and (S,S)-TaDiAS (Tartrate-derived DiAmmonium Salt), a catalyst developed by 
Shibasaki et al.
43
  
Tandem cyclisation of substrate 123 proved somewhat troublesome at first. The reaction showed good 
conversion under acidic conditions; however, the addition of alkali and alkaline earth metal additives 
was required to increase the selectivity for the desired cis-1-azadecalin backbone (Scheme 31, Table 
3). 
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Scheme 31. (i) CSA, 1 equiv additive (see below), DCE, 50 °C. 
Entry Additive Time / h 
d.r. 
(129:130:131) 
Yield / % 
1 - 18 33 : 63 : 4 47 
2 AlCl3 24 87 : 13 : trace 47 
3 La(OTf)3 12 27 : 65 : 8 57 
4 MgCl2 18 87 : 7 : 6 66 
5 MgBr•OEt2 18 82 : 13 : 5 61 
6 LiCl 18 89 : 6 : 5 57 
Table 3. Effect of additive on diastereoselectivity and yield of the Michael addition. 
The desired cyclisation product, 129, was obtained as a mixture of diastereomers; the other products 
isolated were C(5) epimer 130, and C(2) epimer 131. MgCl2 (Table 3, entry 4) proved to be the best 
overall additive, providing a high level of diastereoselectivity and the best recorded yield. 
Shibasaki et al. postulated that the source of the selectivity offered by these additives was due to a 
chelation effect, as outlined in their postulated mechanism in Figure 13. 
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Figure 13. Proposed mechanism for the tandem cyclisation. 
First, acidic conditions bring about removal of the diphenyl methylene group, giving rise to 
intramolecular iminium formation (C-ring formation) and Mannich reaction of the iminium formed 
(A-ring formation) to afford bicyclic structure 133. The stereochemical outcome of the next stage of 
this process is heavily dependent upon the inclusion of an additive. Without the addition of an 
additive, aza-Michael addition occurs preferentially to deliver trans-1-azadecalin 130. However, with 
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the inclusion of a metal additive, chelation of both the pyrrolidine nitrogen and ketone oxygen gives 
rise to enolisation and ultimately epimerisation at C(5), resulting in, after aza-Michael addition, the 
formation of a cis-1-azadecalin backbone 129 required for (+)-cylindricine C. 
The principal product of the tandem cyclisation 129 was then subjected to a further two step pathway 
to complete the synthesis of (+)-cylindricine C (Scheme 31). 
 
Scheme 31. (i) Pd–C, H2, MeOH; (ii) ethyl chloroformate, N-methylmorpholine, THF, –10 °C, then NaBH4, MeOH, rt 
(31 % over 2 steps). 
Hydrogenative removal of the benzyl group revealed the corresponding carboxylic acid, which was 
then converted into a mixed anhydride. This product was subsequently reduced to the required alcohol 
oxidation state, thus completing this synthesis of (+)-cylindricine C. 
Finally, the major product from an additive-free tandem cyclisation process (Scheme 31, Table 3, 
entry 1) was collected and manipulated further to constitute a formal total synthesis of                       
(–)-lepadiformine, intercepting an advanced intermediate 139 in the synthesis by Hsung et al. 
(Scheme 32).
30
 
 
Scheme 32. (i) LiAlH4, THF, Δ; (ii) TBDPSCl, Et3N, DMAP, CH2Cl2 (35 % over 2 steps). 
Shibasaki et al. demonstrated clearly how the diastereoselectivity of tandem and cascade cyclisation 
processes can be influenced by the inclusion of metal additives, and provided a tuneable and 
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expedient route to the structural backbone of the fasicularin alkaloids. They also clearly displayed the 
utility of these types of cyclisations in the building of alkaloid motifs. 
1.1.6 Synthesis of (±)-lepadiformine by Lygo et al. 
Lygo et al. developed an elegant approach to the assembly of (±)-lepadiformine, the key step of which 
was a hetero-Diels–Alder cycloaddition to install both the A- and B-rings of the natural product in a 
single step. Their retrosynthetic analysis is outlined below (Figure 14).
44
 
 
Figure 14. Retrosynthetic analysis of (±)-lepadiformine by Lygo et al. 
The synthesis was envisaged to proceed via an intramolecular [4 + 2] cycloaddition of pyrroline 141, 
with the most probable mode of reaction being via the endo-adduct, installing the correct relative 
stereochemistry at the ring junctions, as well as ensuring the correct orientation of the hexyl side 
chain. The assembly of the Diels–Alder precursor was planned to proceed via an 
ammonium-catalysed Michael addition of glycine Schiff base 142 to enone 143, in a similar vein to 
that proposed by Shibasaki et al.
42
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The synthesis commenced from commercially available trans-2-nonenal as delineated in Scheme 33. 
 
Scheme 33. (i) LDA, BrPh3P(CH2)5CO2H, THF (89 %); (ii) I2, hν ((E,E):(Z,E) 40:60  70:30); (iii) MeNHOMe, EDCI, 
DMAP (94 %); (iv) vinylmagnesium bromide (79 %). 
Wittig olefination of 144 produced diene 145 as a mixture of geometric isomers ((E,E):(Z,E) 40:60), 
which was subsequently isomerised to predominantly the (E,E)-isomer in a 70:30 ratio via treatment 
with iodine under photochemical conditions. Subsequent Weinreb amide formation and alkylation 
with vinylmagnesium bromide afforded dienone 143, which then underwent Michael addition of 
glycine Schiff base 142 and pyrroline formation under acidic conditions (Scheme 34). 
 
Scheme 34. (i) 142, Cs2CO3, i-Pr2O, PhCH2NMe3Br; (ii) 15 % aq. citric acid, THF then K2CO3 (77 % over 2 steps). 
With cycloaddition precursor in hand, Lygo et al. first attempted the reaction at elevated temperatures 
in toluene. Only isomerisation of the diene was observed, and even heating with TFA either gave no 
reaction or decomposition of starting material. At this point, the reaction was attempted with 
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hexafluoroisopropanol (HFIP) as solvent. The advantages of this solvent were two-fold: it is a 
sufficiently acidic medium to promote cyclisation, and yet stabilise any carboxylate intermediates; it 
also effects cleavage of the tert-butyl ester moiety in one step. Thus, 147 was heated in HFIP to 
deliver tricycle 140 in favour of the desired stereochemistry (Scheme 35). 
 
Scheme 35. (i) HFIP, 60 °C (53 %, 5:1 d.r.). 
Lygo et al. postulated that the endo-adduct shown above would be the most favourable transition 
state, a hypothesis which was proven by elaboration of the major diastereomer obtained to 
(±)-lepadiformine. The minor diastereomer obtained in this process was not fully characterised, but 
Lygo et al. believe it corresponds to reaction of the exo-adduct to form a cis-decalin with the hexyl 
side chain on the opposite face.  
The major diastereomer 140 was then readily converted into (±)-lepadiformine (Scheme 36). 
 
Scheme 36. (i) H2, Pd–C, EtOH; (ii) LiAlH4, THF (52 % over 2 steps). 
Hydrogenation of the remaining olefin under conventional conditions, and reduction of the acid to the 
requisite alcohol using LiAlH4 afforded (±)-lepadiformine in seven steps overall from 
trans-2-nonenal. 
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The approach here by Lygo et al. is an excellent example of the exploitation of inherent 
diastereoselectivity of certain cycloaddition substrates, and how cycloadditions remain a powerful and 
effective bond-forming technique for the assembly of natural products. 
1.1.7 Synthesis of (–)-lepadiformine and (–)-fasicularin by Zhao et al. 
More recently, Zhao et al. have taken a slightly different approach to the synthesis of (–)-fasicularin 
and (–)-lepadiformine, making use of a diastereoselective Zn-mediated allylation of chiral 
N-tert-butanesulfinyl imines to install the trans-1-azadecalin core structure of these alkaloids. Their 
retrosynthetic analysis is displayed in Figure 15.
45
 
 
Figure 15. Retrosynthetic analysis of (–)-fasicularin and (–)-lepadiformine by Zhao et al. 
Zhao et al. envisaged the formation of both natural products via cyclisation processes from the 
common intermediate spirocycle 150, which in turn could be obtained from benzyl ether 151. This 
compound was proposed to be a product of Sharpless dihydroxylation and ring-closing of alkene 152. 
Zhao et al. believed that 152 could be synthesised from chiral amine 153, which is a product of 
diastereoselective allylation of N-tert-butylsulfinyl imine 154.  
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Building on previous work by Lin et al., Zhao et al. began their synthesis from known ketone 155, 
which underwent imine formation and diastereoselective allylation as follows (Scheme 37).
46,47
 
 
Scheme 37. (i) (R)-tert-butylsulfinamide, Ti(OEt)4, THF (76 %), 9:1 d.r.); (ii) Zn, allyl bromide, THF (89 %, 12:1 d.r.). 
Ketone 155 was first condensed with (R)-tert-butanesulfinamide to afford imine 154, which was then 
treated with elemental Zn and allyl bromide to provide allylation product 153 in 12:1 d.r. in favour of 
the stereochemistry shown. This process is presumed to proceed via the transition state shown above, 
where the alkylzinc species coordinates to both the nitrogen and oxygen of the Ellman auxiliary to 
deliver the allyl moiety to the bottom face of the molecule. The diastereomers were separable by 
chromatography.  
With the correct stereochemistry installed, 153 was further elaborated to form the common 
intermediate in the (–)-fasicularin and (–)-lepadiformine syntheses (Scheme 38). 
Chapter 1: Introduction  55 
 
 
 
Scheme 38. (i) HCl in dioxirane/MeOH (92 %); (ii) TsCl, Et3N, DMAP, CH2Cl2; (iii) 9-BBN then H2O2, NaHCO3 (86 % 
over 2 steps); (iv) TPAP, NMO, 4 Å MS, CH2Cl2 (80 %); (v) DIBAL-H, CH2Cl2; (vi) NaHMDS, Ph3PCH3Br, THF (92 % 
over 2 steps); (vii) AD-mix-α, OsO4, t-BuOH, H2O; (viii) TsCl, Bu2SnO, Et3N; (ix) NaH, THF, 0 °C (80 % over 3 steps, 
2.8:1 d.r.); (x) TBDPSCl, imidazole, DMAP, DMF; (xi) Pd(OH)2, H2 (94 % over 2 steps); (xii) MsCl, Et3N, DMAP, CH2Cl2; 
(xiii) KCN, DMSO (91 % over 2 steps); (xiv) C6H13MgBr, Et2O, Δ (90 %). 
Sulfinamide 153 first underwent acidic hydrolysis to afford the free amine, which was subsequently 
tosylated. Oxidative hydroboration produced alcohol 157. TPAP oxidation provided a δ-amino 
aldehyde, which spontaneously cyclised to form the corresponding hemiaminal, with further oxidation 
to provide δ-lactam 158. This species was then reductively cleaved with DIBAL-H and the resulting 
aldehyde olefinated under Wittig conditions to afford alkene 152. This alkene was then subjected to 
Sharpless asymmetric dihydroxylation conditions, and the primary alcohol selectively tosylated by 
treatment with dibutyltin oxide. The tosylated compound was obtained as a 2.8:1 mixture of 
diastereomers that were separable by chromatography. The resulting tosylate was then treated with 
base to effect ring closure to the corresponding spirocycle, which subsequently underwent 
O-silylation and debenzylation to deliver 160. Mesylation and cyanation of alcohol 160 provided 
nitrile 161, which underwent alkylation and hydrolysis to the corresponding ketone 150. 
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With ketone 150 in hand, Zhao et al. were able to complete the synthesis of both natural products. The 
final stages of their synthesis of (–)-fasicularin proceeded as follows (Scheme 39). 
 
Scheme 39. (i) Na, naphthalene, DME, –65  –70 °C (77 %); (ii) NaBH4, CeCl3•7H2O, –78 °C (89 %); (iii) TBAF, THF 
(85 %); (iv) NH4SCN, PPh3, DEAD, CH2Cl2 (89 %); (v) MeCN (88 %). 
N-desulfonylation was effected with Na in naphthalene, and brought about concomitant ring-closing 
condensation to afford unstable enamine 162. This was subjected without purification to Luche 
reduction conditions, which provided 163 as a single diastereomer. Other protocols such as 
hydrogenation proved unsuccessful. O-desilylation and Mitsunobu substitution with ammonium 
thiocyanate, as in Kibayashi et al.’s synthesis, delivered (–)-fasicularin 149, as well as its isomer 165. 
Tricycle 165 could be converted into the natural product by dissolution in acetonitrile and stirring for 
24 h.
11
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The closing stages of Zhao et al.’s synthesis of (–)-lepadiformine are delineated in Scheme 40. 
 
Scheme 40. (i) L-Selectride, THF, –78 °C (99 %, 6:1 d.r.); (ii) Na, naphthalene, DME, –65  –70 °C; (iii) Ph3P, CBr4, Et3N, 
DMAP (98 % over 2 steps); (iv) TBAF (95 %). 
Selective reduction of ketone 150 provided alcohol 166 in a 6:1 ratio of diastereomers in favour of the 
stereochemistry shown. Subsequent detosylation and Appel bromination gave rise to spontaneous 
cyclisation, which after O-desilylation gave the natural product 10; spectroscopic data obtained were 
identical to those reported previously. 
Overall, the work of Zhao et al. in this area demonstrates thought-provoking insights into the use of 
auxiliaries and metal chelation effects to carry out diastereoselective alkylation processes, and is a 
fine example of how natural product scaffolds can be constructed using fairly simple, selective 
transformations. 
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1.1.8 Synthesis of (–)-lepadiformines A, B and C by Rychnovsky et al. 
Most recently, Rychnovsky et al. have utilised their trianion alkylation methodology to synthesise 
lepadiformines A, B and C.
48
 They also make use of a reductive cyclisation of α-aminonitriles which 
has been the focus of extensive research and development within the group over the past 14 years.
49–56
 
Their retrosynthetic analysis of the lepadiformine alkaloids is detailed below (Figure 16). 
 
Figure 16. Retrosynthetic analysis of lepadiformines A, B and C by Rychnovsky et al. 
Rychnovsky et al. envisaged the formation of lepadiformines A and B via oxidative cyanation of 
tricycle 170, which in turn could be formed by reductive spirocyclisation and N-alkylation of 
α-aminonitrile 171. This in turn was intended to proceed via diastereoselective trianion alkylation of 
aminonitrile 173 with chiral bromide 172. These starting materials could be produced via simple 
transformations from propargylic alcohol 174 and aldehyde 175. 
Aminonitrile 173 was prepared via a known sequence, involving silylation of 3-amino-1-propanol, 
followed by cyanomethylation and protection of the amine as the Boc-carbamate.
56
 Conversely, a 
novel sequence was conceived for the synthesis of dibromide 172 (Scheme 41). 
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Scheme 41. (i) n-BuLi, TMS-acetylene; (ii) PDC (77 % (R=n-Bu), 76 % (R=n-Hex)); (iii) cat. Ru-(p-cymene)-TsDPEN, 
i-PrOH; (iv) K2CO3, MeOH (93 % (R=n-Bu or R=n-Hex); (v) TIPSOTf, 2,6-lutidine; (vi) n-BuLi, 
5-(tert-butyldimethylsilyloxy)-pentanal 175 (72 % (R=n-Bu), 83 % (R=n-Hex)); (vii) (COCl)2, DMSO, Et3N, CH2Cl2; 
(viii) cat. Ru-(p-cymene)-TsDPEN, i-PrOH (94 % (R=n-Bu), 72 % (R=n-Hex)); (ix) PtO2, H2; (x) PPTS, MeOH (96 % 
(R=n-Bu), 98 % (R=n-Hex)); (xi) PPh3, Br2, Et3N (88 % (R=n-Bu), 86 % (R=n-Hex)). 
First, aldehyde 176 was treated with lithiated TMS-acetylene to afford a propargylic alcohol, which 
was then oxidised directly to the corresponding ynone 177. Noyori–Ikariya hydrogen transfer 
reduction using known catalyst Ru-(p-cymene)-TsDPEN and subsequent desilylation afforded chiral 
propargylic alcohol 178.
57
 TIPS-protection followed by lithiation and treatment with aldehyde 175 
afforded alcohol 179, which was then oxidised to the corresponding ynone and selectively reduced 
using another Noyori–Ikariya process to deliver chiral alcohol 180 as a single diastereomer. 
Hydrogenation of the alkyne moiety over Adams’ catalyst followed by TBS-removal with PPTS 
provided diol 181. Finally, Appel-type bromination of both alcohol groups gave dibromide 172 as a 
single diastereomer. Other bromination processes, such as employment of NBS/PPh3, gave rise to 
inseparable by-product formation, and considerable tetrahydropyran formation.  
With both starting materials for the double alkylation of nitrile 173 in hand, the reaction was 
attempted, and after much optimisation the following protocol was developed (Scheme 42). 
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Scheme 42. (i) 3.5 equiv LDA, DMPU:THF (1:1), –78  0 °C (80 – 82 %). 
Rychnovsky et al. found this process to be rather sensitive, with higher starting temperatures giving 
rise to either decomposition or elimination to form alkene 182. It should be noted also that exclusion 
of the DMPU co-solvent results in either decomposition or no reaction, leading Rychnovsky et al. to 
postulate that aggregation of the anion formed may have been inhibiting the reaction. Once this 
transformation proved to be reliable and reproducible, the key reductive cyclisation to form spirocycle 
184 was carried out (Scheme 43). 
 
Scheme 43. (i) PPTS, MeOH; (ii) diethyl chlorophosphate, N-methylimidazole (72 % (R=n-Bu), 73 % (R=n-Hex); 
(iii) LiDBB (85 % (R=n-Bu), 91 % (R=n-Hex)).  
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Desilylation and phosphorylation of 171 provided cyclisation precursor 183, which when treated with 
single-electron donor lithium(di-tert-butylbiphenylide) (LiDBB) underwent cyclisation to form 
spirocycle 184 as a single diastereomer. The source of the selectivity in this process has been the 
subject of detailed investigation by Rychnovsky et al. In order to elucidate the mechanism of this 
process, precursor 171 was treated with LiDBB and MeOH, to evaluate the geometry of the 
alkyllithium formed (Scheme 44). This gave rise to exclusively cis-disubstituted 185. After 
evaluation, Rychnovsky et al. proposed that the remaining mechanism proceeded as depicted in 
Figure 17. 
 
Scheme 44. (i) LiDBB then MeOH. 
 
Figure 17. Proposed mechanism of reductive cyclisation by Rychnovsky et al. 
It is hypothesised that single electron addition to α-aminonitrile 186 would give rise to a radical 
intermediate 187, which due to allylic 1,3-strain experienced between the larger substituents, would 
undergo a ring flip process to form 188. The addition of a further electron forms a carbanion, which 
when bonded to lithium could form an intermediate with chelation to the carbamate protecting group, 
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as shown in 189. Given that alkylation of 189 with retention at this point would give rise to overall 
inversion of stereochemistry, it must follow that an inversion substitution process must follow (SEinv), 
to provide spirocycle 190 as a single diastereomer with overall retention of stereochemistry. 
The synthesis of (–)-lepadiformine C 168 was completed in three further steps from spirocyclic 
intermediate 184 (when R=n-Bu), and this compound was used to further the synthesis of                  
(–)-lepadiformine B 167. Hexyl substituted spirocycle 184 was also elaborated to provide an 
advanced (–)-lepadiformine A intermediate (Scheme 44). 
 
Scheme 44. (i) TBAF; (ii) MsCl, 2,6-lutidine (75 % (R=n-Bu), 96 % (R=n-Hex); (iii) TFA then aq. NaHCO3 (61 % for       
(–)-lepadiformine C 168). 
Desilylation and mesylation of 184 provided mesylate 191, which after N-Boc removal and in situ 
cyclisation under basic conditions, afforded tricycle (–)-lepadiformine C 168 (when R = n-Bu), and 
advanced lepadiformine A intermediate 192. 
With the tricyclic backbone of these natural products already constructed, Rychnovsky et al. next 
turned to the introduction of the hydroxymethyl side chain required to complete the synthesis of 
lepadiformines A and B. They first turned to a process first investigated by Beak et al., which 
involves α-lithiation and subsequent trapping of N-Boc pyrrolidines.58 Rychnovsky et al. also took 
inspiration from the work of O’Brien et al., which details the development and implementation of a 
(+)-sparteine surrogate 199 for the diastereoselective α-lithiation and alkylation of N-Boc 
pyrrolidines.
59
 This transformation was conducted with a variety of electrophiles and additives, with 
even the best results being unsuitable for a high-yielding and highly selective natural product 
synthesis. These results are collated in Scheme 45 and Table 4. 
Chapter 1: Introduction  63 
 
 
 
Scheme 45. (i) s-BuLi, conditions then E (see table below). 
Entry T / °C Solvent Time E Additive Yield / % 
d.r. 
(S:R) 
1 –78 Et2O 3 h 195 TMEDA 31 4:1 
2 –60  –30 Et2O 1 h 196 TMEDA 54 1:7.4 
3 –60 Et2O 3 h 195 or 196 TMEDA 20  
4 –30 THF 5 min 197 - 9  
5 –30 THF 5 min 198 - 21  
6 –78 Et2O 3 h 195 199 34 2:1 
7 –78 
Me-
THF 
1 h 195 - 10 - 
8 –30 THF 5 min 195 or 196 - 43 1:13.8 
9 –78 Et2O 3 h 195 200 11 1:2 
10 –60 Et2O 4 h 195 or 196 TMEDA 60 - 
Table 4. Conditions for formylation of 171 by Rychnovsky et al. 
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Pleasingly, use of TMEDA as an additive with no chiral ligand afforded the desired product 193 in a 
4:1 mixture of diastereomers, with the configuration of the major diastereomer (S) being confirmed by 
its elaboration to (–)-lepadiformine B.48 DMF and Weinreb amide 196 proved to be the highest 
yielding electrophiles (Table 4, entries 1-3, 6-10). The addition of either O’Brien’s (+)-sparteine 
surrogate 199 or (–)-sparteine 200 itself, resulted in moderate selectivity, with 199 providing the 
desired (S)-193 as the major product, and (–)-sparteine 200 providing (R)-194 as the major product, in 
a 2:1 ratio each time. In addition, several methods to equilibrate the products of this process were 
investigated. Even though promising results were obtained, with treatment with K2CO3 resulting in 
conversion almost entirely to the desired diastereomer, Rychnovsky et al. still felt that a more robust 
process for the introduction of this side chain was required. 
An α-cyanation method was therefore investigated, and after much optimisation, a Polonovski–Potier 
reaction was found to proceed in good yield and high diastereoselectivity (Scheme 46).
60
 
 
Scheme 46. (i) m-CPBA, TFAA, KCN, CH2Cl2, 0 °C  rt (85 % when R=n-Bu, 6:1 d.r.). 
This reaction proceeds via oxidation to form the corresponding N-oxide, followed by TFAA-mediated 
rearrangement to the iminium ion. This species can then undergo nucleophilic attack by cyanide to 
form the aminonitrile 201. The product was obtained as a 6:1 mixture of diastereomers in favour of 
the stereochemistry shown. 
With the requisite aminonitriles in hand, the final stages of the synthesis of (–)-lepadiformines A and 
B proceeded as follows (Scheme 47). 
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Scheme 47. (i) H2SO4, MeOH, 110 °C (28 %); (ii) LiAlH4 (86 %); (iii) H2SO4, MeOH, 110 °C (43 %); (iv) LiAlH4 (94 %). 
Both the n-butyl and n-hexyl substituted cyanation products 202 and 204 were treated with 
methanolic sulfuric acid at elevated temperatures to afford the corresponding methyl esters 203 and 
205. Finally, reduction to the corresponding alcohols completed the synthesis of (–)-lepadiformine B 
167 and (–)-lepadiformine A 10. 
Rychnovsky et al. accomplished an impressively varied synthesis of these alkaloids, with particular 
attention paid to the quick and selective formation of the tricyclic core structure. They have 
demonstrated that their trianion alkylation and reductive cyclisation methodologies can be applied 
elegantly to the synthesis of alkaloid natural products.  
1.1.9 Synthesis of (±)-lepadiformine by Craig et al. 
Craig et al. completed a synthesis of (±)-lepadiformine involving the 5-endo-trig cyclisation of 
vinylic sulfones, which had been a subject of investigation in the group for some time.
61
 It was 
envisaged that the process would proceed via diastereomerically pure N-SES aziridine 207, the 
stereochemistry of which would be the source of the trans-1-azadecalin arrangement found in the 
natural product. The retrosynthesis of (±)-lepadiformine by Craig et al. is outlined below (Figure 18). 
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Figure 18. Retrosynthetic analysis of (±)-lepadiformine by Craig et al. 
Craig et al. envisaged the formation of the final product via concomitant acetal hydrolysis and 
reductive amination-cyclisation of pyrrolidine 206, with interception of an intermediate iminium ion 
with a 6-carbon nucleophile to install the requisite n-hexyl side chain. Pyrrolidine 206 was believed to 
be formed by elaboration of N-SES aziridine 207, which in turn could be formed as a single 
diastereomer from racemic starting ketone 208. 
The synthesis proceeded as planned, with the first steps comprising a diastereoselective synthesis of 
N-SES aziridine 207 (Scheme 48). 
 
Scheme 48. (i) Me3S(O)I, NaH, DMSO (96 %); (ii) SESNH2, K2CO3, DMF (85 %); (iii) ADDP, PMe3, THF (95 %). 
Corey–Chaykovsky methylenation of ketone 208 afforded epoxide 209 as a single diastereomer, 
which was purified by distillation. The purified product was treated with SESNH2 under basic 
conditions to effect epoxide ring-opening to provide aminoalcohol 210. The use of modified 
Mitsunobu conditions allowed for the conversion of alcohol 210 to aziridine 207 with complete 
inversion of stereochemistry at the tertiary alcohol centre, delivering aziridine 207 as a single 
diastereomer. 
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Aziridine 207 was further elaborated to the natural product as described below (Scheme 49). 
 
Scheme 49. (i) PhSO2Me, n-BuLi, THF (97 %); (ii) n-BuLi, –78 °C, THF then BnOCH2CHO, then PhCOCl (60 %); 
(iii) TBAF, THF (97 %); (iv) BBr3, CH2Cl2 (85 %); (v) C4H9C≡CMgCl, THF, 0 °C (99 %, 86:13 d.r.). 
Opening of N-SES aziridine with lithiated methylphenylsulfone afforded amine 211. This compound 
then underwent a novel condensation process with benzyloxyacetaldehyde to afford intermediate 
(E)-vinylic sulfone 212. This intermediate then cyclised to form the pyrrolidine C-ring of the natural 
product as a single diastereomer. Removal of the SES group, followed by concomitant debenzylation 
and acetal hydrolysis, gave rise to a 6-membered iminium intermediate, which was then intercepted 
by the hydroxyl moiety to produce fused tetrahydrofuran 214 as a single diastereomer. Finally, 
addition of a hexynyl Grignard reagent in an SN1-type process afforded advanced intermediate 215 in 
an 86:13 mixture of diastereomers in favour of the stereochemistry shown here. Interestingly, use of 
n-hexylmagnesium bromide gave entirely the opposite epimer, thus positioning the hexyl side chain in 
the wrong position for the natural product.  
Elaboration of 215 required extensive optimisation, and eventually a protocol for hydrogenation, 
desulfonylation and adjustment of the hydroxymethyl side chain disposition was developed (Scheme 
50). 
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Scheme 50. (i) dihydropyran, p-TsOH, CH2Cl2 (100 %); (ii) Pd–Al2O3, H2 (9 bar), EtOAc (72 %); (iii) Na, NH3, Et2O 
(97 %); (iv) p-TsOH, MeOH (100 %); (v) CrO3, H2SO4, CH2Cl2 then MeOH, c. H2SO4; (vi) NaOMe, MeOH; (vii) LiAlH4, 
Et2O (88 % over 3 steps).  
After THP-protection of alcohol 215, hydrogenation over palladium on alumina proceeded smoothly 
to afford 216. Desulfonylation under dissolving metal conditions delivered the backbone of the 
natural product, with subsequent O-deprotection liberating the hydroxymethyl side chain. Finally, 
adjustment of the hydroxymethyl stereochemistry via oxidation to the corresponding ester, base-
mediated epimerisation and reduction provided the natural product 13 as a single diastereomer. Data 
obtained was in accordance with that previously published. 
Craig et al. demonstrated the utility of 5-endo-trig cyclisations of (E)-vinylic sulfones for the 
assembly of natural product motifs, as well as the versatile reactivity of aziridines in synthesis.  
The syntheses featured in this chapter represent some great achievements in synthetic organic 
chemistry. The expedient syntheses conducted by Weinreb and Lygo, where Lygo is the shortest 
synthesis of all those featured in this chapter, demonstrate how complex ring structures can be rapidly 
assembled by the use of relatively simple ring-closing reactions such as cycloadditions and 
Sakurai-type alkylations. Although the syntheses by Zhao, Hsung and Kibayashi are much longer, 
they convey how the stereo- and regiochemical outcome of classic transformations such as Michael 
additions and reductions can be heavily influenced by the structure of the substrate, and how this 
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influence can be relied on to install the requisite stereochemistry for complex polycyclic natural 
products.  
The work from our group on the synthesis of racemic lepadiformine inspired our first generation 
strategy for the synthesis of enantiomerically pure (–)-lepadiformine, the details of which are 
delineated in Chapter 2. 
  
 
 
 
 
Chapter 2 
First-generation 
Strategy 
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2.0.0 First-generation Strategy for the synthesis of (–)-lepadiformine 
It was first our intention to expand on previous work carried out within the Craig group by devising 
and completing a synthesis of (–)-lepadiformine 10, as detailed in the retrosynthetic analysis below 
(Figure 19). 
 
Figure 19. First generation retrosynthetic analysis of (–)-lepadiformine. 
We envisaged the formation of the B-ring of the natural product, and concomitant introduction of the 
n-hexyl side chain, via an acetal deprotection-reductive amination process, with interception of the 
intermediate iminium ion by a nucleophilic hexyl fragment. Bicyclic structure 218 would be provided 
by an SN2-like ring-closure of δ-amino alcohol 219, which would in turn be a product of allylative 
ring-opening and asymmetric dihydroxylation of N-SES aziridine 220. Formation of key aziridine 220 
as a single enantiomer would likely proceed via diastereoselective aziridination of 
methylenecyclohexane 221. Several protocols were imagined for this process, and for the formation of 
precursor 221 as a single enantiomer, and these efforts will be discussed in the chapters to follow. 
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2.1.0 Diastereoselective Aziridination 
2.1.1 Cu(II)-catalysed Aminohydroxylation 
Diastereoselective aziridine formation was proposed to proceed via the oxaziridine-mediated 
aminohydroxylation of olefin 221. This method was first reported by Yoon et al.
62,63
 This process 
involves the treatment of alkenes with oxaziridines and anionic halocuprate complexes derived from 
Cu(II) catalysts to effect aminohydroxylation, the products of which can subsequently be elaborated 
to form aziridines (Scheme 51).  
 
Scheme 51. (i) Cu(II) cat., CH2Cl2, rt; (ii) H3O
+. 
The postulated mechanism for this reaction follows a Cu(II)/Cu(III) catalytic cycle, with an initial 
homolytic step involving the Cu-activated oxaziridine and the alkene (Figure 20).  
 
Figure 20. Postulated mechanism of Cu(II)-catalysed aminohydroxylation (Ns = p-nitrobenzenesulfonyl-). 
Originally, a two-step cationic mechanism was proposed where the Cu catalyst acts as a Lewis acid, 
activating the oxaziridine to nucleophilic attack by the alkene. Yoon et al. later revised their 
mechanistic hypothesis to that shown in Figure 20 based on experimental evidence. Two catalyst 
systems (Cu(TFA)2/HMPA and CuCl2/Bu4N
+
Cl
-
) were compared. A lower reaction time and increased 
yield using the anionic halocuprate system, led Yoon et al. to question their initially proposed cationic 
mechanism. They postulated that it was unlikely that an anionic CuCl3
– 
fragment would be a more 
effective Lewis acid than a neutral CuCl2•HMPA complex. There has been considerable evidence to 
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support oxaziridines reacting with homolytic character,
64
  and so the radical mechanism in Figure 20 
was suggested. The occurrence of a radical species was further supported by attempts at using a 
radical trap. Traditional radical traps such as TEMPO and trialkyltin hydrides were oxidised by the 
oxaziridine under the reaction conditions. However, the addition of excess CBr4 provided addition 
product 228 (Scheme 52).  
 
Scheme 52. (i) CBr4, CuCl2 (5 mol %), Bu4N
+Cl– (5 mol %) (44 %). 
The formation of 228 suggests the interception of a benzylic radical by CBr4, which gives rise to a 
radical chain reaction resulting in addition of CBr4 across the alkene. Although this didn’t provide 
evidence that a radical species was an intermediate in the aminohydroxylation process, it did 
demonstrate the propensity of oxaziridines to react homolytically under the reaction conditions. 
Yoon et al. have also developed an Fe-catalysed variant with opposite regioselectivity (Scheme 53).
65
 
 
Scheme 53. (i) Fe(acac)3, MeCN, 0 °C  rt. 
The cause of the differing regioselectivity in this process is not understood at present, and efforts to 
elucidate the mechanism of this transformation have proved unfruitful.
65
 It is worth noting that, unlike 
the Cu(II)-catalysed process, this reaction can be performed on unactivated terminal olefins, such as 
that depicted in Scheme 54.  
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Scheme 54. (i) 10 mol % Fe(acac)3, 4 equiv 231, 5 Å MS, MeCN, 0 °C  rt (53 %). 
Methylenecyclohexane 230 was subjected to the typical aminohydroxylation conditions to afford 
oxazolidine 232 seemingly as a single diastereomer.
65
 Although less reactive than the styrenic 
substrates, the success of this transformation encouraged us to consider the application of this process 
to the diastereoselective aziridination of methylene cyclohexane 221. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter 2: First-generation Strategy  75 
 
 
Yoon et al. have also developed an enantioselective variant of both the Cu- and Fe-catalysed 
oxyamination processes using BOX-type ligands. The results obtained for Cu-catalysed processes are 
detailed in Scheme 55 and Table 5.
66,67
 
 
Scheme 55. (i) 5 mol % Cu(F6acac)2, 15 mol % (R)-Ph-BOX, 2.5 equiv 234, Me2CO, rt. 
Entry Ar Time / h Yield / % d.r. (cis:trans) 
% e.e. (cis:trans 
weighted average) 
1 Ph 24 81 1.5:1 85/79 (82) 
2 4-MePh 15 72 2.2:1 86/74 (82) 
3 3-MePh 18 78 1.6:1 84/72 (79) 
4 3,5-Me2Ph 16 65 1.6:1 85/70 (79) 
5 2-MePh 26 44 0.2:1 12/47 (20) 
6 4-t-BuPh 17 67 2.3:1 87/78 (84) 
7 4-PhPh 20 71 1.9:1 87/62 (78) 
8 4-BrPh 24 64 1:1 83/47 (65) 
9 4-ClPh 24 70 0.8:1 89/45 (69) 
10 4-FPh 44 57 1.4:1 83/71 (78) 
11 4-MeOPh 17 70 0.4:1 0/24 (9) 
12 3-MeOPh 18 77 1.3:1 83/65 (75) 
13 3-ClPh 19 51 0.8:1 83/39 (60) 
Table 5. Results of asymmetric Cu-catalysed oxyamination reactions for varying Ar. 
This process displays consistently good enantioselectivity, even for substrates containing 
electron-withdrawing or donating groups. Interestingly, ortho-substitution on the aromatic portion of 
the substrate can give rise to a decrease in enantioselectivity (Entry 5, Table 5), which implies that the 
transition state conformation is in some way interrupted by substituents at this position. This 
transformation can also be carried out on a multigram scale, thereby indicating its applicability to 
large scale syntheses of natural products. Enantiomeric excesses could be consistently improved by 
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hydrolysis of the aminal moiety under acidic conditions, and subsequent recrystallisation of the 
resulting amino alcohols.
66
 
The results for enantioselective oxyamination under Fe-catalysis are described in Scheme 56 and 
Table 6.
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Scheme 56. (i) 10 % Fe(NTf)2, 20 mol % 238, 2.5 equiv 231, 400 wt% MgO, C6H6, 0 °C  rt. 
Entry Olefin Product Time / h Yield % e.e. 
1 R = Ph As above 3 75 92 
2 R = 4-MePh As above 3 76 95 
3 R = 3-MePh As above 4 68 91 
4 R = 2-MePh As above 5 62 93 
5 R = 4-ClPh As above 48 64 90 
6 R = 4-BrPh As above 48 63 85 
7 R = 4-AcOPh As above 3 81 95 
8 R = 2-Naphth As above 5 71 91 
9 
 
 
6 52 88 
10  
 
48 - - 
Table 6. Results of asymmetric Fe-catalysed oxyaminations. 
As shown previously, styrenic substrates proved to be excellent candidates for this process, and good 
functional group tolerance is demonstrated. It should also be noted that even ortho-substitution of the 
aromatic portion of the olefinic substrate does not give rise to any considerable drop in 
enantioselectivity (Entry 4, Table 6). Aliphatic substrates also performed well in this reaction. 
Remarkably, the products of the Fe-catalysed process were isolated as exclusively the cis aminal 
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diastereomer, whereas a mixture was consistently observed in the Cu-catalysed variant. Yoon et al. 
investigated whether the Fe catalyst may be acting as a Lewis acid, thereby giving rise to 
stereomutation of the aminal group. However, preparation of the trans analogue and subjection to the 
reaction conditions displayed no isomerisation. Therefore, it was postulated that only one enantiomer 
of the oxaziridine reagent was taking part in the reaction in a kinetic resolution-type process. Indeed, 
it was later found that unreacted oxaziridine can be isolated after the oxyamination reaction, and that 
the material obtained was significantly enantiomerically enriched (80 % e.e.). 
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2.1.2 Studies on hydroxyamination 
Our intention was to probe the applicability of the processes described above to the formation of 
spirocyclic systems. Once a single enantiomer of methylenecyclohexane 221 had been formed, we 
wished to first examine the reactivity of methylenecyclohexane 221 towards this process, and 
secondly investigate the diastereoselectivity of the transformation (Figure 21). 
 
Figure 21. Proposed oxyamination reactions of methylenecyclohexane 221. 
In order to first test whether this protocol was a viable starting point for our synthesis, we prepared 
racemic methylenecyclohexane 244 in three steps from cyclohexanone (Scheme 57). 
 
Scheme 57. (i) Et2O, 4 Å MS, 12 h, rt (76 %); (ii) LDA, 2 h, 0 °C then 2-(2-bromoethyl)-1,3-dioxolane, 16 h, rt then sat. 
NH4Cl (aq.), 5 h, reflux (73 %); (iii) Ph3PCH3I, n-BuLi, THF, 3 h, 0 °C  rt (78 %). 
Cyclohexanone and cyclohexylamine underwent condensation over 4 Å molecular sieves to form 
imine 243. Initial attempts at purification of imine 243 proved problematic: distillation of the product 
after work-up required very forcing conditions, resulting in discolouration and suspected 
Chapter 2: First-generation Strategy  79 
 
 
decomposition of imine 243. It was later found that distillation of the product to remove any residual 
Et2O and starting materials provided us with pure 243 in the distillation flask. This compound was 
then converted into the corresponding enamine by treatment with LDA, and that species alkylated 
with 2-(2-bromoethyl)-1,3-dioxolane. The resulting imine species underwent acidic hydrolysis to 
produce ketone 208. Wittig olefination of 208 under standard conditions delivered 
methylenecyclohexane 244. 
2.1.3 Oxaziridine synthesis 
With racemic substrate 244 in hand, we next turned our attention to the synthesis of the requisite 
N-SES oxaziridine, which we proposed could be synthesised from the corresponding sulfonamide. 
Therefore, the synthesis of 2-trimethylsilylethylsulfonamide began with the synthesis of sulfonate salt 
247, which was prepared according to a literature procedure (Scheme 58).
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Scheme 58. (i) vinylmagnesium bromide, THF, 2 h, reflux then 18 h, rt; (ii) NaHSO3, t-butylperoxybenzoate, MeOH:H2O 
(1:1), 48 h, 50 °C (75 % over 2 steps). 
Rather than use commercially available vinyltrimethylsilane 246 for this process, we prepared the 
compound via vinylation of chlorotrimethylsilane 245. Due to the similarity of the boiling points of 
246 and THF, the product was purified by distillation directly from the reaction flask and 
subsequently washed with copious amounts of water to remove much of the reaction solvent. Once 
1
H 
NMR analysis showed that <10 % THF remained in the mixture, the product was used without further 
purification in the next step. Silane 246 was therefore treated with sodium bisulfite and a radical 
initiator (t-butylperoxybenzoate) to provide sulfonate salt 247. Drying of sulfonate 247 under vacuum 
at 100 °C for several hours was required. 
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At this stage, we attempted the chlorination of sulfonate 247 in order to obtain the corresponding 
sulfonyl chloride 248. The protocol detailed in the literature gave rise to a disappointing yield of the 
desired product, and so several other methods were employed (Scheme 59, Table 7). 
 
Scheme 59. Conversion of sulfonate 247 to sulfonyl chloride 248. 
Entry Reagents Temp / °C Time / h Solvent Yield / % 
1 SOCl2, cat. DMF 0  rt 24 - 21 
2 SO2Cl2, PPh3 0  rt 3 CH2Cl2 14 
3 PCl5 0  rt 1.5 CCl4 24 
4 PCl5 0  rt 3 CHCl3 27 
Table 7. Conditions for chlorination of sulfonate 247. 
Based on literature precedent, chlorination of sulfonate 247 was first attempted by treatment with 
thionyl chloride and catalytic DMF (Entry 1, Table 7).
68
 This transformation was consistently 
low-yielding. A related procedure involving the use of triphenylphosphine and sulfuryl chloride also 
proved inadequate (Entry 2, Table 7).
69
 Finally, the use of phosphorus pentachloride in chlorinated 
solvents showed an improvement in product yield.
70
 We considered the possibility that some loss of 
volatile product was occurring during distillation; changing to a lower-boiling solvent from carbon 
tetrachloride again improved the yield. It has also been suggested that a significant by-product of 
these reactions is the corresponding sulfonic anhydride; we intended to suppress anhydride formation 
by maintaining a lower reaction temperature. Considerable anhydride formation was also observed 
when purification by silica gel was attempted, with <10 % yield of desired product obtained. 
Therefore, in the hope of avoiding the purification of sulfonyl chloride 248, we decided to seek a 
one-pot synthesis of sulfonamide 249 from sulfonate salt 247. 
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As a first step in this investigation, we attempted to convert previously obtained pure samples of 
sulfonyl chloride 248 to the corresponding sulfonamide (Scheme 60). 
 
Scheme 60. (i) NH3 (g), CH2Cl2, 15 min, –10 °C then 16 h, rt (92 %). 
Sulfonyl chloride 248 was treated with ammonia gas, obtained by gentle heating of ammonium 
hydroxide solution. Despite the apparent reliability of this process, attempts at a one-pot procedure 
provided sulfonamide 249 in low yields. 
Alternatively, a biphasic reaction could be employed, where aqueous ammonium hydroxide is 
introduced directly into the reaction. Combining this with our best chlorination conditions led to a 
reproducible two-step procedure for the conversion of sulfonate 247 to sulfonamide 249 without the 
need for purification (Scheme 61). 
 
Scheme 61. (i) PCl5, CH2Cl2, 3 h, 0 °C  rt; (ii) NH4OH (aq.), MeCN, 1.5 h, 0 °C  rt (56 % over 2 steps). 
After a short work-up procedure following chlorination, chloride 248 was directly exposed to 
ammonium hydroxide to complete the synthesis of sulfonamide 249 without any requirement for 
purification. As was observed previously, warming of the chlorination step too rapidly gave rise to a 
considerable reduction in yield; we believe that significant anhydride formation at higher 
temperatures could be the cause of this, with a large amount of material being lost as the 
corresponding sulfonic acid.  
With this portion of the synthesis completed, we next turned our attention to the conversion of 
sulfonamide 249 to the requisite oxaziridine reagent. As 3-phenyl oxaziridines had been proven to be 
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active in oxyamination reactions, we first attempted the condensation of sulfonamide 249 with 
benzaldehyde to obtain the corresponding N-sulfonylimine 250 (Scheme 62). 
 
Scheme 62. (i) PhCHO, 4 Ǻ MS, PhMe, 24 h, reflux (88 %). 
Formation of imine 250 proceeded smoothly via treatment with benzaldehyde and heating in toluene 
with a drying agent. Imine 250 was then subjected to typical Davis oxaziridination conditions to 
produce the requisite oxaziridine 251 (Scheme 63).
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Scheme 63. (i) Oxone®, aq. K2CO3, PhMe, 1.5 h, rt.    
Treatment of N-sulfonylimine 250 with Oxone® under biphasic basic conditions displayed apparent 
formation of a new product via TLC analysis. However, after a typical work-up only starting material 
was observed. Due to the quality of the available Oxone®, Davis’ initial oxaziridination conditions, 
using m-CPBA, were applied (Scheme 64).
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Scheme 64. (i) m-CPBA, sat. NaHCO3 (aq.), BTEAC, CHCl3, 45 min, 0 °C (67 %). 
Oxidation of the C═N bond was effected by reaction with m-CPBA, NaHCO3 and phase-transfer 
catalyst benzyltriethylammonium chloride (BTEAC). Pleasingly, this alternative approach afforded 
N-SES oxaziridine 251 in good yield. Since this initial investigation was completed on a relatively 
small scale, we thought it prudent to examine the activity of our substrate using an oxaziridine that 
had previously been proven to be an efficient oxidant in an oxyamination process.
63
 Therefore, 
N-nosyl oxaziridine 255 was prepared as outlined in Scheme 65. 
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Scheme 65. (i) NH4OH (aq.), THF, 30 min, rt (61 %); (ii) PhCHO, 4 Ǻ MS, PhMe, 24 h, reflux (94 %); (iii) m-CPBA, sat. 
NaHCO3 (aq.), BTEAC, CHCl3. 1 h, 0 °C (65 %). 
p-Nitrobenzylsulfonyl chloride 252 was treated with aqueous ammonium hydroxide solution to afford 
sulfonamide 253, which subsequently underwent condensation with benzaldehyde to produce 
N-sulfonylimine 254. Finally, employment of Davis’ oxaziridination conditions provided oxaziridine 
255. It should be noted that full characterisation of both N-nosyl and N-SES oxaziridines, particularly 
by mass spectrometry, proved difficult due to their apparent air sensitivity. 
With oxaziridine 255 in hand, an oxyamination reaction of methylenecyclohexane 244 was attempted 
using Yoon et al.’s optimised anionic halocuprate conditions (Scheme 66). 
 
Scheme 66. (i) 5 mol % CuCl2, 6 mol % Bu4NCl, CH2Cl2, 2 h, rt (30 % crude yield). 
The apparent formation of oxazolidine 256 was observed by 
1
H NMR, with all previously observed 
olefinic signals having disappeared. We attributed the protons observed in the 5.20-5.60 ppm range to 
the benzylic proton in the oxazolidine ring. These signals were observed in a 1.25:1 ratio, which we 
postulated could correspond to the presence of two diastereomers of 256. The presence of three 
stereogenic centres in this molecule could give rise to a total of 4 different diastereomers, and so the 
presence of seemingly just 2 diastereomers gave us hope that this process exhibited a degree of 
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diastereoselectivity. Purification of 256 proved difficult however, with no analytically pure samples 
being obtained. This may be due to partial hydrolysis of the acetal moiety under the mildly acidic 
reaction conditions, although no significant degradation of the acetal was observed via crude 
1
H NMR 
analysis. 
Despite the modest crude yield of this process, we felt that further investigation into this 
transformation was necessary. Once N-SES oxaziridine 251 had been synthesised in sufficient 
abundance, we were able to attempt an oxyamination reaction as seen below (Scheme 67). 
 
Scheme 67. (i) 5 mol % CuCl2, 6 mol % Bu4NCl, CH2Cl2, 2 h, rt. 
Use of the N-SES oxaziridine 251 in this process proved to be less straightforward than the use of the 
N-nosyl variant. TLC analysis suggested the presence of two products of similar polarity, indicative of 
the diastereomeric mixture formed in previous attempts. Purification was again an issue, and after 
several attempts no pure samples of oxazolidine 257 were obtained. Crude 
1
H NMR analysis 
suggested the presence again of two oxazolidine species, however several other unidentified products 
were present.  
In light of this, we decided to attempt the synthesis of a 3,3-disubstituted oxaziridine, in the hope of 
elucidating the diastereoselecitivity of this process by removing one of the three stereocentres. Based 
on previous work by Yoon et al., we attempted the synthesis of an N-SES-3,3-dimethyloxaziridine via 
condensation with acetone to form N-sulfonylimine 258 (Scheme 68). 
 
Scheme 68. (i) Me2CO, 4 Ǻ MS, PhMe, 36 h, reflux. 
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Despite TLC analysis indicating consumption of starting material and the formation of a new product, 
purification of the crude material resulted only in the isolation of sulfonamide 249; this was attributed 
to the presumed sensitivity of imine 258 to hydrolysis. The nosyl variant gave similar results, and 
attempts at condensation followed by in situ oxaziridination only led to a mixture of starting material 
sulfonamides and apparent decomposition products.  
As a result of this, we decided to focus on the use of another ketone in the condensation process, in 
the hope of increasing the stability of the products. Propiophenone was selected as a suitable reagent, 
since phenyl substituents had previously been shown to be suitable for this process. Thus, the 
reactions outlined in Scheme 69 were carried out. 
 
Scheme 69. (i) PhC(O)Et, 4 Ǻ MS, PhMe, 22 h, reflux (60 %); (ii) m-CPBA, sat. NaHCO3 (aq.), BTEAC, CHCl3. 2 h, 0 °C 
(51 %). 
Condensation of propiophenone with sulfonamide 249 delivered N-SES imine 259. Subsequent 
oxaziridination with m-CPBA yielded oxaziridine 260. This process was difficult to follow by either 
TLC or 
1
H NMR analysis, and so the consumption of imine 259 was monitored by IR spectroscopy. 
With this small amount of material in hand, an oxyamination process was attempted (Scheme 70). 
 
Scheme 70. (i) 5 mol % CuCl2, 6 mol % Bu4NCl, CH2Cl2, 2 h, rt. 
TLC analysis of this reaction indicated the presence of several products with vastly different 
polarities. One species in particular appeared to match the profile previously observed for this class of 
reactions. With that in mind, the attempted purification of the products of this reaction yielded only 
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one product with a 
1
H NMR spectrum similar to that previously observed for the oxazolidine 
products. 
1
H NMR analysis suggested that several oxazolidine species were present; the omission of 
the benzylic proton in oxazolidine 261 meant there were fewer observable, prominent signals for 
characterisation. We were therefore unable to determine at this point whether the product was a 
mixture of just two or more diastereomers.  
With this in mind, we felt it important to complete this synthesis on a large scale, in order to elucidate 
the structure and stereochemistry of the products formed. Despite many attempts however, this 
protocol was not reproducible, and all subsequent attempts at formation of imine 259 resulted in 
100 % return of starting materials, despite careful monitoring of reagent purity and dryness, and 
fastidious maintenance of reaction conditions. At this point, we were uncertain as to why this process 
proved so capricious; regardless, it appeared that this route was not sustainable. 
As a final foray into this area of investigation, we attempted the synthesis of analogous 
acetophenone-based imine 262. Initially, our original condensation conditions were employed, along 
with conditions developed by Carretero et al. involving Lewis acid catalysis (Scheme 71).
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Scheme 71. (i) PhC(O)CH3, 4 Ǻ MS, PhMe, 48 h, reflux OR PhC(O)CH3, TiCl4, Et3N, CH2Cl2, 16 h, reflux. 
Direct condensation of sulfonamide 249 with acetophenone in toluene exhibited no product formation 
by TLC analysis. The method of Carretero et al. using TiCl4 as a catalytic Lewis acid showed promise 
at first, with apparent product formation by TLC analysis. However, attempts at isolation by 
conventional methods provided only traces of the desired N-SES imine 262. Removal of 
Ti-containing by-products was also difficult.  
Despite some encouraging results, it was decided at this point to focus our attention on another area of 
the project, and consequently research into the Cu-catalysed oxyamination of methylenecyclohexane 
221 was abandoned. 
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2.1.4 An alternative aziridination by Sharpless et al. 
Sharpless et al. have developed, over several years, a halogen-catalysed aziridination process using 
Chloramine-T
®
 and catalytic phenyltrimethylammoniumtribromide (PTAB)
 
(Scheme 72).
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Scheme 72. (i) Chloramine-T®, cat. PTAB, MeCN, rt.  
This reaction has shown considerable functional group tolerance, and unlike the oxyamination 
processes discussed previously, appears to be an equally powerful tool for the aziridination of 
aliphatic olefins as well as styrene-derived substrates (Table 8). 
Entry Olefin Product Yield / % 
1   
93 
2   
76 
3  
 
95 
4 
 
 
89 
5 
  
86 
6 
 
 
54 
7   
68 
8 
  
76 
9 
  
51 
Table 8. Substrate scope of the Sharpless aziridination. All reactions carried out with 1.1 equiv Chloramine-T®, 10 mol % 
PTAB, 0.2 M [olefin], 12 h, rt. 
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The proposed mechanistic pathway for this process is as follows (Figure 22). 
 
Figure 22. Proposed catalytic cycle for Sharpless aziridination. 
As depicted above, the olefin first interacts with a “Br+” source, (deriving from Br2, BrCl, or 
TsN(Cl)Br for example), to form the corresponding bromonium ion. Opening of this bromonium ion 
by the highly nucleophilic chloramine species produces an N-chloro-β-bromo amine, which then 
undergoes reduction via removal of the chlorine substituent by a bromide or chloramine anion. The 
negatively charged species generated can then undergo an intramolecular SN2-like process to afford 
the N-Ts aziridine, regenerating the bromide anion which can re-enter the catalytic cycle.  
In the past, our group has had considerable success in the use of this process for the synthesis of 
natural products, and so we decided to examine its applicability to this synthesis.
75,76
 We also wished 
to study the potential facial selectivity of this process, and whether aziridination of enantiomerically 
enriched methylenecyclohexane 221 would occur on one face of the molecule to provide a single 
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diastereomeric product. Without any enantiopure material in hand, at this point we conducted an 
investigation into the selectivity of this process on racemic methylenecyclohexane 208 (Scheme 73). 
 
Scheme 73. (i) 1.5 equiv Chloramine-T® trihydrate, 0.1 equiv PTAB, MeCN, 2 h, rt (87 % 265 (single diastereomer), 
11 % 266). 
Pleasingly, after some optimisation, involving increasing the amount of chloramine required to 1.5 
equivalents, this transformation proceeded in good yield. Substitution of the commercially available 
Chloramine-T® trihydrate for anhydrous Chloramine-T offered little improvement in yield, and so the 
commercially available material was used henceforth. Initial attempts at this reaction showed two 
principal products of similar polarity by TLC analysis. It was assumed that a diastereomeric mixture 
of aziridines 265 was obtained, although crude 
1
H NMR analysis did not confirm this. It was 
eventually determined that the two products were aziridine 265 and β-hydroxy sulfonamide 266, 
obtained via ring-opening of aziridine 265 by water present in the Chloramine-T
®
 reagent (Figure 23). 
We were able to suppress the formation of this side product via careful monitoring of the reaction, and 
found that prolonged exposure to the reaction conditions only increased the amount of side product 
formed. It should also be noted that sulfonamide 266 was formed on standing of aziridine 265 in air, 
and over a period of weeks under N2 at low temperature, a considerable portion of the aziridine had 
converted into sulfonamide 265. This proved somewhat problematic, and precluded large-scale 
syntheses with subsequent storage of aziridine 265. 
Aziridine 265 was obtained as a single diastereomer via this process. Favourable comparison of the 
1
H NMR spectrum with a spectrum obtained previously for a closely related compound implied that 
the diastereomer obtained had the requisite trans disposition of the side chain and the C–N aziridine 
bond (Figure 23).
61
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Figure 23. Partial 1H NMR spectrum of aziridine 265. 
The signals highlighted at 2.50 and 2.33 ppm correspond to the two protons of the aziridine ring. In 
our previous synthesis of (±)-lepadiformine, the N-SES aziridine intermediate 207 displayed singlet 
resonances corresponding to the aziridine protons at 2.46 and 2.35 ppm.
61
 We therefore inferred that 
the correct stereochemistry may have been installed, but at the very least that aziridine 265 was 
obtained as a single diastereomer. 
Little has been published thus far on the facial selectivity of these processes. O’Doherty et al. 
examined the behaviour of one facially-biased system in this process, and compared it with an 
iterative preparation of the two possible diastereomeric products.
77
 It was observed by O’Doherty et 
al. that a single diastereomer was formed upon exposure of dibromide 267 to Sharpless’ aziridination 
conditions (Scheme 74). 
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Scheme 74. (i) Chloramine-T®, 10 mol % PTAB, MeCN. 
Unsure of which diastereomer had been formed, O’Doherty et al. returned to Sharpless’ mechanistic 
hypothesis for this process (vide supra) (Figure 24). 
 
Figure 24. Proposed mechanism of the Sharpless aziridination. 
In the case of dibromide 267, two possible bromonium ions can form. Of the two, the trans isomer 
will form much faster due to bromination occurring on the much less sterically hindered face of the 
molecule. After attack of the chloramine anion in an SN2 fashion, the nitrogen-containing moiety is 
positioned on the opposite face to the bromonium ion, thereby resulting in cis aziridine formation 
from the trans bromonium ion, and vice versa. It would therefore appear that trans bromonium 
formation and therefore cis aziridine formation would be the dominant process. 
It should be noted that although formation of the cis bromonium ion is much slower, subsequent 
nucleophilic attack on this bromonium ion will be much faster, again due to attack occurring on the 
less sterically encumbered face. If the bromonium ions formed are interconverting, then since 
nucleophilic attack of the trans bromonium is slow, there is potential for interconversion to the cis 
bromonium ion, and subsequent rapid attack of the nucleophile to ultimately form the trans aziridine.  
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O’Doherty et al. therefore prepared authentic samples of both the cis and trans aziridines from known 
trans and cis epoxides (respectively) in order to determine which diastereomer was formed during the 
Sharpless aziridination (Scheme 75). 
 
Scheme 75. (i) NaN3, 10 mol % NH4Cl, MeOH, 3 days, rt (82 %); (ii) PPh3 then TsCl, pyridine (22 %); (iii) NaN3, 
10 mol % NH4Cl, MeOH, 3 h, rt (82 %); (iv) PPh3 then TsCl, pyridine (84 %). 
Epoxides 273 and 276 were treated with sodium azide to afford azido alcohols 274 and 277 
respectively. Interestingly, the nucleophilic ring opening of the trans epoxide 273 required a much 
longer reaction time of 3 days (cf. 3 h for cis epoxide 276), giving credence to the theory that 
nucleophilic ring opening of the trans bromonium ion 269 would be a much slower process. 
Subsequent Staudinger reaction of azido alcohols 274 and 277, followed by tosylation and aziridine 
ring closure, afforded the two diastereomeric products 275 and 278. The low yield of the cis aziridine 
is presumed to be a result of steric clash between the dibromocyclopentane moiety and the azide.  
Upon comparison of the spectral data obtained for aziridines 275 and 278, it appears that exclusively 
cis aziridine 275 was formed during the Sharpless aziridination process in Scheme 74. This would 
suggest that the much faster bromonium ion formation step is the dominant factor in determining the 
facial selectivity of this process.  
With regard to this project, Sharpless aziridination of enantiomerically enriched 
methylenecyclohexane 221 might proceed as outlined below (Figure 25).  
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Figure 25. Proposed mechanism of Sharpless aziridination of methylenecyclohexane 221. 
If trans bromonium formation is indeed the dominant effect, we might expect to isolate the cis 
diastereomer 280 from aziridination of enantiomerically enriched methylenecyclohexane 221, thereby 
installing the wrong stereochemistry for the natural product. Though at first discouraging, we decided 
to continue with this investigation for several reasons: very few accounts of facial selectivity in this 
process exist, and so no definitive model for selectivity has been prepared; the dibromide system 
detailed above is very different in structure to the methylenecyclohexane system we wish to examine; 
the formation of a single diastereomer in the aziridination of racemic methylenecyclohexane 244 
requires further examination to prove which diastereomer was obtained. 
O’Brien and co-workers have also investigated the outcome of treating cyclic allylic alcohols with 
Chloramine-T and PTAB.
78
 After examining a range of substitution levels, a preference for cis 
aziridine products in most cases was demonstrated (Scheme 76, Table 9). 
 
Chapter 2: First-generation Strategy  94 
 
 
 
Scheme 76. (i) Chloramine-T® trihydrate (1.1 eq.), PTAB (0.1 eq.), MeCN, 12 h, rt. 
Entry R1 R2 cis:trans 284:285 
1 H H 60:40 
2 H Me 75:25 
3 H n-Bu 70:30 
4 H Allyl 65:35 
5 H i-Pr 55:45 
6 Me H 75:25 
7 n-Bu H 70:30 
8 Allyl H 65:35 
9 i-Pr H 55:45 
10 Me Me >98:2 
11 Me n-Bu >98:2 
12 Allyl n-Bu >98:2 
Table 9. Sharpless aziridinations of cyclic allylic alcohols by O’Brien et al. 
The findings depicted above clearly demonstrate a stereochemical preference for the cis aziridine 284 
in all cases, albeit modest when an isopropyl group is one of the substituents (Entries 5 and 9, Table 
9). Similar to the work by O’Doherty et al., it was found here that the opening of the trans 
bromonium ion intermediate is much faster, thereby giving rise to the majority of the selectivity 
shown above. In the case of the 1,3-disubstituted allylic alcohols (Entries 10-12, Table 9), one can 
imagine that the intermediate bromonium ions are much more sterically encumbered; this in turn 
gives rise to an almost complete preference for attack of the trans bromonium ion, and thus almost 
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exclusive formation of the cis aziridine product 284. This rationale proposed by O’Brien et al. is 
outlined in Figure 26. 
 
Figure 26. Rationale for the stereochemical outcome of Sharpless aziridination of cyclic allylic alcohols. 
From Figure 26 it is evident that considerable steric hindrance is observed upon the approach of the 
chloramine to the trans bromonium intermediate. This effect is exacerbated with substituents at both 
the 1- and 3-positions, which explains the excellent selectivity observed in these cases. Attack of the 
cis bromonium species appears to be much less encumbered, with the additional stabilising effect of a 
hydrogen bond forming between the chloramine and alcohol. Armstrong et al. have observed a similar 
effect upon treatment of dihydropyran substrate 286 with Chloramine-T and PTAB (Scheme 77).
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Scheme 77. (i) Chloramine-T® trihydrate (3 eq.), NBS (0.2 eq.), MeCN, 1 h, rt (>90:10 d.r.). 
Sharpless aziridination of 286 yielded aziridine 287 in >90:10 d.r., with the cis stereochemistry shown 
being the predominant product. This further substantiates the work by O’Brien et al. and demonstrates 
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how important substrate structure is in influencing the stereochemical outcome of these 
transformations.  
With the results of these investigations in mind, we next attempted to make use of our apparently 
selective aziridination process and attempt the next proposed step in the synthesis. 
2.1.5 Allylation of N-Ts aziridine 265 
In order to install the carbon framework for the pyrrolidine ring of (–)-lepadiformine, we planned to 
treat N-tosyl aziridine 265 with a nucleophilic allyl source. We first attempted to develop the 
allylative ring opening of racemic spiroaziridine 265 (Figure 27, Table 10).  
 
Figure 27. Allylation of spiroaziridine 265. 
Entry Reagents Solvent Time / h Result 
1  THF 24 
SM as part of 
intractable 
mixture 
2  CH2Cl2 48 
Decomposition 
during 
chromatography 
3  THF 48 
Decomposition 
during 
chromatography 
4  
n-BuLi 
THF 72 SM 
5  
n-BuLi 
THF:TMEDA 36 5 % of 289 
Table 10. Conditions for allylation of aziridine 265. 
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Most attempts at this allylation resulted in an intractable mixture of >10 different products, none of 
which was identifiable by crude 
1
H NMR analysis. Entries 2 and 3 displayed promising product 
formation by TLC and crude 
1
H NMR analysis, but no product was able to be isolated after silica gel 
chromatography. We also treated aziridine 265 with lithiated allylphenylsulfone, in the hope of 
installing the requisite allyl group, with only a slight modification to the later synthesis (global 
desulfonylation). Utilising lithiated allylphenylsulfone as the nucleophile gave rise to a small amount 
of isolable product, although on repeating this reaction, no more of this product has been obtained. 
Furthermore, lithiated phenylmethylsulfone was employed, in the hope of assessing the activity of 
aziridine 265 towards any nucleophile. No product was isolated and 
1
H NMR analysis of the crude 
material showed no indication of the correct product. 
Interestingly, a similar substrate was subjected to simple treatment with 4 equivalents of 
allylmagnesium bromide in Funk et al.’s synthesis of (±)-lepadiformine.80 However, emulation of 
these conditions still provided us with no allylated product. 
It was suggested at this point that the aziridine ring protons might be fairly acidic, and that a basic 
nucleophile could instead give rise to deprotonation at this centre, and either salt formation or an 
unwanted further reaction. With this in mind, we decided to investigate a neutral or acidic method for 
allylative ring opening. Lewis acid-induced attack of allyltrimethylsilane (Hosomi–Sakurai reaction) 
was visited first (Scheme 78).
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Scheme 78. (i) allyltrimethylsilane, 2 equiv TiCl4, CH2Cl2, 16 h, rt. 
Allylated sulfonamide 288 was not observed as a product of this reaction. One principal product 
appeared to form by both TLC and crude 
1
H NMR analysis. Alteration of the Lewis acid catalyst to 
either BF3•OEt2 or Bi(OTf)3 gave similar yields of this principal product in the range 35 – 42 %.  
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After some purification, from which a mixture of several products was obtained, it was suggested that 
tetrahydropyridine 291 might have been formed (Figure 28). 
 
Figure 28. Proposed formation of tetrahydropyridine 291. 
After ring-opening of aziridine 265, it is possible that the Lewis acid catalyst present gave rise to 
acetal hydrolysis to form oxonium species 290. Subsequent condensation of the oxonium ion and 
sulfonamide moiety would give rise to cyclic enamine 291. Despite mass spectrometric analysis 
indicating the presence of this product, this structure could not be reconciled with the 
1
H NMR 
spectrum obtained. At this point we examined any other possible mechanistic pathways, with 
particular focus on what would result if acetal hydrolysis occurred prior to aziridine ring-opening 
(Figure 29). 
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Figure 29. Potential side product formation in attempted ring opening of aziridine 265. 
If acetal hydrolysis were to occur first, we could expect oxonium ion 292 to be formed. Allylation of 
this highly electrophilic species would produce homoallylic alcohol 293, which could then, under 
Lewis acidic conditions, cyclise to form stable pyran 294. This compound did agree more closely with 
the crude 
1
H NMR spectra obtained, although no correlation was observed when IR or MS analysis 
were carried out. Regardless of the outcome of this process, it was determined that allylative ring 
opening of N-Ts aziridine 265 was capricious. 
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2.1.6 Chloramine-SES 
At this point it was still intended to use the SES protecting group for protection at the aziridine 
nitrogen, rather than the tosyl group installed by Chloramine-T 295. As an alternative to detosylation 
and reprotection with SESCl, we decided to investigate the synthesis and reactivity of the analogous 
SES-based chloramine reagent 296, henceforth known as Chloramine-SES (Figure 30).  
 
Figure 30. Chloramine-T® 290 and Chloramine-SES 291. 
The two most conventional methods for the synthesis of chloramines, involve the treatment of amines, 
or in this case sulfonamides, with either trichloroisocyanuric acid or tert-butyl hypochlorite. Both of 
these methods were invoked to attempt to convert sulfonamide 249 into Chloramine-SES (Scheme 
79). 
 
Scheme 79. (i) trichloroisocyanuric acid, 2 M NaOH, 1h, rt (28 %); (ii) t-BuOCl, NaOH, MeOH, 0 °C  rt. 
Previous examples of this type of transformation relied on the spontaneous precipitation of the 
product from 2 M NaOH. The solid formed via treatment with trichloroisocyanuric acid was collected 
and analysed, and did appear to be Chloramine-SES 296, as demonstrated by the disappearance of the 
2H singlet at 4.82 ppm corresponding to the sulfonamide NH2 in the starting material in the 
1
H NMR 
spectrum. Mass spectrometry proved inconclusive however, and this reaction was consistently low-
yielding as well as the material appearing to be very unstable. Reactions with tert-butyl hypochlorite 
also proved capricious. Synthesis of the reagent from tert-butanol and NaOCl proved difficult, and 
handling of the resulting hypochlorite gave rise to considerable reversion to the starting alcohol. In 
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addition, the compound obtained after work-up appeared to be the desired chloramine 296 by 
1
H 
NMR analysis, but the physical properties of the product varied for each attempt, with either a white 
solid or a colourless oil obtained. It was thought that chloramine 296 may have a melting point similar 
to room temperature, and as such displayed some ionic liquid-like properties.  Though capricious, we 
thought it prudent to use whatever material was available to probe some aziridination reactions 
(Scheme 80, Table 11). 
 
Scheme 80. (i) Conditions (see below). 
Entry Reagents Solvent Time Result 
1 
Chloramine-SES (1.5 equiv) 
PTAB (0.5 equiv) 
MeCN 2 h SM as part of intractable mixture 
2 
Chloramine-SES (1.5 equiv) 
PTAB (0.5 equiv) 
MeCN 24 h SM as part of intractable mixture 
3 
Chloramine-SES (1.5 equiv) 
PTAB (0.5 equiv) 
MeCN 48 h SM as part of intractable mixture 
4 
Chloramine-SES (5 equiv) 
PTAB (0.5 equiv) 
MeCN 4 days SM & SESNH2 
5 
Chloramine-SES (2 equiv) 
PTAB (0.2 equiv) 
MeCN 7 days SM & SESNH2 
6 
Chloramine-SES (1.5 equiv) 
PTAB (0.2 equiv) 
MeCN 10 days Intractable mixture 
7 
Chloramine-SES (1.5 equiv) 
PTAB (1 equiv) 
MeCN 3 h Intractable mixture 
Table 11. Conditions for the aziridination of methylenecyclohexane 244 with Chloramine-SES. 
As is evident from Table 10, formation of N-SES aziridine 297 using Chloramine-SES was 
unsuccessful. When consumption of starting material was observed, several other products were 
present by TLC. Purification of the complex mixtures by silica gel chromatography frequently lead to 
apparent decomposition of the mixture to >10 different compounds. N-SES aziridine is identifiable by 
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1
H NMR due to two singlet resonances at 2.30 and 2.45 ppm respectively, which correspond to the 
two protons of the aziridine ring. Crude 
1
H NMR analysis of the aziridination attempts showed no 
evidence of these resonances, making it fairly certain that the N-SES aziridine 297 was either not 
forming, or was too unstable to be isolated.  
In order to test the efficacy of Chloramine-SES, we attempted to oxidise thioanisole to the 
corresponding sulfilimine (Scheme 81).  
 
Scheme 81. (i) Chloramine-SES, Bu4NBr, CH2Cl2, 2 h, rt. 
TLC analysis of this reaction suggested the formation of a new product. Work-up and isolation of this 
product proved difficult, with very little mass ultimately obtained. Although 
1
H NMR analysis seemed 
to indicate some formation of sulfilimine 299, further analysis showed only the presence of 
SES-sulfonamide 249 and thioanisole.  
Despite Chloramine-SES being reactive enough to form sulfilimine 299, aziridination using 
Chloramine-SES is not a plausible step in the synthesis of (–)-lepadiformine, and as such research in 
this area was abandoned, and our efforts focussed on utilising N-Ts aziridine 265 as an intermediate in 
this synthesis instead. At this point, it was acknowledged that both the aziridination and allylative ring 
opening processes were capricious, and as such work on this area of the project was suspended. We 
wished to focus first on the synthesis of enantiomerically enriched methylenecyclohexane 221, and 
return to the myriad synthetic issues we had encountered with the racemic material once we had a 
stock of enantiopure compound. 
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2.2.0 Studies on the synthesis of enantioenriched methylenecyclohexane 221 
2.21 Diastereoselective Mukaiyama–Michael Additions 
Our first strategy for the synthesis of enantiomerically enriched 221 involved the use of an 
enantioselective Mukaiyama–Michael addition. This reaction typically involves the addition of a silyl 
enol ether nucleophile to an α,β-unsaturated carbonyl moiety under Lewis acidic conditions (Scheme 
82).
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Scheme 82. (i) cat. TiCl4, CH2Cl2. 
Titanium(IV) chloride has traditionally been most often used in this transformation, but many other  
Lewis acid catalysts work well. Some efforts have been made to develop diastereo- and 
enantioselective variants of this process, using a variety of catalysts including pyrrolidine-derived 
organocatalysts,
83,84
 tethered bis(8-quinolinolato) aluminium catalysts,
85
 oxazaborolidinone 
catalysts,
86
 and catalysis by bis(oxazoline) copper(II) complexes.
87
 The latter inspired us to investigate 
this transformation as a means of installing the requisite stereochemistry for the trans-1-azadecalin 
motif of (–)-lepadiformine. 
Evans et al. developed these bis(oxazoline) copper(II) complexes to behave as both a Lewis acid and 
to induce asymmetry. The bulk of their work focussed on the addition of silyl enol ethers to 
acryloyloxazolidinones (Figure 31). 
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Figure 31. Diastereoselective Mukaiyama–Michael addition devised by Evans et al. 
Other catalyst systems were examined, and ultimately the highest level of asymmetric induction was 
achieved when using [Cu((S,S)-t-Bu-BOX)](SbF6)2 306. This transformation was also conducted with 
a variety of substrates, with the highest selectivities and yields obtained for thioester-derived silyl enol 
ethers (Scheme 83, Table 12). 
 
Scheme 83. 10 mol % 301, HFIP, CH2Cl2, –10 °C. 
Entry R R’ E:Z of 307 T / °C e.e. / % Yield / % 
1 TES Me 98:2 –78 89 80 
2 TIPS Me 95:5 –20 86 80 
3 TES i-Pr 90:10 –78 76 94 
4 TIPS i-Pr 95:5 –20 92 84 
5 TES Ph 97:3 –78 83 83 
6 TIPS Ph 92:8 –20 40 93 
Table 12. Results of enantioselective Mukaiyama–Michael additions by Evans et al. 
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Hexafluoro-2-propanol (HFIP) was used as an additive to accelerate the reaction, and on average a 
drop of 70 % in reaction time was observed.
87
 In general, this process exhibits good enantioselectivity 
from easily prepared starting materials in good yields. It should also be noted that enolsilane geometry 
plays an important role in the stereochemical outcome of these processes.  
Evans et al. also investigated the potential mechanistic pathways for this process. Two potential 
pathways were postulated (Figure 32). 
 
Figure 32. Mechanistic pathways hypothesised by Evans et al. 
The expected pathway for this reaction is via the conventional Mukaiyama–Michael transition state 
312. Subsequent silicon transfer followed by hydrolysis allows for the conversion of 312 to the 
product 313. However, after monitoring a reaction using IR spectroscopy, no evidence of an 
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intermediate ketone absorption was observed. This implies that one of the following is true: open 
intermediate 312 forms dihydropyran intermediate 311 which can then collapse to the product 313; 
the reaction proceeds directly via a [4 + 2] process to afford dihydropyran intermediate 311. Evans et 
al. considered the possibility of a cycloaddition based on previous work on the Mukaiyama–Michael 
additions of α-acyl β,γ-unsaturated phosphonates.88 In one case, Evans et al. were able to isolate a 
dihydropyran intermediate (Scheme 84). 
 
Scheme 84. (i) 5 mol % 301, CH2Cl2, –20 °C (6 % 317, 79 % 318). 
Dihyropyran intermediate 317 was isolated in 6 % yield from the reaction depicted above. It was also 
considered that the presence of a dihydropyran intermediate could be the cause of the original long 
reaction times for these processes. A dihydropyran intermediate may have sufficient Lewis basicity to 
coordinate to a free site on the Cu(II) catalyst, thereby decreasing the Lewis acidity of the catalyst and 
so inhibiting the overall reaction. Evans et al. also suggested that the observed rate increase on 
addition of an alcoholic additive (HFIP principally) may be due to the alcohol-promoted cleavage of 
the dihydropyran intermediate, thereby lessening its inhibiting effect.  
Interaction of the catalyst with the oxazolidinone 1,4-acceptor is believed to follow the model 
illustrated in Figure 33, which is based on the interaction of water ligands with the catalyst as proven 
by X-ray crystallography. Positioning of the bulky tert-butyl group on one face of the acrylate 
Michael acceptor gives rise to nucleophilic attack on the opposite face, and this is the source of the 
stereochemical induction observed (Figure 33). 
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Figure 33. Transition state models for Evans et al.’s Mukaiyama–Michael additions. 
Based on the presence of a dihydropyran intermediate, and the premise that this may arise from a 
cycloaddition taking place between the starting materials, one can imagine a transition state such as 
that above, where the boat-like endo transition state arises due to secondary orbital interactions 
between the silyl enol ether HOMO and the carbonyl LUMO. It should be noted that in certain cases, 
this preference may be disrupted, particularly when the geminal substituent (R1 in Figure 33) can 
more effectively exhibit stereoelectronic control than the enol ether oxygen (e.g. RS or C4H4N). 
Interestingly, when silyl ketene acetals derived from ester starting materials are employed, the 
selectivity of the reaction is compromised, most likely due to competing interaction of the 
trimethylsilyloxy and alkoxy substituents with the carbonyl LUMO as depicted above.  
In conclusion, Evans et al. have demonstrated a synthetically useful and wide-reaching method for the 
diastereo- and enantioselective Mukaiyama–Michael additions of silyl enol ethers to N-acryloyl 
oxazolidinones. 
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2.2.2 Attempted synthesis of 221 via Mukaiyama–Michael addition 
We envisaged the utilisation of this Mukaiyama–Michael addition in the synthesis of enantiomerically 
enriched methylenecyclohexane 221. We first wished to examine the feasibility of an all-carbon 
analogue, comprising the addition of trimethylsilylmethylcyclohexene 321 to N-acryloyl 
oxazolidinone 308 (Scheme 85). 
 
Scheme 85. (i) cat. 306, CH2Cl2, –20 °C. 
We imagined the all-carbon analogue of this reaction to proceed as shown above, with subsequent 
reductive cleavage of oxazolidinone 322 and protection of the resultant aldehyde as acetal 221. Given 
how integral the silyl enol ether moiety was in the mechanistic analysis of this reaction by Evans et 
al., we were unsure at this point whether this reaction would proceed with any selectivity at all. 
However, we felt that this was worth pursuing. 
With that in mind, we first attempted the synthesis of the two requisite starting materials. 
Oxazolidinone 308 was prepared as follows (Scheme 86). 
 
Scheme 86. (i) acrylic acid, DIC, DMAP, CH2Cl2, 16 h, rt (56 %). 
Carbodiimide-promoted amide formation proceeded smoothly to afford N-acryloyl oxazolidinone 
308. The principal by-product of this coupling, diisopropylurea, was present in the crude product, and 
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persisted even after purification by silica gel chromatography. However, several triturations with Et2O 
allowed most of the product to be separated from the urea by product.  
The synthesis of trimethylsilylmethyl cyclohexene 321 proved challenging. Initially it was our 
intention to form cyclohexenyl bromide 324, and the corresponding Grignard reagent 325, which 
could then displace the chloride of trimethylsilylmethyl chloride 326 to afford the required 
trimethylsilylmethyl cyclohexene 321 (Figure 34).  
 
Figure 34. Proposed synthesis of 316. 
In order to synthesise bromide 324, we envisaged exploiting recent work within the group on the 
conversion of cyclic vinyl triflates into the corresponding vinyl bromides, using TiBr4 as a 
brominating agent (Scheme 87).  
 
Scheme 87. (i) LDA, PhNTf2, THF, 3 h, –78 °C  0 °C (64 %); (ii) TiBr4, CH2Cl2, 20 h, –78 °C  rt. 
Cyclohexanone was treated with LDA and phenyl triflimide to form vinyl triflate 327. Subsequent 
bromination by treatment with TiBr4 was unsuccessful, and return of starting material was observed. 
Alternatively, bromination using LiBr and catalytic Ru(acac)3 was attempted (Scheme 88). 
 
Scheme 88. (i) LiBr, 3 mol % Ru(acac)2, EtMgBr, THF, 3 h, 60 °C. 
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This approach also proved unsuccessful, and several attempts gave only returned starting material. 
Direct formation of bromide 324 from cyclohexanone was investigated also (Scheme 89).  
 
Scheme 89. (i) P(OPh3), Br2, Et3N, CH2Cl2, 18 h, –60 °C  rt. 
TLC analysis of this process was promising, indicating two potential products in the reaction mixture. 
However, attempts at purification by silica gel chromatography afforded none of the desired product. 
It was considered at this point that bromides of this type may well be volatile, and as such purification 
of all of the above crude mixtures by distillation was attempted, but none of the desired bromide was 
obtained.  
We next investigated using a homologated bromide 328 to synthesise trimethylsilylmethyl 
cyclohexene 321 (Figure 35).  
 
Figure 35. Second proposed synthesis of 321. 
Our first efforts involved α-bromination of cyclohexane carboxaldehyde, with subsequent elimination 
to form the required cyclohexene motif. Reduction of the aldehyde to the corresponding alcohol, 
direct bromination or mesylation and substitution would afford bromide 328 (Figure 36).   
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Figure 36. Proposed synthesis of 328.  
Bromination at the α-position of 331 proved to be troublesome however (Scheme 90). 
 
Scheme 90. (i) Br2, NaHCO3, CH2Cl2, 18 h, 0 °C  rt. 
Crude 
1H NMR analysis indicated the presence of α-bromoaldehyde 331, but purification was 
difficult. Yields for this process were also lower than expected, suggesting that volatility may be an 
issue with this route also. To avoid isolation problems, a one-pot bromination-elimination process was 
attempted (Scheme 91).  
 
Scheme 91. (i) K2CO3, Br2, CHCl3, 16 h, 0 °C  rt, then PhNMe2, 14 h, reflux. 
This one-pot procedure delivered an intractable mixture with very little evidence by 
1
H NMR analysis 
of product presence. After storage of the crude samples for several hours at low temperature under N2, 
oxidation to the corresponding carboxylic acid was observed by 
1
H NMR spectroscopy. With this in 
mind, we decided to attempt the synthesis of cyclohexene carboxylic acid 334, with a view to 
reducing it to the corresponding alcohol and afterwards forming the desired bromide. A Pd-catalysed 
carbonylation of vinyl triflate 327 was therefore attempted (Scheme 92). 
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Scheme 92. (i) 10 mol % Pd(OAc)2, dppf, Mo(CO)6, pyridine, H2O, 150 °C, μwave. 
As an alternative to carrying out the reaction under an atmosphere of CO, Mo(CO)6
 
was used as a CO 
source. This reaction was capricious, and although crude 
1
H NMR analysis indicated the presence of 
acid 334, separation of the acid from the by products of this reaction, by recrystallisation, extraction 
or silica gel chromatography, proved difficult. With this in hand, and owing to the total cost of the 
reagents required for this process, we decided to use commercially available cyclohexene carboxylic 
acid 334 to aid investigation of this route to bromide 328. This strategy is outlined in Scheme 93. 
 
Scheme 93. (i) c. H2SO4, MeOH, 3 h, reflux then 16 h, rt (quant.); (ii) DIBAL-H, CH2Cl2, 1.5 h, –78 °C (85 %); 
(iii) PPh3, Br2, MeCN, 3 h, 0 °C (23 %). 
Cyclohexene carboxlic acid 334 was esterified with MeOH to afford methyl ester 335 in quantitative 
yield. Ester 335 was then reduced to the corresponding alcohol by treatment with DIBAL-H, and 
subsequent Appel bromination afforded cyclohexenyl bromide 328. Despite low yields for the Appel 
reaction, we thought it prudent at this point to probe the feasibility of the formation of the 
corresponding Grignard reagent from bromide 328, and thus the subsequent electrophilic substitution 
of the bromide by a trimethylsilyl group (Scheme 94).  
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Scheme 94. (i) Mg turnings, THF, 45 min, reflux then Me3SiCl, THF, 1 h, rt. 
The magnesium turnings used for Grignard formation were pre-activated mechanically by stirring 
under N2 overnight, and the formation of the Grignard reagent was confirmed by partial titration with 
diphenylacetic acid. TLC analysis indicated the formation of a very apolar product corresponding to 
silane 316, however isolation proved difficult. Despite the use of low-boiling solvents during 
work-up, only very small amounts (<10 mg) of a mixture of products were obtained regardless of the 
scale of the reaction. 
1
H NMR analysis seemed to indicate the presence of the desired product. 
However, due to the suspected volatility of silane 321, this process, and ultimately the use of silane 
321 in our proposed synthesis, was brought into question. 
As an alternative, we envisaged using the trimethylsilyl enol ether of cyclohexanone 241 to carry out 
the Mukaiyama–Michael addition, with subsequent chemoselective methylenation of the ketone, 
followed by reductive cleavage of the oxazolidinone portion and acetal formation (Scheme 95). 
 
Scheme 95. (i) cat. 301, CH2Cl2; (ii) Ph3PCH3I, n-BuLi, THF; (iii) DIBAL-H then ethylene glycol, p-TsOH, HC(OEt)3. 
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Synthesis of silyl enol ether 336 was achieved in one step from by treatment of cyclohexanone with 
LDA and chlorotrimethylsilane, followed by distillation; the product was stored at low temperature 
under N2 (Scheme 96).  
 
Scheme 96. (i) LDA, Me3SiCl, THF, 0 °C  rt, 30 min (54 %). 
The required BOX ligand was synthesised as described by Evans et al. (Scheme 97).
89
 
 
Scheme 97. (i) NaBH4, I2, THF, 19 h, reflux (99 %); (ii) (COCl)2, cat. DMF, CH2Cl2, 18 h, rt (83 %); (iii) Et3N, 
CH2Cl2, 35 min, rt (49 %); (iv) TsCl, Et3N, DMAP, 16 h, rt (74 %). 
(S)-tert-leucine 338 was treated with NaBH4 and catalytic iodine to afford (S)-tert-leucinol 339. 
Dimethylmalonic acid 340 underwent chlorination with oxalyl chloride and catalytic DMF to afford 
dimalonyl dichloride 341, which was purified by Kugelrohr distillation. Alcohol 339 and chloride 341 
were then treated with stoichiometric base to deliver diamide 342 which underwent double 
O-tosylation and cyclisation to give BOX ligand 343.  
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Complexing the BOX ligand to copper proved to be more difficult than first thought, and the need to 
carry out this process under a rigorously inert atmosphere became apparent. Addition of the ligand to 
dry Cu(II) chloride proceeded smoothly to afford the dichloro complex 344 (Scheme 98).  
 
Scheme 98. (i) CuCl2, CH2Cl2, 3.5 h, rt (67 %). 
Dichloride 344 was found to be reasonably air stable, and characterisation by IR spectroscopy was in 
direct agreement with those published in the literature. This complex is reportedly poor at catalysing 
the Mukaiyama–Michael process, and so an anion exchange process was developed to form the more 
active hexafluoroantimonate complex (Scheme 99).  
 
Scheme 99. (i) AgSbF6, CH2Cl2, rt. 
This experiment was conducted using fresh silver hexafluoroantimonate inside an inert atmosphere 
box, and after addition of the reagents the reaction was continued inside a sealed Schlenk vessel. 
Despite these precautions, a blue colour rapidly developed in the reaction mixture, in place of the 
desired dark green solution that corresponds to formation of the correct product. This blue colour is a 
result of the formation of the corresponding bis-aquo complex. The bis-aquo complex is also 
reportedly inactive in the Mukaiyama–Michael addition, and cannot be reverted to the anhydrous 
triflate complex. The bis-aquo complex was exclusively formed after several attempts at this 
transformation. 
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Due to the operationally difficult synthesis of complex 306 and its high propensity to hydration, 
investigation into this method for the synthesis of enantiopure spiroaziridines was suspended, and 
other methods were sought. 
  
 
 
 
 
Chapter 3 
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3.0.0 Claisen Rearrangements 
3.0.1 The Claisen Rearrangement 
First discovered in 1912 by Rainer Ludwig Claisen, the Claisen rearrangement has since become a 
powerful and adaptable tool for organic synthesis.
90
 The transformation involves a [3,3]-sigmatropic 
rearrangement of an allyl vinyl ether to form γ,δ-unsaturated carbonyl compounds (Figure 37).  
 
Figure 37. Claisen rearrangement. 
The Claisen rearrangement has spawned many variants since its inception including, but not limited 
to, the Belluš−Claisen rearrangement, the Johnson−Claisen rearrangement and the Ireland−Claisen 
rearrangement.  
3.0.2 The Belluš−Claisen rearrangement 
The Belluš−Claisen rearrangement was developed in 1978 by Belluš et al., and comprises the 
conversion of adducts of allylic ethers, amines and thioethers with ketenes to γ,δ-unsaturated esters, 
amides and thioesters (Figure 38).
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Figure 38. Belluš−Claisen rearrangement. 
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3.0.3 The Johnson−Claisen Rearrangement 
The Johnson−Claisen rearrangement was first published in 1970 by Johnson et al..92 The 
rearrangement involves the in situ generation of the rearrangement substrate via condensation of an 
allylic alcohol with an orthoester, to provide γ,δ-unsaturated esters (Figure 39). 
 
Figure 39. Johnson−Claisen rearrangement. 
3.0.4 The Ireland−Claisen rearrangement 
This variant of the Claisen rearrangement was discovered by Ireland et al. in 1972, and involves the 
conversion of an allylic acetate to its corresponding enolate with a strong base, and subsequent 
[3,3]-sigmatropic rearrangement of this enolate to afford a γ,δ-unsaturated carboxylic acid 
(Figure 40).
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Figure 40. The Ireland−Claisen rearrangement. 
Adding chlorotrimethylsilane to this reaction serves to accelerate the rearrangement of less 
highly-substituted acetates, by forming a silyl ketene acetal intermediate that is more susceptible to 
rearrangement. It is under these modified conditions that the majority of Ireland−Claisen 
rearrangements are carried out.  
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3.1.0 The decarboxylative Claisen rearrangement (dCr) 
 3.1.1 Overview of the decarboxylative Claisen rearrangement 
Since 2005, the Craig group has developed a variant of the Claisen rearrangement, the 
decarboxylative Claisen rearrangement (dCr). This transformation was uncovered when investigating 
the effect of bulky, removable substituents on the diastereoselectivity of Ireland−Claisen 
rearrangements, by introducing them at the α-position of the ketene acetal. Tosylsulfonyl substituents 
were the group’s focus, owing to their electron-withdrawing capability and ease of removal after 
rearrangement. Prior to this work, a single example of the Claisen rearrangement of α-sulfonyl esters 
was documented, wherein the rearrangement took place under standard Ireland−Claisen conditions 
(low temperature deprotonation using LDA, addition of chlorotrimethylsilane and subsequent 
warming to ambient temperature); the rearranged product was subjected to a separate decarboxylation 
step to afford the desired homoallylic sulfone.
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A one-pot rearrangement-decarboxylation process was therefore developed. Homoallylic sulfones 356 
are formed by the [3,3]-sigmatropic rearrangement of an α-sulfonyl silyl ketene acetal 349, which is 
generated in situ by treatment of sulfonylacetic esters 353 with bis(trimethylsilyl)acetamide (BSA) 
and catalytic potassium acetate, followed by concomitant desilylation-decarboxylation (Figure 41).
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Figure 41. The decarboxylative Claisen rearrangement. 
The dCr proceeds in reliably high yields and with good diastereoselectivity. The transformation is 
conventionally effected under reflux conditions in toluene, with N,O-bis(trimethylsilyl)acetamide 
(1.0 equiv) and KOAc (0.1 equiv), but can also be carried out under microwave irradiation conditions, 
or in the absence of solvent, with no significant decrease in yield or selectivity.
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 Oxygen and nitrogen 
functionalities are untouched by this procedure, providing that the heteroatom is fully masked, which 
provide a handle for functionalisation after the rearrangement (Scheme 100).  
 
Scheme 100. (i) BSA (1 equiv.), KOAc (0.1 equiv.), PhMe, reflux, 16 h (77 %); (ii) BSA (1 equiv.), KOAc (1 equiv.), 
PhMe, reflux, 16 h (74 %). 
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The procedure allows for the formation of quaternary carbon centres; the yields are consistently good 
regardless of the substitution level of the olefinic carbons in the allylic portion of the substrate, or the 
geometry of the double bond (Scheme 101). 
 
Scheme 101. (i) BSA (1 equiv.), KOAc (0.1 equiv.), PhMe, reflux, 16 h (80 %); (ii) BSA (1 equiv.), KOAc (0.1 equiv.), 
PhMe, reflux, 16 h (92 %); (iii) BSA (1 equiv.), KOAc (0.1 equiv.), PhMe, reflux, 16 h (88 %); (iv) BSA (1 equiv.), KOAc 
(0.1 equiv.), PhMe, reflux, 16 h (87 %). 
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In certain cases, the rearrangement occurs completely selectively to deliver 369 and 371 as single 
diastereomers, as confirmed by 
1
H NMR and X-ray crystallography, respectively (Scheme 102). 
 
Scheme 102. (i) BSA (1 equiv.), KOAc (0.1 equiv.), PhMe, reflux, 16 h (89 %, single diastereomer); (ii) BSA (1 equiv.), 
KOAc (0.1 equiv.), PhMe, reflux, 16 h (81 %, single diastereomer). 
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3.1.2 Diastereoselective decarboxylative Claisen rearrangements 
Given the encouraging selectivity of these processes, it was next the Craig group’s intention to 
develop an asymmetric variant of the dCr. Up until this point, most published research on asymmetric 
Claisen and Ireland–Claisen variants displayed selectivity derived from the presence of chiral 
substituents positioned adjacent to the pericyclic array, most commonly adjacent to the vinylic 
moiety. With this in mind, N-arylsulfonylsulfoximine groups were selected as a chiral sulfone 
surrogate in the dCr (Figure 42).
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Figure 42. Proposed diastereoselective dCr. 
It was proposed that given the suggested mechanism of the dCr process, sulfoximines bearing a 
nitrogen atom substituted with an electron-withdrawing group would be most suitable. As such, an 
expedient route to several racemic sulfoximine-containing cinnamyl acetates was devised, with each 
substrate furnished with a different sulfonyl group on the sulfoximine nitrogen (Scheme 103).   
 
Scheme 103. (i) n-BuLi (1.1 equiv), THF, –78 °C then gaseous CO2; (ii) cinnamyl alcohol (1 equiv), EDCI (1 equiv), 
CH2Cl2, 0 °C. 
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The dCr reactions of esters 376 were analysed (Scheme 104, Table 13).  
 
Scheme 104. (i) BSA (0.25 equiv), KOAc (0.1 equiv), PhMe, reflux. 
Entry R Ar Time / h Yield / % d.r. (SS*, S*):(SS*, R*) 
1 tolyl Ph 2 85 70:30 
2 2,4,6-triisopropylphenyl Ph 1.5 91 82:18 
3 1-naphthyl Ph 8 83 75:25 
4 CF3 Ph 7 ~30 66:34 
5 2-CF3OC6H4 Ph 8 64 75:25 
6 2,5-(CF3CH2O)2C6H3 Ph 15 83 78:22 
7 tolyl 2-pyridyl 18 ~50 68:32 
8 tolyl mesityl 10 0 - 
Table 13. Summary of arylsulfonyl substituents on sulfoximine nitrogen and their effect on the d.r. of the dCr reaction. 
It was therefore determined that the 2,4,6-triisopropylbenzenesulfonyl (Tris) substituent on the 
nitrogen of the sulfoximine gave rise to the greatest stereochemical preference in the rearranged 
products. The stereochemistry of these products was assigned by comparison with 
1
H NMR data of an 
unambiguously assigned compound (determined by X-ray crystallography). Alteration of the S-aryl 
substituent resulted in either greatly reduced yield (Ar = 2-pyridyl) or no reaction (Ar = mesityl). 
With this information in hand, 
(+)-(SS)-S-methyl-S-phenyl-N-(2,4,6-triisopropylphenylsulfonyl)sulfoximine was prepared via 
resolution of S-methyl-S-phenylsulfoximine as described in the literature.
98
 This compound was 
subsequently subjected to the standard carboxylic acid formation conditions as described above 
(Scheme 101), and then esterified with a variety of alcohols to obtain a library of dCr substrates that 
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could then be examined. Exposure of these substrates to standard dCr reaction conditions afforded the 
results below (Scheme 105, Table 14).  
 
Scheme 105. (i) BSA (0.25 equiv), KOAc (0.1 equiv), PhMe, reflux. 
Entry R1 R2 R3 R4 Time / h Yield / % d.r. (380:381) 
1 H H H Ph 1.5 91 82:18 
2 H H H C6H4-p-NO2 9 65 78:22 
3 H H H n-Pr 6 78 75:25 
4 H H n-Pr H 8 67 87:13 
5 H Me H Ph 8 76 75:25 
6 H H Me CH2CH2CH=C(CH3)2 6 84 70:30 
7 Me H H Me 8 94 53:47 
Table 14. Diastereoselective dCr reactions. 
Cinnamyl esters once again gave rise to a high level of diastereoselectivity, delivering the product in 
82:18 d.r. The most encouraging result provided afforded the product in 87:13 d.r., which represents 
the best diastereoselectivity in a dCr process to date. 
The selectivity for 380 observed in this process is explained using the following models (Figure 43). 
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Figure 43. Proposed pseudochair transition state model. 
These models assume Z-geometry for the silylketene acetals formed in situ. In the favoured transition 
state 383, the S═N bond (and thus the bulky arylsulfonyl group) is positioned antiperiplanar with 
respect to the ketene acetal C═C bond. This conformational preference is more pronounced with 
bulkier arylsulfonyl groups, giving credence to the increase in diastereoselectivity observed when 
N-Tris-sulfoximines are employed. To further minimise steric interactions, the preferred approach of 
the allylic portion of the substrate is syn with respect to the sulfoximine oxygen atom and anti with 
respect to the phenyl group. This would explain the enhanced diastereoselectivity when this allylic 
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portion has Z-geometry (Table 14, Entry 4); the unfavourable steric interaction of the n-Pr and phenyl 
groups is maximised in transition state 381, thereby giving this substrate a stronger preference for 
transition state 383. 
At first it was not clear how introducing extra substitution at the α-position to the ester would affect 
the diastereoselectivity of this process. We envisaged that a more sterically encumbered starting 
material would only increase the conformational preference for the least sterically hindered transition 
state, thereby increasing the diastereoselectivity of the process. With this in mind, we devised a 
modified synthetic route to (–)-lepadiformine, based on the utilisation of a key diastereoselective dCr 
process to install the correct stereochemistry for the trans-1-azadecalin motif of the natural product. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter 3: Second-generation Strategy: The Decarboxylative Claisen Rearrangement                   129 
 
 
3.2.0 (–)-Lepadiformine: a revised strategy 
Our revised approach to the synthesis of (–)-lepadiformine is outlined below (Figure 44). 
 
Figure 44. Revised retrosynthetic analysis of (–)-lepadiformine. Tris = 2,4,6-tri(isopropyl)benzenesulfonyl. 
As with previous hypotheses, we imagined the final stages of the synthesis to proceed via 
acid-catalysed acetal deprotection of 389 and subsequent reductive amination ring closure, with the 
interception of an intermediate iminium ion by an n-hexyl nucleophile in a diastereoselective manner, 
thus forming the B-ring of the natural product. Pyrrolidine 389 would be synthesised from amino 
alcohol 390 via an SN2-like ring closure process followed by reductive desulfonylation. We envisaged 
the synthesis of 390 to proceed from enantiomerically enriched spiroaziridine 391, which we believed 
could be accessed using a Sharpless aziridination protocol. Methylenecyclohexane 392 was proposed 
to be the product of a diastereoselective decarboxylative Claisen rearrangement of 
sulfoximine-containing ester 393, which in turn would be synthesised from enantiopure sulfoximine 
394. 
Our mechanistic rationale for the rearrangement of 393 is outlined below (Figure 45). 
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Figure 45. Mechanistic rationale for the rearrangement of ester 392. 
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As with our previous models, the discussion above assumes Z-geometry of the silyl ketene acetals 
formed. In addition, in the favoured transition state 395, the sulfoximine S═N bond is once again 
positioned anti-periplanar to the ketene acetal C═C bond, thus giving minimal steric interactions 
between the pericyclic array and the bulky Tris group. Also, the approach of the allylic portion, this 
time part of a cyclohexene ring, is again syn with respect to the sulfoximine oxygen atom, and anti to 
the sulfoximine phenyl substituent. In transition state 397, which we believe will be less favoured, we 
envisage potential steric interactions between the S-phenyl group and the pericyclic array, as well as 
the Tris group and the cyclohexene ring. Crucially, it was at this point unknown whether the 
dioxolane substituent would influence which transition state was more stable. As drawn above, it 
would seem that in transition state 395, the dioxolane ring may well encounter steric interactions, 
however, given its ability to rotate, this may be fleeting. That being said, it is hoped that the presence 
of this extra substituent will provide a larger energy barrier to interconversion between the two 
transition states, thereby augmenting the preference for transition state 395, and thus giving rise to an 
increase in diastereoselectivity.  
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3.2.1 dCr Substrate synthesis 
Our initial efforts were focussed on the synthesis of (+)-(SS)-S-methyl-S-phenyl-N-(2,4,6-
triisopropylphenylsulfonyl)sulfoximine 394, which proceeded from thioanisole according to the 
method of Johnson and co-workers, as described in Scheme 106.
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Scheme 106. (i) Chloramine-T®, Bu4NBr, CH2Cl2, 2 h, rt (97 %); (ii) RuO2•xH2O, NaIO4, CCl4, MeCN, H2O, 2 h, rt (90 %); 
(iii) c. H2SO4, 25 min, 120 °C (99 %); (iv) (1S)-(+)-CSA, acetone, 16 h, rt (38 % of poss. 50 %); (v) TrisCl, pyridine, 24 h, rt 
(97 %). 
Thioanisole 298 was first oxidised to the corresponding sulfilimine 400 with Chloramine-T®, after 
which ruthenium(IV)-catalysed oxidation took place to afford N-Ts sulfoximine 401. Detosylation in 
conc. sulfuric acid at elevated temperature provided N-H sulfoximine 402. This compound then 
underwent resolution with (1S)-(+)-camphorsulfonic acid to deliver sulfoximinium camphorsulfonate 
403 as a single enantiomer, in line with a literature procedure. Finally, protection of the sulfoximine 
nitrogen with 2,4,6-tri(isopropyl)benzenesulfonyl chloride under basic conditions produced 
sulfoximine 394. This synthesis can be completed on up to 100 g scale with no observable erosion of 
yield or enantiopurity. 
In order to synthesise a basic test substrate for this transformation, we first prepared the acetic acid 
and methyl acetate derivatives shown in Scheme 107, based on work previously carried out in the 
group. 
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Scheme 107. (i) NaH, dimethyl carbonate, THF, 20 h, reflux (94 %); (ii) n-BuLi, CO2 (g), THF, 0 °C – rt (60 %). 
Deprotonation of the sulfoximine methyl with sodium hydride and subsequent treatment with 
dimethyl carbonate afforded methyl ester 404. Alternatively, use of n-BuLi as a base and quenching 
of the resulting carbanion with gaseous carbon dioxide led to the formation of carboxylic acid 405. 
With acid 405 in hand, we decided to carry out an esterification with cyclohexene-1-methanol 333. 
Previously, our synthesis of this key alcohol had involved esterification-reduction of 
cyclohexene-1-carboxylic acid 334. However, due to our dwindling supply of this starting material, 
and its exorbitant price, we sought another route for the synthesis of alcohol 333, which is outlined in 
Scheme 108. 
 
Scheme 108. (i) trimethylsulfonium iodide, KOt-Bu, DMSO, 16 h, rt; (ii) p-TsOH, N,N-dimethylimidazolidinone, CH2Cl2, 
16 h, rt (75 % over 2 steps). 
Thus, alcohol 333 was prepared in two steps from commercially available cyclohexanone. The first 
step comprised Corey–Chaykovsky methylenation to afford spiroepoxide 406 which was used without 
further purification.
99
 This was followed by regiospecific ring-opening to form the more stable 
carbocation, which was subsequently quenched by elimination, to deliver alcohol 333. This compound 
was prepared according to a procedure by Motherwell et al., where the use of a more polar solvent 
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encourages the formation and longevity of carbocations in solution, allowing for interconversion to 
the more stable isomer.
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Scheme 109. (i) DIC, DMAP, CH2Cl2, 16 h, rt (88 %). 
Carbodiimide-promoted esterification proceeded smoothly to afford ester 407 (Scheme 109). This 
compound was then subjected to typical dCr conditions, by treatment with substoichiometric 
silylating agent and base, at elevated temperature in PhMe (Scheme 110). 
 
Scheme 110. (i) BSA (0.25 equiv), KOAc (0.1 equiv), PhMe, 5 h, reflux (80 %, 74:26 d.r.). 
Ester 407 underwent rearrangement and concomitant decarboxylation to afford homoallyl sulfoximine 
408 in 74:26 d.r. Although the absolute stereochemistry of the major diastereomer could not be 
proven, based on our previous transition state models we envisaged the formation of 408 as the major 
diastereomer. This result was in line with our previous work on similar substrates, and as such 
encouraged us to pursue this route further.  
We hoped that the installation of an extra substituent between the sulfoximine and carboxyl moieties 
would increase the diastereoselectivity of the process. Therefore, our first attempts at developing this 
type of substrate comprised the attempted α-alkylation of methyl ester 404 with 
2-bromomethyl-1,3-dioxolane 409 (Scheme 111, Table 15). 
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Scheme 111. Attempted alkylation of methyl ester 404. 
Entry Reagents Solvent Time / h Temp / °C Result 
1 
3 equiv NaH 
1 equiv 409 
THF 20  0  rt SM 
2 
5 equiv NaH 
1 equiv 409 
THF 24  0 50 Complex mixture 
3 
1 equiv NaH                
1.2 equiv 409 
DMF 16  0  rt SM 
4 
2 equiv NaH                  
1 equiv 409 
DMF 16  80 Decomposition 
5 
3 equiv NaH 
1 equiv 409              
0.5 equiv Bu4NI 
DMF 24  0  rt 
SM and 
decomposition 
6 
1 equiv Cs2CO3 
1 equiv 409 
DMF 60  0  rt 
Complex mixture 
and decomposition 
Table 15. Conditions for dioxolane formations. 
All attempts at this point proved unsuccessful, either resulting in no reaction, or the formation of 
several intractable products. Crude 
1
H NMR analysis did suggest that a dioxolane moiety was present, 
but this was due mostly to the presence of bromide 409 in the crude mixture. The difficulty of this 
process is believed to be due to the poor electrophilicity of bromide 409.  At this point it was also 
noted that the next planned step was to be saponification with LiOH to form the corresponding 
carboxylic acid. Although the basic reaction conditions would not affect the dioxolane, the standard 
work-up procedure of acid-base extraction would most likely give hydrolysis of the dioxolane to the 
aldehyde, compounds similar to which had been observed to be unstable in previous attempts. For this 
reason, direct alkylation onto dCr substrate 407 was attempted, but again no product was isolated after 
Chapter 3: Second-generation Strategy: The Decarboxylative Claisen Rearrangement                   136 
 
 
several attempts. In addition to this, the alternative 2-(2-bromoethyl)-1,3-dioxolane was employed, as 
this acts as a slightly better electrophile. However, no product was isolated after several attempts. In 
addition, attempts at alkylation of both carboxylic acid 405 and ester 404 resulted in no reaction with 
either dioxolane-containing electrophiles. 
It was at this point that we decided to look into an alternative α-substituent for this process, in hope of 
observing the proposed increase in diastereoselectivity. Several methods for the incorporation of an 
allyl substituent were attempted (Scheme 112, Table 16).  
 
Scheme 112. Allylation of methyl ester 404. 
Entry Reagents Solvent Time / h Temp Result 
1 
1 equiv DBU 
1 equiv  
0.1 equiv Bu4NI 
DMF 18  rt 2:1 411:412 and SM 
2 
1 equiv NaH 
1 equiv  
THF 16  0  rt Complex mixture 
3 
1 equiv  
0.05 equiv Pd2(dba)3 
0.5 equiv PPh3 
 
THF 6  rt 412 only and SM 
4 
1 equiv  
0.05 equiv Pd2(dba)3 
0.5 equiv PPh3 
Slow addition of carbonate 
THF 0.5 rt 411 only 
Table 16. Allylation conditions. 
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The use of both allyl bromide and allyl iodide resulted in both the mono- and bis-alkylated products 
(411 and 412 respectively) forming. Pd-catalysed allylation with allylmethyl carbonate originally 
yielded only the bis-alkylated product 412. However, slow addition of the carbonate in solution via 
syringe pump resulted in clean formation of the mono-alkylated product 411.  
With this in hand, ester 404 was converted into the allyl-substituted dCr substrate 414 in three steps 
(Scheme 113).  
 
Scheme 113. (i) Allylmethyl carbonate, Pd2(dba)3, PPh3, THF, 45 min, rt (89 %); (ii) 2 M aq. LiOH, THF, 16 h, rt (97 %); 
(iii) 1-cyclohexene-1-methanol, DIC, DMAP, CH2Cl2, 16 h, rt (96 %).  
Ester 411 was formed via a Pd-catalysed allylation of ester 404, with subsequent saponification with 
2 M aq. LiOH to afford acid 413. Acid 413 was then converted into ester 414 under 
carbodiimide-mediated esterification conditions. 
It was deemed beneficial to attempt a dCr process with substrate 414 in order to probe the 
diastereoselectivity of the process, and whether or not a more crowded transition state required more 
forcing conditions to complete the rearrangement. Based on previous work on similar substrates, ester 
414 was subjected to typical dCr conditions using a microwave reactor (Scheme 114, Table 17).  
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Scheme 114. dCr reaction of 414. 
Entry Reagents Solvent Time Temp / °C Result 
1 
0.25 equiv BSA     
0.1 equiv KOAc 
PhMe 24 h Reflux SM and decomposition 
2 
1 equiv BSA             
0.1 equiv KOAc 
PhMe 2 x 10 min 
160 
(microwave) 
SM and decomposition 
3 
7 equiv BSA              
0.1 equiv KOAc 
- 2 x 5 min 
150 
(microwave) 
SM and decomposition 
4 
15 equiv BSA              
0.1 equiv KOAc 
- 7 x 1 min 
230 
(microwave) 
Decomposition 
5 
10 equiv BSA             
0.1 equiv KOAc 
- 5 x 2 min 
180 
(microwave) 
SM and decomposition 
6 
7 equiv BSA          
0.1 equiv KOAc 
DMF 3 x 2 min 
240 
(microwave) 
Decomposition 
7 
1 equiv BSA 
0.1 equiv KOAc 
DMF 3 x 1 min 
200 
(microwave) 
SM and decomposition 
Table 17. dCr conditions. 
Reaction of ester 414 under the previously successful dCr conditions resulted in several new 
decomposition compounds being formed, none of which were isolated. Elimination of the sulfoximine 
moiety from both the starting material and the product gives rise to volatile compounds that could not 
be isolated. Analysis by 
1
H NMR suggested that these volatile products are readily formed at high 
temperatures and prolonged reaction times in the microwave. Curiously, in many cases unreacted 
starting material was present in the crude mixture, suggesting that the reaction had not proceeded 
fully. In the past, the group has found pulsed reaction times to be of greater efficacy in these types of 
transformations, as the frequent, short pulses of energy are sufficient to surmount the activation 
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barrier to rearrangement, but the reaction times are not long enough to give significant decomposition 
of the starting materials or products. One such example is the Claisen rearrangement employed in the 
synthesis of Azadirachtin by Ley et al.
101
 Adjustment of the reaction times to shorter pulses (Entries 
4-7, Table 17) seemed promising at first, however similar results were achieved after purification and 
NMR analysis.  
At this point we decided to synthesise a model substrate to avoid the loss of large amounts of 
enantiopure material. The racemic tosyl analogue of 414, ester 420, was synthesised in four steps 
from methyl bromoacetate 416 (Scheme 115).  
 
Scheme 115. (i) p-Toluenesulfinic acid (sodium salt), DMF, 24 h, rt (99 %); (ii) allylmethyl carbonate, Pd2(dba)3, PPh3, 
THF, 45 min, rt (73 %); (iii) 2 M LiOH, THF, 16 h, rt (99 %); (iv) 1-cyclohexene-1-methanol, DIC, DMAP, CH2Cl2, 16 h, rt 
(85 %). 
Methyl bromoacetate 416 was converted into methyl tosylacetate 417 by treatment with the sodium 
salt of p-toluenesulfinic acid, with subsequent Pd-catalysed allylation to afford 418. Saponification 
with 2 M aq.  LiOH delivered acid 419, which then underwent esterification with 
1-cyclohexene-1-methanol to give ester 420.  
Ester 420 was then subjected to dCr conditions, where a shorter, pulsed reaction time was employed 
in the hope of avoiding decomposition (Scheme 116). 
Chapter 3: Second-generation Strategy: The Decarboxylative Claisen Rearrangement                   140 
 
 
 
Scheme 116. (i) BSA (1 equiv), KOAc (0.1 equiv), DMF, 4 x 30 seconds at 200 °C (microwave) (80 %). 
Ester 420 was successfully converted into homoallyl sulfone 421, which was isolated as an 
inseparable 1:1 mixture of two diastereomers.  
Upon repeating this reaction with chiral ester 414 under identical conditions, only starting material 
and decomposition were again observed (Entry 1, Table 18). In order to identify at which temperature 
decomposition is more likely to occur, the reaction was repeated at a lower temperature, with 
promising results (Scheme 117, Table 18).  
 
Scheme 117. dCr reaction of 414. 
Entry Reagents Solvent Time Temp / °C Result 
1 
1 equiv BSA         
0.1 equiv KOAc 
DMF 
2 x 30 
seconds 
200 
SM and 
decomposition 
2 
1 equiv BSA           
0.1 equiv KOAc 
DMF 
1 x 30 
seconds 
150 
Intractable mixture 
of product and SM 
\3 
1 equiv BSA        0.1 
equiv KOAc 
DMF 
6 x 15 
seconds 
150 
Decomposition and 
SM 
4 
1 equiv BSA          
0.1 equiv KOAc 
DMF 
3 x 15 
seconds 
150 415 only (75 %) 
Table 18. dCr conditions. 
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As mentioned above, heating the reaction to 200 °C gave rise to decomposition and recovery of 
starting material. Lowering both the reaction temperature and time resulted in an apparently 
incomplete reaction by TLC, but 
1
H NMR analysis suggested that the isolated compound was actually 
a mixture of product and SM (Entry 2, Table 18). With that in mind, we attempted to follow the 
progress of the reaction by IR spectroscopy as opposed to TLC, in the hope that the consumption of 
starting material would correspond to the diminution of the strong C═O absorption of ester 414. 
However, residual BSA in the reaction mixture proved difficult to remove, the IR absorptions of 
which eclipsed those of the starting material. As a result, the reaction was allowed to proceed for too 
long (Entry 3, Table 18), and only starting material and decomposition products were observed. 
Finally, a suitable TLC solvent system (acetone/PhMe) was developed to allow for clear monitoring 
of the reaction’s progress. With this in hand it was possible to achieve full conversion to the dCr 
product in 75 % yield with minimal decomposition observed. 
The product was formed as a mixture of four diastereomers, in a ratio of 4:3:2:1 (Figure 46).  
 
Figure 46. Potential diastereomers resulting from dCr reaction of 409. 
Although it was possible to assign the 
1
H and 
13
C NMR signals of this mixture, separation was not 
achieved. Given the anticipated diastereoselectivity of this process, we postulated that the two major 
diastereomers might correspond to sulfoximine epimers of the correct diastereomer, i.e. 422 and 423 
with the desired (R)-configuration at the allylic ring position. This would give rise to an overall d.r. of 
70:30 for this centre, which is lower than we initially expected.  
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In an attempt to elucidate the diastereomeric mixture, and to simplify the very complex 
1
H and 
13
C 
NMR spectra obtained, homoallylic sulfoximine 415 was subjected to ring-closing metathesis 
conditions, in the hope of obtaining a crystalline bicyclic compound 426 (Scheme 118).  
 
Scheme 118. (i) Grubbs-II (cat.), CH2Cl2, 16 h, reflux. 
TLC analysis of this reaction was promising, with two apparent products forming, presumably 
corresponding to the two sulfoximine epimers of bicycle 426. Separation of the two compounds 
proved very difficult however, and a pure sample of neither compound was obtained. A mixture of the 
two products was obtained, however the 
1
H NMR spectrum was also very complex, and clearly 
showed the presence of at least two diastereomers, along with some other unidentified impurities. 
In hope of simplifying further the NMR spectra further for this compound, we decided to treat the 
sulfoximine epimers with substoichiometric base, in the hope that one sulfoximine would be more 
conformationally stable, thus leaving only one (potentially) undefined stereocentre and therefore 
maximum two diastereomers present (Scheme 119).  
 
Scheme 119. (i) KOt-Bu, t-BuOH, THF, 16 h, rt. 
Neither 427 nor 428 was formed exclusively, although 
1
H NMR analysis did indicate that the ratio of 
epimers had altered, with resonances corresponding to the CHS proton switching preference from 2:1 
in favour of one epimer to 2:1 in favour of the other epimer. This also raised another issue: at present 
it is difficult to determine whether the splitting of the CHS proton resonances is due to the presence of 
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two sulfoximine epimers, or whether they are simply diastereotopic due to the adjacent C-based 
stereocentre.  
In order to simplify the NMR spectra for these types of transformations, another test substrate was 
postulated, with a benzyl-like substituent in place of the allyl group in 420. It was hoped that the relief 
of the congestion in the olefinic area of the 
1
H NMR may help to clarify the ratio of diastereomers 
present. In order to test how feasible this synthesis would be, the racemic tosyl analogue ester 417 was 
alkylated and elaborated into dCr substrate 431 (Scheme 120).  
 
Scheme 120. (i) DBU, PMBCl, THF, 40 h, rt (40 %); (ii) 2 M LiOH, THF, 24 h, rt (92 %); (iii) 1-cyclohexene-1-methanol, 
DIC, DMAP, CH2Cl2, 16 h, rt (68 %). 
Ester 417 was alkylated with p-methoxybenzyl chloride to afford ester 429, which was subsequently 
saponified under standard conditions to yield acid 430. Esterification with 1-cyclohexene-1-methanol 
delivered dCr substrate ester 431.  
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Subjection of ester 431 to previously optimised dCr conditions gave clean product formation with 
very little decomposition (Scheme 121).  
 
Scheme 121. (i) 2 equiv BSA, 0.1 equiv KOAc, DMF, 3 x 15 seconds at 150 °C (microwave), (37 %). 
Despite proceeding in moderate yield, rearrangement of ester 431 provided homoallylic sulfone 432 
as a 1:1 mixture of diastereomers. Despite this appearing to be a reliable process, and the olefinic 
region of the 
1
H NMR being considerably easier to interpret, before extending this methodology to the 
synthesis of a chiral sulfoximine ester dCr substrate, we first wished to explore the possibility of 
converting allyl-substituted sulfoximine ester 411 into the requisite dioxolane-containing species 410. 
We postulated that ozonolysis of the terminal alkene of 411 would provide us with an aldehyde that 
could then be converted in to the required acetal. Ozonolyis of 411 was attempted first (Scheme 122). 
 
Scheme 122. (i) O2/O3, CH2Cl2, –78 °C then PPh3, 16 h, rt. 
Subjection of ester 411 to ozonolytic conditions resulted in the development of a blue solution after 
10 minutes, corresponding to the presence of excess ozone in the solution, thereby signalling that all 
olefinic starting material had been consumed. After quenching with triphenylphosphine, TLC analysis 
indicated the presence of several products. Crude 
1
H NMR analysis revealed several aldehydic 
signals, and the absence of the majority of the sulfoximine resonances. We considered that formation 
of aldehyde 433 could also give rise to facile elimination processes whereby the aldehyde enolate is 
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formed and subsequently eliminates the sulfoximine moiety to produce the corresponding 
α,β-unsaturated aldehyde. This outcome was supported by the presence of some olefinic signals in the 
crude 
1
H NMR. 
In order to probe whether this outcome was a result of employing ozone in this transformation, a 
Lemieux–Johnson protocol was also attempted (Scheme 123). 
 
Scheme 123. (i) OsO4 (5 % in H2O), NaIO4, NMO, 3:1 THF:H2O, rt. 
Indeed, a similar result was obtained with this protocol; no product was detected and NMR analysis 
indicated the absence of any sulfoximine signals. 
Given the apparent instability of aldehyde 433, we next decided to attempt a one-pot synthesis of 
dioxolane 410 from allyl-substituted ester 411 (Scheme 124). 
 
Scheme 124. (i) O3/O2, 9:1 CH2Cl2:ethylene glycol, 20 min, –78 °C then Me2S, p-TsOH, HC(OEt)3, 48 h, rt (16 %). 
Treatment of olefin 411 with ozone for 20 minutes in a mixture of CH2Cl2 and ethylene glycol 
resulted in a blue reaction mixture, which after removal of excess ozone was placed under an inert 
atmosphere and treated with dimethyl sulfide, p-TsOH and triethyl orthoformate. After 48 h, one 
predominant product was observed by TLC analysis. After isolation, dioxolane 410 was isolated, 
albeit in low yield, as a 1:1 mixture of diastereomers. Although this result was encouraging, attempts 
at optimisation of this reaction only led to a decrease in yield and formation of a significant number of 
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by-products. Despite the low yield of this process, the next step in the synthesis, saponification of 
methyl ester 410, was attempted (Scheme 125). 
 
Scheme 125. (i) 2 M LiOH, THF, 24 h, rt. 
Subjection of ester 410 to our standard saponification conditions appeared to proceed well by TLC 
analysis. However, the conventional work-up procedure involving partitioning of the reaction mixture 
between water and diethyl ether and subsequent acidification and extraction of the aqueous layer, 
resulted in the isolation of a complex mixture of products. Some aldehydic signals were again 
observed by 
1
H NMR analysis, along with several potential olefinic signals. It appears that, 
unsurprisingly, the acidification process gave rise to acetal hydrolysis and subsequent reaction or 
elimination of the resulting aldehyde, as observed previously. It was also postulated that, even if an 
alternative work-up procedure was developed, that carboxylic acid 434 may well be prone to an 
autocatalytic decomposition pathway, whereby the carboxylic acid moiety provides the requisite 
acidity to bring about acetal hydrolysis. We proposed that a transesterification process would 
circumvent this issue, however subjection of methyl ester 410 to several conventional 
transesterification procotols with 1-cyclohexene-1-methanol 333 proved unfruitful. The principal 
issue with this transformation was the requirement for excess incoming alcohol in order to effect the 
transesterification. Since our supply of alcohol 333 was somewhat precious, we were hesitant to 
commit so much material to this process. In addition, the relatively high boiling point of alcohol 333 
(compared to frequently-used low-boiling alcohols such as ethanol) resulted in the reaction being 
difficult to follow by TLC and the products being difficult to purify. In another attempt to avoid acetal 
hydrolysis, we contemplated subjecting allyl-substituted dCr substrate 414 to similar one-pot 
ozonolysis-acetal formation conditions. However, the presence of another olefin in the ester portion of 
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the molecule would no doubt give rise to competing ozonolysis processes and ultimately the 
degradation of this material.  
3.2.2 Alternative dioxolane syntheses 
At this point we devised an alternative route to dioxolane 410. During the group’s previous research 
on the synthesis and reactivity of 1,4-bis(arylsulfonyl)-1,2,3,4-tetrahydropyridines, we completed the 
synthesis of dimethyl acetal 436, which was subsequently used in an aziridine ring-opening process, 
based on a literature procedure (Scheme 126).
102,103
 We therefore considered if an analogous 
sulfoximine-containing compound could be prepared. 
 
Scheme 126. (i) acrolein, AcOH, 12 h, rt; (ii) HC(OEt)3, p-TsOH, MeOH, 20 h, 50 °C. 
Sodium p-toluenesulfinate was combined with acrolein to produce the corresponding β-tosyl 
aldehyde, which underwent subsequent dimethyl acetal formation to afford 436. The use of a 
comparable procedure for the synthesis of a sulfoximine-containing variant, gave rise to several 
issues. Firstly, we imagined the synthesis of a sulfoximine salt similar to 435 would be difficult, and 
that conservation of its enantiopurity would also be problematic. Secondly, if we considered 
sulfoximine 394 to be the starting point for this synthesis, then installation of the dioxolane portion 
would require an electrophile similar to 1-bromomethyl-1,3-dioxolane, which as demonstrated 
previously, behaves poorly in these types of transformations. 
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Upon searching the literature for the synthesis of similar compounds, we discovered a process which 
detailed the conversion of olefins bearing electron-withdrawing groups at the vinylic position to 
dioxolanes via a radical-mediated addition of 1,3-dioxolane (Scheme 127).
104
 
 
Scheme 127. 2 equiv TBAP, rt. 
In this work, olefins 438 were treated with dioxolanes 439 and radical initiator tetrabutylammonium 
peroxydisulfate (TBAP) to effect formation of dioxolanes 440. The TBAP reagent can be prepared 
easily from potassium peroxydisulfate and tetrabutylammonium sulfate according to a literature 
procedure.
105
 This process is believed to proceed via formation of a carbon-based radical at the 
2-position of the dioxolane, followed by addition to the electron-deficient olefin. With regard to our 
synthesis, the inclusion of vinyl sulfones in this work was of particular interest. 
Therefore, we applied this methodology to the synthesis of sulfoximine-containing dioxolane 437 
(Scheme 128). 
 
Scheme 128. (i) n-BuLi, paraformaldehyde, THF, 1 h, –78 °C  0 °C then Et3N, MsCl, 20 min, 0 °C then Et3N, 20 min, rt 
(45 %); (ii) 2 equiv TBAP, 1,3-dioxolane, 16 h, rt (62 %).  
Vinyl sulfoximine 441 was prepared via deprotonation of methyl sulfoximine 394 and reaction with 
paraformaldehyde, followed by mesylation and elimination of the resulting alcohol, according to a 
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literature procedure.
106
 Subjection of 441 to radical addition conditions with 1,3-dioxolane provided 
dioxolane 437 in moderate yield.  
With this compound in hand, we next wished to synthesise either carboxylic acid 434 or methyl ester 
410 with a view to ultimately forming the requisite dCr substrate. Both of these processes were 
attempted (Scheme 129). 
 
Scheme 129. (i) n-BuLi, CO2 (g), THF, 12 h, –78 °C; (ii) n-BuLi, methyl chloroformate, THF, 16 h, –78 °C  rt. 
Frustratingly, both of these processes only gave rise to decomposition, and no product was isolated. 
As observed previously, no sulfoximine resonances were detected by crude 
1
H NMR analysis, and the 
dioxolane portion of the compound also appeared to have partially decomposed. In the case of 
formation of carboxylic acid 434, this result was somewhat expected, given our theory earlier in this 
project that compounds of this type may undergo autocatalytic decomposition via acetal hydrolysis. 
With regard to the formation of methyl ester 410, a similar decomposition pattern was observed. It is 
possible that the chloride resulting from the addition of methyl chloroformate may have brought about 
a similar decomposition pathway involving sulfoximine elimination. Given the apparent issues with 
the use of a chloroformate electrophile, the synthesis of the methylcyclohexene-containing 
chloformate, which would allow the direct synthesis of dCr substrate 393 from dioxolane 437, was not 
attempted. The operational difficulty of chloroformate synthesis, which often requires the use of 
phosgene, was also considered.  
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In order to circumvent the issues presented by carrying a dioxolane moiety through this synthesis, we 
contemplated the use of a masked olefin functionality, with the intention of installation of the 
dioxolane fragment at the latest possible stage via TBAP-promoted radical addition. Dimethylamine 
adduct 442 was considered suitable for this role (Scheme 130). 
 
Scheme 130. (i) Me2NH (2 M in THF), EtOH, rt (quant.). 
Formation of dimethylamine adduct 442 proceeded in quantitative yield via treatment of vinyl 
sulfoximine 441 with a solution of dimethylamine in THF. It was believed that elaboration of 
dimethylamine adduct 441 to methylcyclohexene ester 443 would be followed by quaternisation and 
elimination of the dimethylamine portion to form α,β-unsaturated ester 444. Ester 444 could then 
undergo radical addition of 1,3-dioxolane to the olefin moiety in line with chemistry demonstrated 
previously.  
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Despite facile formation of the dimethylamine adduct 442, subsequent elaboration of this compound 
was unsuccessful (Scheme 131). 
 
Scheme 131. (i) n-BuLi, CO2 (g), THF, 4 h, –78 °C; (ii) n-BuLi, methyl chloroformate, THF, 16 h, –78 °C  rt. 
Attempted formation of either carboxylic acid 445 or methyl ester 446 resulted in no product being 
isolated. It is possible that the acidic conditions required to purify acid 445 would have resulted in 
formation of an ammonium salt which would then have remained dissolved in aqueous media. There 
is also the possibility that acid 445 exists as a zwitterionic species, and as such was difficult to isolate 
using conventional work-up procedures. Treatment with methyl chloroformate to afford ester 446 
gave rise to unidentified products, probably through decomposition. Again, formation of ammonium 
salts or indeed extraneous reactivity of the amine and ester moieties to form an azetidinium 
intermediate may have hindered this process. 
Given that myriad issues had arisen during our attempted synthesis of dCr substrate 393, we instead 
revised our proposed synthesis of (–)-lepadiformine to incorporate a different substituent. This 
approach, and our efforts on its completion to date, are outlined in the next section. 
 
 
 
 
Chapter 3: Second-generation Strategy: The Decarboxylative Claisen Rearrangement                   152 
 
 
3.3.0 (–)-Lepadiformine: An alternative approach 
We felt it necessary at this point to consider an alternative approach to the synthesis of                       
(–)-lepadiformine. Our reimagined retrosynthesis is displayed in Figure 47. 
 
Figure 47. Retrosynthesis of (–)-lepadiformine. 
Although this retrosynthetic analysis bears many similarities to our previous approaches, there are 
some key differences. We envisaged the final stages of the synthesis to proceed via formation of the 
C-ring of the natural product, which involves asymmetric dihydroxylation of olefin 447, followed by 
selective protection of the primary alcohol and concomitant N-desulfonylation and ring-closure onto 
the remaining alcohol. The B-ring would be incorporated by a similar SN2-like ring-closure of the 
sulfonamide moiety onto the chiral alcohol in 448. Hydroxysulfonamide 448 would then be formed by 
allylative ring-opening of N-Ts aziridine 449. Finally, aziridine 449 would be synthesised via 
Sharpless aziridination of methylenecyclohexane 450, along with reductive removal of the 
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sulfoximine auxiliary. We considered two principal possibilities for the formation of 
methylenecyclohexane 450 as a single enantiomer. Firstly, we imagined the extension of the 
previously studied dCr process to ester 451, where the chiral alcohol moiety has been incorporated. In 
addition, we contemplated the utility of lactone 452 in a Johnson–Claisen process, comprising 
formation of an ortholactone from 452, and subsequent reaction with 1-cyclohexene-1-methanol. A 
more detailed discussion of these two processes is outlined below. 
3.3.1 dCr reaction of ester 451 
It was proposed that ester 451 would undergo dCr reaction to form methylenecyclohexane 450 as 
predominantly a single enantiomer. Our mechanistic rationale is in line with that proposed previously, 
and is shown in Figure 48. 
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Figure 48. dCr reaction of 451. 
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Once again, the antiperiplanar alignment of the sulfoximine S═N bond and the ketene acetal C═C 
bond is evident in transition state 452, which we believe will be the favoured pathway. We imagined 
that the chiral alcohol side chain would act in much the same way as the dioxolane moiety, increasing 
the diastereoselectivity of this process.  
We also devised a retrosynthetic analysis of ester 451, which we believe could be synthesised 
succinctly from sulfoximine 394 (Figure 49). 
 
Figure 49. Retrosynthetic analysis of 446. 
We envisaged the formation of ester 451 via esterification of carboxylic acid 459 with the requisite 
alcohol. Acid 459 would in turn be formed from quenching of lithiated sulfoximine 460 with gaseous 
carbon dioxide. The first step in this synthesis would be the lithiation of sulfoximine 394 and 
treatment with (S)-1,2-epoxyoctane 461 to install the chiral alcohol side chain. The completion of this 
route is discussed below. 
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3.3.2 Johnson–Claisen rearrangement of lactone 452 
It was postulated that formation of an orthoester species from lactone 452 and subsequent treatment 
with alcohol 333 under acidic conditions could give rise to a Johnson–Claisen process, as detailed in 
Figure 50. 
 
Figure 50. Johnson–Claisen rearrangement of lactone 452. 
We postulated that upon formation of ortholactone 462 and treatment with alcohol 333, intermediate 
463 would form. This intermediate could then undergo a [3,3] sigmatropic rearrangement to afford 
lactone 464, which after hydrolysis and decarboxylation could be converted into alcohol 450, an 
advanced intermediate in our retrosynthetic analysis of (–)-lepadiformine. 
 
 
 
 
Chapter 3: Second-generation Strategy: The Decarboxylative Claisen Rearrangement                   157 
 
 
Our rationalisation of the stereochemical outcome of this process is detailed below (Figure 51). 
 
Figure 51. Mechanistic and stereochemical rationale for the Johnson–Claisen rearrangement of 452. 
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We envisaged the alignment of the sulfoximine S═N bond and the ketene acetal C═C bond to remain 
anti-periplanar, and that the approach of the cyclohexene portion would still be syn with respect to the 
sulfoximine oxygen, as displayed in both transition states 465 and 467.  We therefore rationalised that 
the effect dominating the transition state preference in this process would be the interaction of the 
sulfoximine moiety with the cyclohexene ring. In transition state 465, possessing a boat-like 
pericyclic array, the closest carbon of the cyclohexene ring to the sulfoximine moiety is 
sp
2
-hybridised. Conversely, in chair-like transition state 467, the sulfoximine is more likely to have an 
interaction with an sp
3
-hybridised carbon of the cyclohexene ring, which we suggested would 
constitute greater steric hindrance. If our rationale is correct, and boat-like transition state 465 is 
favoured, then lactone 464 will be formed as the major product, and thus the requisite stereochemistry 
for the natural product will have been installed.  
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 3.3.3 Commencement of revised (–)-lepadiformine synthesis 
Our revised approach to the synthesis of (–)-lepadiformine began with the synthesis of several 
compounds, which are common intermediates in the syntheses of both dCr substrate 451 and lactone 
452. Initially we prepared (S)-1,2-epoxyoctane using a hydrolytic kinetic resolution (HKR) process 
developed by Jacbosen et al. (Scheme 132).
107
 
 
Scheme 132. (i) 0.5 mol % 471, 2 mol % AcOH, 0.55 equiv H2O, 16 h, rt (42 %). 
Treatment of racemic 1,2-epoxyoctane 470 with catalyst 471, AcOH and H2O afforded 
(S)-1,2-epoxyoctane 461 in 42 % yield, which was in complete agreement with published 
spectroscopic data.
108
 The active catalytic species is the acetate adduct 472, which is formed by 
addition of acetic acid to the cobalt salen catalyst 471. We found this process to be reproducible on 
scales up to 50 g. 
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With a stock of epoxide 461 in hand, we were able to continue with our proposed synthesis (Scheme 
133). 
 
Scheme 133. (i) n-BuLi, (S)-1,2-epoxyoctane, DMPU, THF, 16 h, –78 °C  rt (99 %). 
Sulfoximine 394 was treated with n-BuLi and epoxide 461 in a mixture of DMPU and THF to afford 
alcohol 473 according to a procedure previously developed within the group.
109
 At this point, our 
synthesis diverged, and we first decided to attempt the synthesis of lactone 452. 
3.3.4 Studies on lactone synthesis 
Based on literature precedent, lactone 452 was synthesised as described in Scheme 134. 
 
Scheme 134. (i) ethyl chloroformate, pyridine, 72 h, 0 °C  rt (54 %); (ii) LiHMDS (1 M in THF), THF, 3 h, –78 °C  rt, 
(38 %). 
Mixed carbonate 474 was formed first via treatment of alcohol 473 with ethyl chloroformate under 
basic conditions. Subsequently, lithiation of sulfoximine 474 and intramolecular attack of the 
resulting carbanion on the carbonate moiety provided lactone 452 as a 1:1 mixture of diastereomers. 
Although the yields for these processes were somewhat disappointing, we thought it prudent to 
examine the reactivity of lactone 452 in the proposed Johnson–Claisen process before carrying out 
any optimisation.  
Initial efforts centred around the treatment of lactone 452 with Meerwein’s salt in hope of bringing 
about ortholactone formation (Scheme 135). 
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Scheme 135. (i) Et3OBF4, CH2Cl2, 16 h, rt then NaH, EtOH, 5 min, –78 °C. 
According to a published procedure by Deslongchamps et al., lactone 452 was first treated with 
Meerwein’s salt (triethyloxonium tetrafluoroborate) for 16 h, before the addition of a solution of 
sodium ethoxide in ethanol.
110
 The addition of ethoxide is intended to undergo an addition reaction to 
the ethyl ketene acetal intermediate to form ortholactone 462. We envisaged that ortholactone 462 
would be unstable, and thus difficult to isolate. As predicted, attempts at isolation of 462 resulted in 
only recovery of starting material. Furthermore, an attempt at in situ Johnson–Claisen rearrangement 
via acidification of the reaction mixture and addition of alcohol 333, resulted again in only recovery 
of starting material.  
Based on this result, we decided to attempt the formation of rearrangement precursor 463 via 
O-alkylation of lactone 452 with a suitably hard electrophile (Scheme 136). 
 
Scheme 136. (i) 333, Hünig’s base, Tf2O, CH2Cl2, –35 °C added to a solution of 452, Cs2CO3, CH2Cl2, –35 °C. 
The triflate of alcohol 333 was first formed in a separate flask by treatment of 333 with Hünig’s base 
and triflic anhydride. The development of a dark red colour in solution suggested the formation of the 
corresponding triflate had occurred. Addition of this solution to a separate vessel containing lactone 
452 and caesium carbonate in CH2Cl2 followed. However, TLC analysis and crude 
1
H NMR analysis 
indicated the recovery of both starting materials in full. 
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In a similar vein, we attempted the formation of triflyl ketene acetal 475 with subsequent addition of 
alcohol 333, in the hope of effecting an addition-elimination reaction to produce Johnson–Claisen 
precursor 463 (Scheme 137). 
 
Scheme 137. (i) Cs2CO3, Tf2O, CH2Cl2, –35 °C; (ii) 333. 
Disappointingly, only starting material was recovered from this process also. 
At this point, we re-evaluated our mechanistic rationale for the proposed Johnson–Claisen process. It 
was noted that when considering the dominant conformational effects in the transition states for this 
process, that the sulfoximine moiety had little bearing besides being a sterically demanding group. 
Therefore, we completed an analogous synthesis of lactone 479, where a simpler phenylsulfonyl 
group is incorporated (Scheme 138).  
 
Scheme 138. (i) n-BuLi, (S)-1,2-epoxyoctane, DMPU, THF, 3 h, –78 °C  rt (84 %); (ii) ethyl chloroformate, pyridine, 
16 h, 0 °C  rt (77 %); (iii) LiHMDS (1 M in THF), THF, 2 h, –78 °C  rt (62 %, 65:35 d.r.).  
Phenyl methyl sulfone 476 underwent lithiation and treatment with epoxide 461 to deliver alcohol 
477, which subsequently underwent carbonate formation with ethyl chloroformate in pyridine. 
Finally, lithiation and ring-closure afforded lactone 479 as a 65:35 mixture of diastereomers. Given 
the nature of the proposed next step in the synthesis however, this was inconsequential.  
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Subjection of lactone 479 to ortholactone formation, as described previously, was unsuccessful and 
resulted again in recovery of starting material.  
3.3.5 Pinner reaction and subsequent rearrangement 
With this in mind, we began to consider another protocol for the formation of orthoesters. The Pinner 
reaction came to our attention, which involves the reaction of nitriles with alcohols under acidic 
conditions, to afford either orthoesters or alkyl imidates, depending on whether or not the alcohol is in 
excess (Scheme 139).
111
 
 
Scheme 139. (i) excess R’OH, HCl; (ii) 1 equiv R’OH, HCl. 
Employing excess alcohol gives orthoester 480 as the product, whereas one equivalent of alcohol will 
causes the reaction to cease at alkyl imidate 482. We imagined exploiting this process by using 
phenylsulfonyl acetonitrile 483 as the starting material (Figure 52). 
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Figure 52. Proposed Pinner reaction and subsequent rearrangement. 
We postulated that treatment of phenylsulfonyl acetonitrile 483 with a base and epoxide 461 would 
form alkoxide 484 in situ, which upon acidification would form imidate intermediate 485, as occurs in 
the Pinner reaction. It was then our intention to introduce alcohol 333, which would hopefully 
undergo a condensation process to form oxonium intermediate 486. Tautomerisation of this species 
provides ketene acetal 487, which, in theory, will then undergo [3,3] sigmatropic rearrangement to 
afford lactone 488.  
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Therefore, with a new strategy devised, we attempted this transformation (Scheme 140). 
 
Scheme 140. (i) NaH, (S)-1,2-epoxyoctane, THF, 3 h, 0 °C  reflux then CSA, 328, 30 min, reflux (60 % 479). 
Phenylsulfonyl acetonitrile 483 was treated with NaH and epoxide 461 to afford imidate intermediate 
489. At this point, the reaction was acidified to pH 3 by the addition of CSA, and 3 equivalents of 
alcohol 333 were added. After 30 min at reflux, TLC analysis indicated the formation of a new 
product. Upon isolation, it was discovered that rearrangement product 488 had not been formed, and 
that lactone 479 was the sole product of the reaction. Alcohol 333 was also recoverable in full. After 
several attempts at this reaction, we decided to focus on utilising this type of process in a different 
way. Despite this reaction not proceeding exactly as we might have planned, this work does constitute 
the discovery of a novel synthesis of lactones from sulfonyl acetonitriles. 
The formation of imidate intermediate 489 could not be proven. However, since lactone 479 was 
isolated from this process, it appears that 489 must be present, at least transiently, in the reaction 
mixture. Based on this assumption, we contemplated the utility of imidate 489 in an aza-Claisen 
process instead (Figure 53). 
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Figure 53. Postulated aza-Claisen rearrangement. 
We hypothesised that imidate intermediate 489 could be trapped in one of two ways: by treatment 
with HCl to form imidate salt 491; by the addition of TsCl or a similar sulfonyl chloride to afford 
N-sulfonyl imidate 490. Both of these species could then undergo N-alkylation to form ketene aminal 
492. We suggested that this compound could then undergo an aza-Claisen rearrangement, with 
subsequent hydrolysis of the imidate moiety to deliver lactone 488.  
For either of these routes, we would require a suitable electrophile, and the corresponding bromide of 
alcohol 333 seemed to be a good candidate. In our previous work, we had synthesised this compound 
via an Appel-type bromination with bromine and triphenylphosphine, however on repeating this 
process we found that several unwanted and inseparable by-products were formed. For this reason, we 
attempted an analogous process using phosphorus tribromide (Scheme 141). 
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Scheme 141. (i) PBr3, Et2O, 16 h, 0 °C  rt (87 %). 
Pleasingly, this transformation proceeded in good yield with no observable by-products. With 
bromide 328 in hand, we next attempted the isolation of the requisite imidate intermediates 490 and 
491 (Scheme 142). 
 
Scheme 142. (i) Cs2CO3, (S)-1,2-epoxyoctane, DMF, 30 min, 150 °C (microwave) then TsCl, 16  h, rt; (ii) Cs2CO3, 
(S)-1,2-epoxyoctane, DMF, 30 min, 150 °C (microwave) then HCl (1 M in Et2O), 16 h, rt. 
For these reactions, we decided to alter the base used. Cs2CO3 was selected as an alternative, because 
in the event that we decided to attempt a one-pot N-alkylation process, a larger counterion such as Cs
+
 
would hopefully encourage N- rather than C-alkylation at the enolate position. That being said, we 
were unable to isolate any of either desired product from the reactions shown above. In the case of 
tosylation, some potential product signals were observed by crude 
1
H NMR analysis. However, 
several other products, predominantly lactone 479, were present also. The acidification process did 
not, as we had hoped, produce a precipitate, which may be due to DMF being a polar enough solvent 
to solvate the imidate salt.  
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Given these difficulties, we next attempted a one-pot interception of imidate intermediate 489 with 
bromide 328 (Scheme 143). 
 
Scheme 143. (i) Cs2CO3, (S)-1,2-epoxyoctane, DMF, 30 min, 150 °C (microwave) then 323, 20 min, 150 °C (microwave). 
TLC analysis of this reaction indicated the formation of a novel product. Crude 
1
H NMR analysis 
indicated the presence of lactone 479, however no pure sample could be isolated, and the crude mass 
indicated a low yield. Interestingly, it was unclear whether the desired ketene aminal intermediate had 
been formed, and subsequent aza-Claisen rearrangement had occurred, or whether 493 was formed 
simply via an SN2’ C-alkylation process. In any event, the crude NMR analysis suggested that product 
488 had not formed with any great selectivity, which brought the utility of this process into question. 
At this point we would have liked to have explored this process further, particularly by synthesising 
an alternative bromide electrophile. However, due to time constraints, it was deemed necessary to 
devote the majority of our time to the synthesis and reactivity of the proposed dCr substrate 451. 
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3.3.6 dCr reactions of substrates based on ester 451 
We intended first to synthesise the proposed dCr substrate 451 via previously-used 
carboxylation/esterification processes, with the introduction of the cyclohexene alcohol portion in a 
carbodiimide-promoted esterification reaction. In order to explore this pathway, we first needed to 
protect alcohol 473 with a suitable protecting group; a silyl group was selected due to its 
orthogonality with any other planned protecting groups, and its ease of removal (Scheme 144). 
 
Scheme 144. (i) TBSCl, imidazole, DMAP, CH2Cl2, 16 h, rt (87 %). 
This protection process afforded TBS-ether 494 in 87 % yield, and this process was reproducible on 
up to 20 g scale. Our next task was to carry out a carboxylation or esterification procedure with 
TBS-ether 494 (Scheme 145). 
 
Scheme 145. (i) n-BuLi, CO2 (g), THF, 12 h,  –78 °C; (ii) LiHMDS, methyl chloroformate, THF, 48 h, –78 °C  rt (67 %, 
52:48 d.r.). 
After several attempts at lithiation and carboxylation of 494, only traces of product were isolated. 
Carboxylic acid 495 was found to have a repugnant odour, and was prone to decomposition even 
when stored under an inert atmosphere at low temperatures. We suspected that this case may have 
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mirrored some of the obstacles of our previous synthesis incorporating a dioxolane substituent, 
whereby the carboxylic acid moiety may bring about desilylation. One could then imagine the 
γ-hydroxy carboxylic acid undergoing rapid ring-closure to the corresponding lactone. However, the 
formation of methyl ester 496 was carried out without issue to deliver ester 496 in moderate yield. 
At this juncture, we were faced with several possibilities. As with previous syntheses, the next logical 
step would be the saponification of methyl ester 496 and subsequent esterification of the resulting 
carboxylic acid. This option did not seem viable at this point, due to the apparent difficulty in 
handling unstable acid 495. An alternative approach was the synthesis of a chloroformate containing 
the requisite methylcyclohexene motif, in order to deliver the dCr substrate in one step from 
TBS-ether 494. Though a seemingly attractive option, we considered that the synthesis of such 
chloroformates presents several hazards, not least of which is the use of phosgene or phosgene 
equivalents. 
With these issues in mind, we first decided to examine the reaction of a p-nitrophenyl carbonate 
species as opposed to a chloroformate. According to previous work within the group, we first 
synthesised mixed carbonate 497 (Scheme 146).
112
 
 
Scheme 146. (i) Et3N, p-nitrophenyl chloroformate, CH2Cl2, 16 h, –10 °C  rt (70 %). 
Treatment of alcohol 333 with p-nitrophenyl chloroformate under basic conditions afforded mixed 
carbonate 497 in good yield. It was then our intention to use carbonate 497 as a chloroformate 
substitute, and thus we attempted the reaction outlined in Scheme 147. 
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Scheme 147. (i) LiHMDS (1 M in THF), 497, THF, 16 h, –78 °C  rt (quant.). 
TBS-ether 494 was treated with LiHMDS to effect α-lithiation, followed by immediate addition of 
p-nitrophenyl carbonate 497 as a solution in THF. Two distinct products were observed by TLC 
analysis, which we believed corresponded to the two diastereomers of 498. Attempts at separating the 
diastereomers were unsuccessful however, and it was postulated that the highly acidic proton at the 
α-position would simply give rise to epimerisation in an acidic medium such as silica gel. Ester 498 
was therefore obtained as a 1:1 mixture of diastereomers, and with this product in hand, we were next 
able to attempt the key decarboxylative Claisen rearrangement.  
Based on previous successes with pulsed microwave heating with an allyl substituted sulfoximine 
ester, we first subjected ester 498 to our best dCr conditions. However, in light of the formation of a 
significant number of by-products (presumed to be elimination products and the components of the 
sulfoximine moiety) it was necessary to examine the reaction conditions more closely (Scheme 148, 
Table 19). 
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Scheme 148. dCr of ester 498. 
Entry Reagents Solvent Time Temp / °C Result 
1 
2 equiv BSA             
0.1 equiv KOAc 
DMF 5 x 10 sec 150 Intractable mixture 
2 
6 equiv BSA 
0.1 equiv KOAc 
DMF 6 x 10 min 80 
~10 % 
1:1 Product:SM 
3 
6 equiv BSA 
0.1 equiv KOAc 
DMF 3 x 30 min 100 
~20 % 
2:1 Product:SM 
4 
6 equiv BSA            
0.1 equiv KOAc 
DMF 4 x 30 min 100 
39 %                          
4:1 Product:SM 
5 
6 equiv BSA            
0.1 equiv KOAc 
DMF 4 x 5 min 120 
42 % 
9:1 Product:SM 
Table 19. dCr conditions. All reactions were carried out in a microwave reactor. 
Our first attempts at this transformation were unsuccessful (Entry 1, Table 19). Although this method 
and temperature seemed to be optimal for the dCr reaction of allyl-substituted sulfoximine ester 414, 
in this case a mixture of several products was obtained. It seemed that some of the required product 
was present, along with a large amount of starting material and some unidentified by-products. We 
therefore postulated that a lower temperature and longer reaction time might be more suitable in this 
case. Indeed, lowering the temperature to 80 °C gave formation of the product in a 1:1 ratio with the 
starting material, but in a low isolated yield (Entry 2, Table 19). Again, a sizeable portion of the crude 
mixture corresponded to unwanted by-products, and the starting material and product proved to be 
completely inseparable by all methods tried. We have previously observed that prolonged heating of 
these reaction mixtures more commonly gives rise to by-product formation. However, heating at 
higher temperature with longer pulse time and longer overall reaction time appeared to improve both 
the yield and the product:SM ratio (Entries 3 and 4, Table 19). However, the yield for this process was 
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still fairly low. A compromise between heating time and temperature, as displayed in Entry 5, 
provided a 42 % yield of a 9:1 product:SM mixture. This remains our best isolated yield of 
methylenecyclohexane 499.  
Despite obtaining relatively clean samples of 499, we were still unable to determine the 
diastereoselectivity of this process by 
1
H NMR analysis. With this in mind, we imagined two 
transformations might help to elucidate this. The first involved simply taking a sample of 499 and 
subjecting it to typical desilylation conditions using TBAF (Scheme 149). 
 
Scheme 149. (i) TBAF•3H2O, THF, 48 h, 0 °C  rt (50 %). 
When treated with TBAF, three distinct products were observed by TLC analysis. 
1
H NMR analysis 
clearly showed three observable diastereomers present in a 1:4:12.5 ratio. Upon attempted separation, 
the two minor diastereomers were combined, and the major diastereomer was isolated. Despite there 
appearing to be a high degree of diastereoselectivity in this process, it was still unclear as to which 
diastereomers were isolated. From the ratio of diastereomers observed in this process, it appeared that 
the allylic epimer ratio in 499 was either 2.5:1 or 16.5:1. However, it was difficult to prove this, and 
so we focussed our efforts on the removal of the troublesome sulfoximine group.  
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Traditionally, sulfoximine groups have been removed by reductive single-electron transfer agents. 
Based on literature precedent, several different methods were examined (Scheme 150, Table 20). 
 
Scheme 150. Reductive sulfoximine removal. 
Entry Reagents Solvent Time / h Temp / °C Result 
1 Sm, CH2I2 
7:1 
MeOH:THF 
24 0 °C  rt No reaction 
2 Mg MeOH 24 0 °C  reflux No reaction 
3 Mg, dibromoethane MeOH 24 0 °C  reflux No reaction 
4 
Mg, AcOH/NaOAc 
buffer solution 
DMF 16 rt No reaction 
5 
Na(Hg) (10 % Na) 
Na2HPO4 
MeOH 2 rt 
71 % of a mixture of 
500 and by-products 
Table 20. Sulfoximine removal conditions. 
Most prevalent in the literature for sulfoximine removal was the use of samarium diiodide, often 
prepared in situ by reaction of elemental samarium and diiodomethane.
113
 However, treatment of 
sulfoximine 499 under the described conditions resulted in no reaction and complete recovery of 
starting material (Entry 1, Table 20). Another common protocol for this type of transformation 
involves the use of elemental magnesium in methanol.
114
 Disappointingly, even on the addition of 
dibromoethane, no reaction was observed with this system (Entries 2 and 3, Table 20). Interestingly, 
we noted that the choice of buffer system in these types of reactions tends to affect significantly the 
outcome of the reaction. In alcoholic solvents such as methanol, basic species are readily formed in 
the presence of reductants, and so maintaining a relatively neutral pH is essential to avoid any 
unwanted elimination side reactions. As we had already observed the propensity of these compounds 
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to undergo elimination processes, we considered carefully which buffer to use. Some success had 
been had with an AcOH/NaOAc buffer solution (Entry 3, Table 20) but no reaction was observed in 
this case.
114
 The use of sodium amalgam is more prominent in the removal of sulfones than 
sulfoximines, but we felt nevertheless it was worth investigation in this case.
115
 Pleasingly, employing 
sodium amalgam with a disodium hydrogen phosphate buffer afforded the desired product, albeit as a 
mixture with other unwanted side products (Entry 5, Table 20). It was postulated, though not proven, 
that these side products corresponded to elimination of the sulfoximine moiety, which is consistent 
with new olefinic signals being detected by crude 
1
H NMR analysis. 
Therefore, it would appear that although sodium amalgam promotes the removal of the sulfoximine 
group, the reaction medium was too basic. Disodium hydrogen phosphate (Na2HPO4) has a pH in 
aqueous solution of between 8.0 and 11.0. Conversely, sodium dihydrogen phosphate (NaH2PO4) has 
a pH in aqueous solution of between 6.8 and 7.2, and therefore appears like a more suitable buffer for 
this process. Indeed, in some instances where an elimination process will give rise to a conjugated 
system (e.g. a β-sulfonyl ketone could undergo elimination to a conjugated α,β-unsaturated ketone), 
the more acidic buffer system is employed. With this in mind, we attempted the transformation in 
Scheme 151. 
 
Scheme 151. (i) Na(Hg) (6 % Na), NaH2PO4, MeOH, 1 h, rt (65 %, 95:5 d.r.). 
Treatment of sulfoximine 499 with a freshly prepared sample of sodium amalgam and sodium 
dihydrogen phosphate as buffer provided methylenecyclohexane 500 in 65 % yield and as a 95:5 ratio 
of diastereomers. Despite the yield being slightly lower than that observed previously, no side 
products were observed. Interestingly, the diastereomeric ratio obtained indicates that the material is 
predominantly one diastereomer. We can therefore conclude that the decarboxylative Claisen 
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rearrangement employed earlier in the synthesis must have proceeded in an excellent 95:5 d.r. This 
result was encouraging, and seemed to substantiate our hypothesis regarding increased 
diastereoselectivity with these systems. 
Although this result was encouraging, we did wish to improve the yields of these processes. We 
contemplated at which point any side reactions could occur, and first focussed on the rearrangement 
itself. Several polar side products had been observed previously by TLC analysis, but attempts at 
isolating and identifying these products were unsuccessful. Based on our previous observations when 
silyl ethers were incorporated into dCr substrates, we postulated that trans-silylation might be 
occurring under the reaction conditions, and that the resulting TMS-ether was undergoing hydrolysis 
to the corresponding alcohol on work-up.
96
 Indeed, upon comparing TLC analysis of these unwanted 
side products and alcohol 450 synthesised via desilylation of 499, they appeared to be the same 
compound. With this in mind, rather than carrying out a purification of the dCr mixture, and thus 
removing some of the product, we attempted a three-step procedure with no intermediate purification 
to afford alcohol 501 (Scheme 152). 
 
Scheme 152. (i) 6 equiv BSA, 0.1 equiv KOAc, DMF, 4 x 5 min, 120 °C (microwave); (ii) TBAF•3H2O, THF, 48 h, 
0 °C  rt; (iii) Na(Hg) (6 % Na), NaH2PO4, MeOH, 1 h, rt (65 % over 3 steps, 95:5 d.r.). 
Subjection of ester 498 to our best dCr conditions afforded methylenecyclohexane 499, which without 
further purification was subjected to desilylation conditions with TBAF. Once TLC analysis indicated 
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the complete consumption of all dCr product, the reaction was arrested and a work-up procedure 
carried out. Again without purification, the crude product was treated with sodium amalgam and 
sodium dihydrogen phosphate to deliver alcohol 501 in 65 % yield over 3 steps, and pleasingly as a 
95:5 mixture of diastereomers. This three-step process constituted a vast improvement over our 
iterative yields, and we believe that this is due in part to avoiding loss of desilylated dCr product 
during purification. Simple silica gel chromatography was required in the final step to remove any 
mercury or unreacted amalgam from the reaction mixture. We have found this protocol to be 
reproducible on scales up to 1.5 g; on larger scales, frequent pressure and temperature spikes are 
observed in the microwave reactor. Upon closer inspection, we were also able to separate the two 
diastereomers of alcohol 501, thereby providing us with an authentic enantiopure sample of alcohol 
501 in 62 % from sulfoximine ester 498. 
With this result in hand, we next turned our attention to the aziridination process we proposed as our 
next step in this synthesis. Based on our previous successes with the Sharpless aziridination processes, 
we decided to investigate the feasibility and diastereoselectivity of this transformation for products of 
the decarboxylative Claisen rearrangement. As a test substrate, we first carried out the aziridination of 
methylene cyclohexane 408, which was employed as a 72:28 mixture of diastereomers (Scheme 153). 
 
Scheme 153. Chloramine-T®, PTAB, MeCN, 1 h, rt. 
Treatment of methylene cyclohexane 408 with Chloramine-T® and PTAB resulted in the formation of 
a complex mixture of products. Crude 
1
H NMR analysis indicated the presence of at least two 
aziridine species. In fact, it seemed that four aziridine species appeared to be present, in a 72:72:28:28 
ratio. Although these species could not be isolated via chromatography, and therefore were not fully 
characterised, it appeared that this process was non-selective, as each diastereomer of the starting 
material appeared to have formed two diastereomers of aziridine 502 in equal proportion. We 
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therefore surmised that this process is not selective. In addition, subjection of enantiopure alcohol 501 
to the conditions displayed above resulted in an intractable mixture of products, with only a small 
amount of aziridine present. 
3.4.0 Intramolecular haloaminations and carboaminations 
Given the apparent lack of selectivity in the Sharpless aziridination process, we began to consider 
whether an intramolecular process might offer a higher degree of selectivity. Given that the substrate 
for this reaction, alcohol 501, had been obtained as a single enantiomer, we wished to examine 
whether it would exhibit any substrate control in an intramolecular process. 
Chemler et al. have published extensively on this subject, having developed a Cu(II)-mediated 
carboamination process of unactivated alkenes.
116
 One of their first forays into this area, and the 
examples most pertinent to this project, involved pyrrolidine and piperidine formation via a copper(II) 
carboxylate-promoted  process; some examples are displayed in Scheme 154. 
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Scheme 154. (i) 3 equiv Cu(OAc)2, 1 equiv Cs2CO3, DMF, DMSO, 24 h, 120 °C (73 %); (ii) 3 equiv Cu(ND)2, 1 equiv 
Cs2CO3, DMF, 72 h, 200 °C (43 %); (iii) 3 equiv Cu(ND)2, 1 equiv Cs2CO3, DMF, 3 h, 210 °C (microwave) (51 %, >20:1 
d.r.). 
The examples shown indicate an intramolecular carboamination has taken place, where 
Cu(II)-promoted amination of the olefin occurs first, followed by attack of the resulting carbon radical 
(after oxidative cleavage of the C–Cu bond) to the aromatic ring of the sulfonyl group. The first two 
examples display formation of pyrrolidine and piperidine rings respectively, using either Cu(OAc)2 or 
Cu(ND)2 (ND = neodecanoate). Interestingly, the third example depicts the formation of 
cis-2,5-disbustituted pyrrolidine 508 in >20:1 d.r.. This process in particular has been completed for a 
variety of substrates, with all exhibiting impressive diastereoselectivity. We were encouraged by this 
research, as it appears that substrate control does indeed play a part in the stereochemical outcome of 
these transformations. 
Chemler et al. subsequently carried out investigations into the mechanism of this process.
117
 They 
determined that the reaction proceeds via a cis-aminocupration step, followed by homolysis of the   
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C–Cu bond to reveal a carbon-centred radical that subsequently attacks the sulfonyl aromatic ring 
(Figure 54). 
 
Figure 54. Mechanism of cis-2,5-pyrrolidine ring formation. 
Having established that the key (and rate-limiting) step of this process was a cis-aminocupration step, 
Chemler et al. next considered the ramifications of this in the diastereoselectivity of these processes. 
They postulated that there were four possible transition states leading to the formation of the 
2,5-pyrrolidine motif shown above (Figure 55). 
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Figure 55. Possible cis-aminocupration transition states for the carboamination of 509. 
Clearly, of the four potential transition states (two chair-like and two boat-like), transition states 517 
and 518 display unfavourable steric interactions due to the syn disposition of the ring substituent and 
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the arylsulfonyl group. It is for this reason that Chemler et al. hypothesised that transition states 515 
and 516 would be more prevalent in this transformation. This is supported by their findings, as these 
types of processes reliably provide the cis-2,5-disubstituted pyrrolidine product 514 in >20:1 d.r, 
which one can rationalise as the product of both transition states 515 and 516. 
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3.4.1 Application of Chemler’s carboamination to the synthesis of (–)-lepadiformine 
We devised a reimagined retrosynthesis of (–)-lepadiformine to incorporate a proposed intramolecular 
carboamination process (Figure 56). 
 
Figure 56. Retrosynthetic analysis of (–)-lepadiformine, incorporating a Cu(II)-promoted carboamination. 
We imagined the final stages of this synthesis to proceed as described previously from bicyclic 
structure 447. We plan to form the piperidine B-ring of the natural product via intramolecular 
Cu(II)-promoted carboamination of sulfonamide 520, which in turn would be synthesised from 
alcohol 501 using a Mitsunobu process. Finally, as detailed earlier, alcohol 501 will be formed from 
ester 451 via a 3 step process involving decarboxylative Claisen rearrangement, desilylation and 
reductive sulfoximine removal. 
We wished to incorporate an intermolecular alkylation step into the cyclisation of 520, whereby the 
carbon-centred radical formed as a result of the cyclisation is trapped by an electrophilic allyl source. 
Our mechanistic and stereochemical rationale for this process is outlined in Figure 57. 
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Figure 57. Proposed mechanism of the intramolecular carboamination of 520. 
We hypothesised that transition state 523 would experience increased steric interactions between the 
tosyl group and the forming piperidine ring, thereby rendering it a less favourable intermediate. 523 
ultimately gives rise to a cis-fused 1-aza-decalin structure, which is the core structure of the 
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cylindricine alkaloids, and thus not the desired stereochemical outcome in this case. Conversely, 
transition state 521 displays no significant steric interactions, and gives rise to the desired 
trans-1-azadecalin structure 447, which we intend to elaborate to form (–)-lepadiformine.  
Having decided to pursue this route, our next task was the synthesis of sulfonamide 520. Mitsunobu 
processes with sulfonamides have been heavily investigated, owing to the fact that primary 
sulfonamides do not undergo reaction with traditional Mitsunobu reagents (e.g. DEAD, DIAD etc.). 
Tsunoda et al. have developed a protocol involving Mitsunobu alkylation of sulfonamides using 
cyanomethylenetrialkylphosphoranes.
118,119
 Despite the efficacy of this process, we wished to avoid 
the synthesis of the highly air- and water-sensitive cyanomethylenephosphorane reagent. Therefore, 
we decided to carry out Weinreb et al.’s protocol involving traditional Mitsunobu reaction of a 
secondary sulfonamide, with a subsequent deprotection process.
120
 Secondary sulfonamide 527 was 
prepared first, and subsequently reacted with alcohol 501 under conventional Mitsunobu conditions 
(Scheme 155).  
 
Scheme 155. (i) Et2N, DMAP, Boc2O, CH2Cl2, 2 h, rt (94 %); (ii) 522, DIAD, PPh3, THF, 2.5 h, 0 °C  rt (65 %, 95:5 d.r.). 
Pleasingly, both the synthesis of sulfonamide 527 and its use in the Mitsunobu amination of alcohol 
501 proceeded in good yield. The stereochemistry of alcohol 501 was preserved in the Mitsunobu 
process, as expected, to deliver tertiary amine 528 as a 95:5 mixture of two diastereomers. In order to 
synthesise the N–H sulfonamide required for the carboamination process, we next attempted the 
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acid-mediated deprotection of amine 528. Perhaps unsurprisingly, deprotection proceeded smoothly, 
but the acidic reaction conditions brought about spontaneous hydroamination-cyclisation to form 
bicyclic structure 529 as a mixture of diastereomers (Scheme 156). 
 
Scheme 156. (i) TFA, CH2Cl2, 16 h, rt (80 % crude yield). 
Although a somewhat encouraging result, as cyclisation to form this bicyclic motif appears to be 
facile, this reaction proceeded with little selectivity, delivering 529 as a 45:55 mixture of 
diastereomers (as determined by crude 
1
H NMR analysis). Since thermolysis of N-Boc amines has 
been carried out in the past, and given that high temperature conditions are required for the proposed 
Cu(II)-mediated carboamination reaction, we decided to submit tertiary amine 528 to the 
carboamination reaction conditions in the hope of effecting concomitant Boc-removal and cyclisation 
with greater selectivity (Scheme 157). 
 
Scheme 157. (i) 3 equiv Cu(eh)2, 1 equiv Cs2CO3, DMF, 3 h, 210 °C (microwave). 
The more readily available copper(II) 2-ethylhexanoate (Cu(eh)2) was employed in this reaction, and 
has been shown to be active in these reactions by Chemler et al.
121
 Despite prolonged heating in a 
microwave reactor, only N–H sulfonamide 520 was isolated from the reaction, and no cyclisation 
product was observed. Thermolysis of the Boc group prior to addition of the carboamination reagents 
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also showed no reaction whatsoever. We therefore attempted to isolate a reasonable amount of N–H 
sulfonamide 520 in order to screen carboamination conditions (Scheme 158). 
 
Scheme 158. (i) DMF, 30 min, 200 °C (microwave) (85 %, single diastereomer). 
Tertiary amine 528 was heated for 30 min at 200 °C to effect clean Boc removal, affording 
sulfonamide 520 as a single diastereomer and a colourless crystalline solid. 
At this point, we had not yet been able to prove unequivocally that the dCr had installed the correct 
stereochemistry. Attempts to synthesise the 3,5-dinitrobenzoate analogue of alcohol 501 produced 
only a mixture of products, none of them crystalline. Thus, with slow evaporation from petroleum 
ether, we were able to obtain an X-ray crystal structure of sulfonamide 520, proving our initial 
hypothesis and stereochemical model to be correct (Figure 58). 
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Figure 58. X-ray crystal structure of sulfonamide 515. 
The structure in Figure 58 clearly shows that sulfonamide 520 has the desired (S) stereochemistry at 
the allylic position (C(7) above), which was installed via diastereoselective decarboxylative Claisen 
rearrangement.  
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3.4.2 Alternative cyclisations 
Given that our attempts at a Cu(II)-promoted carboamination cyclisation proved unsuccessful, we 
turned our attention to alternative cyclisation protocols. We postulated that replacing the Boc group of 
tertiary amine 528 with an Alloc protecting group, might enable a one-pot 
deprotection-cyclisation-allylation process. This hypothesis is outlined in Figure 59. 
 
Figure 59. Proposed Pd-catalysed reaction of 531. 
Initially, we envisaged coordination of the palladium species to the allyl portion of the Alloc group, 
followed by oxidative insertion and concomitant aminopalladation to form η3-π-allyl complex 533. 
This step relies on a Tsuji–Trost-type rationale, whereby a hard nucleophile will first attack the 
palladium species whereas soft nucleophiles will attack the π-allyl species and undergo direct 
N-allylation. We hoped that the sulfonamide anion formed after decarboxylation may well be a hard 
enough nucleophile to undergo aminopalladation rather than N–C bond formation. From complex 
Chapter 3: Second-generation Strategy: The Decarboxylative Claisen Rearrangement                   190 
 
 
533, we imagined that two processes could take place. The first (unwanted) process would be a  
Tsuji–Trost-type reductive elimination to give the N-allyl product. The second process would involve 
activation of the exocyclic olefin as shown, to bring about a carbopalladation-cyclisation sequence, 
furnishing the B-ring of the natural product. At this point, we were unsure whether any 
diastereoselectivity would be observed. Once cyclisation has occurred to form bicycle 534, one could 
imagine a simple reductive elimination process to form alkene 535, with the eliminated palladium 
catalyst re-entering the catalytic cycle. Although ambitious, we felt this idea was worth investigating, 
and so secondary amine 537 was synthesised, and subsequently reacted with alcohol 501 under 
Mitsunobu conditions (Scheme 159). 
 
Scheme 159. (i) allyl alcohol, Et3N, Et2O, 48 h, 0 °C  rt (64 %); (ii) 532, DIAD, PPh3, THF, 48 h, 0 °C  rt (59 %, 85:15 
d.r.). 
Treatment of tosyl isocyanate 536 with allyl alcohol under basic conditions afforded secondary amine 
537. This species then took part in a Mitsunobu reaction with alcohol 501 to deliver tertiary amine 
531. Interestingly, although the sample entering the reaction was a 95:5 mixture of diastereomers, the 
product obtained appeared to have a d.r. of 85:15. It is not currently known why the diastereomeric 
ratio was eroded in this process.  
With amine 531 in hand, we next attempted a palladium-catalysed cascade reaction, by simple 
treatment of 531 with catalytic tetrakis(triphenylphosphine)palladium. A single product, 
corresponding to N-allylation, was isolated from this reaction (Scheme 160). 
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Scheme 160. (i) 2 mol % Pd(PPh3)4, MeCN, 3 h, rt (65 %, 85:15 d.r.). 
No other products were isolated from this reaction, and no further investigation was carried out into 
this process. 
Another alternative cyclisation we considered was the formation of an iodonium ion at the exocyclic 
alkene position with subsequent nucleophilic attack by the sulfonamide to provide a bicylic structure 
with an iodomethyl substituent. We imagined that this product could then act as an electrophile for a 
nucleophilic allyl source, thereby forming the desired alkene 447. The possible outcomes of this 
reaction are outlined in Figure 60. 
 
Figure 60. Proposed iodine-mediated cyclisation. 
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One can imagine the formation of two diastereomeric iodonium ions 539 and 541. If a polar solvent, 
such as MeCN is used, we postulated that any HI formed may remain in solution and thus allow for 
interconversion between the two iodonium species. If this is the case, then the more stable 
thermodynamic product will form, which we postulate is the trans-fused bicycle 542. Similar to the 
Sharpless aziridination protocol, this interconversion would allow for the pathway of nucleophilic 
attack with the least steric hindrance to prevail, which as postulated for the copper-mediated 
carboamination reactions, would give rise to trans-1-aza-decalin 542. 
This reaction was attempted and monitored by 
1
H NMR analysis (Scheme 161). 
 
Scheme 161. (i) I2, MeCN, 72 h, rt. 
After just 2 h, we observed by 
1
H NMR analysis that the majority of the starting material had been 
consumed; this was signalled by the disappearance of any olefinic resonances. The spectrum collected 
was very complex, and so pinpointing a reference signal to determine a diastereomeric ratio was 
difficult. It was possible to observe two separate tosyl methyl signals, the ratio of which altered over 
time. After 2 h, a 2:1 ratio of tosyl methyl resonances was observed. We rationalised that allowing the 
reaction to continue, would allow for further interconversion between the two iodonium species, and 
thus the production of a greater proportion of the desired trans-fused diastereomer. However, the ratio 
was observed to be 1.5:1 after 20 h reaction time, and fell again to 1:1 after 48 h. It therefore appeared 
that this process was not selective. Having said that, since no products were isolated, this reaction may 
warrant further investigation in the future. 
Since our previous synthesis of (±)-lepadiformine featured a reliably diastereoselective              
Corey–Chaykovsky methylenation of a structurally-related ketone, we next decided to carry out 
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oxidative cleavage of alkene 528 and examine the reactivity of the resulting ketone under these 
conditions (Scheme 162). 
 
Scheme 162. (i) O3/O2, CH2Cl2, 10 min, –78 °C then PPh3, 16 h, rt (92 %, 95:5 d.r.). 
Pleasingly, ozonolysis of 528 proceeded smoothly to afford ketone 544 with no observable erosion of 
the diastereomeric ratio. Ketone 544 was then subjected to our previously optimised                  
Corey–Chaykovsky conditions (Scheme 163). 
 
Scheme 163. (i) NaH, Me3S(O)I, DMSO, 1 h, rt then 4 h, 55 °C. 
Disappointingly, this reaction produced epoxide 545, along with minor by-products, as a 1:1 mixture 
of diastereomers. The compounds were not isolated, although TLC analysis indicated that they were 
likely to be inseparable. This again gave us cause for concern, as it appeared that no facial selectivity 
was provided by the ring substituent adjacent to the exocyclic alkene or ketone, and as such a 
diastereoselective B-ring formation process might well prove difficult. 
Frustratingly, this result coincided with the end of our allotted research time for this project, and all 
investigation into this synthesis of (–)-lepadiformine has been suspended. We wish to build on the 
encouraging results we have achieved, and an outline of future plans for this project will be covered in 
the next section 
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3.5.0 Summary & Future Work  
3.5.1 Summary 
In conclusion, we have developed a highly diastereoselective synthesis of (–)-lepadiformine and 
(+)-fasicularin sulfonamide precursor 520 via a diastereoselective decarboxylative Claisen 
rearrangement. The absolute stereochemistry of this product has been proven by X-ray 
crystallography. We have demonstrated that the diastereoselectivity of these processes is enhanced by 
the incorporation of an extra substituent adjacent to the sulfoximine moiety, thereby substantiating our 
earlier hypotheses. In addition, we have expanded on previous work within the group to allow rapid 
assembly of sulfoximine ester dCr substrates, including improvements in yield of sulfoximine 394. In 
the course of our investigation into these dCr processes, we have accrued an arsenal of 
transformations which will prove useful in future work on these reactions: a high yielding reductive 
sulfoximine removal with sodium amalgam; a one step synthesis of chiral α-sulfonyl lactones from 
sulfonyl acetonitriles; an expedient route to sulfoximine esters via treatment with mixed 
para-nitrophenyl carbonates under basic conditions.  
Although the proposed Sharpless aziridination of olefin 501 did not proceed with any observable 
selectivity, we initiated investigation into piperidine ring formation from sulfonamide 520 using 
copper catalysis, palladium catalysis or Brønsted acid catalysis. We intend to continue with this mode 
of investigation, in the hope of completing the synthesis of (–)-lepadiformine and structurally related 
(+)-fasicularin.  
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3.5.2 Future Work 
Primarily, future work on this project will consist of the completion of the proposed natural product 
syntheses. We envisage that the principal focus will be the piperidine ring formation procedure to 
form the bicyclic core of the natural product targets. Also, examination of the effect of different 
α-substituents on the diastereoselectivity of the dCr, with a view to collating a library of examples, 
would be an interesting endeavour. This would demonstrate the value and versatility of this 
rearrangement in the synthesis of enantiopure natural products. 
We also hope to conduct investigations into the synthesis of other natural product motifs using the 
procedures we have developed. Firstly, variation of the chiral epoxide reagent used could allow access 
to lepadiformines B and C (Figure 61). 
 
Figure 61. Proposed synthesis of (–)-lepadiformines B and C. 
Similarly, employing (R)-1,2-epoxyoctane 548 would give access to the (+)-fasicularin core structure 
(Figure 62). 
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Figure 62. Proposed synthesis of (+)-fasicularin. 
Alternatively, synthesis of the (SR) enantiomer of sulfoximine 394 would in theory provide the 
opposite stereochemical outcome in the dCr process, thereby allowing for the synthesis of the 
cis-1-azadecalin core structure observed in the cylindricines. 
 
  
 
 
 
 
 
 
Chapter 4 
Experimental 
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4.1.0 General Experimental 
All reactions were performed under an atmosphere of nitrogen unless otherwise stated. Infrared 
spectra were recorded on a Perkin-Elmer Spectrum RX FT-IR System spectrometer with samples 
prepared as thin films on NaCl plates. Proton (
1
H) and carbon-13 (
13
C) nuclear magnetic resonance 
spectra were recorded in CDCl3 on a Bruker AV-400 or AV-500 spectrometer. Chemical shifts are 
reported in parts per million (ppm) and are referenced relative to the residual proton-containing 
solvent (
1
H NMR: 7.26 ppm for CDCl3; 
13
C NMR: 77.0 ppm for CDCl3). Coupling constants (J) are 
reported to the nearest 0.5 Hz. Mass spectra (CI, ESI and EI) were recorded using Micromass 
AutoSpec-Q or Micromass Platform II instruments. Thin layer chromatography (TLC) was performed 
on aluminium plates pre-coated with silica gel (0.2 mm, Merck 60 F254) and development was effected 
with UV light, potassium permanganate or vanillin as required. Flash column chromatography was 
performed using BDH (40-63 μm) silica gel according to the method of W. C. Still et al.122 Standard 
solvents were distilled under nitrogen prior to use: THF from sodium-benzophenone ketyl, CH2Cl2, 
MeOH, DMSO and acetonitrile from CaH2 and PhMe from sodium. All other solvents used were 
reagent grade. Petroleum ether refers to petroleum ether b.p. 40-60 °C. KOAc was oven-dried at 
120 °C for several days prior to use. Microwave-assisted reactions were carried out in a Biotage 
Initiator instrument. Ozonolyses were performed using an Ozonia Triogen LAB2B ozone generator. 
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4.2.0 Compounds pertaining to Chapter 2 
N-cyclohexylidenecyclohexylamine (243) 
 
Cyclohexylamine (23.1 mL, 204 mmol, 1 equiv) was added to a solution of cyclohexanone 
(21.1 mL, 204 mmol, 1 equiv) in Et2O (150 mL). The reaction was left to stand over 4 Å molecular 
sieves for 12 h when TLC confirmed consumption of starting material. The reaction was passed 
through a Celite® pad and the cake washed with Et2O (2 x 50 mL). The filtrate was concentrated 
under reduced pressure. The crude oil was purified by distillation (120 °C, 0.1 mmHg) to afford pure 
imine 243 as a brown oil (27.8 g, 76 %).  
Characteristic spectral data: δH (400 MHz, CDCl3) 3.35-3.20 (1H, m, HCN═C), 2.40-1.95 (4H, m, 
CH2C(═N)CH2), 1.90-0.95 (16H, m, NCHCH2CH2CH2CH2CH2 / N═CCH2CH2CH2CH2CH2); 
δC (101 MHz, CDCl3) 170.9 (C═N), 57.9 (HC═N), 42.0 (N═CCH2), 40.3 (N═CCH2), 36.9 
(CH2CHN═C), 34.2 (CH2CHN═C), 27.9 (N═CCH2CH2), 27.6 (N═CCH2CH2), 27.0 
(CH2CH2CHN═C), 26.2 (CH2CH2CHN═C), 25.7 (N═CCH2CH2CH2), 25.1 (CH2CH2CH2CHN═C); 
νmax (film)/cm
-1 2829, 2856, 1710, 1654 (C═N), 1551, 1451, 1388, 1344, 1132, 1038, 891; m/z (ESI) 
[M+H]
+
 for C12H12N req. 180.1752, found 180.1746. 
Values in accordance with those found in the literature.
123
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2-(2-(1,3-dioxolan-2-yl)ethyl)cyclohexanone (208) 
 
n-Butyllithium (13.6 mL, 1.96 M in hexanes, 26.7 mmol, 1.1 equiv) was added dropwise at –78 °C to 
a stirring solution of diisopropylamine (4.09 mL, 29.2mmol, 1.2 equiv) in THF (66.5 mL). Imine 243 
(4.36 g, 24.3 mmol, 1 equiv) in THF (66.5 mL) was added dropwise at –78 °C. The reaction was 
allowed to warm to rt and stirred for 2 h. 2-(2-bromoethyl)-1,3-dioxolane (3.09 mL, 26.7 mmol, 
1.1 equiv) was then added and the reaction stirred overnight at rt. After 16 h, sat. NH4Cl (aq) 
(87.2 mL) was added and the reaction heated to 80 ºC for 5 h when TLC (20 % EtOAc in petroleum 
ether) indicated complete consumption of starting material. The phases were separated and the 
aqueous layer extracted with Et2O (3 x 30 mL). The combined organic extracts were then washed with 
water (3 x 30 mL), dried over MgSO4, filtered and concentrated under reduced pressure. The crude oil 
was purified by silica gel chromatography (1030 % Et2O in petroleum ether) to afford ketone 208 
as a pale brown oil (3.51 g, 73 %). 
Characteristic spectral data: δH (400 MHz, CDCl3) 4.86 (1H, t, J 5.0, OCHO), 
3.99-3.96 (2H, m, OCH2CH2O), 3.89-3.83 (2H, m, OCH2CH2O), 2.43-2.27 (3H, m, CHC(O)CH2), 
2.19-1.99 (2H, m, O═CCHCH2CH2), 1.99-1.62 (6H, m, C(O)CH2CH2 /  O═CCHCH2 / O═CCHCH2), 
1.45-1.30 (2H, m, C(O)CH2CH2CH2); δC  (101 MHz, CDCl3) 213.0 (C═O), 104.4 (OCHO), 66.0 
(OCH2CH2O), 64.9 (OCH2CH2O), 50.4 (C(O)CH2), 42.1 (O═CCH), 34.0 (O═CCHCH2CH2), 31.3 
(O═CCHCH2), 28.1 (O═CCHCH2), 25.0 (C(O)CH2CH2), 23.8 (C(O)CH2CH2CH2); νmax (film)/cm
-1
 
2933, 2862, 1710 (C═O), 1451, 1410, 1312, 1146 (C–O), 1132 (C–O), 1034, 945, 888; m/z  (ESI) 
[M+H]
+
 for C11H18O3 req. 199.1334, found 199.1332. 
Values in accordance with those found in the literature.
61
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2-(2-(2-methylenecyclohexyl)ethyl)-1,3-dioxolane (244) 
 
n-Butyllithium (10.2 mL, 1.96 M in hexanes, 20 mmol, 1.15 equiv) was added dropwise at 0 ºC to a 
slurry of methyl triphenylphosphonium iodide (8.44 g, 20.9 mmol, 1.2 equiv) in THF (140 mL). The 
reaction was allowed to warm to rt and stirred for 10 min before being re-cooled to 0 ºC. Ketone 208 
(3.45 g, 17.4 mmol, 1 equiv) in THF (69 mL) was added dropwise at 0 ºC. The reaction was allowed 
to warm to rt and stirred for 3 h, when TLC (10 % EtOAc in petroleum ether) indicated complete 
consumption of starting material. The reaction was cooled to 0 ºC and carefully quenched with water 
(80 mL). The phases were separated and the aqueous layer extracted with Et2O (3 x 50 mL). The 
combined organic extracts were dried over Na2SO4, filtered and concentrated under reduced pressure. 
The crude oil was purified by silica gel chromatography (10 % Et2O in petroleum ether) to yield 
alkene 221 as a pale yellow oil (2.67 g, 78 %). 
Characteristic spectral data: δH (400 MHz, CDCl3) 4.89 (1H, t, J 5.0, OCHO), 4.64 (2H, d, J 4.5, 
C=CH2), 4.03-3.95 (2H, m, OCH2CH2O), 3.92-3.84 (2H, m, OCH2CH2O), 2.27-2.21 (1H, m, 
H2C═CCH), 2.09-2.00 (2H, m, C(O)CH2), 1.82-1.62 (6H, m, H2C═CCHCH2 / H2C═CCHCH2 / 
H2C═CCHCH2CH2), 1.62-1.38 (4H, m, H2C═CCH2CH2CH2); δC (101 MHz, CDCl3) 152.4 (C=CH2), 
105.9 (C=CH2), 104.9 (OCHO), 64.9 (OCH2CH2O), 64.7 (OCH2CH2O), 43.1 (H2C═CCH), 34.6 
(C(O)CH2), 33.8 (H2C═CCHCH2), 31.9 (H2C═CCHCH2CH2), 28.8 (H2C═CCHCH2), 26.3 
(H2C═CCH2CH2), 24.1 (H2C═CCH2CH2CH2); νmax (film)/cm
-1
 2929, 2856, 1646 (C═C), 1448, 1412, 
1144 (C–O), 1142 (C–O), 1042, 973, 945, 888; m/z (CI) [M+H]+ for C12H20O2 req. 197.1542, found 
197.1544. 
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Vinyltrimethylsilane (246) 
 
Vinylmagnesium bromide (52.6 mL, 0.7 M in THF, 36.8 mmol, 2 equiv) in THF (9.2 mL) was heated 
to reflux in a two-necked round-bottomed flask. Chlorotrimethylsilane (2.35 mL, 18.4 mmol, 1 equiv) 
in THF (9.2 mL) was added dropwise so as to maintain a gentle reflux. The reaction was heated at 
reflux for 2 h, then allowed to cool to rt and stirred for 18 h. The product was distilled directly from 
the reaction flask (64 ºC, 760 mmHg) and washed with water (20 x 30 mL). 
1
H NMR of 
vinyltrimethylsilane 246 indicated the presence of ~20 % THF. 246 was used without further 
purification.  
Characteristic spectral data: δH (400 MHz, CDCl3) 6.17 (1H, dd, J 6.0, CH=CHHtrans), 5.93 (1H, dd, J 
6.0, CH=CHHcis), 5.67 (1H, dd, J 5.5, CH=CH2), 0.08 (9H, s, Si(CH3)3).  
Values in accordance with those found in the literature.
70
 
Sodium 2-(trimethylsilyl)ethanesulfonate (247) 
 
tert-Butylperoxybenzoate (0.17 mL, 0.92 mmol, 0.02 equiv) was added to a stirring solution of 
vinyltrimethylsilane 246 (4.56 g, 46.0 mmol, 1 equiv) in MeOH (18.4 mL). A solution of NaHSO3 
(9.1 g, 87.4 mmol, 1.9 equiv) in water (18.4 mL) was added dropwise at rt. The reaction was heated to 
50 ºC and stirred for 48 h, when TLC (50 % Et2O in petroleum ether) indicated complete consumption 
of starting material. The reaction was cooled to 0 ºC and carefully quenched with sat. Na2S2O3 (aq.) 
(30 mL).The reaction was concentrated carefully under reduced pressure. The resultant white solid 
was washed thoroughly with MeOH, and the filtrate concentrated under reduced pressure. The 
resultant white solid was dried under vacuum at 100 ºC for 24 h to afford sulfonate salt 247 as a white 
solid (6.66 g, 75 % over 2 steps). 
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Characteristic spectral data: mp not obtained, decomposition observed at 225 °C; δH (400 MHz, 
d6-DMSO) 2.31-2.27 (2H, m, CH2SO3Na), 0.83-0.79 (2H, m, Me3SiCH2), -0.02 (9H, s, (CH3)3Si); 
δC (101 MHz, d6-DMSO), 46.7 (CH2SO3Na), 12.5 (Me3SiCH2), –1.28 ((CH3)3Si); νmax (film)/cm
-1
 
1253, 1199, 1179.3 (SO2), 1050, 903, 869, 849, 837.6 (S–O); m/z (ESI) [M–Na]
–
 for C5H13O3SSiNa 
req. 181.0355, found 181.0340. 
Values in accordance with those found in the literature.
70
 
2-(trimethylsilyl)ethanesulfonyl chloride (248) 
 
Phosphorus pentachloride (294 mg, 1.41 mmol, 1.5 equiv) was added portionwise to a stirring 
suspension of sodium trimethylsilylethanesulfonate 247 (200 mg, 0.940 mmol, 1 equiv) at 0 °C. The 
reaction was allowed to warm to rt overnight when TLC indicated complete consumption of starting 
material. The reaction mixture was transferred to a separating funnel and washed with sat. NaHCO3 
(aq.) (3 x 20 mL). The organic layer was dried over MgSO4, filtered and concentrated under reduced 
pressure to afford sulfonyl chloride 248 as a pale yellow liquid, which was used without further 
purification. 
Characteristic spectral data: δH (400 MHz, CDCl3) 3.66-3.60 (2H, m, CH2SO2Cl), 1.36-1.30 (2H, m, 
Me3SiCH2), 0.13 (9H, s, (CH3)3Si).  
Values in accordance with those found in the literature.
70
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2-(trimethylsilyl)ethanesulfonamide (249) 
 
Ammonia (33 % in water, 0.08 mL, 4.14 mmol, 4.4 equiv) in MeCN (1 mL) was added dropwise at 
0 °C to a stirring solution of sulfonyl chloride 248 (188 mg, 0.940 mmol, 1 equiv) in MeCN (2 mL). 
The reaction was allowed to warm to rt over 1.5 h when TLC (50 % EtOAc in petroleum ether) 
indicated complete consumption of starting material. The reaction was concentrated under reduced 
pressure, the residue dissolved in water (20 mL) and transferred to a separating funnel. The aqueous 
layer was extracted with EtOAc (4 x 30 mL). The combined organic extracts were dried over MgSO4, 
filtered and concentrated under reduced pressure to afford sulfonamide 249 as a pale brown 
crystalline solid (100 mg, 56 % over 2 steps).  
Characteristic spectral data: mp. 80 – 82 °C; δH (400 MHz, CDCl3) 4.81 (2H, s, SO2NH2), 3.08-3.03 
(CH2SO2NH2), 1.12-1.07 (2H, m, Me3SiCH2), 0.08 (9H, s, ((CH3)3Si); δC (101 MHz, CDCl3) 51.5 
(CH2SO2NH2), 10.9 (Me3SiCH2), –2.0 ((CH3)3Si); νmax (film)/cm
-1 
1334, 1312, 1251, 1150 (SO2), 
1134, 887, 840, 834; m/z (CI) [M+NH4]
+ 
for C5H15NO2SSi req. 199.0937, found 199.0937. 
Values in accordance with those found in the literature.
124
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(E)-N-benzylidene-2-(trimethylsilyl)ethanesulfonamide (250) 
 
Benzaldehyde (0.012 mL, 0.117 mmol, 1 equiv) was added to a stirring solution of sulfonamide 249 
(25 mg, 0.117 mmol, 1 equiv) in PhMe (50 mL) over activated 4 Ǻ molecular sieves. A reflux 
condenser was attached and the reaction was heated at reflux for 22 h, when TLC (50 % EtOAc in 
petroleum ether) indicated complete consumption of starting material. The reaction mixture was then 
filtered through a Celite® pad, the filtrate poured onto saturated NaHCO3 solution and transferred to a 
separating funnel. The phases were separated and the aqueous layer extracted with CH2Cl2 (3 x 20 
mL). The combined organic extracts were dried over MgSO4, filtered and concentrated under reduced 
pressure to afford imine 250 as a pale yellow solid.  
Characteristic spectral data: mp. 94 – 97 °C; δH (400 MHz, CDCl3) 9.06 (1H, s, N=CH), 
7.99 (2H, d, J 7.0, o-Ph), 7.68 (1H, t, J 7.5, p-Ph), 7.56 (2H, t, J 8.0, m-Ph), 
3.20-3.15 (2H, m, CH2SO2), 1.11-1.07 (2H, m, Me3SiCH2), 0.08 (9H, s, (CH3)3Si); 
δC (101 MHz, CDCl3) 172.3 (C=N), 135.1 (ipso-Ph), 131.3 (p-Ph), 129.3 (m-Ph), 128.6 (o-Ph), 48.9 
(CH2SO2), 9.5 (Me3SiCH2), –2.0 ((CH3)3Si); νmax (film)/cm
-1
 1690 (C=N), 1310 (SO2), 1169 (SO2); 
m/z (ESI) [M+H]
+
 for C12H19NO2SSi req.  270.0984, found 270.0981. 
Values in accordance with those found in the literature.
125
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3-phenyl-2-(2-trimethylsilyl)ethylsulfonyl)-1,2-oxaziridine (251) 
 
m-CPBA (36 mg, 0.208 mmol, 1.1 equiv) in CHCl3 (0.5 mL) was added dropwise at 0 °C to a stirring 
solution of imine 250 (51 mg, 0.190 mmol, 1 equiv) and BTEAC (3.5 mg, 0.019 mmol, 0.1 equiv) in 
CHCl3 (0.3 mL) and sat. NaHCO3 (aq.) (0.3 mL). The reaction was stirred for 45 min at 0 °C when 
TLC (20 % Et2O in petroleum ether) indicated consumption of starting material. The reaction was 
transferred to a separating funnel and the layers separated. The organic layer was washed with water 
(3 x 10 mL), 10 % Na2SO3 (aq.) (3 x 10 mL), water (3 x 10 mL) and brine (3 x 10 mL). The organic 
layer was dried over MgSO4, filtered and concentrated under reduced pressure to afford oxaziridine 
251 as a white solid (36 mg, 67 %). 
Characteristic spectral data: mp. 120 – 125 °C; δH (400 MHz, CDCl3) 8.08-8.09 (2H, m, o-Ph), 
8.01-8.00 (1H, m, p-Ph), 7.69-7.67 (2H, m, m-Ph), 5.48 (1H, s, N–CH), 3.34-3.27 (2H, m, CH2SO2), 
1.32-1.18 (2H, m, Me3SiCH2), 0.14 (9H, s, ((CH3)3Si); δC (101 MHz, CDCl3) 134.5 (ipso-Ph), 130.3 
(p-Ph), 129.8 (m-Ph), 128.3 (o-Ph), 74.5 (N–CH), 48.1 (CH2SO2), 8.8 (Me3SiCH2), –2.0 ((CH3)3Si); 
νmax (film)/cm
-1
 1310 (SO2), 1252 (N–O), 1169 (SO2). 
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4-nitrobenzenesulfonamide (253) 
 
Ammonia (33 % in water, 0.65 mL, 11.3 mmol, 6.1 equiv) was added dropwise to a stirring solution 
of 4-nitrobenzenesulfonyl chloride (412 mg, 1.86 mmol, 1 equiv) in THF (2.9 mL) at rt. The reaction 
was stirred for 30 min when TLC (20 % EtOAc in petroleum ether) indicated consumption of starting 
material. A solution of 4:1 EtOAc:brine (10 mL) was added and the reaction was transferred to a 
separating funnel. The organic layer was washed with brine (3 x 20 mL). The layers were separated 
and the organic layer dried over Na2SO4, filtered and concentrated under reduced pressure. The 
resulting solid was recrystallised (4:1 hexane:EtOAc) and the crystals collected to afford sulfonamide 
253 as a pale orange crystalline solid (247 mg, 66 %). 
Characteristic spectral data: mp. 175 – 179 °C; δH (400 MHz, d6-acetone) 8,45 (2H, d, J 7.0, m-Ns), 
8.19 (2H, d, J 6.5, o-Ns), 7.00 (2H, s, SO2NH2); δC (101 MHz, d6-acetone) 205.3 (CNO2), 204.6 
(CSO2NH2), 127.6 (m-Ns), 124.3 (o-Ns); νmax (film)/cm
-1
 1533 (NO2), 1352 (NO2), 1314 (SO2), 1171 
(SO2), 1082, 1015, 975, 856, 744, 685, 671, 615; m/z (ES) [M–H]
–
 for C6H6N2O4S req. 200.9970, 
found 200.9963.  
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(E)-N-benzylidene-4-nitrobenzenesulfonamide (254) 
 
Benzaldehyde (0.11 mL, 1.11 mmol, 1 equiv) was added to a stirring solution of sulfonamide 253 
(224 mg, 1.11 mmol, 1 equiv) in PhMe (80 mL) over activated 4 Ǻ molecular sieves. A reflux 
condenser was attached and the reaction heated at reflux for 24 h, when TLC (10 % EtOAc in 
petroleum ether) indicated complete consumption of starting material. The reaction was filtered 
through a Celite
®
 pad, the pad washed with PhMe (30 mL), and the filtrate concentrated under 
reduced pressure. The resultant solid was washed with hexane (50 mL) and collected on a sintered 
glass funnel to afford imine 254 as a pale yellow crystalline solid (301 mg, 94 %). 
Characteristic spectral data: mp. 160 – 164 °C; δH (400 MHz, CDCl3) 9.16 (1H, s, N=CH), 8.42 (2H, 
d, J 7.5, m-Ns), 8.24 (2H, d, J 5.0, o-Ns), 7.98 (2H, d, J 7.0, o-Ph), 7.70-7.68 (1H, m, p-Ph), 7.55 (2H, 
t, J 7.1, m-Ph); δC (101 MHz, CDCl3) 205.3 (CNO2), 204.3 (CSO2NH2), 172.4 (C═N), 135.8 
(ipso-Ph), 133.1 (p-Ph), 132.0 (m-Ph), 131.7 (o-Ph), 129.3 (m-Ns), 124.4 (o-Ns); νmax (film)/cm
-1
 
1696  (C═N), 1596, 1571, 1529 (NO2), 1453, 1338 (SO2), 1310 (NO2), 1225, 1158 (SO2), 1086, 1013, 
860, 800, 764, 748, 739, 685, 647, 599; m/z (ESI) [2M–H]– for C13H10N2O4S req. 579.0650, found 
579.0684.  
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2-(4-nitrophenylsulfonyl)-3-phenyl-1,2-oxaziridine (255) 
 
m-CPBA (24 mg, 0.140 mmol, 1.1 equiv) in CHCl3 (0.3 mL) was added dropwise at 0 °C to a stirring 
solution of imine 254 (37 mg, 0.128 mmol, 1 equiv) and BTEAC (2 mg, 0.0128 mmol, 0.1 equiv) in 
CHCl3 (0.2 mL) and sat. NaHCO3 (aq.) (0.2 mL). The reaction was stirred for 45 min at 0 °C when 
TLC (30 % EtOAc in petroleum ether) indicated complete consumption of starting material. The 
reaction was transferred to a separating funnel and the layers separated. The organic layer was diluted 
with CHCl3 (20 mL) and washed with water (3 x 10 mL), 10 % Na2SO3 (aq.) (3 x 10 mL), water (3 x 
10 mL) and brine (3 x 10 mL). The organic layer was dried over MgSO4, filtered and concentrated 
under reduced pressure to afford oxaziridine 255 as a white solid (37 mg, 90 %). 
Characteristic spectral data: mp. not obtained – decomposition observed at 100 °C; 
δH (400 MHz, CDCl3) 8.53-8.50 (2H, m, m-Ns), 8.31-8.28 (2H, m, o-Ns), 7.93-7.91 (1H, m, p-Ph), 
7.49-7.44 (4H, m, o-Ph / m-Ph), 5.63 (1H, s, NCH); δC (101 MHz, CDCl3) 205.3 (p-Ns), 
204.6 (ipso-Ns), 131.8 (ipso-Ph), 130.8 (p-Ph), 129.9 (m-Ph), 129.0 (o-Ph), 128.9 (m-Ns), 128.3 
(o-Ns), 77.2 (NCH); νmax (film)/cm
-1
 2925, 2854, 1771, 1698, 1604, 1579, 1535 (NO2), 1453, 1418, 
1350 (SO2), 1318 (NO2), 1287, 1217, 1148 (SO2), 1022, 858, 738, 715. 
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 (E)-N-(1-phenylpropylidene)-2-(trimethylsilyl)ethanesulfonamide (259) 
 
Propiophenone (0.12 mL, 0.917 mmol, 1 equiv) was added to a stirring solution of sulfonamide 249 
(166 mg, 0.917 mmol, 1 equiv) in PhMe (60 mL) over activated 4 Ǻ molecular sieves. A reflux 
condenser was attached and the reaction heated at reflux for 24 h, when TLC (20 % EtOAc in 
petroleum ether) indicated complete consumption of starting material. The reaction was filtered 
through a Celite
®
 pad, the pad washed with PhMe (30 mL) and the filtrate concentrated under reduced 
pressure to afford imine 259 as a brown oil (182 mg, 67 %). 
Characteristic spectral data: δH (400 MHz, CDCl3) 8.00-7.98 (2H, m, o-Ph), 7.59-7.55 (1H, m, p-Ph), 
7.50-7.46 (2H, m, m-Ph), 3.10-3.00 (4H, m, CH2SO2 / N═CCH2), 1.25 (3H, t, J 7.5, N═CCH2CH3), 
1.13-1.08 (2H, m, Me3SiCH2), 0.08 (9H, s, (CH3)3Si); δC (101 MHz, CDCl3) 161.8  (C=N), 
136.9 (ipso-Ph), 132.9 (p-Ph), 128.6 (m-Ph), 128.0 (o-Ph), 51.5 (CH2SO2), 31.8 (N═CCH2), 
10.9 (Me3SiCH2), 8.3 (N═CCH2CH3), –2.0 ((CH3)3Si); νmax (film)/cm
-1 
1687 (C═N), 1327 (SO2), 
1142 (SO2); m/z (ESI) [M+H2O]
+
 for C14H23NO2SSi req. 315.1324, found 315.1201. 
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N-chloro-2-(trimethylsilyl)ethanesulfonamide sodium salt (296) 
 
Trichloroisocyanuric acid (194 mg, 0.84 mmol, 0.75 equiv) was added slowly to a stirring solution of 
sulfonamide 249 (200 mg, 1.10 mmol, 1 equiv) in 2 M NaOH (aq.) (1.1 ml). The resulting slurry was 
stirred for 1 h at rt. After 1 h, the reaction was cooled to 0 °C and the resultant precipitate collected on 
a glass sinter funnel. The resultant white solid was dried under vacuum overnight, and collected to 
afford chloramine 296 as a waxy white solid which was used without further purification 
(105 mg, 40 %). 
Characteristic spectral data: δH (400 MHz, CDCl3) 3.55-3.21 (2H, m, CH2SO2), 1.25-1.21 (2H, m, 
Me3SiCH2), 0.14 (9H, s, Si(CH3)3).  
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4-(2-(1,3-dioxolan-2-yl)ethyl)-1-tosyl-1-azaspiro[2.5]octane (265) 
 
Chloramine-T
®
 (359 mg, 1.28 mmol, 1.5 equiv) was added in one portion to a stirring solution of 
methylenecyclohexane 244 (167 mg, 0.85 mmol, 1 equiv) in MeCN (4.3 mL) at rt. PTAB (64 mg, 
0.17 mmol, 0.2 equiv) was then added in one portion. The reaction was stirred for 2 h at rt, when TLC 
(30 % EtOAc in petroleum ether) indicated complete consumption of starting material. The reaction 
was filtered under gravity and the filtrate concentrated under reduced pressure. The crude oil was 
purified by silica gel chromatography (10 % EtOAc in petroleum ether) to afford aziridine 265 as a 
viscous colourless oil (260 mg, 87 %). α-hydroxyamine 266 was also obtained as a pale yellow 
viscous oil (32 mg, 11 %). 
Characteristic spectral data (265): δH (400 MHz, CDCl3) 7.86 (2H, d, J 8.0, o-Ts), 7.34 (2H, d, J 8.0, 
m-Ts), 4.83 (1H, t, J 4.5, OCHO), 4.02-3.84 (4H, m, OCH2CH2O), 2.50 (1H, s, NCHaHb), 
2.46 (3H, s, Ts-CH3), 2.33 (1H, s, NCHaHb) 2.21-0.85 (13H, m, NCCH2CH2CH2CH2CHCH2CH2); 
δC (101 MHz, CDCl3) 143.6 (ipso-Ts), 138.2 (p-Ts), 129.4 (o-Ts), 127.3 (m-Ts), 104.5 (OCHO), 
64.9 (OCH2CH2O), 64.8 (OCH2CH2O), 57.2 (NC (4°)), 41.0 (OCHCH2), 38.5 (NCH2), 31.8 (NCCH2), 
29.7 (NCCH), 29.4 (NCCHCH2), 25.5 (NCCH2CH2), 23.5 (NCCHCH2), 21.6 (Ts-CH3), 
14.2 (NCCH2CH2CH2); νmax (film)/cm
-1
 3504, 3273, 3061, 2932, 2866, 1720, 1655, 1598, 1495, 1448, 
1411, 1331 (SO2), 1290, 1268, 1213, 1161 (SO2), 1093, 956, 945, 873, 848, 815, 735, 706, 664, 551; 
m/z (ESI) [M+H]
+
 for C19H27NO4S req. 366.1739, found 366.1725.  
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N-(2-(2-(1,3-dioxolan-2-yl)ethyl)-1-(hydroxymethyl)cyclohexyl)-4-methylbenzenesulfonamide 
(266) 
 
Characteristic spectral data (266): δH (400 MHz, CDCl3) 7.75 (2H, d, J 8.5, o-Ts), 7.31 (2H, d, J 8.0, 
m-Ts), 5.57 (1H, s, TsNH), 4.82 (1H, t, J 4.5, OCHO), 4.03-3.85 (4H, m, OCH2CH2O), 3.66-3.59 
(1H, m, HOCHaCHb), 3.46-3.59 (1H, m, HOCHaCHb), 2.44 (3H, s, Ts-CH3), 2.03-0.85 (13H, m, 
TsNHCCH2CH2CH2CH2CHCH2CH2); δC (101 MHz, CDCl3) 143.2 (ipso-Ts), 135.8 (p-Ts), 129.6 
(m-Ts), 127.2 (o-Ts), 104.6 (OCHO), 34.9 (OCH2CH2O), 64.8 (OCH2CH2O), 47.6 (HOCH2), 34.1 
(TsNHCCH), 31.0 (TsNHCCH2), 26.6 (TsNHCCHCH2), 26.1 (TsNHCCHCH2CH2), 25.2 
(TsNHCCHCH2), 23.8 (Ts-CH3), 21.5 (TsNHCCH2CH2), 19.0 (TsNHCCH2CH2CH2); 
νmax (film)/cm
-1 
3486 (N–H), 3278 (O–H), 3060, 2932, 2865, 1720, 1651, 1598, 1495, 1449, 1402, 
1335 (SO2), 1307, 1290, 1271, 1213, 1161 (SO2), 1092, 1025, 974, 944, 889, 847, 815, 736, 706, 665, 
619, 584, 549; m/z [M+H]
+ 
for C19H29NO5S req. 384.1845, found 384.1854. 
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1-(2-Oxo-1,3-oxazolidin-3-yl)-2-propen-1-one (308) 
 
Prepared according to a literature procedure.
126
 
DMAP (93 mg, 0.76 mmol, 0.13 equiv) and acrylic acid (0.79 ml, 11.48 mmol, 2 equiv) were added 
to a stirring solution of oxazolidin-2-one (500 mg, 5.74 mmol, 1 equiv) in CH2Cl2 (7.6 ml) at 0 °C. 
DIC (1.78 ml, 11.48 mmol, 2 equiv) was added in one portion at 0 °C. The reaction was allowed to 
warm to rt and stirred overnight, when TLC indicated complete consumption of starting material. The 
reaction was filtered under gravity, and the precipitate washed with CH2Cl2 (10 ml). The filtrate was 
transferred to a separating funnel and washed with sat. NaHCO3 (aq) (3 x 20 ml). The organic layer 
was dried over Na2SO4, filtered and concentrated under reduced pressure. The crude oil was purified 
by silica gel chromatography (60 % EtOAc in petroleum ether) to afford 308 as a pale yellow oil 
(450 mg, 56 %). 
Characteristic spectral data: δH (400 MHz, CDCl3) 7.52 (1H, dd, J 17.0, 10.5, H2C=CH), 6.59 (1H, dd, 
J 17.0, 1.5, HC=CHtrams), 5.93 (1H, dd, J 10.5, 1.5, HC=CHcis), 4.47 (2H, t, J 9.0, NCH2CH2O), 4.12 
(2H, t, J 9.5, NCH2CH2O); δC (101 MHz, CDCl3) 165.1 (NC(O)O), 153.4 (NC(O)CH═CH2), 131.9 
(CH2=CH), 127.0 (CH2═CH), 62.2 (NCH2CH2O), 42.6 (NCH2CH2O); νmax (film)/cm
-1 
3289, 2985, 
1780 (C═O), 1688, 1649, 1617, 1541, 1525, 1467, 1409, 1387, 1365, 1326, 1284, 1250, 1189, 1130, 
1068, 1013, 974, 959, 868, 815, 793, 760, 693, 612.  
Values in accordance with those found in the literature.
126
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(2S)-2-Amino-3,3-dimethylbutanol (339) 
 
Prepared according to a literature procedure.
89
 
(S)-tert-leucine (1.35 g, 10.3 mmol, 1 equiv) was added in one portion to a stirring solution of 
NaBH4 (938 mg, 24.8 mmol, 2.4 equiv) in THF (30.5 ml) in a pre-dried two-necked flask at rt. The 
reaction was cooled to 0 °C and a reflux condenser attached. A solution of iodine (2.61 g, 10.3 mmol, 
1 equiv) in THF (3.4 mL) was added dropwise at 0 °C. The reaction was allowed to warm to rt, and 
once the brown colour had dissipated to give a cloudy white solution, the reaction was heated to 
reflux for 19 h. After 19 h, the resulting cloudy white solution was allowed to cool to rt, and 
MeOH (3 mL) added slowly until all of the white solid had dissolved. The reaction was concentrated 
under reduced pressure to afford a pasty white oil, to which was added 20 % w/w KOH (aq.) (20 mL) 
and the resulting solution stirred for 4 h until a pale green colour had developed. The resulting 
solution was transferred to a separating funnel and extracted with CH2Cl2 (3 x 20 mL). To minimise 
emulsion, brine (20 mL) was added to the aqueous layer after the first extraction. The combined 
organic extracts were dried over Na2SO4, filtered and concentrated under reduced pressure to afford 
(S)-tert-leucinol 339 as a pale yellow oil which was used without further purification (1.20 g, 99 %). 
Characteristic spectral data: δH (400 MHz, CDCl3) 3.69 (1H, dd, J 10.0, 3.0, HOCHaHb), 
3.19 (1H, t, J 10.0, HOCH2CH), 2.49 (1H, dd, J 10.0, 3.0, HOCHaHb), 2.30 (3H, br s, NH2 / OH), 
0.88 (9H, s, C(CH3)3); δC (101 MHz, CDCl3) 62.4 (HOCH2), 61.8 (HOCH2CHNH2), 33.2 (C(CH3)3), 
26.3 (C(CH3)); νmax (film)/cm
-1  
3296 (N–H), 3167 (O–H), 2955, 2870, 1588, 1477, 1396, 1365, 1101, 
1044, 996, 912, 855.  
Values in accordance with those found in the literature.
89
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Dimethylmalonyl dichloride (341) 
 
Prepared according to a literature procedure.
89
 
Oxalyl chloride (3.90 mL, 45.4 mmol, 3 equiv) was added dropwise to a stirring solution of 
dimethylmalonic acid (2 g, 15.10 mmol, 1 equiv) and DMF (0.15 mL, 2.00 mmol, 0.13 equiv) in 
CH2Cl2 (23 mL) at 0 °C. The reaction was allowed to warm to rt and stirred for 18 h, when TLC 
(20 % EtOAc in petroleum ether) indicated complete consumption of starting material. The resulting 
pale yellow solution was concentrated under reduced pressure to afford a pale yellow oil. The crude 
oil was purified by Kugelrohr distillation (160 °C, 760 mmHg) to afford dimethylmalonyl dichloride 
341 as a colourless oil (2.12 g, 83 %). 
Characteristic spectral data: δH (400 MHz, CDCl3) 1.71 (6H, s, C(CH3)2); δC (101 MHz, CDCl3) 172.0 
(2 x C=O), 69.1 (C(CH3)2), 23.2 (C(CH3)2). 
Values in accordance with those found in the literature.
89
 
1,3-Bis[(1S)-1-(hydroxymethyl)-2,2-dimethylpropylamino]-2,2-dimethyl-1,3-propanedione (342) 
 
Prepared according to a literature procedure.
89
 
Triethylamine (3.64 mL, 26.10 mmol, 5 equiv) was added dropwise to a stirring solution of 
(S)-tert-leucinol 339 (1.22 g, 10.43 mmol, 2 equiv) in CH2Cl2 (11.5 mL) at 0 °C. A solution of 
dimethylmalonyl dichloride 341 (882 mg, 5.22 mmol, 1 equiv) in CH2Cl2 (4 mL) was then added 
dropwise at 0 °C with vigorous stirring. The reaction was allowed to warm to rt and the resulting thick 
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white suspension stirred for 35 min. The reaction was diluted with CH2Cl2 (30 mL) to dissolve any 
remaining white solid, and the resulting solution transferred to a separating funnel. The organic layer 
was washed with 1 M HCl (3 x 30 mL), and the aqueous layer back-extracted with 
CH2Cl2 (2 x 10 mL). The combined organic extracts were then washed with sat. 
NaHCO3 (aq.) (3 x 30 mL), and the aqueous layer back-extracted with CH2Cl2 (2 x 10 mL). The 
combined organic extracts were then washed with brine (3 x 30 mL) and the aqueous layer 
back-extracted with CH2Cl2 (2 x 10 mL). The combined organic extracts were dried over Na2SO4, 
filtered and concentrated under reduced pressure. The resultant white solid was recrystallised from 
EtOAc and collected on a glass sinter funnel, to afford diamide 342 as a white crystalline solid 
(836 mg, 49 %). 
Characteristic spectral data: δH (400 MHz, CDCl3) 6.47 (2H, d, J 10.0, 2 x NH), 3.94-3.84 (4H, m, 
2 x HOCHaHb / 2 x CH(CH3)3), 3.58-3.44 (4H, m, 2 x HOCHaHb / 2 x OH), 1.52 (6H, s, C(CH3)2), 
0.94 (18 H, 2 x C(CH3)3); δC (101 MHz, CDCl3) 174.7 (C═O), 62.2 (CH2OH), 59.6 (CHCH2OH), 
50.3 (C(O)C(CH3)2C(O)), 33.5 (C(CH3)3), 26.8 (C(CH3)3), 23.8 (C(O)C(CH3)2C(O)).  
Values in accordance with those found in the literature.
89
 
(4S)-2-{1-[(4S)-4-(tert-Butyl)Δ2-1,3-oxazolin-2-yl]-1-methylethyl}-4-(tert-butyl)Δ2-1,3-oxazoline 
(343) 
 
Prepared according to a literature procedure.
89
 
DMAP (10 mg, 0.085 mmol, 0.1 equiv) and triethylamine (0.52 mL, 3.76 mmol, 4.4 equiv) were 
added slowly to a stirring solution of diamide 342 (282 mg, 0.85 mmol, 1 equiv) in CH2Cl2 (3.4 mL) 
at rt. A solution of TsCl (326 mg, 1.71 mmol, 2 equiv) in CH2Cl2 (0.71 mL) was then added dropwise 
at rt, and the resulting mixture stirred for 16 h at rt, when TLC (30 % EtOAc in petroleum ether) 
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indicated complete consumption of starting material. The reaction was then diluted with CH2Cl2 
(5 mL) and the reaction transferred to a separating funnel. The organic layer was separated and 
washed with sat. NH4Cl (aq.) (3 x 10 mL), with water added to dissolve any white solid that forms in 
the aqueous layer. The organic layer was then washed with sat. NaHCO3 (aq.) (3 x 20 mL) and the 
aqueous layer back-extracted with CH2Cl2 (2 x 10 mL). The combined organic extracts were then 
dried over Na2SO4, filtered and concentrated under reduced pressure. The resulting white solid was 
recrystallised from hot pentane, and the resulting crystals collected on a glass sinter funnel to afford 
bis(oxazoline) 343 as an off-white crystalline solid (188 mg, 74 %). 
Characteristic spectral data: δH (400 MHz, CDCl3) 4.13 (4H, dt, J 15.5, 9.0, 2 × OCH2), 3.85 (2H, dd, 
J 10.0, 7.0, 2 × OCH2CHN), 1.52 (6H, s, C(CH3)2), 0.88 (9H, s, CHC(CH3)3); δC (101 MHz, CDCl3) 
168.6 (C═N), 69.0 (OCH2), 38.6 (C(CH3)2), 33.9 (OCH2CHN), 27.0 (C(CH3)2), 25.8 (C(CH3)3), 24.4 
(C(CH3)3); νmax (film)/cm
-1 
 1659 (C═N), 1537, 1479, 1366, 1265, 1115, 1060, 982, 896, 732, 703; 
m/z (ESI) [M+H]
+
 for C17H30N2O2 req. 295.2386, found 295.2399.  
Values in accordance with those found in the literature..
89
 
[Cu((S,S)-tert-butyl-BOX]Cl2•CH2Cl2 (344) 
 
CuCl2 (79 mg, 0.59 mmol, 1 equiv) was added to bis(oxazoline) 343 (173 mg, 0.59 mmol, 1 equiv) 
under an atmosphere of N2 in a flame-dried vial. The vial was sealed and charged with CH2Cl2 
(2.4 mL), and the reaction stirred for 3.5 h at rt, by which time all the brown colour in the solution had 
dissipated. The reaction mixture was passed via cannula through a 0.45 μm microfilter into a 
round-bottomed flask under an atmosphere of N2. The resulting green solution was concentrated 
under reduced pressure and dried under vacuum to afford 344 as a green powder (169 mg, 67 %). 
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Characteristic spectral data: νmax (film)/cm
-1
 2962.5 (C–H), 1654.0 (C═N), 1480.0, 1370.0, 1239.0 
(C–O), 1136.0, 944.0 (cf. literature values of 2968, 1655, 1484, 1371, 1239, 1135, 947).  
Values in accordance with those found in the literature.
89
 
Methyl 1-cyclohexene-1-carboxylate (335) 
 
Conc. H2SO4 (0.1 mL) was added dropwise to a stirring solution of 1-cyclohexene-1-carboxylic acid 
(1.38 g, 11.0 mmol, 1 equiv) in MeOH (20.2 mL) at rt. The reaction was heated at reflux for 4 h, 
when TLC indicated complete consumption of starting material. The reaction was diluted with water 
(20 mL), transferred to a separating funnel and extracted with CH2Cl2 (3 x 50 mL). The combined 
organic extracts were dried over Na2SO4, filtered and concentrated under reduced pressure to afford 
methyl 1-cyclohexene-1-carboxylate 335 as a pale yellow oil (1.57 g, quant.). 
Characteristic spectral data: δH (400 MHz, CDCl3) 7.00 (1H, tt, J 3.5, 1.5, C=CH), 3.74 (3H, s, 
CO2CH3), 2.32-2.25 (2H, m, HC=CCH2), 2.23-2.16 (2H, m, CH2CH=C), 1.70-1.58 (4H, m, 
HC=CCH2CH2CH2CH2); νmax (film)/cm
-1
 2991, 2937, 2861, 1714 (C═O), 1649 (C═C), 1436, 1378, 
1351, 1342,  1304, 1276, 1248, 1190, 1176, 1139, 1087 (C–O), 985, 930, 915, 870, 851, 798, 747, 
703.  
Values in accordance with those found in the literature.
127
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(1-Cyclohexen-1-yl)methanol (333) 
 
Alcohol 333 was prepared according to either of the following literature procedures: 
Method A
128
 
Ester 335 (1.60 g, 11.43 mmol, 1 equiv) was added dropwise to a stirring solution of DIBAL-H (1.0 
M in hexanes, 26.3 mL, 26.3 mmol, 2.3 equiv) in CH2Cl2 (32.1 mL) at –78 °C. The reaction was 
stirred for 1.5 h at –78 °C, when TLC (30 % EtOAc in petroleum ether) indicated complete 
consumption of starting material. The reaction was quenched cautiously with MeOH (16 mL) at –78 
°C, and then diluted with 15 % NaOH (aq.) (32 mL). The resultant slurry was allowed to warm to rt 
and stirred for 30 min. The biphasic mixture was transferred to a separating funnel, the layers 
separated and the aqueous layer extracted with CH2Cl2 (3 x 40 mL). The combined organic extracts 
were dried over MgSO4, filtered and concentrated under reduced pressure to afford 
cyclohexenylmethanol 333 as a colourless oil which was used without further purification (1.09 g, 
85 %). 
Method B
99,100
 
Cyclohexanone (15 mL, 144.7 mmol, 1 equiv) was added dropwise to a stirring solution of 
trimethylsulfonium iodide (47.9 g, 234.5 mmol, 1.62 equiv) in DMSO (30 mL) at rt. KOt-Bu (24.4 g, 
217.1 mmol, 1.5 equiv) in DMSO (30 mL) was added dropwise at rt. The reaction was allowed to stir 
at rt for 16 h, when TLC indicated complete consumption of starting material. The reaction was 
quenched by the addition of water (60 mL) and transferred to a separating funnel. The aqueous layer 
was extracted with Et2O (4 x 50 mL). The combined organic extracts were washed with 
water (3 x 50 mL), dried over MgSO4, filtered and concentrated under reduced pressure to afford the 
corresponding spiroepoxide as a colourless oil, which was used without further purification. 
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p-TsOH (13.8 g, 72.35 mmol, 0.5 equiv) was added in one portion to a stirring solution of the 
spiroepoxide obtained above (16.23 g, 144.7 mmol, 1 equiv) in N,N-dimethylimidazolidinone 
(31.6 mL) and CH2Cl2 (400 mL) at rt. The reaction was allowed to stir at rt for 72 h, when TLC 
indicated complete consumption of starting material. The reaction was quenched by the addition of 
water (100 mL), and transferred to a separating funnel. The aqueous layer was extracted with CH2Cl2 
(3 x 100 mL). The combined organic extracts were dried over Na2SO4, filtered and concentrated under 
reduced pressure. The crude product was purified by silica gel chromatography (0  10 % EtOAc in 
petroleum ether) to afford alcohol 333 as a pale yellow oil (12.2 g, 75 % over 2 steps). 
Characteristic spectral data: δH (400 MHz, CDCl3) 5.68 (1H, br s, HC═C), 3.99-3.95 (2H, m, 
CH2OH), 2.05-1.99 (4H, m, CH2CH═CCH2), 1.82 (1H, br s, OH), 1.69-1.56 
(CH2CH2CH═CCH2CH2); δC (101 MHz, CDCl3) 137.5 (C═CH), 122.9 (C═CH), 67.6 (CH2OH), 25.6 
(CH2CH═C), 24.9 (CH═CCH2), 22.5 (CH═CH2CH2), 22.4 (CH2CH2CH═C); νmax (film)/cm
-1 
3077 
(O–H), 2938, 2862, 2623, 2529, 1690 (C═C), 1644, 1450, 1425, 1367, 1344, 1307, 1284, 1261, 1176, 
1140, 1118, 1090, 1073, 1041, 924, 871, 800, 782, 740, 695, 640.  
Values in accordance with those found in the literature.
128
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1-(Bromomethyl)cyclohexene (328) 
 
Bromide 328 was prepared via either of the following two literature procedures. 
Method A
129
 
Bromine (0.65 mL, 12.57 mmol, 1.1 equiv) was added dropwise to a stirring slurry of 
triphenylphosphine (3.30 g, 12.57 mmol, 1.1 equiv) in MeCN (18.5 mL) at 0 °C. A solution of alcohol 
333 (1.44 g, 11.43 mmol, 1 equiv) in MeCN (1.85 mL) was then added dropwise at 0 °C. The reaction 
was allowed to stir for 1.5 h at 0 °C when TLC (petroleum ether) indicated complete consumption of 
starting material. The reaction was concentrated under reduced pressure and the resulting brown oil 
loaded directly onto a column of silica gel. Silica gel chromatography (petroleum ether) afforded 
bromide 328 as a pale yellow liquid (495 mg, 23 %). 
Method B
130
 
Phosphorus tribromide (0.084 mL, 0.893 mmol, 0.5 equiv) was added dropwise to a stirring solution 
of alcohol 333 (200 mg, 1.79 mmol, 1 equiv) in Et2O (3.6 mL) at 0 °C. The reaction was allowed to 
warm to rt and stirred for 16 h, when TLC indicated complete consumption of starting material. The 
reaction was re-cooled to 0 °C and quenched by the addition of water (1.8 mL) and 5 % K2CO3 (aq.) 
(1.8 mL). The reaction was transferred to a separating funnel, the layers separated and the organic 
layer washed with brine (2 x 10 mL). The organic layer was dried over Na2SO4, filtered and 
concentrated under reduced pressure, to afford bromide 328 as a pale yellow liquid, which was used 
without further purification (271 mg, 87 %).  
Characteristic spectral data: δH (400 MHz, CDCl3) 5.91 (1H, br s, CH═C), 3.97 (2H, s, CH2Br), 
2.19-2.12 (CH═CCH2), 2.08-2.04 (2H, m, CH2CH═C), 1.73-1.67 (2H, m, CH═CCH2CH2), 1.62-1.56 
(2H, m, CH2CH2CH═C); δC (101 MHz, CDCl3) 134.7 (CH═C), 128.2 (CH═C), 39.9 (CH2Br), 
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26.4 (CH═CCH2), 25.4 (CH2CH═C), 22.4 (CH═CCH2CH2), 21.9 (CH2CH2CH═C); νmax (film)/cm
-1
 
2926, 2854, 1719,
 1679 (C═C), 1456, 1432, 1377, 1348, 1326, 1255, 1212, 1189, 1048, 966, 902, 
656, 632 (C–Br). All data collected was in accordance with published data.130 
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5.3.0 Compounds pertaining to Chapter 3 
(±)-S-methyl-S-phenyl-N-tosylsulfilimine (400) 
 
Chloramine-T
® 
(21.12 g, 74.95 mmol, 1.1 equiv) was added dropwise to a stirring solution of 
thioanisole (8 mL, 68.14 mmol, 1 equiv) and Bu4NI (1.09 g, 3.41 mmol, 0.05 equiv) at 0 °C. The 
reaction was allowed to warm to rt and stirred for 2 h. After 2 h, the reaction was transferred to a 
separating funnel and the organic layer washed with cold 5 % NaOH (aq.) (3 x 50 mL) and 
water (3 x 50 mL). The organic layer was dried over MgSO4, filtered and concentrated under reduced 
pressure. The resulting white solid was recrystallised (9:1 MeOH:H2O) to afford sulfilimine 400 as a 
white crystalline solid (19.46 g, 97 %).  
Characteristic spectral data: mp. 125 – 127 °C; δH (400 MHz, CDCl3) 7.75 (2H, d, J 8.0, o-Ts), 7.71 
(2H, d, J 8.5, o-Ph), 7.58-7.47 (3H, m, m-Ph / p-Ph), 7.18 (2H, d, J 8.0, m-Ts), 2.86 (3H, s, SCH3), 
2.37 (3H, s, Ts-CH3); δC (101 MHz, CDCl3) 141.7 (ipso-Ts), 141.2 (ipso-Ph), 135.8 (p-Ts), 132.4 
(p-Ph), 129.9 (m-Ts), 129.3 (o-Ts), 126.2 (o-Ph), 125.8 (m-Ph), 38.9 (SCH3), 21.4 (Ts-CH3); 
νmax (solid)/cm
-1
 1593, 1446, 1278 (S═N), 1139 (SO2), 1083 (S═N), 926 (S═N), 826, 744, 716, 651; 
m/z (ESI) [M]
+
 for C14H15NO2S2 req. 293.0544, found 293.0537. 
Values in accordance with those found in the literature.
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(±)-S-methyl-S-phenyl-N-tosylsulfoximine (401) 
 
RuO2•xH2O (405 mg, 3.04 mmol, 0.02 equiv) was added in one portion to a stirring solution of 
sulfilimine 400 (44.54 g, 152.0 mmol, 1 equiv) in CH2Cl2 (196 mL) and MeCN (196 mL) at rt. A 
solution of NaIO4 (64.96 g, 304.0 mmol, 2 equiv) in H2O (500 mL) was added slowly via cannula at 
rt. The reaction was stirred for a further 1.5 h at rt. After 1.5 h, the reaction was transferred to a 
separating funnel, the layers separated and the aqeuous layer extracted with CH2Cl2 (3 x 100 mL). 
i-PrOH (15.2 mL) was added to the combined organic extracts, and the mixture was stirred for 1 h at 
rt. After 1 h, the mixture was filtered through a Celite
® 
pad, and the cake washed with CH2Cl2 
(300 mL). The filtrate was dried over MgSO4, filtered and concentrated under reduced pressure. The 
resulting yellow/green solid was washed with EtOH (300 mL) to afford sulfoximine 401 as a pale 
yellow solid (42.1 g, 90 %). 
Characteristic spectral data: mp. 100 – 102 °C; δH (400 MHz, CDCl3) 8.00 (2H, d, J 7.0, o-Ts), 
7.85 (2H, d, J 7.0, o-Ph), 7.73-7.67 (1H, m, p-Ph), 7.63-7.57 (2H, m, m-Ph), 7.26 (2H, d, J 8.0, m-Ts), 
3.43 (3H, s, SCH3), 2.40 (3H, s, Ts-CH3); δC (101 MHz, CDCl3) 142.9 (ipso-Ts), 140.7 (ipso-Ph), 
138.3 (p-Ts), 134.4 (p-Ph), 129.7 (m-Ts), 129.3 (o-Ts), 127.5 (o-Ph), 126.7 (m-Ph), 46.6 (SCH3), 21.6 
(Ts-CH3); νmax (solid)/cm
-1
 1478, 1313 (SO2), 1227 (S═N), 1146 (SO2), 1088 (S═N), 1063, 982 
(S═N), 810, 743, 686, 653; m/z (ESI) [M+H]+ for C14H15NO3S2 req. 310.0572, found 310.0576. 
Values in accordance with those found in the literature.
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(±)-S-methyl-S-phenylsulfoximine (402) 
 
N-Ts sulfoximine 401 (7.71 g, 24.9 mmol, 1 equiv) was dissolved in conc. H2SO4 (13.2 mL) and 
heated to 120 °C with stirring for 25 min. After 25 min, the reaction was poured onto ice and 
neutralised by the addition of 2 M NaOH (aq.). The mixture was transferred to a separating funnel and 
the aqueous layer extracted with CH2Cl2 (3 x 50 mL). The combined organic extracts were dried over 
MgSO4, filtered and concentrated under reduced pressure to afford sulfoximine 402 as a colourless oil 
(3.80 g, 98 %). 
Characteristic spectral data: δH (400 MHz, CDCl3) 7.52 (2H, d, J 7.5, o-Ph), 7.12 (1H, t, J 7.5, p-Ph), 
7.04 (2H, t, J 7.5, m-Ph), 3.02 (1H, s, NH), 2.59 (3H, s, SCH3); δC (101 MHz, CDCl3) 143.2 (ipso-Ph), 
132.6 (p-Ph), 128.9 (o-Ph), 127.3 (m-Ph), 45.8 (SCH3); νmax (film/cm
-1
) 3267 (N–H), 1445, 410, 1321, 
1215, 1094 (S═N), 1007, 991 (S═N), 946, 738, 688; m/z (ESI) [M+H]+ for C7H9NOS req.156.0483, 
found 156.0495. 
Values in accordance with those found in the literature.
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(+)-(S)-methyl-S-phenylsulfoximine-(+)-camphorsulfonic acid (403) 
 
(1S)-(+)-camphorsulfonic acid (2.57 g, 11.08 mmol, 0.5 equiv) was added slowly to a stirring solution 
of sulfoximine 402 (3.43 g, 22.15 mmol, 1 equiv) in acetone (30 mL) at rt. The reaction was stirred 
for 16 h at rt. After 16 h, the cloudy reaction mixture was filtered and the white ppte. collected on a 
sintered glass funnel. The residue was washed with dry acetone (3 x 10 mL) and dried under vacuum 
to afford (S)-403 (3.24 g, 38 % of poss. 50 %).  
Characteristic spectral data: mp. 97 – 99 °C; [α]D
20
 +36.6 (c 0.08, CHCl3) (cf. lit. value +36.2 (c 1.10, 
acetone)
98; δH (400 MHz, CDCl3) 8.21 (2H, dd, J 8.0, 3.0, o-Ph), 7.84 (1H, m, p-Ph), 
7.75 (2H, td, J 7.5, 4.5, m-Ph), 3.82 (3H, d, J 3.5, SCH3), 3.18 (1H, d, J 14.5, SCHAHB), 2.68 (1H, d, J 
14.5, SCHAHB), 2.54-2.43 (1H, m, SCH2CCHAHB), 2.29 (1H, dt, J 18.5, 4.0, C(O)CHAHB), 
2.02 (1H, t, J 4.5, CHCH2C(O)), 1.95 (1H, tq, J 12.0, 4.5, CHAHBCHCH2C(O)), 1.85 (1H, d, J 18.0, 
C(O)CHAHB), 1.56 (1H, ddd, J 14.0, 9.5, 4.5, SCH2CCHAHB), 1.33 (1H, td, J 11.0, 9.5, 4.0, 
CHAHBCHCH2C(O)), 1.00 (3H, s, bridge CH3), 0.78 (3H, s, bridge CH3); δC (101 MHz, CDCl3) 
216.6 (C═O), 136.0 (p-Ph), 133.9 (ipso-Ph), 130.3 (m-Ph), 128.9 (o-Ph), 58.3 (SO3CH2C), 
47.9 (C(CH3)2), 47.3 (SO3CH2), 43.8 (SCH3), 42.8 (C(O)CH2), 42.6 (CHCH2C(O)), 27.0 
(CH2CHCH2C(O)), 24.4 (SCH2CCH2), 19.9 (bridge CH3), 19.8 (bridge CH3); νmax (solid)/cm
-1
 2957 
(N–H), 2909, 1727 (C═O), 1448, 1408, 1252 (S═N), 1140 (S═N), 1037, 959 (S═N), 750, 607; 
m/z (ESI) [M]
+
 for C17H25NO5S2 req. 156.0483 (sulfoximine portion only), found 156.0494.  
Values in accordance with those found in the literature.
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(+)-(S)-S-methyl-S-phenyl-N-tosylsulfoximine (394) 
 
2,4,6-tri(isopropyl)benzenesulfonyl chloride (2.12 g, 7.00 mmol, 1 equiv) was added slowly to a 
stirring solution of sulfoximine salt 403 (2.71 g, 7.00 mmol, 1 equiv) in pyridine (4.93 mL) at rt. The 
reaction was stirred for 18 h at rt. After 18 h, the reaction was poured onto water, the layers separated, 
and the aqueous layer extracted with CH2Cl2 (3 x 30 mL). The combined organic extracts were dried 
over MgSO4, filtered and concentrated under reduced pressure to afford N-Tris sulfoximine 394 as a 
cream crystalline solid (2.85 g, 97 %).  
Characteristic spectral data: mp. 138 – 140 °C; [α]D
20
 +20.5 (c 0.50, CHCl3) (cf. lit. value +20.0 (c 
5.0, CHCl3))
131; δH (400 MHz, CDCl3) 8.02 (2H, m, o-Ph), 7.71 (1H, m, p-Ph),  7.61 (2H, t, J 7.5, 
m-Ph), 7.14 (2H, s, m-Tris),  4.41 (2H, hept, J 7.0, 2 x ortho-CH(CH3)2), 3.44 (3H, s, SCH3), 2.91 
(1H, hept, J 7.0, para-CH(CH3)2), 1.33-1.18 (18H, m, 3 x CH(CH3)2); δC (101MHz, CDCl3)  152.0 
(ipso-Tris), 149.1 (ipso-Ph), 138.9 (p-Tris), 137.1 (o-Tris), 134.1 (p-Ph), 129.6 (m-Ph), 127.5 (o-Ph), 
123.4 (m-Tris), 47.0 (SCH3), 34.2 (para-CH(CH3)2), 29.3 (ortho-CH(CH3)2), 24.7 (ortho-C(CH3)2), 
23.7 (para-C(CH3)2); νmax (solid)/cm
-1
 2964, 2927, 2868, 1602, 1362 (SO2), 1297 (S═N), 1236, 1142 
(SO2), 1097 (S═N), 1055, 996 (S═N), 754, 649; m/z (ESI) [M+H]
+
 for C22H31NO3S req.  422.1824, 
found 422.1829. 
Values in accordance with those found in the literature.
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(+)-(S)-S-carboxymethyl-S-phenyl-N-tosylsulfoxmine (405) 
 
n-Butyllithium (2.5 M in hexanes, 0.175 mL, 0.40 mmol, 1.1 equiv) was added dropwise to a stirring 
solution of N-Tris sulfoximine 394 (154 mg, 0.37 mmol, 1 equiv) in THF (2.85 mL) at –78 °C. The 
reaction was stirred for 1 h at –78 °C. CO2 (g) was then bubbled through the solution for 2 h at –78 
°C. After 2 h, the reaction was allowed to warm to rt, and then diluted with 1:1 hexane:Et2O (10 mL) 
and H2O (10 mL). The mixture was transferred to a separating funnel and the layers separated. The 
aqueous layer was acidified to pH 1 with 2 M HCl (aq.), forming a white ppte. The aqueous layer was 
extracted with Et2O (3 x 30 mL). The combined organic extracts were dried over MgSO4, filtered and 
concentrated under reduced pressure to afford carboxylic acid 405 as a colourless viscous oil (105 mg, 
60 %).  
Characteristic spectral data: [α]D
20
 +44.2 (c 0.15, CHCl3) (cf. lit. value of +46.1 (c 0.76, CHCl3))
97; δH 
(400 MHz, CDCl3) 8.04 (2H, m, o-Ph), 7.72 (1H, t, J 7.5, p-Ph), 7.60 (2H, t, J 8.0, m-Ph), 7.14 (2H, s, 
m-Tris), 4.70 (2H, dd, J 23.0, 14.0, CH2CO2H), 4.36 (2H, hept, J 6.5, ortho-CH(CH3)2), 2.90 (1H, 
hept, J 7.0, para-CH(CH3)2), 1.23 (18H, m, 3 x CH(CH3)2); δC (101 MHz, CDCl3) 163.6 (CO2H), 
152.4 (ipso-Tris), 149.2 (ipso-Ph), 136.7 (p-Tris), 136.3 (o-Tris), 134.8 (p-Ph), 129.4 (m-Ph), 128.7 
(o-Ph), 123.4 (m-Tris), 61.2 (CH2CO2H), 34.2 (para-CH(CH3)2), 29.3 (ortho-CH(CH3)2), 24.74 
(ortho-CH(CH3)2), 24.5 (ortho-CH(CH3)2), 23.6 (para-CH(CH3)2); νmax (film)/cm
-1
 3462 (O–H), 3065, 
2960, 2930, 2870, 2630, 1736 (C═O), 1600, 1564, 1463, 1448, 1424, 1384, 1363 (SO2), 1293 (S═N), 
1253, 1147 (SO2), 1095 (S═N), 1066, 1023, 998 (S═N), 939, 903, 882, 844, 817, 762, 683; m/z (ESI) 
[M+H]
+
 for C23H31NO5S2 req. 466.1722, found 466.1739.  
Values in accordance with those found in the literature.
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(+)-(S)-methyl 2-(N-tosylphenylsulfonimidoyl) acetate (404) 
 
Sodium hydride (60 % disp. in mineral oil, 198 mg, 4.93 mmol, 5 equiv) was washed with hexane and 
dried under reduced pressure. THF (3.75 mL) was added and the reaction was heated to reflux. 
Sulfoximine 394 (416 mg, 0.99 mmol, 1 equiv) was added dropwise to the stirring solution of sodium 
hydride in THF at reflux. The reaction was stirred for 10 min at reflux. Dimethyl carbonate (1.65 mL) 
was added dropwise to the reaction at reflux. The reaction was stirred for 20 h at reflux, when TLC 
(20 % EtOAc in petroleum ether) indicated complete consumption of starting material. The reaction 
was cooled to 0 °C and quenched cautiously by the addition of 2:1 MeOH:AcOH (5 mL). The mixture 
was transferred to a separating funnel and the layers separated. The aqueous layer was extracted with 
Et2O (3 x 30 mL), and the combined organic extracts washed with sat. NaHCO3 (aq.) (3 x 20 mL) and 
water (3 x 20 mL).  The organic layer was dried over MgSO4, filtered and concentrated under reduced 
pressure to afford ester 404 as a viscous brown oil which was used without further purification 
(444 mg, 94 %). 
Characteristic spectral data: [α]D
20
 +12.4 (c 0.30, CHCl3) (cf. lit. value +11.0 (c 5.0, CH2Cl2))
97
; mp. 
105 – 110 °C; δH (400 MHz, CDCl3) 8.04 (2H, dd, J 8.5, 1.0, o-Ph), 7.74, (1H, m, p-Ph), 7.62 (2H, t, J 
8.0, m-Ph), 7.15 (2H, s, m-Tris), 4.75 (1H, d, J 14.0, SCHAHBCO2Me), 4.63 (1H, d, J 14.0, 
SCHAHBCO2Me), 4.41 (2H, hept, J 6.5, ortho-CH(CH3)2), 3.68 (3H, s, CO2CH3), 2.90 (1H, hept, J 
7.0, para-CH(CH3)2), 1.35-1.12 (18H, m, 3 x CH(CH3)2); δC (101 MHz, CDCl3) 162.2 (CO2Me), 
152.2 (ipso-Tris), 149.1 (ipso-Ph), 137.0 (p-Tris), 136.5 (o-Tris), 134.8 (p-Ph), 129.4 (m-Ph), 128.6 
(o-Ph), 123.4 (m-Tris), 61.8 (CH2CO2Me), 53.2 (CO2CH3), 34.2 (para-CH(CH3)2), 29.3 (para-
CH(CH3)2), 24.7 (ortho-CH(CH3)2), 24.6 (ortho-CH(CH3)2), 23.7 (para-CH(CH3)2); νmax (film)/cm
-1
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2947, 1753 (C═O), 1601, 1305, 1292 (S═N), 1243, 1096 (S═N), 1065, 685, 560; m/z (ESI) [M+Na]+ 
for C24H33NO5S2 req. 502.1698, found 502.1692. 
Values in accordance with those found in the literature.
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(S)-cyclohexenylmethyl 2-(N-(2,4,6-triisopropylphenylsulfonyl)phenylsulfonimidoyl)acetate 
(407) 
 
Carboxylic acid 405 (53 mg, 0.11 mmol, 1.5 equiv) in CH2Cl2 (0.25 mL) was added dropwise to a 
stirring solution of 1-cyclohexene1-methanol (10 mg, 0.08 mmol, 1 equiv) in CH2Cl2 (0.75 mL) at 
0 °C. DMAP (2 mg, 0.011 mmol, 0.15 equiv) and DIC (0.02 mL, 0.11 mmol, 1.5 equiv) were then 
added in one portion at 0 °C. The reaction was allowed to warm to rt and stirred for 24 h at rt when 
TLC (40 % EtOAc in petroleum ether) indicated complete consumption of starting material. The 
reaction mixture was filtered under gravity, the filtrate transferred to a separating funnel and washed 
with sat. NaHCO3 (aq.) (3 x 10 mL). The organic layer was dried over MgSO4, filtered and 
concentrated under reduced pressure. The crude product was purified by silica gel chromatography 
(10 % EtOAc in petroleum ether) to afford ester 407 as a colourless oil (44 mg, 88 %). 
Characteristic spectral data: [α]20D +32.8 (c 0.05, CHCl3); δH (400 MHz, CDCl3) 8.02 (2H, dd, J 8.5, 
1.0, o-Ph), 7.71 (1H, m, p-Ph), 7.60 (2H, t, J 8.0, m-Ph), 7.13 (2H, s, m-Tris), 5.67-5.65 (1H, m, 
C═CH), 4.79 (1H, d, J 14.5, CHAHBCO2), 4.55 (1H, d, J 14.5, CHAHBCO2), 4.47-4.29 (4H, m, 
CO2CH2/ortho-CH(CH3)2), 2.88 (1H, hept, J 7.0, para-CH(CH3)2), 2.07-1.94 (2H, m, CO2CH2CCH2), 
1.91-1.72 (2H, m, CO2CH2C═CHCH2), 1.68-1.94 (4H, m, CO2CH2C═CHCH2CH2CH2), 
1.34-1.11 (18H, 3 x CH(CH3)2); δC (101 MHz, CDCl3) 161.7 (CO2), 152.1 (ipso-Tris), 149.1 
(ipso-Ph), 136.7 (C═CH), 134.6 (p-Ph), 129.3 (m-Ph), 128.7 (o-Ph), 128.1 (C═CH), 123.5 (m-Tris), 
71.3 (CO2CH2), 61.9 (CH2CO2), 34.1 (para-CH(CH3)2), 29.3 (ortho-CH(CH3)2),  25.7 (C═CHCH2), 
25.0 (CO2CH2CCH2), 24.7 (ortho-CH(CH3)2), 24.6 (ortho-CH(CH3)2), 23.6 (para-CH(CH3)2), 22.2 
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(C═CHCH2CH2), 21.2 (C═CHCH2CH2CH2); νmax (film/cm
-1
) 3062, 2958, 2868, 2837, 2097, 1741 
(C═O), 1671, 1600 (C═C), 1563, 1460, 1448, 1424, 1383, 1363 (SO2), 1295 (S═N), 1149 (SO2), 
1094 (S═N), 1023, 998 (S═N), 961, 940, 922, 881, 843, 800, 738, 683, 582, 563, 501; m/z [M+Na]+ 
for C30H41NO5S2 req. 582.2324, found 582.2330. 
((S)-S-(((R)-2-methylenecyclohexyl)methyl)sulfonimidoyl)benzene (408) 
 
BSA (0.011 mL, 0.045 mmol, 0.25 equiv) was added dropwise to a stirring solution of ester 407 
(100 mg, 0.18 mmol, 1 equiv) and KOAc (2 mg, 0.018 mmol, 0.1 equiv) in PhMe (1 mL) at rt. The 
reaction was heated under reflux for 5 h when TLC (20 % EtOAc in petroleum ether) indicated 
complete consumption of starting material. The reaction was concentrated under reduced pressure, 
and the crude oil purified by silica gel chromatography (20 % EtOAc in petroleum ether) to afford 
methylene cyclohexanes 408 as a colourless oil (79 mg, 80 %, 74:26 d.r. ((R,S):(S,S)). 
Characteristic spectral data: [α]D
20
 –6.2 (c 0.20, CHCl3); δH (400 MHz, CDCl3) 8.02 (2H, d, J 7.5, 
o-Ph (major)), 7.98 (2H, m, o-Ph (minor)), 7.70-7.64 (1H, m, p-Ph), 7.60-7.52 (2H, m, m-Ph), 
4.62-4.43 (1H, m, C═CHcis), 4.42-4.29 (3H, m, C═CHtrans/ortho-CH(CH3)2), 3.77-3.68 (1H, m, 
SCHAHB), 3.59 (1H, dd, J 14.5, 5.0, SCHAHB (major)), 3.52 (1H, dd, J 14.5, 7.5, SCHAHB (minor)), 
2.89 (1H, hept, J 7.0, para-CH(CH-3)2), 2.77 (1H, dt, J 7.5, 4.0, SCH2CH (minor)), 2.64 (1H, p, J 6.0, 
SCH2CH (major)), 2.16-1.78 (4H, m, SCH2CHCH2/CH2═CCH2), 1.62-1.36 (4H, m, 
CH2═CCH2CH2CH2), 1.31-1.16 (18H, m, 3 x CH(CH3)2); δC (101 MHz, CDCl3) 151.1 (ipso-Tris), 
149.1 (C═CH2 (minor)), 149.0 (C═CH2 (major)), 148.7 (ipso-Ph (minor)), 148.4 (ipso-Ph (major)), 
137.6 (p-Tris (major)), 137.5 (p-Tris (minor)), 134.1 (p-Ph (minor)), 134.1 (p-Ph (major)), 
129.4 (m-Ph (minor)), 129.4 (m-Ph (major)), 128.3 (o-Ph (major)), 128.2 (o-Ph (minor)), 
123.4 (m-Tris (minor)), 123.3 (m-Tris (major)), 108.0 (CH2═C (major)), 107.5 (CH2═C (minor)), 
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60.9 (SCH2 (minor)), 60.5 (SCH2 (major)), 38.2 (SCH2CH (minor)), 37.8 (SCH2CH (major)), 
34.5 (SCH2CHCH2 (minor)), 34.1 (para-CH(CH3)2), 34.0 (SCH2CHCH2 (major)), 33.3 (CH2═CCH2 
(major)), 33.2 (CH2═CCH2 (minor)), 29.3 (ortho-CH(CH3)2), 28.0 (SCH2CHCH2CH2 (minor)), 
27.9 (SCH2CHCH2CH2 (major)), 24.8 (ortho-CH(CH3)2), 24.7 (ortho-CH(CH3)2), 
24.7 (ortho-CH(CH3)2), 23.2 (para-CH(CH3)2 (minor)), 23.7 (para-CH(CH3)2 (major)), 
23.4 (CH2═CCH2CH2); νmax (solid)/cm
-1
 2953, 2928, 2866, 1741, 1601, 1566, 1462, 1447, 1424, 
1383, 1361 (SO2), 1291 (S═N), 1225, 1142 (SO2), 1095 (S═N), 1068, 1022, 997 (S═N), 940, 908, 
882, 845, 786, 747, 685, 664; m/z (ESI) [M+H]
+
 for C29H41NO3S2 req. 516.2606, found 516.2606. 
Cyclohexenylmethyl 2-tosylacetate (551) 
 
DMAP (57 mg, 0.467 mmol, 0.15 equiv) was added in one portion to a stirring solution of alcohol 
333 (349 mg, 3.11 mmol, 1 equiv) and tosylacetic acid (1.00 g, 4.67 mmol, 1.5 equiv) in CH2Cl2 
(15.6 mL) at 0 °C. DIC (0.482 mL, 3.11 mmol, 1 equiv) was  added in one portion at 0 °C. The 
reaction was allowed to warm slowly to rt, and stirred for 16 h at rt when TLC (5 % acetone in PhMe) 
indicated complete consumption of starting material. The reaction was filtered under gravity and the 
filtrate washed with sat. NaHCO3 (3 x 30 mL). The organic layer was dried over Na2SO4, filtered and 
concentrated under reduced pressure. The crude product was purified by silica gel chromatography 
(3 % acetone in PhMe) to afford ester 551 as a pale yellow oil (751 mg, 78 %).  
Characteristic spectral data: δH (400 MHz, CDCl3) 7.84 (2H, d, J 8.5, o-Ts), 7.39 (2H, d, J 8.0, m-Ts), 
5.72 (1H, s, C=CH), 4.46 (2H, s, CO2CH2), 4.13 (2H, s, SCH2CO2), 2.48 (3H, s, Ts-CH3), 2.08-1.99 
(2H, m, CO2CH2CCH2), 1.92-1.85 (2H, m, C=CHCH2), 1.67-1.55 (4H, m, C=CHCH2CH2CH2); 
δC (101 MHz, CDCl3) 162.4 (C=O), 145.4 (ipso-Ts), 135.8 (p-Ts), 131.8 (C=CH), 129.8 (m-Ts), 
128.6 (o-Ts), 127.9 (C=CH), 70.8 (CO2CH2), 61.0 (SCH2CO2), 25.7 (C=CHCH2), 25.0 
(CO2CH2CCH2), 22.3 (C=CHCH2CH2), 22.0 (C=CHCH2CH2CH2), 21.7 (Ts-CH3); νmax (film)/cm
-1
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2928, 2858, 1737, 1597, 1495, 1448, 1400, 1325, 1304, 1275, 1148, 1084, 1019, 963, 921, 901, 812, 
727, 640, 604, 513; m/z (ESI) [M+Na]
+ 
for C16H20O4S req. 331.0980, found 331.1003. 
1-methyl-4-((2-methylenecyclohexyl)methylsulfonyl)benzene (552) 
 
BSA (0.43 mL, 1.73 mmol, 1 equiv) was added to a stirring solution of ester 551 (534 mg, 1.73 mmol, 
1 equiv) and KOAc (17 mg, 0.173 mmol, 0.1 equiv) in PhMe (8.65 mL) at rt. The reaction was heated 
under reflux for 4 h, when TLC (30 % EtOAc in petroleum ether) indicated complete consumption of 
starting material. The reaction was concentrated under reduced pressure, and the crude product 
purified by silica gel chromatography (20 % EtOAc in petroleum ether) to afford 
methylenecyclohexane 552 as a pale yellow oil (423 mg, 93 %). 
Characteristic spectral data: δH (400 MHz, CDCl3) 7.81 (2H, d, J 8.5, o-Ts), 7.37 (2H, d, J 8.0, m-Ts), 
4.66 (1H, s, C=CHAHB), 4.48 (1H, s, C=CHAHB), 3.35 (1H, dd, J 14.0, 4.5, SCHAHB), 3.16 (1H, dd, 
J 14.1, 8.5, SCHAHB), 2.75 (1H, tt, J 8.0, 4.5, SCH2CH), 2.47 (3H, s, Ts-CH3), 2.19 (1H, ddd, J 12.0, 
8.5, 4.0, CH2=CCHAHB), 2.11-2.00 (2H, m, CH2=CHAHB / SCH2CHCHAHB), 1.70-1.58 (2H, m, 
CH2=CCH2CHAHBCHAHB), 1.58-1.38 (3H, dddt, J 26.5, 18.0, 9.5, 4.5, CH2=CCH2CHAHBCHAHB / 
SCH2CHCHAHB); δC (101 MHz, CDCl3) 149.7 (C=CH2), 144.5 (ipso-Ts), 137.3 (p-Ts), 128.9 (m-Ts), 
127.9 (o-Ts), 106.8 (C=CH2), 58.8 (SCH2), 38.0 (SCH2CH), 34.8 (CH2=CCH2), 33.5 (SCH2CHCH2), 
28.2 (CH2=CCH2CH2), 24.0 (SCH2CHCH2CH2), 21.6 (Ts-CH3); νmax (film)/cm
-1
 2928, 2856, 1647 
(C═C), 1598, 1495, 1448, 1402, 1313 (SO2), 1301, 1289, 1142 (SO2), 1087, 895, 875, 816, 756, 660, 
565, 513; m/z (ESI) [M+H]
+
 for C15H20O2S req. 265.1262, found 265.1268. 
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Methyl 2-((S)-N-(2,4,6-triisopropylphenylsulfonyl)phenylsulfonimidoyl)pent-4-enoate (411) 
 
Pd2(dba)3 (85 mg, 0.093 mmol, 0.05 equiv) and triphenylphosphine (244 mg, 0.93 mmol, 0.5 equiv) 
were added in one portion to a stirring solution of ester 404 (890 mg, 1.89 mmol, 1 equiv) in THF 
(15 mL) at rt. Allylmethyl carbonate (215 mg, 1.89 mmol, 1 equiv) in THF (6.1 mL) was added via 
syringe pump over 15 min at rt. The reaction was stirred for 30 min at rt when TLC (30 % EtOAc in 
petroleum ether) indicated complete consumption of starting material. The reaction was concentrated 
under reduced pressure, and the crude dark brown slurry purified by silica gel chromatography 
(20 % EtOAc in petroleum ether) to afford α-allyl ester 411 as a pale orange oil (861 mg, 89 %, 55:45 
d.r.). 
Characteristic spectral data: [α]D
20
 +8.6 (c 0.20, CHCl3); δH (400 MHz, CDCl3) 
7.99-7.93 (2H, m, o-Ph), 7.79-7.72 (1H, m, p-Ph), 7.65-7.59 (2H, m, m-Ph), 7.15 (2H, s, m-Tris 
(diastereomer A)), 7.14 (2H, s, m-Tris (diastereomer B)), 5.69-5.59 (1H, m, CH═CH2), 5.16-5.07 (2H, 
m, C═CH2), 4.94 (1H, dd, J 12.0, 3.5, CHCO2Me (diastereomer A)), 4.55 (1H, dd, J 12.0, 3.5, 
CHCO2Me (diastereomer B)), 4.47-4.29 (2H, m, ortho-CH(CH3)2), 3.75 (3H, s, CO2CH3 
(diastereomer A)), 3.66 (3H, s, CO2CH3 (diastereomer B)), 2.97-2.84 (2H, m, 
para-CH(CH3)2/CHAHBCH═CH2 (diastereomers A & B)), 2.53 (1H, td, J 13.0, 7.5, CHAHBCH═CH2 
(diastereomer B)), 2.42 (1H, td, J 13.0, 7.5, CHAHBCH═CH2 (diastereomer A)), 1.32-1.20 (18H, m, 
3 x CH(CH3)2); δC (101 MHz, CDCl3) 163.4 (CO2Me), 152.2 (ipso-Tris (diastereomer A)), 152.0 
(ipso-Tris (diastereomer B)), 149.2 (ipso-Ph (diastereomer A)), 149.1 (ipso-Ph (diastereomer B)), 
137.1 (p-Tris), 134.9 (p-Ph (diastereomer A)), 134.8 (p-Ph (diastereomer B)), 134.1 (o-Tris), 
130.7 (CH═CH2), 129.9 (o-Ph), 129.1 (m-Ph), 123.5 (m-Tris (diastereomer A)), 123.4 (m-Tris 
(diastereomer B)), 119.9 (CH═CH2 (diastereomer A)), 119.8 (CH═CH2 (diastereomer B)), 71.5 
(CHCO2Me (diastereomer B)), 70.8 (CHCO2Me (diastereomer A)), 53.2 (CO2CH3 (diastereomer A)), 
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53.1 (CO2CH3 (diastereomer B)), 34.2 (para-CH(CH3)2), 32.4 (CH2CH═CH2 (diastereomer A)), 
30.9 (CH2CH═CH2 (diastereomer B)), 29.4 (ortho-CH(CH3)2 (diastereomer A)), 
29.3 (ortho-CH(CH3)2), 24.7 (ortho-CH(CH3)2), 24.6 (ortho-CH(CH3)2), 23.7 (para-CH(CH3)2); 
νmax (film)/cm
-1
 2986, 1735 (C═O), 1598, 1447, 1373 (SO2), 1325, 1304 (S═N), 1237, 1147 (SO2), 
1086 (S═N), 1044, 939, 847, 817, 786, 713, 667, 634, 608, 575, 519, 463; m/z (ESI) [M+H]+ for 
C27H37NO5S2 req. 520.2191, found 520.2181. 
2-((S)-N-(2,4,6-triisopropylphenylsulfonyl)phenylsulfonimidoyl)pent-4-enoic acid (413) 
 
LiOH (2 M in H2O, 21.7 mL, 43.30 mmol, 20 equiv) was added dropwise to a stirring solution of 
methyl ester 411 (1.13 g, 2.17 mmol, 1 equiv) in THF (10.9 mL) at rt. The reaction was stirred at rt 
for 16 h. After 16 h, the reaction was partitioned between water and Et2O, transferred to a separating 
funnel and the layers separated. The aqueous layer was acidifed to pH 1 with 2 M HCl (aq.), and then 
extracted with Et2O (3 x 30 mL). The combined organic extracts were dried over MgSO4, filtered and 
concentrated under reduced pressure to afford carboxylic acid 413 as a brown foam (1.06 g, 97 %, 
1:1 mixture of diastereomers). 
Characteristic spectral data:  [α]D
20
 +9.8 (c 0.15, CHCl3); δH (400 MHz, CDCl3) 
8.03-7.96 (2H, m, o-Ph), 7.75 (1H, t, J 7.5, p-Ph), 7.64-7.58 (2H, m, m-Ph), 7.15 (2H, s, m-Tris), 
5.74-5.61 (1H, m, CH═CH2), 5.22-5.12 (2H, m, CH═CH2), 4.88 (1H, dd, J 12.0, 3.5, CHCO2H 
(diastereomer A)), 4.67 (1H, dd, J 11.5, 3.5, CHCO2H (diastereomer B)), 4.37 (2H, hept, J 6.5, 
ortho-CH(CH3)2), 2.96-2.82 (2H, m, para-CH(CH3)2/CHAHBCH═CH2), 2.55-2.40 (1H, m, 
CHAHBCH═CH2), 1.30-1.20 (18H, m, 3 x CH(CH3)2); δC (101 MHz, CDCl3) 167.6 (CO2H 
(diastereomer A)), 166.3 (CO2H (diastereomer B)), 152.4 (ipso-Tris (diastereomer A)), 
152.3 (ipso-Tris (diastereomer B)), 149.2 (ipso-Ph), 136.9 (p-Tris (diastereomer A)), 136.7 (p-Tris 
(diastereomer B)), 135.0 (p-Ph (diastereomer A)), 134.9 (p-Ph (diastereomer B)), 134.0 (o-Tris 
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(diastereomer A)), 133.9 (o-Tris (diastereomer B)), 130.7 (CH═CH2 (diastereomer A)), 
130.6 (CH═CH2 (diastereomer B)), 130.0 (o-Ph (diastereomer A)), 129.9 (o-Ph (diastereomer B)), 
129.3 (m-Ph (diastereomer A)), 129.2 (m-Ph (diastereomer B)), 123.6 (m-Tris (diastereomer A)), 
123.5 (m-Tris (diastereomer B)), 120.1 (CH═CH2), 71.6 (CHCO2H (diastereomer A)), 
71.0 (CHCO2H (diastereomer B)), 34.2 (para-CH(CH3)2), 32.1 (CH2CH═CH2 (diastereomer A)), 
31.1 (CH2H═CH2 (diastereomer B)), 29.3 (ortho-CH(CH3)2), 24.7 (ortho-CH(CH3)2 
(diastereomer A)), 24.6 (ortho-CH(CH3)2 (diastereomer B)), 24.6 (ortho-CH(CH3)2 (diastereomer A)), 
24.6 (ortho-CH(CH3)2), 23.6 (para-CH(CH3)2); νmax (film/cm
-1
) 3480 (O–H), 2959, 2929, 2869, 1677 
(C═O), 1640, 1600, 1463, 1447, 1424, 1383, 1364 (SO2), 1312, 1294 (S═N), 1234, 1195, 1146 (SO2), 
1093 (S═N), 1064, 1056, 1022, 998 (S═N), 923, 881, 844, 769, 684, 644, 623, 580, 563, 528, 508; 
m/z (ESI) [M+H]
+
 for C27H37NO5S2 req. 506.2035, found 506.2035. 
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Cyclohexenylmethyl 2-((S)-N-(2,4,6-triisopropylphenylsulfonyl)phenylsulfonimidoyl) 
pent-4-enoate (414) 
 
Carboxylic acid 413 (190 mg, 0.38 mmol, 1.2 equiv) in CH2Cl2 (0.25 mL) was added dropwise to a 
stirring solution of 1-cyclohexene-1-methanol (35 mg, 0.31 mmol, 1 equiv) in CH2Cl2 (0.75 mL) at 
0 °C. DMAP (6 mg, 0.047 mmol, 0.15 equiv) and DIC (0.07 mL, 0.47 mmol, 1.5 equiv) were then 
added in one portion at 0 °C. The reaction was allowed to warm to rt and stirred for 24 h at rt when 
TLC (20 % EtOAc in petroleum ether) indicated complete consumption of starting material. The 
reaction was filtered under gravity, the filtrate transferred to a separating funnel and washed with 
sat. NaHCO3 (aq.) (3 x 20 mL). The organic layer was dried over MgSO4, filtered and concentrated 
under reduced pressure. The crude oil was purified by silica gel chromatography (10 % EtOAc in 
petroleum ether) to afford ester 414 as a yellow oil (196 mg, 96 %, 60:40 d.r.).  
Characteristic spectral data: [α]20D +5.6 (c 0.25, CHCl3); δH (400 MHz, CDCl3) 8.07-8.02 (2H, m, 
o-Ph (major)), 7.96 (2H, t, J 7.5, o-Ph (minor)), 7.77-7.69 (1H, p-Ph), 7.64-7.55 (2H, m, m-Ph), 7.14 
(2H, s, m-Tris (major)), 7.13 (2H, s, m-Tris (minor)), 5.74 (1H, br s, C═CH (diastereomer A)), 5.65 
(1H, br s, C═CH (diastereomer B)), 5.65-5.56 (1H, m, CH═CH2), 5.18-5.06 (2H, m, CH═CH2), 4.94 
(1H, dd, J 12.0, 3.5, CHCO2 (major)), 4.53-4.24 (5H, m, CHCO2 (minor) / ortho-CH(CH3)2 / 
CO2CH2), 2.90 (2H, th, J 13.5, 6.5, para-CH(CH3)2 / CHAHBCH═CH2), 2.58 (1H, td, J 13.0, 7.5, 
CHAHBCH═CH2 (minor)), 2.40 (1H, td, J 12.5, 8.0, CHAHBCH═CH2 (major)), 2.06-1.98 (2H, m, 
CO2CH2CCH2), 1.98-1.89 (1H, m, C═CHCHAHB), 1.89-1.79 (1H, m, C═CHCHAHB), 1.67-1.53 (4H, 
m, CO2CH2C═CHCH2CH2CH2), 1.34-1.15 (18H, m, 3 x CH(CH3)2); δC (101 MHz, CDCl3) 164.8 
(CO2 (major)), 164.4 (CO2 (minor)), 152.1 (ipso-Tris (major)), 152.0 (ipso-Tris (minor)), 149.1 (ipso-
Ph), 137.3 (p-Tris (major)), 137.2 (p-Tris (minor)), 135.2 (C═CH), 134.8 (p-Ph (major)), 134.7 (p-Ph 
(minor)), 134.0 (o-Tris (major)), 133.1 (o-Tris (minor)), 131.9 (CH═CH2 (major)), 131.7 (CH═CH2 
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(minor)), 129.9 (o-Ph (major)), 129.1 (m-Ph (minor)), 128.1 (C═CH (major)), 128.0 (C═CH (minor)), 
123.5 (m-Tris (major)), 123.4 (m-Tris (minor)), 119.9 (CH═CH2 (major)), 119.8 (CH═CH2 (minor)), 
71.5 (CHCO2 (major)), 71.1 (CO2CH2), 70.8 (CHCO2 (minor)), 34.1 (para-CH(CH3)2), 32.5 
(CH2CH═CH2 (major)), 30.8 (CH2CH═CH2 (minor)), 29.3 (ortho-CH(CH3)2 (major)), 29.2 (ortho-
CH(CH3)2 (minor)), 25.7 (C═CHCH2), 25.1 (CO2CH2CCH2 (major)), 25.0 (CO2CH2CCH2 (minor)), 
24.8 (ortho-CH(CH3)2 (major)), 24.7 (ortho-CH(CH3)2 (minor)), 24.7 (ortho-CH(CH3)2 (major)), 24.6 
(ortho-CH(CH3)2 (minor)), 23.7 (para-CH(CH3)2), 22.3 (CO2CH2CCH2CH2 (major)), 22.2 
(CO2CH2CCH2CH2 (minor)), 22.0 (C═CHCH2CH2 (major)), 21.9 (C═CHCH2CH2 (minor)); νmax 
(film/cm
-1) 2957, 2930, 2869, 2838, 1739 (C═O), 1643, 1600, 1564, 1460, 1448, 1425, 1383, 1363 
(SO2), 1318, 1298 (S═N), 1246,  1196, 1160, 1149 (SO2), 1092 (S═N), 1055, 1023, 998 (S═N), 923, 
901, 881, 842, 801, 767, 684, 665, 580, 565, 534, 505; m/z (ESI) [M+Na]
+
 for C33H45NO5S2 req. 
622.2637, found 622.2618. 
((S,1R)-1-((R)-2-methylenecyclohexyl)but-3-enyl-(N-(2,4,6-triisopropylphenylsulfonyl) 
sulfonimidoyl) benzene (415) 
 
BSA (0.08 mL, 0.324 mmol, 2 equiv) was added to a stirring solution of ester 414 (97 mg, 
0.162 mmol, 1 equiv) and KOAc (1.5 mg, 0.0162 mmol, 0.1 equiv) in DMF (0.54 mL) in a pre-dried 
microwave vial. The reaction was subjected to 3 x 15 sec pulses at 150 °C in the microwave, when 
TLC (5 % acetone in PhMe) indicated complete consumption of starting material. The reaction was 
concentrated under reduced pressure, and residual DMF and BSA removed via azeotrope with PhMe. 
The crude product was purified by silica gel chromatography (10 % EtOAc in petroleum ether) to 
afford methylenecyclohexane 415 as a colourless oil and as a mixture of four diastereomers in the 
ratio 4:3:2:1 (A:B:C:D) (67 mg, 75 %). 
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Characteristic spectral data: [α]D
20
 –13.2 (c 0.01, CHCl3); δH (400 MHz, CDCl3) 8.06 (2H, d, J 7.5, 
o-Ph (diastereomer D)), 7.96 (2H, d, J 6.5, 4.5, o-Ph (diastereomers A and B)), 7.87 (2H, d, J 7.5, 
o-Ph (diastereomer C)), 7.72-7.62 (1H, m, p-Ph), 7.56 (2H, dt, J 12.5, 8.0, m-Ph), 7.13 (2H, s, m-Tris 
(diastereomer D)), 7.12 (2H, s, m-Tris (diastereomer B)), 7.10 (2H, s, m-Tris (diastereomers A and 
C)), 6.07-5.88 (1H, m, CH═CH2 (diastereomer A)), 5.64-5.44 (1H, m, CH═CH2 (diastereomer B)), 
5.17 (1H, ddd, J 17.0, 8.5, 5.5, CH═CH2 (diastereomers C and D)), 5.12-5.02 (2H, m, CH═CH2 
(diastereomers A and C)), 4.90-4.80 (2H, m, CH═CH2 (diastereomer B)), 4.78 (1H, d, J 2.5, 
C═CHAHB (diastereomers A and D)), 4.75 (1H, s, C═CHAHB (diastereomer C)), 4.72-4.70 (1H, m, 
CH═CH2 (diastereomer D)), 4.68 (1H, s, C═CHAHB (diastereomer B)), 4.66 (1H, s, C═CHAHB 
(diastereomers A and D)), 4.40 (1H, s, C═CHAHB (diastereomer B)), 4.36 (1H, s, C═CHAHB 
(diastereomer C)), 4.35-4.22 (2H, m, 2 x ortho-CH(CH3)2), 3.90-3.82 (1H, m, SCH (diastereomer B)), 
3.77 (1H, ddd, J 7.0, 4.5, 2.5, SCH (diastereomer A)), 3.70-3.65 (1H, m, SCH (diastereomer C)), 
3.60-3.52 (1H, m, SCH (diastereomer D)), 3.24 (1H, d, J 10.0, SCHCHAHBCH═CH2 (diastereomer 
D)), 2.89 (2H, dtt, J 13.0, 10.0, 6.5, para-CH(CH3)2 / SCHCHAHBCH═CH2 (diastereomers A and B)), 
2.74-2.64 (1H, m, SCHCHAHBCH═CH2 (diastereomer C)), 2.63-2.45 (1H, m, SCHCHAHBCH═CH2), 
2.41-2.28 (1H, m, H2C═CCHCHS), 2.21 (1H, d, J 13.5, H2C═CCHAHB (diastereomer B)), 2.18-1.97 
(2H, m, H2C═CCHAHB (diastereomers A, C and D) / H2C═CCHAHB), 1.89-1.34 (6H, m, 
H2C═CCH2CH2CH2CH2), 1.33-1.10 (18H, m, 3 x CH(CH3)2); δC (101 MHz, CDCl3) 151.7 (C═CH2 
(diastereomers A and B)), 151.7 (C═CH2 (diastereomers C and D)), 149.1 (ipso-Tris (diastereomers B 
and C)), 149.1 (ipso-Tris (diastereomer A)), 149.0 (ipso-Tris (diastereomer D)), 148.4 (p-Tris 
(diastereomers A and C)), 147.6 (p-Tris (diastereomers B and D)), 137.8 (o-Tris (diastereomers A and 
D)), 137.7 (o-Tris (diastereomers B and C)), 137.3 (ipso-Ph (diastereomers A and D)), 137.2 (ipso-Ph 
(diastereomers B and C)), 135.0 (CH═CH2 (diastereomer A)), 134.1 (CH═CH2 (diastereomers B and 
D)), 134.0 (CH═CH2 (diastereomer C)), 133.9 (p-Ph (diastereomers B and C)), 133.9 (p-Ph 
(diastereomers A and D)), 129.3 (m-Ph (diastereomer B)), 129.3 (m-Ph (diastereomer C)), 129.3 (m-
Ph (diastereomer A)), 129.2 (m-Ph (diastereomer D)), 129.2 (o-Ph), 123.2 (m-Tris (diastereomers A 
and B)), 123.2 (m-Tris (diastereomers C and D)), 117.7 (CH═CH2 (diastereomers A and B)), 117.4 
(CH═CH2 (diastereomers C and D)), 111.8 (C═CH2 (diastereomer A)), 111.5 (C═CH2 (diastereomer 
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D)), 107.1 (C═CH2 (diastereomer B)), 106.3 (C═CH2 (diastereomer C)), 68.2 (SCH (diastereomer 
C)), 67.8 (SCH (diastereomer A)), 67.1 (SCH (diastereomer B)), 67.0 (SCH (diastereomer D)), 44.2 
(SCHCH2CH═CH2 (diastereomers C and D)), 44.1 (SCHCH2CH═CH2 (diastereomers A and B)), 
41.6 (H2C═CCHCHS (diastereomer B)), 41.5 (H2C═CCHCHS (diastereomer D)), 37.1 
(H2C═CCHCHS (diastereomer C)), 36.6 (H2C═CCHCHS (diastereomer A)), 34.1 (para-CH(CH3)2), 
33.6 (H2C═CCH2 (diastereomer A)), 32.1 (H2C═CCH2 (diastereomer B)), 31.2 (H2C═CCH2 
(diastereomers C and D)), 29.6 (ortho-CH(CH3)2), 29.3 (ortho-CH(CH3)2), 28.1 (H2C═CCHCH2 
(diastereomers C and D)), 28.1 (H2C═CCHCH2 (diastereomer B)), 27.8 (H2C═CCHCH2 
(diastereomer A)), 25.6 (H2C═CCH2CH2 (diastereomers C and D)), 25.4 (H2C═CCH2CH2 
(diastereomers A and B)), 24.9 (CH(CH3)2), 24.8 (CH(CH3)2), 24.8 (CH(CH3)2), 24.7 (CH(CH3)2), 
23.7 (H2C═CCH2CH2CH2 (diastereomers A and C)), 23.7 (H2C═CCH2CH2CH2 (diastereomers B and 
D)); νmax (film)/cm
-1
 3075, 2955, 2931, 2867, 1741, 1643 (C═C), 1600, 1564, 1461, 1425, 1382, 1362 
(SO2), 1313, 1297 (S═N), 1254, 1231, 1195, 1148 (SO2), 1092 (S═N), 1051, 1022, 998 (S═N), 914, 
896, 882, 844, 764, 748, 687, 665, 623, 581, 564, 534; m/z (ESI) [M+H]
+
 for C32H45NO3S2 req. 
556.2919, found 556.2902. 
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Methyl (p-tolylsulfonyl)acetate (417) 
 
Methyl bromoacetate (1.91 mL, 20.16 mmol, 1.2 equiv) was added dropwise to a stirring solution of 
p-toluenesulfinic acid (sodium salt) (3 g, 16.80 mmol, 1 equiv) in DMF (23.8 mL) at rt. Evolution of 
heat was observed. The reaction was stirred for 24 h at rt, when TLC (40 % EtOAc in petroleum 
ether) indicated consumption of starting material. The reaction was diluted with water (20 mL) and 
transferred to a separating funnel. The layers were separated and the aqueous layer extracted with 
EtOAc (3 x 30 mL). The combined organic extracts were washed with water (3 x 20 mL) and brine 
(3 x 20 mL). The organic layer was dried over MgSO4, filtered and concentrated under reduced 
pressure to afford methyl tosylacetate 417 as a colourless oil (3.80 g, 99 %).  
Characteristic spectral data: δH (400 MHz, CDCl3) 7.84 (2H, d, J 8.5, o-Ts), 7.39 (2H, d, J 8.0, m-Ts), 
4.13 (2H, s, CH2CO2Me), 3.73 (3H, s, CO2CH3), 2.48 (3H, s, CH3 (Ts)); δC (101 MHz, CDCl3) 163.0 
(CO2Me), 145.6 (ipso-Ts), 135.7 (p-Ts), 129.9 (o-Ts), 128.5 (m-Ts), 60.9 (CH2CO2Me), 53.1 
(CO2CH3), 21.8 (CH3 (Ts)); νmax (film/cm
-1) 2998, 2947, 2867, 1752 (C═O), 1672, 1600, 1563, 1447, 
1434, 1381, 1363 (SO2), 1304, 1291, 1243, 1215, 1183, 1147 (SO2), 1068, 1024, 998, 940, 913, 879, 
870, 844, 807, 772, 759, 715, 685, 677, 649, 610; m/z (CI) [M+NH4]
+
 for C10H12O4S req. 246.0800, 
found 246.0807. 
Methyl 2-(p-tolylsulfonyl)-4-pentenoate (418) 
 
Pd2(dba)3 (201 mg, 0.22 mmol, 0.05 equiv) and triphenylphosphine (576 mg, 2.20 mmol, 0.5 equiv) 
were added in one portion to a stirring solution of methyl tosylacetate 417 (1 g, 4.39 mmol, 1 equiv) 
in THF (40 mL) at rt. The reaction was stirred for 30 min at rt when TLC (25 % EtOAc in petroleum 
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ether) indicated complete consumption of starting material. The reaction was concentrated under 
reduced pressure and the crude slurry purified by silica gel chromatography (20 % EtOAc in 
petroleum ether) to afford α-allyl ester 418 as a yellow oil (855 mg, 73 %).  
Characteristic spectral data: δH (400 MHz, CDCl3) 7.76 (2H, d, J 8.5, o-Ts), 7.38 (2H, d, J 8.0, m-Ts), 
5.73-5.61 (1H, m, CH═CH2), 5.18-5.06 (2H, m, CH═CH2), 4.02 (1H, dd, J 11.5, 4.0, CHCO2Me), 
3.69 (3H, s, CO2CH3), 2.82-2.73 (1H, m, CHAHBCH═CH2), 2.72-2.62 (1H, m, CHAHBCH═CH2), 2.48 
(3H, s, CH3 (Ts)); δC (101 MHz, CDCl3) 166.0 (CO2Me), 145.6 (ipso-Ts), 133.9 (p-Ts), 131.7 
(CH═CH2), 129.8 (o-Ts), 129.4 (m-Ts), 119.1 (C═CH2), 70.1 (CHCO2Me), 52.9 (CO2CH3), 31.1 
(CH2CH═CH2), 21.8 (CH3 (Ts); νmax (film/cm
-1) 2955, 1743 (C═O), 1597, 1437, 1327 (SO2), 1243, 
1199, 1149 (SO2), 1085, 926, 816, 719, 663, 573, 519; m/z (ESI) [M+Na]
+
 for C13H16O4S req. 
291.0667, found 291.0673. 
2-(p-Tolylsulfonyl)-4-pentenoic acid (419) 
 
LiOH (2 M in H2O, 28.3 mL, 56.60 mmol, 20 equiv) was added dropwise to a stirring solution of 
ester 418 (759 mg, 2.83 mmol, 1 equiv) in THF (14.2 mL) at rt. The reaction was stirred for 16 h at rt. 
After 16 h, the reaction was partitioned between H2O and Et2O, transferred to a separating funnel and 
the layers separated. The aqueous layer was acidifed to pH 1 with 2 M HCl (aq.), and then extracted 
with Et2O (3 x 50 mL). The combined organic extracts were dried over MgSO4, filtered and 
concentrated under reduced pressure to afford carboxylic acid 419 as a yellow foam (712 mg, 99 %).  
Characteristic spectral data: δH (400 MHz, CDCl3) 10.38 (1H, br s, CO2H), 7.76 (2H, d, J 8.5, o-Ts), 
7.34 (2H, d, J 8.0, m-Ts), 5.67 (1H, ddt, J 17.0, 10.0, 7.0, CH═CH2), 5.16-5.04 (2H, m, CH═CH2), 
4.00 (1H, dd, J 11.0, 4.0, CHCO2H), 2.79-2.57 (2H, m, CH2CH═CH2), 2.43 (3H, s, CH3 (Ts)); 
δC (101 MHz, CDCl3) 169.5 (CO2H), 145.9 (ipso-Ts), 133.6 (p-Ts), 131.4 (CH═CH2), 129.9 (m-Ts), 
129.4 (o-Ts), 70.0 (CHCO2H), 31.0 (CH2CH═CH2), 21.8 (CH3 (Ts)); νmax (film)/cm
-1
 3510, 3195, 
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3086 (O–H), 2926, 2588, 1737 (C═O), 1643, 1597, 1494, 1439, 1402, 1317, 1304, 1291, 1239, 1182, 
1145 (SO2), 1083, 1040, 1018, 995, 925, 856, 814, 711, 662, 572, 517; m/z (ESI) [M–H]
– 
for 
C12H14O4S req. 205.0535, found 253.0536. 
(1-Cyclohexen-1-yl)methyl-2-(p-tolylsulfonyl)-4-pentenoate (420) 
 
Carboxylic acid 419 (633 mg, 2.49 mmol, 1.2 equiv) in CH2Cl2 (2 mL) added dropwise to a stirring 
solution of 1-cyclohexene-1-methanol (233 mg, 2.08 mmol, 1 equiv) in CH2Cl2 (1.3 mL) at 0 °C. 
DMAP (38 mg, 0.31 mmol, 0.15 equiv) and DIC (0.48 mL, 3.11 mmol, 1.5 eqjuiv) were then added in 
one portion at 0 °C. The reaction was allowed to warm to rt and stirred for 48 h at rt when TLC 
(20 % EtOAc in petroleum ether) indicated complete consumption of starting material. The reaction 
was filtered under gravity, the filtrate transferred to a separating funnel and washed with sat. NaHCO3 
(aq.) (3 x 20 mL). The organic layer was dried over MgSO4, filtered and concentrated under reduced 
pressure. The crude oil was purified by silica gel chromatography (10 % EtOAc in petroleum ether) to 
afford ester 420 as a yellow oil (733 mg, 85 %).  
Characteristic spectral data: δH (400 MHz, CDCl3) 7.77 (2H, d, J 8.0, o-Ts), 7.37 (2H, d, J 8.0, m-Ts), 
5.68 (1H, ddd, J 17.5, 6.5, 3.5, CH═CH2/), 5.20-5.04 (2H, m, CH═CH2), 4.50-4.32 (2H, m, CO2CH2), 
4.02 (1H, dd, J 11.5, 4.0, CHCO2), 2.85-2.76 (1H, m, CHAHBCH═CH2), 2.73-2.62 (1H, m, 
CHAHBCH═CH2), 2.47 (3H, CH3 (Ts)), 2.05-1.99 (2H, m, CO2CH2CCH2), 1.94-1.78 (2H, m, 
C═CHCH2), 1.68-1.49 (4H, m, C═CHCH2CH2CH2); δC (101 MHz, CDCl3) 165.4 (CO2), 145.4 
(ipso-Ts), 134.0 (p-Ts), 131.9 (C═CH), 131.8 (CH═CH2), 129.7 (m-Ts), 129.4 (o-Ts), 127.7 (C═CH), 
119.0 (CH═CH2), 70.2 (CHCO2), 31.1 (CH2CH═CH2), 25.7 (C═CHCH2), 25.0 (CO2CH2CCH2), 22.3 
(C═CHCH2CH2), 22.0 (CO2CH2CCH2CH2), 21.7 (CH3 (Ts)); νmax (film)/cm
-1
 3005, 2929, 1737 
(C═O), 1643, 1597, 1437, 1494, 1372 (SO2), 1324, 1291, 1263, 1237, 1200, 1170, 1146 (SO2), 1084, 
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1018, 985, 901, 850, 814, 718, 665, 575, 517; m/z (ESI) [M+Na]
+
 for C19H24O4S req. 371.1293, found 
371.1302. 
1-methyl-4-(1-(2-methylenecyclohexyl)but-3-enylsulfonyl)benzene (421) 
 
BSA (0.12 mL, 0.50 mmol, 1 equiv) was added to a stirring solution of ester 420 (175 mg, 0.50 mmol, 
1 equiv) and KOAc (5 mg, 0.05 mmol, 0.1 equiv) in DMF (1.71 mL) in a pre-dried microwave vial at 
rt. The reaction was then subjected to four 30 second pulses at 200 °C in the microwave, when TLC 
(15 % EtOAc in petroleum ether) indicated complete consumption of starting material. The reaction 
was concentrated under reduced pressure and the resulting oil purified by silica gel chromatography 
(3 % EtOAc in petroleum ether) to afford methylene cyclohexane 421 as a colourless oil 
(120 mg, 80 %, 1:1 mixture of diastereomers).  
Characteristic spectral data: δH (400 MHz, CDCl3) 7.79 (2H, dd, J 10.5, 8.5, o-Ts), 7.36 (2H, dd, 
J 8.0, 4.5, m-Ts), 5.78-5.47 (1H, m, CH═CH2), 5.01 (1H, dd, J 17.0, 1.5, CH═CHtrans (diastereomer 
A)), 4.92 (1H, d, J 10.0, CH═CHcis), 4.82 (1H, s, C═CHAHB (diastereomer A)), 4.81 (1H, dd, J 17.0, 
1.5, CH═CHtrans (diastereomer B)), 4.76 (1H, s, C═CHAHB (diastereomer B)), 4.74 (1H, s, C═CHAHB 
(diastereomer A)), 4.44 (1H, s, C═CHAHB (diastereomer B)), 3.50-3.40 (1H, m, CHTs), 2.86-2.79 
(1H, dd, J 9.0, 4.0, CHCHTs), 2.74 (1H, dt, J 15.5, 7.5, CHAHBCH═CH2 (diastereomer A)), 2.59-2.51 
(1H, m, CHAHBCH═CH2 (diastereomer A)), 2.47 (3H, s, CH3 (Ts)), 2.44-2.35 (2H, m, CH2CH═CH2 
(diastereomer B)), 2.35-2.25 (2H, m, TsCHCCH2 (diastereomer A)), 2.18-2.08 (2H, m, 
TsCHCHCH2 (diastereomer A)), 2.05-1.95 (TsCHCHCCH2 (diastereomer B)), 
1.82-1.24 (6H, m, TsCHCHCH2 (diastereomer B)/TsCHCHCH2CH2CH2); δC (101 MHz, CDCl3) 
149.3 (C═CH2 (diastereomer A)), 148.5 (C═CH2 (diastereomer B)), 144.5 (ipso-Ts (diastereomer A)), 
144.4 (ipso-Ts (diastereomer B)), 136.8 (p-Ts (diastereomer A)), 136.4 (p-Ts (diastereomer B)), 
135.3 (CH═CH2 (diastereomer A)), 134.2 (CH═CH2 (diastereomer B)), 129.7 (m-Ts 
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(diastereomer A)), 129.7 (m-Ts (diastereomer B)), 128.8 (o-Ts (diastereomer A)), 128.7 (o-Ts 
(diastereomer B)), 117.4 (CH═CH2 (diastereomer A)), 117.0 (CH═CH2 (diastereomer B)), 110.8 
(C═CH2 (diastereomer A)), 106.3 (C═CH2 (diastereomer B)), 65.4 (CHTs (diastereomer A)), 
63.4 (CHTs (diastereomer B)), 43.5 (CHCHTs (diastereomer A)), 41.8 (CHCHTs (diastereomer B)), 
36.8 (TsCHCHCCH2 (diastereomer A)), 33.4 (TsCHCHCCH2 (diastereomer B)), 32.7 (CH2CH═CH2 
(diastereomer A)), 30.9 (TsCHCHCH2 (diastereomer B)), 29.8 (CH2CH═CH2 (diastereomer B)), 
28.4 (TsCHCHCH2 (diastereomer A)), 28.3 (TsCHCHCH2CH2 (diastereomer A)), 28.0 
(TsCHCHCH2CH2 (diastereomer B)), 25.6 (TsCHCHCCH2CH2), 22.0 (CH3 (Ts)), 21.7 (CH3 (Ts)); 
νmax (film)/cm
-1
 3077, 2931, 2857, 1642 (C═C), 1597, 1495, 1449, 1416, 1402, 1381 (SO2), 1311, 
1301, 1288, 1251, 1223, 1183, 1140 (SO2), 1085, 1039, 1019, 987, 893, 845, 815, 801, 775, 727, 657, 
573, 556, 537, 528; m/z (ESI) [M+H]
+
 for C18H24O2S req. 305.1575, found 305.1588.  
Methyl 3-(4-methoxyphenyl)-2-tosylpropanoate (429) 
 
DBU (0.35 mL, 2.34 mmol, 1 equiv) was added dropwise to a stirring solution of methyl tosylacetate 
417 (534 mg, 2.34 mmol, 1 equiv) in THF (11.3 mL) at rt. p-Methoxybenzyl chloride (0.32 mL, 
2.34 mmol, 1 equiv) in THF (20 mL) was then added dropwise to the solution over 30 min. The 
reaction was stirred at rt for 40 h, when TLC (40 % EtOAc in petroleum ether) indicated complete 
consumption of starting material. The reaction was quenched by the addition of sat. NH4Cl (aq.) 
(20 mL) and transferred to a separating funnel. The layers were separated and the aqueous layer 
extracted with CH2Cl2 (3 x 30 mL). The combined organic extracts were washed with brine 
(3 x 30 mL). The organic layer was dried over MgSO4, filtered and concentrated under reduced 
pressure. The resulting crude oil was purified by silica gel chromatography (10 % EtOAc in 
petroleum ether) to afford ester 429 as a colourless oil (325 mg, 40 %).  
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Characteristic spectral data: δH (400 MHz, CDCl3) 7.81 (2H, dd, J 8.5, o-Ts), 7.41 (2H, d, J 8.0, 
m-Ts), 7.06 (2H, d, J 8.5, o-Ar), 6.81 (2H, d, J 8.5, m-Ar), 4.66 (1H, d, J 5.0, CHCO2Me), 3.79 (3H, s, 
OCH3 (Ar)), 3.35 (1H, dd, J 13.5, 3.5, CHAHBCHCO2Me), 3.16 (1H, dd, J 13.5, 12.0, 
CHAHBCHCO2Me), 2.51 (3H, s, CH3 (Ts)); δC (101 MHz, CDCl3) 166.0 (CO2Me), 158.8 (COMe 
(Ar)), 145.6 (ipso-Ts), 133.9 (p-Ts), 132.0 (ipso-Ar), 129.9 (m-Ar), 129.9 (m-Ts), 129.8 (o-Ts), 114.2 
(o-Ar), 65.1 (CHCO2Me), 55.2 (COCH3 (Ar)), 52.9 (CO2CH3), 32.0 (CH2CHCO2Me), 21.8 
(CH3 (Ts)); νmax (film)/cm
-1
 3002, 2955, 2838, 1742 (C═O), 1612, 1598, 1513, 1442, 1403, 1322 
(SO2), 1303, 1249, 1179, 1147 (SO2), 1085, 1034, 957, 876, 844, 816, 714, 664, 577, 516; m/z (ESI) 
[M+H]
+
 for C18H20O5S req. 349.1110, found 349.1110. 
3-(4-methoxyphenyl)-2-tosylpropanoic acid (430) 
 
LiOH (2 M in H2O, 4.2 mL, 8.39 mmol, 20 equiv) was added dropwise to a stirring solution of ester 
429 (146 mg, 0.42 mmol, 1 equiv) in THF (2.1 mL) at rt. The reaction was stirred for 24 h at rt. After 
24 h, the reaction was partitioned between H2O and Et2O, transferred to a separating funnel and the 
layers separated. The aqueous layer was acidifed to pH 1 with 2 M HCl (aq.), and then extracted with 
Et2O (3 x 20 mL). The combined organic extracts were dried over MgSO4, filtered and concentrated 
under reduced pressure to afford carboxylic acid 430 as a yellow oil and was used without further 
purification (129 mg, 92 %). 
Characteristic spectral data: δH (400 MHz, CDCl3) 7.81 (2H, d, J 8.5, o-Ts), 7.38 (2H, d, J 8.0, m-Ts), 
7.07 (2H, d, J 8.5, o-Ar), 6.81 (2H, d, J 8.5, m-Ar), 4.18 (1H, dd, J 12.0, 3.5, CHCO2Me), 3.78 (3H, s, 
OCH3 (Ar)), 3.36 (1H, dd, J 13.5, 3.5, CHAHBCHCO2Me), 3.13 (1H, dd, J 13.5, 12.0, 
CHAHBCHCO2Me), 2.49 (3H, s, CH3 (Ts)); δC (101 MHz, CDCl3) 168.4 (CO2H), 158.8 (COMe (Ar)), 
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145.8 (ipso-Ts), 133.7 (p-Ts), 129.9 (m-Ar), 129.9 (m-Ts), 129.4 (o-Ts), 127.1 (ipso-Ar), 114.3 
(o-Ar), 72.1 (CHCO2H), 55.2 (OCH3 (Ar)), 32.0 (CH2CHCO2H), 21.8 (CH3 (Ts)).  
Cyclohexenylmethyl 3-(4-methoxyphenyl)-2-tosylpropanoate (431) 
 
Carboxylic acid 430 (119 mg, 0.32 mmol, 1.1 equiv) in CH2Cl2 (0.41 mL) was added dropwise to a 
stirring solution of 1-cyclohexene-1-methanol (32 mg, 0.29 mmol, 1 equiv) in CH2Cl2 (1 mL) at 0 °C. 
DMAP (5 mg, 0.043 mmol, 0.15 equiv) and DIC (0.07 mL, 0.43 mmol, 1.5 equiv) were then added in 
one portion at 0 °C. The reaction was allowed to warm to rt and stirred for 16 h at rt when TLC 
(20 % EtOAc in petroleum ether) indicated complete consumption of starting material. The reaction 
was filtered under gravity, the filtrate transferred to a separating funnel and washed with sat. NaHCO3 
(aq.) (3 x 20 mL). The organic layer was dried over MgSO4, filtered and concentrated under reduced 
pressure. The crude oil was purified by silica gel chromatography (20 % EtOAc in petroleum ether) to 
afford ester 431 as a yellow oil (84 mg, 68 %).  
Characteristic spectral data: δH (400 MHz, CDCl3) 7.81 (2H, d, J 8.0, o-Ts), 7.39 (2H, d, J 8.0, m-Ts), 
7.06 (2H, d, J 8.5, o-Ar), 6.80 (2H, d, J 8.5, m-Ar), 5.52 (1H, s, C═CH), 4.41-4.21 (2H, m, CO2CH2), 
4.19 (1H, dd, J 12.0, 3.5, CHCO2), 3.77 (3H, s, OCH3 (Ar)), 3.36 (1H, dd, J 13.5, 3.5, 
CHAHBCHCO2), 3.21-3.09 (1H, m, CHAHBCHCO2), 2.48 (3H, s, CH3 (Ts)), 1.99-1.92 (2H, m, 
CO2CH2CCH2), 1.69-1.57 (2H, m, CO2CH2C═CHCH2), 1.57-1.44 (CO2CH2CCH2CH2CH2); 
δC (101 MHz, CDCl3) 165.4 (CO2), 158.8 (COMe (Ar)), 145.5 (ipso-Ts), 134.0 (p-Ts), 131.8 
(C═CH), 130.0 (m-Ar), 129.9 (m-Ts), 129.5 (o-Ts), 127.4 (C═CH), 127.3 (ipso-Ar), 114.1 (m-Ar), 
72.4 (CHCO2), 70.4 (CO2CH2), 55.2 (OCH3 (Ar)), 32.1 (CH2CHCO2), 25.4 (CO2CH2C═CHCH2), 
25.0 (CO2CH2CCH2), 22.0 (CO2CH2C═CHCH2CH2), 21.9 (CO2CH2CCH2CH2), 21.8 (CH3 (Ts)); 
νmax (film)/cm
-1
 2930, 2858, 2837, 1737 (C═O), 1612, 1598, 1514, 1442, 1402, 1373 (SO2), 1323, 
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1250, 1193, 1180, 1146 (SO2), 1110, 1084, 1035, 987, 942, 922, 903, 874, 815, 333, 580, 524; 
m/z (ESI) [M+H2O]
+
 for C24H28O5S req. 446.1763, found 446.1760. 
1-methoxy-4-(2-(2-methylenecyclohexyl)-2-tosylethyl)benzene (432) 
 
BSA (0.07 mL, 0.29 mmol, 2 equiv) was added to a stirring solution of ester 431 (62 mg, 0.14 mmol, 
1 equiv) and KOAc (1 mg, 0.014 mmol, 0.1 equiv) in DMF (0.48 mL) in a pre-dried microwave vial 
at rt. The reaction was then subjected to four 30 second pulses at 200 °C in the microwave, when TLC 
(30 % EtOAc in petroleum ether) indicated complete consumption of starting material. The reaction 
was concentrated under reduced pressure and the resulting oil purified by silica gel chromatography 
(20 % EtOAc in petroleum ether) to afford methylene cyclohexane 432 as a colourless oil (19 mg, 
37 %, 1:1 mixture of two diastereomers). 
Characteristic spectral data: δH (400 MHz, CDCl3) 7.74 (2H, d, J 8.0, o-Ts (diastereomer A)), 
7.48 (2H, d, J 8.0, o-Ts (diastereomer B)), 7.30 (2H, d, J 9.0, m-Ts (diastereomer A)), 7.10 (2H, d, 
J 8.0, m-Ts (diastereomer B)), 6.99 (2H, d, J 8.5, m-Ar (diastereomer A)), 6.80 (2H, d, J 8.5, m-Ar 
(diastereomer B)), 6.69 (2H, d, J 8.5, o-Ar (diastereomer A)), 6.64 (2H, d, J 8.5, o-Ar (diastereomer 
B)), 4.87 (2H, d, J 5.0, C═CH2 (diastereomer A)), 4.77 (1H, s, C═CHAHB), 4.54 (1H, s, C═CHAHB), 
3.87 (1H, dt, J 9.5, 3.0, CHTs (diastereomer A)), 3.77 (3H, s, OCH3 (Ar) (diastereomer A)), 3.76 (3H, 
s, OCH3 (Ar) (diastereomer B)), 3.67 (1H, dt, J 8.5, 5.5, CHTs (diastereomer B)), 3.31-3.18 (2H, m, 
CH2CHTs (diastereomer A)), 3.15-3.09 (CHCHTs (diastereomer A)), 3.06 (1H, dd, J 15.5, 5.0, 
CHAHBCHTs (diastereomer B)), 2.86 (1H, dd, J 15.5, 6.0, CHAHBCHTs (diastereomer B)), 2.78 (1H, 
dt, J 8.5, 4.5, CHCHTs (diastereomer B)), 2.46 (3H, s, CH3 (Ts) (diastereomer A)), 2.37 (3H, s, CH3 
(Ts) (diastereomer B)), 2.35-2.31 (1H, m, CH2═CCHAHB (diastereomer B)), 2.28-2.21 (1H, m, 
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TsCHCHCHAHB (diastereomer A)), 2.16-2.06 (1H, m, CH2═CCHAHB (diastereomer B)), 1.99 (1H, dt, 
J 13.5, 4.5, CH2═CCHAHB (diastereomer A)), 1.85-1.80 (1H, m, TsCHCHCHAHB (diastereomer B)), 
1.76 (1H, dt, J 14.0, 3.0, CH2═CCHAHB (diastereomer A)), 1.66-1.28 (6H, m, TsCHCHCHAHB 
(diastereomer A))/TsCHCHCHAHB (diastereomer B)/CH2═CCH2CH2CH2); δC (101 MHz, CDCl3) 
158.1 (MeOC (Ar)), 157.9 (MeOC (Ar)), 149.6 (ipso-Ts (diastereomer A)), 148.7 (ipso-Ts 
(diastereomer B)), 144.3 (C═CH2 (diastereomer A)), 143.6 (C═CH2 (diastereomer B)), 137.5 (p-Ts 
(diastereomer A)), 136.8 (p-Ts (diastereomer B)), 129.7 (m-Ts (diastereomer A)), 129.7 (m-Ar 
(diastereomer A)), 129.5 (m-Ar (diastereomer B)), 129.2 (m-Ar (diastereomer B)), 128.6 (o-Ts 
(diastereomer A)), 128.2 (o-Ts, (diastereomer B)), 113.7 (o-Ar), 111.1 (C═CH2 (diastereomer A)), 
105.8 (C═CH2 (diastereomer B)), 66.7 (CHTs (diastereomer A)), 66.1 (CHTs (diastereomer B)), 55.2 
(OCH3 (Ar)), 44.6 (CHCHTs (diastereomer B)), 41.6 (CHCHTs (diastereomer A)), 37.1 (CH2═CCH2 
(diastereomer B)), 33.9 (CH2═CCH2 (diastereomer A)), 33.6 (CH2CHTs (diastereomer B)), 30.6 
(CH2CHTs (diastereomer A)), 29.1 (TsCHCHCH2 (diastereomer A)), 28.1 (CH2═CCH2CH2 
(diastereomer A)), 28.0 (CH2═CCH2CH2 (diastereomer B)), 25.9 (TSCHCHCH2 (diastereomer B)), 
22.6 (TSCHCHCH2CH2), 21.9 (CH3 (Ts) (diastereomer A)), 21.7 (CH3 (Ts) (diastereomer B)); 
νmax (film)/cm
-1
 2931, 2858, 1742, 1645 (C═C), 1598, 1585, 1513, 1448, 1375 (SO2), 1401, 1309, 
1300, 1249, 1141, 1086, 1036, 998, 891, 813, 684, 658, 573, 514; m/z (ESI) [M+H]
+
 for C23H28O3S 
req. 385.1837, found 385.1842.  
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Cyclohexenylmethyl 3-(1,3-dioxolan-2-yl)-2-((S)-N-(2,4,6-triisopropylphenylsulfonyl)phenylsulfo
nimidoyl)propanoate (410) 
 
Through a stirred solution of α-allyl ester 411 (136 mg, 0.26 mmol, 1 equiv) in CH2Cl2 (8.4 mL) and 
ethylene glycol (0.94 mL) at 0 °C was bubbled O2 (10 min) then O3 (20 min) until the solution turned 
blue, then O2 (10 min). The reaction vessel was immediately capped and placed under N2. Me2S 
(0.06 mL, 0.79 mmol, 3 equiv), p-TSA (25 mg, 0.13 mmol, 0.5 equiv) and triethyl orthoformate 
(0.043 mL, 0.39 mmol, 1.5 equiv) were added at rt. The reaction was stirred for 48 h at rt, when TLC 
(40 % EtOAc in petroleum ether) indicated complete consumption of starting material. The reaction 
was quenched by the slow addition of sat. NaHCO3 (aq.) (10 mL), and transferred to a separating 
funnel. The aqueous layer was extracted with CH2Cl2 (3 x 20 mL), and the combined organic extracts 
were washed with water (3 x 20 mL) and brine (3 x 20 mL). The organic layer was dried over 
Na2SO4, filtered and concentrated under reduced pressure. The crude oil was purified by silica gel 
chromatography (30 % EtOAc in petroleum ether) to afford dioxolane 410 as a colourless oil 
(23 mg, 16 %, 1:1 mixture of diastereomers).  
Characteristic spectral data: [α]D
20
 +15.3 (c 0.16, CHCl3); δH (400 MHz, CDCl3) 7.94 (2H, d, J 8.5, 
o-Ph), 7.76-7.69 (1H, m, p-Ph), 7.59 (2H, td, J 8.0, 3.0, m-Ph), 7.12 (2H, s, m-Tris), 5.05-4.94 (1H, m 
CH (acetal)), 4.88 (1H, dd, J 11.5, 2.0, CHCO2Me (diastereomer A)), 4.59 (1H, dd, J 11.5, 2.5, 
CHCO2Me (diastereomer B)), 4.48-4.24 (2H, m, ortho-CH(CH3)2), 3.99-3.78 (4H, m, OCH2CH2O), 
3.74 (3H, s, CO2CH3 (diastereomer A)), 3.63 (3H, s, CO2CH3 (diastereomer B)), 2.89 (1H, heptd, J 
6.5, 1.5, para-CH(CH3)2), 2.56-2.44 (1H, m, CHAHBCHCO2Me), 
2.33-2.16 (1H, m, CHAHBCHCO2Me), 1.28-1.19 (18H, m, 3 x CH(CH3)2); δC (101 MHz, CDCl3) 
165.5 (CO2Me (diastereomer B)), 165.4 (CO2Me (diastereomer A)), 152.0 (ipso-Tris 
(diastereomer A)), 152.0 (ipso-Tris (diastereomer B)), 149.2 (ipso-Ph (diastereomer A)), 
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149.1 (ipso-Ph (diastereomer B)), 137.3 (p-Tris (diastereomer B)), 137.1 (p-Tris (diastereomer A)), 
135.3 (o-Tris (diastereomer A)), 134.8 (p-Ph (diastereomer A)), 134.7 (p-Ph (diastereomer B)), 134.6 
(o-Tris (diastereomer B)), 129.8 (o-Ph (diastereomer A)), 129.8 (o-Ph (diastereomer B)), 129.1 (m-Ph 
(diastereomer A)), 129.1 (m-Ph (diastereomer B)), 123.4 (m-Tris (diastereomer A)), 123.4 (m-Tris 
(diastereomer B)), 101.0 (CH (acetal) (diastereomer A)), 100.9 (CH (acetal) (diastereomer B)), 67.5 
(CHCO2Me (diastereomer B)), 67.2 (CHCO2Me (diastereomer A)), 65.2 (OCH2CH2O), 65.2 
(OCH2CH2O), 53.2 (CO2CH3 (diastereomer A)), 53.1 (CO2CH3 (diastereomer B)), 
34.1 (para-CH(CH3)2), 32.0 (CH2CHCO2Me (diastereomer A)), 30.6 (CH2CO2Me (diastereomer B)), 
24.7 (ortho-CH(CH3)2), 24.7 (ortho-CH(CH3)2), 23.7 (para-CH(CH3)2); νmax (film)/cm
-1
 2957, 2928, 
2870, 1746 (C═O), 1600, 1563, 1463, 1448, 1436, 1426, 1363 (SO2), 1314, 1299 (S═N), 1244, 1195, 
1149 (SO2), 1094 (S═N), 1053, 1022, 998 (S═N), 946, 901, 883, 844, 769, 685, 666, 581, 564, 534, 
506; m/z (ESI) [M+Na]
+
 for C28H39NO7S2 req. 588.2066, found 588.2068. 
(+)-(S)-S-vinyl-S-phenyl-N-tosylsulfoximine (441) 
 
n-Butyllithium (2.22 M in hexanes, 0.54 mL, 1.19 mmol, 1 equiv) was added dropwise to a stirring 
solution of methylsulfoximine 394 (500 mg, 1.19 mmol, 1 equiv) in THF (5.6 mL) at –78 °C. The 
reaction was allowed to warm to rt and stirred for 10 min before being re-cooled to –78 °C. 
Paraformaldehyde (53 mg, 1.78 mmol, 1.5 equiv) was added in one portion at –78 °C. The reaction 
was allowed to warm to 0 °C and stirred for 45 min. Et3N (0.18 mL, 1.31 mmol, 1.1 equiv) and 
MsCl (0.10 mL, 1.31 mmol, 1.1 equiv) were then added at 0 °C. The reaction was stirred for 20 min at 
0 °C. Et3N (0.18 mL, 1.31 mmol, 1.1 equiv) was then added at 0 °C. The reaction was allowed to 
warm to rt and stirred for a further 20 min, when TLC (20 % EtOAc in petroleum ether) indicated 
complete consumption of starting material. The reaction was quenched by the addition of sat. NH4Cl 
(aq.) (1 mL), transferred to a separating funnel and the layers separated. The aqueous layer was 
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extracted with CH2Cl2 (3 x 30 mL). The combined organic extracts were dried over MgSO4, filtered 
and concentrated under reduced pressure. The crude product was purified by silica gel 
chromatography (20 % EtOAc in petroleum ether) to afford vinyl sulfoximine 441 as an off-white 
solid (234 mg, 45 %). 
Characteristic spectral data: [α]D
20
 +17.4 (c 0.15, CHCl3); δH (400 MHz, CDCl3) 7.98-7.94 (2H, dd, 
J 8.5, 1.0, o-Ph), 7.69-7.62 (1H, m, p-Ph), 7.59-7.53 (2H, t, J 7.5, m-Ph), 7.13 (2H, s, m-Tris), 
6.87-6.78 (1H, dd, J 16.0, 9.5, SCH=CH2), 6.51-6.45 (1H, dd, J 16.5, 1.0, SCH=CHTRANS), 6.19-6.15 
(1H, dd, J 9.5, 1.0, SCH=CHCIS), 4.40 (2H, hept, J 6.5, 2 x o-CH(CH3)2), 2.89 (1H, hept, J 7.0, 
p-CH(CH3)2), 1.31-1.21 (18H, m, 3 x CH(CH3)2); δC (101 MHz, CDCl3) 152.0 (ipso-Ph), 149.1 
(ipso-Tris), 138.0 (SCH═CH2), 137.8 (o-Tris), 137.3 (p-Tris), 134.2 (p-Ph), 129.6 (m-Ph), 128.9 
(SCH=CH2), 128.0 (o-Ph), 123.4 (m-Tris), 34.1 (p-CH(CH3)2), 29.3 (o-CH(CH3)2), 24.8 (CH(CH3)2), 
24.7 (CH(CH3)2), 24.6 (CH(CH3)2); νmax (film)/cm
-1
 2958, 2924, 2869, 2854, 1600 (C═C), 1563, 
1463, 1448, 1424, 1382, 1363 (SO2), 1313, 1297 (S═N), 1234, 1148 (SO2), 1096 (S═N), 1055, 1023, 
997 (S═N), 774, 738, 684, 663, 560; m/z (ESI) [M+H]+ for C23H31NO3S req. 434.1824, found 
434.1822. 
(S)-2-(2-(N-(2,4,6-triisopropylphenylsulfonyl)phenylsulfonimidoyl)ethyl)-1,3-dioxolane (437) 
 
TBAP (313 mg, 0.462 mmol, 2 equiv) was added in one portion to a stirring solution of vinyl 
sulfoximine 441 (100 mg, 0.231 mmol, 1 equiv) in 1,3-dioxolane (2.3 mL) at rt. The reaction was 
allowed to stir at rt when TLC (50 % EtOAc in petroleum ether) indicated complete consumption of 
starting material. The reaction was concentrated under reduced pressure, the resulting slurry dissolved 
in water (20 mL) and transferred to a separating funnel. The aqueous layer was extracted with CH2Cl2 
(3 x 30 mL). The combined organic extracts were dried over MgSO4, filtered and concentrated under 
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reduced pressure. The crude product was purified by silica gel chromatography (40 % EtOAc in 
petroleum ether) to afford dioxolane 437 as a colourless oil (73 mg, 62 %). 
Characteristic spectral data: [α]D
20
 +8.6 (c 0.05, CHCl3); δH (400 MHz, CDCl3) 7.97-7.90 (2H, m, 
o-Ph), 7.67 (1H, t, J 7.0, p-Ph), 7.56 (2H, t, J 7.5, m-Ph), 7.11 (2H, s, m-Tris), 4.89 (1H, t, J 4.0, 
OCHO), 4.35 (2H, hept, J 6.5, ortho-CH(CH3)2), 3.93-3.74 (4H, m, OCH2CH2O), 3.56 (1H, qdd, 
J 14.0, 9.0, 7.0, SCH2), 2.87 (1H, hept, J 7.0, para-CH(CH3)2), 2.08-2.00 (2H, m, SCH2CH2), 
1.29-1.16 (18H, m, 3 x CH(CH3)2); δC (101 MHz, CDCl3) 151.8 (ipso-Tris), 149.0 (ipso-Ph), 
137.4 (p-Tris), 136.9 (o-Tris), 134.3 (p-Ph), 129.5 (m-Ph), 128.2 (o-Ph), 123.3 (m-Tris), 101.4 
(OCHO), 65.1 (OCH2CH2O), 53.0 (SCH2), 34.1 (para-CH(CH3)2), 29.2 (ortho-CH(CH3)2), 26.9 
(SCH2CH2), 24.7 (ortho-CH(CH3)2), 23.7 (para-CH(CH3)2); νmax (film)/cm
-1
 2957, 2925, 2855, 1600, 
1563, 1463, 1448, 1383, 1363 (SO2), 1312, 1296 (S═N), 1236, 1147 (SO2), 1097 (S═N), 1067, 1022, 
998 (S═N), 942, 882, 844, 806, 767, 742, 685, 581, 563, 534, 504; m/z (ESI) [M+H]+ for 
C26H37NO5S2 req. 508.2191, found 508.2188. 
(S)-N,N-dimethyl-2-(N-(2,4,6-triisopropylphenylsulfonyl)phenylsulfonimidoyl)ethanamine (442) 
 
Dimethylamine (2 M in THF, 3.46 mL, 6.92 mmol, 2.8 equiv) was added dropwise to a stirring 
solution of vinyl sulfoximine 441 (1.07 g, 2.47 mmol, 1 equiv) in EtOH (1.87 mL) at rt. The reaction 
was allowed to stir at rt for 20 min when TLC (50 % EtOAc in petroleum ether) indicated complete 
consumption of starting material. The reaction was filtered through a silica pad and the pad washed 
with EtOH (50 mL). The filtrate was concentrated under reduced pressure to afford dimethylamine 
adduct 442 as a yellow oil (1.18 g, quant.). 
Characteristic spectral data: [α]D
20
 +10.4 (c 0.25, CHCl3); δH (400 MHz, CDCl3) 7.98 (2H, dd, J 8.5, 
1.0, o-Ph), 7.72-7.65 (1H, m, p-Ph), 7.58 (2H, t, J 8.0, m-Ph), 7.12 (2H, s, m-Tris), 4.37 (2H, hept, 
J 7.0, ortho-CH(CH3)2), 3.64 (2H, t, J 7.5, SCH2), 2.89 (1H, hept, J 6.5, para-CH(CH3)2), 2.71 (2H, 
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qt, J 13.0, 7.0, SCH2CH2NMe2), 2.12 (6H, s, N(CH3)2), 1.24 (18H, t, J 6.5, 3 x CH(CH3)2); 
δC (101 MHz, CDCl3) 151.9 (ipso-Ph), 149.0 (ipso-Tris), 137.6 (o-Tris), 137.5 (p-Tris), 134.1 (p-Ph), 
129.4 (m-Ph), 128.2 (o-Ph), 123.4 (m-Tris), 55.9 (SCH2), 52.2 (SCH2CH2NMe2), 44.8 (N(CH3)2), 
34.1 (para-CH(CH3)2), 29.2 (ortho-CH(CH3)2), 24.7 (para-CH(CH3)2), 23.7 (ortho-CH(CH3)2), 
23.6 (ortho-CH(CH3)2); νmax (film)/cm
-1 
2957, 2929, 2869, 2827, 2775, 1600, 1564, 1462, 1448, 1425, 
1382, 1363 (SO2), 1312, 1297 (S═N), 1233, 1148 (SO2), 1096 (S═N), 1067, 1023, 998 (S═N), 940, 
903, 881, 844, 779, 684, 669; m/z (ESI) [M+H]
+
 for C25H38N2O3S2 req. 479.2402, found 479.2402. 
(S)-1-((S)-N-(2,4,6-triisopropylphenylsulfonyl)phenylsulfonimidoyl)nonan-3-ol (473) 
 
n-BuLi (2.2 M in hexanes, 0.94 mL, 2.06 mmol, 1.1 equiv) was added dropwise to a stirring solution 
of S-methylsulfoximine 394 (788 mg, 1.87 mmol, 1 equiv) in THF (5 mL) and DMPU (2.17 mL) at    
–78 °C. The reaction was stirred for 30 min at –78 °C. (S)-1,2-epoxyoctane in THF (0.5 mL) was 
added dropwise at –78 °C. The reaction was allowed to warm slowly to rt. After 16 h, TLC (20 % 
EtOAc in petroleum ether) indicated complete consumption of starting material. The reaction was 
quenched by the addition of sat. NH4Cl (aq.) (10 mL), diluted with EtOAc (30 mL), transferred to a 
separating funnel and the layers separated. The aqueous layer was extracted with EtOAc (3 x 30 mL). 
The combined organic extracts were then washed with brine (2 x 30 mL), dried over Na2SO4, filtered 
and concentrated under reduced pressure. The crude product was purified by silica gel 
chromatography (1030 % EtOAc in petroleum ether) to afford alcohol 473 as a pale yellow oil 
(1.01 g, 99 %, single diastereomer). 
Characteristic spectral data: [α]D
20
 +28.6 (c 0.01, CHCl3); δH (400 MHz, CDCl3) 8.00-7.95 (2H, m, 
o-Ph), 7.74-7.65 (1H, m, p-Ph), 7.64-7.56 (2H, m, m-Ph), 7.13 (2H, s, m-Tris), 4.39 (2H, dq, J 13.5, 
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7.0, 6.5, 2 x CH(CH3)2 (Tris)), 3.74-3.58 (3H, m, SCH2 / CHOH), 2.89 (1H, hept, J 7.0, CH(CH3)2 
(Tris)), 2.02-1.93 (1H, m, SCH2CHAHB), 1.76-1.63 (2H, m, SCH2CHAHB), 1.40-1.32 (2H, m, 
CH(OH)CH2CH2CH2CH2CH2CH3), 1.28-1.23 (3 x CH(CH3)2 (Tris) / CH(OH)CH2CH2CH2CH2CH2), 
0.89 (3H, t, J 7.0, CH2CH2CH3); δC (101 MHz, CDCl3) 151.9 (ipso-Ph), 149.0 (ipso-Tris), 137.4 
(o-Tris), 137.1 (p-Tris), 134.2 (p-Ph), 129.5 (m-Ph), 128.2 (o-Ph), 123.4 (m-Tris), 69.7 (CHOH), 55.6 
(SCH2), 37.5 (CH(OH)CH2CH2CH2CH2CH2CH3), 34.1 (p-CH(CH3)2 (Tris)), 30.3 (SCH2CH2CHOH), 
29.3 (o-CH(CH3)2 (Tris)), 25.4 (CH(OH)CH2CH2CH2CH2CH2CH3), 24.7 (o-C(CH3)2 (Tris)), 
24.6 (CH(OH)CH2CH2CH2CH2CH2CH3), 23.7 (p-C(CH3)2 (Tris)), 
22.6 (CH(OH)CH2CH2CH2CH2CH2CH3), 14.0 (CH(OH)CH2CH2CH2CH2CH2CH3); 
νmax (film)/cm
-1
 3507 (O–H), 2956, 2928, 2689, 1600, 1462, 1448, 1424, 1383, 1363 (SO2), 1310, 
1294 (S═N), 1235, 1146 (SO2), 1096 (S═N), 1054, 1023, 998 (S═N), 881, 844, 766, 739, 685, 665, 
581, 564; m/z (ESI) [M+H]
+
 for C30H47NO4S4 calcd. 550.3025, found 550.3023. 
tert-Butyldimethyl((S)-1-((S)-N-(2,4,6-triisopropylphenylsulfonyl)phenylsulfonimidoyl)nonan-3-
yloxy)silane (494) 
 
Imidazole (1.22 g, 20.27 mmol, 2 equiv), tert-butyldimethylsilyl chloride (3.06 g, 20.27 mmol, 
2 equiv) and DMAP (248 mg, 2.03 mmol, 0.2 equiv) were added to a stirring solution of alcohol 473 
(5.57 g, 10.14 mmol, 1 equiv) in CH2Cl2 (14.5 mL) at rt. The reaction was stirred at rt for 16 h, when 
TLC (10 % EtOAc in petroleum ether) indicated complete consumption of starting material. The 
reaction was quenched by the addition of water (20 mL), transferred to a separating funnel and the 
layers separated. The aqueous layer was extracted with CH2Cl2 (3 x 30 mL). The combined organic 
extracts were dried over Na2SO4, filtered and concentrated under reduced pressure. The crude product 
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was purified by silica gel chromatography (10 % EtOAc in petroleum ether) to afford silyl ether 494 
as an off-white solid (5.88 g, 87 %, single diastereomer).  
Characteristic spectral data: mp. 85 – 87 °C; [α]D
20
 +31.4 (c 0.065, CHCl3); δH (400 MHz, CDCl3) 
8.00-7.91 (2H, m, o-Ph), 7.69 (1H, t, J 7.5, p-Ph), 7.58 (2H, t, J 7.5, m-Ph), 7.12 (2H, s, m-Tris), 4.37 
(2H, hept, J 6.5, 2 x o-CH(CH3)2 (Tris)), 3.72-3.64 (1H, m, CHOSi), 3.63-3.51 (1H, m, SCHAHB), 
3.50-3.40 (1H, m, SCHACHB), 2.89 (1H, hept, J 6.5, p-CH(CH3)2 (Tris)), 1.80-1.71 (2H, m, 
SCH2CH2), 1.38 (2H, dq, J 10.5, 6.0, 4.5, CH(OSi)CH2), 1.32-1.12 (26H, 3 x CH(CH3)2 (Tris) / 
CH(OSi)CH2CH2CH2CH2CH2CH3), 0.88 (3H, t, J 7.0, CH2CH2CH3), 0.80 (9H, s, SiC(CH3)3), –0.03 
(3H, s, SiCH3), –0.11 (3H, s, SiCH3); δC (101 MHz, CDCl3) 151.8 (ipso-Tris), 149.0 (ipso-Ph), 
137.5 (o-Tris), 137.0 (p-Tris), 134.0 (p-Ph), 129.5 (m-Ph), 128.3 (o-Ph), 123.3 (m-Tris), 
69.9 (CHOSi), 54.9 (SCH2), 36.7 (CH(OSi)CH2), 34.1 (p-CH(CH3)2 (Tris)), 31.7 (CH(OSi)CH2CH2), 
29.2 (SCH2CH2), 29.2 (2 x o-CH(CH3)2 (Tris)), 25.7 (SiC(CH3)2), 24.7 (CH(OSi)CH2CH2CH2), 
24.7 (o-CH(CH3)2 (Tris)), 23.7 (CH(OSi)CH2CH2CH2CH2), 23.6 (p-CH(CH3)2), 
22.7 (CH(OSi)CH2CH2CH2CH2CH2CH3), 17.9 (SiC(CH3)3), 14.0 (CH2CH2CH3),         –4.5 (SiCH3), –
4.8 (SiCH3); νmax (film)/cm
-1
 2955, 2928, 2858, 1600, 1463, 1447, 1424, 1382, 1362 (SO2), 1314, 
1253 (S═N), 1149 (SO2), 1097 (S═N), 1056, 1023, 998 (S═N), 939, 880, 836, 776, 740, 685, 663, 
584, 563, 535, 505; m/z (ESI) [M+H]
+
 for C36H61NO4S2Si req. 664.3890, found 664.3900. 
(4S)-methyl 4-(tert-butyldimethylsilyloxy)-2-((S)-N-(2,4,6-triisopropylphenylsulfonyl)phenylsulf
onimidoyl)decanoate (496) 
 
LiHMDS (1M in THF, 1.65 mL, 1.65 mmol, 2.2 equiv) was added dropwise to a stirring solution of 
silyl ether 494 (499 mg, 0.752 mmol, 1 equiv) in THF (3.8 mL) at –78 °C. Methyl chloroformate 
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(0.064 mL, 0.827 mmol, 1.1 equiv) was added immediately afterwards at –78 °C. The reaction was 
stirred for 1 h at –78 °C, allowed to warm to rt and stirred for a further 48 h, when TLC (10 % EtOAc 
in petroleum ether) indicated complete consumption of starting material. The reaction was quenched 
by the addition of sat. NH4Cl (aq.) (20 mL), transferred to a separating funnel and the layers 
separated. The aqueous layer was extracted with Et2O (3 x 30 mL). The combined organic extracts 
were dried over Na2SO4, filtered and concentrated under reduced pressure. The crude product was 
purified by silica gel chromatography (515 % EtOAc in petroleum ether) to afford methyl ester 496 
as a colourless foam (361 mg, 67 %, 52:48 d.r.).  
Characteristic spectral data: [α]D
20 
+11.6 (c0.05, CHCl3); δH
 
(400 MHz, CDCl3) 7.93 (2H, dd, J 8.5, 
1.1, o-Ph), 7.76-7.68 (1H, m, p-Ph), 7.59 (2H, td, J 8.0, 2.5, m-Ph), 7.12 (2H, s, m-Tris (minor)), 
7.12 (2H, s, m-Tris (major)),  4.76 (1H, dd, J 10.5, 2.5, SCHCO2 (minor)), 4.64 (1H, dd, J 12.0, 2.5, 
SCHCO2 (major)), 4.45-4.25 (2H, m, 2 x o-CH(CH3)2 (Tris)), 3.76-3.68 (1H, m, CHOSi (minor)), 
3.73 (3H, s, CO2CH3 (minor)), 3.62 (3H, s, CO2CH3 (major)), 3.61-3.56 (1H, m, CHOSi (major)), 
2.89 (1H, hept, J 6.5, p-CH(CH3)2), 2.27-2.13 (1H, SCHCHAHBCHOSi), 2.08-1.90 (1H, 
SCHCHAHBCHOSi), 1.52-1.42 (2H, m, CH(OSi)CH2 (minor)), 1.42-1.34 (2H, m, CH(OSi)CH2 
(major)), 1.28-1.18 (26H, m, 3 x CH(CH3)2 (Tris) / CH(OSi)CH2CH2CH2CH2CH2CH3), 0.89 (3H, t, 
J 7.0, CH2CH2CH3), 0.85 (9H, s, SiC(CH3)3 (minor)), 0.82 (9H, s, SiC(CH3)3 (major)), –0.02 (6H, dd, 
J 16.5, 6.5, 2 x SiCH3); δC (101 MHz, CDCl3) 165.8 (CO2CH3 (minor)), 165.5 (CO2CH3 (major)), 
152.0 (ipso-Ph (minor)), 151.8 (ipso-Ph (major)), 149.2 (ipso-Tris (minor)), 149.1 (ipso-Tris (major)), 
137.5 (p-Tris (minor)), 137.2 (p-Tris (major)), 135.6 (o-Tris (minor)), 134.9 (o-Tris (major)), 134.6 
(p-Ph (minor)), 134.5 (p-Ph (major)), 129.7 (o-Ph (minor)), 129.6 (o-Ph (major)), 129.1 (m-Ph 
(minor)), 129.0 (m-Ph (major)), 123.4 (m-Tris (minor)), 123.3 (m-Tris (major)), 70.2 (CHOSi 
(minor)), 69.5 (SCHCO2 (minor)), 69.3 (SCHCO2 (major) / CHOSi (major)), 53.1 (CO2CH3 (minor)), 
52.9 (CO2CH3 (major)), 37.3 (CH(OSi)CH2 (minor)), 36.7 (CH(OSi)CH2 (major)), 34.3 
(SCHCH2CH(OSi) (minor)), 34.1 (p-CH(CH3)2 (Tris)), 33.0 (SCHCH2CH(OSi) (major)), 31.7 
(CH(OSi)CH2CH2), 29.3 (CH(OSi)CH2CH2CH2), 29.2 (o-CH(CH3)2 (Tris)), 25.8 (SiC(CH3)3 
(minor)), 25.8 (SiC(CH3)3 (major)), 24.7 (o-CH(CH3)2 (Tris)), 24.6 (o-CH(CH3)2), 24.5 
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(CH(OSi)CH2CH2CH2CH2), 23.6 (p-CH(CH3)2 (Tris)), 22.5 (CH(OSi)CH2CH2CH2CH2CH2CH3), 18.0 
(SiC(CH3)3 (minor)), 17.9 (SiC(CH3)3 (major)), 14.0 (CH2CH2CH3), –4.3 (SiCH3 (minor)), –4.7 
(SiCH3 (major and minor)), –5.0 (SiCH3 (major)); νmax (film)/cm
-1
 2955, 2929, 2859, 1743 (C═O), 
1676, 1600, 1563, 1463, 1448, 1436, 1382, 1363 (SO2), 1322, 1250 (S═N), 1150 (SO2), 1092 (S═N), 
1054, 1022, 998 (S═N), 939, 881, 810, 775, 684, 664, 581, 564, 527, 512; m/z (ESI) [M+H]+ for 
C38H63NO6S2Si req. 722.3944, found 722.3922. 
Ethyl (S)-1-((S)-(N-(2,4,6-triisopropylphenylsulfonyl)phenylsulfonimidoyl)nonan-3-yl carbonate 
(474) 
 
Ethyl chloroformate (0.32 mL, 3.38 mmol, 5 equiv) was added dropwise to a stirring solution of 
alcohol 473 (371 mg, 0.675 mmol, 1 equiv) in pyridine (1.61 mL) at 0 °C. The reaction was allowed 
to warm to rt and stirred for 72 h, when TLC (30 % EtOAc in petroleum ether) indicated complete 
consumption of starting material. The reaction was diluted with CH2Cl2 (20 mL) and transferred to a 
separating funnel. The mixture was washed with 2 M HCl (aq.) (3 x 20 mL), sat. NaHCO3 (aq.) (3 x 
20 mL) and brine (2 x 20 mL). The organic layer was dried over Na2SO4, filtered and concentrated 
under reduced pressure. The crude product was purified by silica gel chromatography (20 % EtOAc in 
petroleum ether) to afford carbonate 474 as a yellow oil and a single diastereomer (223 mg, 54 %, 
single diastereomer).  
Characteristic spectral data: [α]D
20
 +12.8 (c 0.15, CHCl3); δH (400 MHz, CDCl3) 7.96 (2H, d, J 7.5, 
o-Ph), 7.70 (1H, t, J 6.5, p-Ph), 7.59 (2H, t, J 8.0, m-Ph), 7.12 (2H, s, m-Tris), 4.67 (1H, tt, J 8.0, 5.5, 
4.0, CHOCO2Et), 4.45-4.25 (2H, m, 2 x o-CH(CH3)2 (Tris)), 4.25-4.08 (2H, m, CO2CH2CH3), 3.60-
3.46 (2H, m, SCH2), 2.95-2.85 (1H, m, p-CH(CH3)2), 2.16-2.06 (1H, m, SCH2CHAHB), 2.01-1.86 (2H, 
m, SCH2CHAHB), 1.75-1.39 (4H, m, SCH2SCH2CHCH2CH2), 1.37-1.15 (27H, CO2CH2CH3 / 
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3 x CH(CH3)2 / SCH2CH2CHCH2CH2CH2CH2CH2CH3), 0.93-0.80 (3H, m, CH2CH2CH3); δC (101 
MHz, CDCl3) 154.6 (CO2), 151.9 (ipso-Tris), 149.0 (ipso-Ph), 137.3 (o-Tris), 136.9 (p-Tris), 134.3 
(p-Ph), 129.6 (m-Ph), 128.2 (o-Ph), 123.4 (m-Tris), 75.9 (CHOC(O)), 64.1 (CO2CH2CH3), 54.9 
(SCH2), 34.1 (para-CH(CH3)2), 33.9 (SCH2CH2CHCH2), 31.5 (SCH2CH2CHCH2CH2), 29.2 (ortho-
CH(CH3)2), 28.9 (SCH2CH2CHCH2CH2CH2), 27.3 (SCH2CH2), 24.9 (CH2CH2CH3), 24.7 (para-
CH(CH3)2), 23.7 (ortho-CH(CH3)2), 23.6 (ortho-CH(CH3)2), 22.5 (CH2CH2CH3), 14.2 (CO2CH2CH3), 
14.0 (CH2CH2CH3); νmax (film)/cm
-1
 2930, 2958, 2869, 1743 (C═O), 1601, 1514, 1465, 1373 (SO2), 
1276 (S═N), 1253, 1149 (SO2), 1098 (S═N), 1065, 1023, 880, 844, 792, 586; m/z (ESI) [M+H]
+
 for 
C33H51NO6S2 req. 622.3236, found 622.3240.  
(5S)-5-hexyl-3-((S)-(N-(2,4,6-triisopropylphenylsulfonyl)phenylsulfonimidoyl)dihydrofuran-
2(3H)-one (452) 
 
LiHMDS (1M in THF, 2.78 mL, 2.78 mmol, 2.2 equiv) was added dropwise to a stirring solution of 
carbonate 474 (780 mg, 1.25 mmol, 1 equiv) in THF (20.2 mL) at –78 °C. The reaction was allowed 
to warm slowly to rt and stirred for 3 h, when TLC (30 % EtOAc in petroleum ether) indicated 
consumption of starting material. The reaction was quenched by the addition of sat. NH4Cl (aq.) 
(20 mL), transferred to a separating funnel and the layers separated. The aqueous layer was extracted 
with EtOAc (3 x 30 mL). The combined organic extracts were dried over Na2SO4, filtered and 
concentrated under reduced pressure. The crude product was purified by silica gel chromatography 
(15 % EtOAc in petroleum ether) to afford δ-lactone 452 as a pale yellow foam (275 mg, 38 %, 1:1 
mixture of diastereomers). 
Characteristic spectral data: [α]D
20
 +16.2 (c 0.10, CHCl3); δH (400 MHz, CDCl3) 8.10 (2H, dd, J 8.5, 
1.0, o-Ph (diastereomer A)), 7.95 (2H, dd, J 8.5, 1.0, o-Ph (diastereomer B)), 7.79-7.68 (1H, m, p-Ph), 
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7.65-7.54 (2H, m, m-Ph), 7.13 (2H, s, m-Tris (diastereomer A)), 7.12 (2H, s, m-Tris (diastereomer 
B)), 5.16 (1H, dd, J 11.0, 9.5, SCHCO2 (diastereomer A)), 4.63 (1H, p, J 7.5, CO2CH (diastereomer 
A)), 4.48 (1H, dd, J 10.0, 3.5, SCHCO2 (diastereomer B)), 4.42 (1H, dd, J 6.5, 2.5, CO2CH 
(diastereomer B)), 4.45-4.25 (2H, m, 2 x o-CH(CH3)2 (Tris) (diastereomer A)), 4.27 (2H, hept, J 6.7, 
2 x o-CH(CH3)2 (Tris) (diastereomer B)), 3.30 (1H, ddd, J 15.0, 7.0, 3.5, SCHCHAHB (diasteromer 
A)), 3.10 (1H, ddd, J 13.5, 9.5, 6.5, SCHCHAHB (diastereomer B)), 2.89 (1H, dq, J 13.5, 7.0, p-
CH(CH3)2), 2.40 (1H, ddd, J 14.5, 9.5, 8.0, SCHCHAHB (diastereomer A)), 2.32 (1H, ddd, J 13.5, 
10.5, 9.0, SCHCHAHB (diastereomer B)), 1.73-1.56 (2H, m, CO2CHCH2 (diastereomer A)), 1.48-1.39 
(2H, m, CO2CHCH2 (diastereomer B)), 1.28-1.22 (26H, m, 3 x CH(CH3)2 / 
CO2CHCH2CH2CH2CH2CH2CH3), 0.89 (3H, td, J 7.0, 3.0, CH2CH2CH3); δC (101 MHz, CDCl3) 
166.7 (CO2 (diastereomer A)), 166.0 (CO2 (diastereomer B)), 152.3 (ipso-Tris), 149.2 (ipso-Ph 
(diastereomer A)), 149.1 (ipso-Ph (diastereomer B)), 136.8 (p-Tris (diastereomer A)), 136.7 (p-Tris 
(diastereomer B)), 135.2 (p-Ph (diastereomer A)), 135.0 (p-Ph (diastereomer B)), 130.3 (o-Ph 
(diastereomer A)), 129.6 (m-Ph (diastereomer A)), 129.4 (m-Ph (diastereomer B)), 129.3 (o-Ph 
(diastereomer B)), 123.5 (m-Tris (diastereomer A)), 123.4 (m-Tris (diastereomer B)), 80.1 (CO2CH 
(diastereomer A)), 78.0 (CO2CH (diastereomer B)), 67.4 (SCHCO2 (diastereomer A)), 67.1 (SCHCO2 
(diastereomer B)), 35.7 (CO2CHCH2 (diastereomer A)), 35.0 (CO2CHCH2 (diastereomer B)), 34.1 
(p-CH(CH3)2 (Tris)), 31.5 (CO2CHCH2CH2 (diastereomer A)), 31.5 (CO2CHCH2CH2 
(diastereomer B)), 31.4 (SCHCH2 (diastereomer B)), 30.9 (SCHCH2 (diastereomer A)), 29.4 
(o-CH(CH3)2 (diastereomer A)), 29.3 (o-CH(CH3)2 (diastereomer B)), 28.8 (CO2CHCH2CH2CH2 
(diastereomer A)), 28.7 (CO2CHCH2CH2CH2 (diastereomer B)), 24.9 (o-CH(CH3)2 (diastereomer A)), 
24.8 (CO2CHCH2CH2CH2CH2), 24.7 (o-CH(CH3)2 (diastereomer B)), 24.6 (o-CH(CH3)2 
(diastereomer A)), 24.5 (o-CH(CH3)2 (diastereomer B)), 23.6 (p-CH(CH3)2), 22.5 (CH2CH2CH3 
(diastereomer A)), 22.4 (CH2CH2CH3 (diastereomer B)), 14.0 (CH2CH2CH3); νmax (film)/cm
-1
 2956, 
2930, 2868, 1780 (C═O), 1643, 1600, 1448, 1425, 1383, 1362 (SO2), 1314, 1235 (S═N), 1148 (SO2), 
1094 (S═N), 1054, 1023, 998 (S═N), 931, 881, 844, 765, 748, 685, 664, 565, 515; m/z (ESI) [M+H]+ 
for C31H45NO5S2 req. 576.2817, found 576.2805. 
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(S)-1-(phenylsulfonyl)nonan-3-ol (477) 
 
n-Butyllithium (2.2 M in hexanes, 1.97 mL, 4.33 mmol, 1.1 equiv) was added dropwise to a stirring 
solution of phenylmethylsulfone (615 mg, 3.98 mmol, 1 equiv) in THF (9 mL) and DMPU (4.8 mL) 
at –78 °C. The reaction was stirred for 30 min at –78 °C. (S)-1,2-epoxyoctane (0.66 mL, 4.33 mmol, 
1.1 equiv) in THF (2.1 mL) was added dropwise at –78 °C. The reaction was allowed to warm to rt 
and stirred for 3 h, when TLC (30 % EtOAc in petroleum ether) indicated complete consumption of 
starting material. The reaction was quenched by the addition of sat. NH4Cl (aq.) (15 mL) at 0 °C, and 
the reaction diluted with EtOAc (20 mL). The reaction was transferred to a separating funnel, the 
layers separated and the aqueous layer extracted with EtOAc (3 x 20 mL). The combined organic 
extracts were washed with brine (2 x 30 mL), dried over MgSO4, filtered and concentrated under 
reduced pressure. The crude product was purified by silica gel chromatography (30 % EtOAc in 
petroleum ether) to afford alcohol 477 as a pale yellow oil (943 mg, 84 %). 
Characteristic spectral data: [α]D
20
 +16.2 (c 0.05, CHCl3); δH (400 MHz, CDCl3) 7.92 (2H, d, J 8.0, 
o-Ph), 7.67 (1H, dt, J 7.0, 3.5, p-Ph), 7.58 (2H, t, J 7.5, m-Ph), 3.69 (1H, br s, CHOH), 3.34 (1H, ddd, 
J 15.5, 10.5, 5.0, SCHAHB), 3.22 (1H, ddd, J 14.5, 10.5, 5.5, SCHAHB), 2.03-1.89 (1H, m, 
SCH2CHAHB), 1.77 (1H, tt, J 9.0, 5.0, SCH2CHAHB), 1.48-1.36 (2H, m, HOCHCH2CH2CH2CH2), 
1.33-1.20 (8H, m, HOCHCH2CH2CH2CH2CH2CH3), 0.88 (3H, t, J 6.5, CH2CH2CH3); δC (101 MHz, 
CDCl3) 139.1 (ipso-Ph), 133.7 (p-Ph), 129.3 (m-Ph), 128.0 (o-Ph), 70.0 (CHOH), 53.1 (SCH2), 
37.5 (HOCHCH2CH2CH2CH2), 31.7 (HOCHCH2CH2CH2CH2), 29.9 (SCHCH2), 29.2 
(HOCHCH2CH2CH2), 25.5 (CH2CH2CH3), 22.6 (CH2CH2CH3), 14.1 (CH2CH2CH3); νmax (film)/cm
-1
 
3514 (O–H), 2928, 2857, 1586, 1480, 1447, 1407, 1378, 1304 (SO2), 1255, 1231, 1146 (SO2), 1086, 
1072, 1053, 999, 958, 901, 865, 793, 743, 688, 628, 604, 570, 595, 537, 526; m/z (ESI) [M+H]
+
 for 
C15H24O3S req. 285.1524, found 285.1526. 
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(S)-ethyl 1-(phenylsulfonyl)nonan-3-yl carbonate (478) 
 
Ethyl chloroformate (1.35 mL, 14.15 mmol, 5 equiv) was added dropwise to a stirring solution of 
alcohol 477 (804 mg, 2.83 mmol, 1 equiv) in pyridine (6.75 mL) at 0 °C. The reaction was allowed to 
warm to rt and stirred for 16 h, when TLC (30 % EtOAc in petroleum ether) indicated complete 
consumption of starting material. The reaction was diluted with CH2Cl2 (20 mL) and transferred to a 
separating funnel. The organic layer was washed with 2 M HCl (aq.) (3 x 30 mL), sat. NaHCO3 (aq.) 
(3 x 30 mL) and brine (2 x 30 mL). The organic layer was dried over MgSO4, filtered and 
concentrated under reduced pressure. The crude product was purified by silica gel chromatography 
(20 % EtOAc in petroleum ether) to afford carbonate 478 as a pale yellow oil (780 mg, 77 %). 
Characteristic spectral data: [α]D
20
 +12.8 (c 0.08, CHCl3); δH (400 MHz, CDCl3) 7.95-7.89 (2H, m, 
o-Ph), 7.69 (1H, tt, J 6.5, 1.5, p-Ph), 7.60 (2H, td, J 7.5, 1.5, m-Ph), 4.78-4.69 (1H, m, CHCO2Et), 
4.16 (2H, tdd, J 8.5, 6.5, 1.5, CO2CH2CH3), 3.25-3.09 (2H, m, SCH2), 2.15-2.04 (1H, m, 
SCH2CHAHB), 2.03-1.91 (1H, m, SCH2CHAHB), 1.69-1.56 (1H, m, OCHCHAHB), 1.56-1.43 (1H, m, 
OCHCHAHB), 1.37-1.16 (11H, m, CO2CH2CH3 / OCHCH2CH2CH2CH2CH2CH3), 0.88 (3H, t, J 6.0, 
CH2CH2CH3); δC (101 MHz, CDCl3) 154.7 (C═O), 138.9 (ipso-Ph), 133.8 (p-Ph), 129.4 (m-Ph), 
128.1 (o-Ph), 76.3 (CHCO2Et), 64.1 (CO2CH2CH3), 52.5 (SCH2), 33.9 (OCHCH2), 31.6 
(OCHCH2CH2CH2CH2), 28.9 (OCHCH2CH2CH2CH2), 27.1 (SCH2CH2), 24.9 (CH2CH2CH3), 22.5 
(CH2CH2CH3), 14.2 (CO2CH2CH3), 14.0 (CH2CH2CH3); νmax (film)/cm
-1
 2956, 2930, 2859, 1740 
(C═O), 1586, 1467, 1447, 1375 (SO2), 1308, 1257, 1148 (SO2), 1087, 1051, 906, 848, 792, 764, 689, 
669, 606, 597, 566, 535; m/z (ESI) [M+Na]
+
 for C18H28O5S req. 379.1555, found 379.1565. 
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(5S)-5-hexyl-3-(phenylsulfonyl)dihydrofuran-2(3H)-one (479) 
 
Lactone 479 was prepared according to either of the following two procedures: 
Method A 
LiHMDS (1M in THF, 4.63 mL, 4.63 mmol, 2.2 equiv) was added dropwise to a stirring solution of 
carbonate 478 (750 mg, 2.11 mmol, 1 equiv) in THF (34.1 mL) at –78 °C. The reaction was allowed 
to warm slowly to 0 °C and stirred for 2 h, when TLC (30 % EtOAc in petroleum ether) indicated 
complete consumption of starting material. The reaction was quenched by the addition of sat. NH4Cl 
(aq.) (30 mL) and transferred to a separating funnel. The aqueous layer was extracted with EtOAc (3 x 
40 mL). The combined organic extracts were dried over MgSO4, filtered and concentrated under 
reduced pressure. The crude product was purified by silica gel chromatography (20 % EtOAc in 
petroleum ether) to afford lactone 479 as a yellow oil (401 mg, 62 %, 65:35 d.r.). 
Method B 
(S)-1,2-epoxyoctane (0.18 mL, 1.16 mmol, 1.05 equiv) was added to a stirring solution of 
phenylsulfonylacetonitrile (200 mg, 1.10 mmol, 1 equiv) and Cs2CO3 (378 mg, 1.16 mmol, 1.05 
equiv) in DMF (1.8 mL) in a pre-dried microwave vial. The reaction was subjected to 30 min at 150 
°C in the microwave, when TLC (30 % EtOAc in petroleum ether) indicated complete consumption of 
starting material. The reaction was diluted with EtOAc (30 mL), transferred to a separating funnel and 
the organic layer washed alternately with water (3 x 40 mL) and brine (3 x 40 mL). The organic layer 
was dried over Na2SO4, filtered and concentrated under reduced pressure. The crude product was 
purified by silica gel chromatography (20 % EtOAc in petroleum ether) to afford lactone 479 as a 
yellow oil (242 mg, 71 %, 65:35 d.r.). 
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Characteristic spectral data: [α]D
20
 +16.8 (c 0.02, CHCl3); 8.01 (2H, dd, J 8.5, 1.0, o-Ph (minor)), 7.96 
(2H, dd, J 8.5, 1.0, o-Ph (minor)), 7.74 (1H, td, J 7.5, 5.5, p-Ph), 7.63 (2H, td, J 8.0, 2.0, m-Ph), 
4.81-4.70 (1H, m, CO2CH (major)), 4.52-4.41 (1H, m, CO2CH (minor)), 4.28 (1H, t, J 10.0, SCHCO2 
(minor)), 4.10 (1H, dd, J 10.0, 3.0, SCHCO2 (major)), 3.12 (1H, ddd, J 14.5, 6.5, 3.0, SCHCHAHB 
(major)), 2.80 (1H, ddd, J 14.0, 10.0, 7.0, SCHCHAHB (minor)), 2.54 (1H, ddd, J 14.0, 9.5, 8.0, 
SCHCHAHB (minor)), 2.31 (1H, ddd, J 14.5, 10.0, 9.0, SCHCHAHB (major)), 1.89-1.56 (2H, m, 
CO2CHCH2), 1.55-1.20 (8H, m, CO2CHCH2CH2CH2CH2CH2CH3), 0.91 (3H, t, J 6.5, CH2CH2CH3); 
δC (101 MHz, CDCl3) 167.8 (CO2 (major)), 167.4 (CO2 (minor)), 136.9 (ipso-Ph (minor)), 136.7 
(ipso-Ph (major)), 134.8 (p-Ph (major)), 134.6 (p-Ph (minor)), 129.6 (m-Ph (minor)), 129.3 (m-Ph / 
o-Ph (major)), 129.2 (o-Ph (minor)), 80.5 (CO2CH (major)), 78.5 (CO2CH (minor)), 65.3 (SCHCO2 
(major)), 64.2 (SCHCO2 (minor)), 35.7 (CO2CHCH2 (major)), 35.3 (CO2CHCH2 (minor)), 31.6 
(CO2CHCH2CH2), 30.1 (SCHCH2 (major)), 29.1 (SCHCH2 (minor)), 28.9 (CO2CHCH2CH2CH2), 25.0 
(CH2CH2CH3), 22.5 (CH2CH2CH3), 14.1 (CH2CH2CH3); νmax (film)/cm
–1
 2954, 2929, 2858, 1771 
(C═O), 1690, 1607, 1585, 1448, 1353 (SO2), 1323, 1311, 1183, 1148 (SO2), 1084, 1035, 1017, 999, 
965, 932, 849, 781, 756, 727, 687, 632, 597, 579, 526; m/z (ESI) [M+H]
+
 for C16H22O4S req. 
311.1317, found 311.1326. 
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Cyclohexenylmethyl 4-nitrophenyl carbonate (497) 
 
Et3N (2.13 mL, 15.28 mmol, 2 equiv) was added dropwise to a stirring solution of alcohol 333 
(856 mg, 7.64 mmol, 1 equiv) and p-nitrophenyl chloroformate (1.69 g, 8.41 mmol, 1.1 equiv) in 
CH2Cl2 (38 mL) at –10 °C. The reaction was stirred for 30 min at –10 °C and then allowed to warm to 
rt and stirred for 16 h, when TLC (40 % EtOAc in petroleum ether) indicated complete consumption 
of starting material. The reaction was partitioned between EtOAc (40 mL) and sat. NH4Cl (aq.) (40 
mL). The mixture was transferred to a separating funnel, the layers separated and the organic layer 
washed with sat. NH4Cl (aq.) (3 x 30 mL). The organic layer was dried over Na2SO4, filtered and 
concentrated under reduced pressure. The crude product was purified by silica gel chromatography (0 
 2 % EtOAc in petroleum ether) to afford carbonate 497 as a pale yellow crystalline solid (1.49 g, 
70 %).  
Characteristic spectral data: mp. 85 – 87 °C; δH (400 MHz, CDCl3) 8.29 (2H, d, J 9.0, m-Ph), 7.40 
(2H, d, J 9.0, o-Ph), 5.89 (1H, s, C=CH), 4.66 (2H, s, CO2CH2), 2.09 (4H, dt, J 6.0, 3.0, 
CO2CH2CCH2 / C=CHCH2), 1.75-1.66 (2H, m, CO2CH2CCH2CH2), 1.66-1.57 (2H, m, 
C=CHCH2CH2); δC (101 MHz, CDCl3) 155.7 (CNO2), 152.5 (C═O), 145.3 (ipso-Ph), 131.6 (C═CH), 
128.7 (C=CH), 125.3 (m-Ph), 121.8 (o-Ph), 74.0 (CO2CH2), 26.0 (CO2CH2CCH2), 25.8 (C═CHCH2), 
22.2 (CO2CCH2CH2), 21.9 (C═CHCH2CH2); νmax (film)/cm
-1
 2932, 1765 (C═O), 1616, 1595, 1524 
(N–O), 1493, 1448, 1348 (N–O), 1257, 1209, 1110, 1038, 1012, 950, 920, 900, 863.  
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Cyclohexenylmethyl 2-((S)-N-(2,4,6-triisopropylphenylsulfonyl)phenylsulfonimidoyl)decanoate 
(498) 
 
LiHMDS (1M in THF, 1.66 mL, 1.66 mmol, 2.2 equiv) was added dropwise to a stirring solution of 
silyl ether 494 (500 mg, 0.754 mmol, 1 equiv) in THF (2.5 mL) at –78 °C. Carbonate 497 (230 mg, 
0.830 mmol, 1.1 equiv) in THF (1.3 mL) was added dropwise at –78 °C. The reaction was allowed to 
warm slowly to rt and stirred for 16 h, when TLC indicated complete consumption of starting 
material. The reaction was quenched by the addition of sat. NH4Cl (aq.) (20 mL), transferred to a 
separating funnel and the layers separated. The aqueous layer was extracted with Et2O (3 x 40 mL). 
The combined organic extracts were dried over Na2SO4, filtered and concentrated under reduced 
pressure. The crude product was purified by silica gel chromatography (5 % EtOAc in petroleum 
ether) to afford ester 498 as a colourless oil (603 mg, quant., 60:40 d.r.). 
Characteristic spectral data: [α]D
20
 +38.6 (c 0.085, CHCl3); δH (400 MHz, CDCl3) 7.95-7.90 (2H, m, 
o-Ph), 7.75-7.65 (1H, m, p-Ph), 7.57 (2H, td, J 8.0, 7.5, 3.0, m-Ph), 7.12 (2H, s, m-Tris (minor)), 7.11 
(2H, s, m-Tris (major)), 5.74 (1H, s, C=CH (minor)), 5.66 (1H, s, C=CH (major)), 4.74 (1H, dd, 
J 11.0, 2.5, SCHCO2 (minor)), 4.53 (1H, dd, J 12.0, 2.5, SCHCO2 (major)), 4.47 (2H, s, CO2CH2 
(minor)), 4.34 (3H, hept, J 7.0, o-CH(CH3)2 / CO2CH2 (major)), 3.67 (1H, p, J 6.0, CHOSi (minor)), 
3.57 (1H, dddd, J 9.5, 7.0, 4.5, 3.0, CHOSi (major)), 2.89 (1H, pd, J 7.0, 2.5, p-CH(CH3)2), 2.26-2.15 
(2H, m, SCHCH2 (minor)), 2.09-1.97 (3H, m, C=CHCH2 / C(=CH)CH2 (minor)), 1.96-1.91 (2H, m, 
SCHCH2 (major)), 1.87-1.81 (1H, m, CO2CH2C(=CH)CH2 (major)), 1.59 (4H, ddd, J 15.0, 8.5, 4.0, 
C=CHCH2CH2CH2), 1.51-1.43 (2H, m, CH(OSi)CH2 (minor)), 1.42-1.33 (2H, m, CH(OSi)CH2 
(major)), 1.30-1.18 (26H, m, 3 x CH(CH3)2 / CH(OSi)CH2CH2CH2CH2CH2CH3), 0.89 (3H, t, J 7.0, 
Chapter 4: Experimental                                                                                                                      268 
 
 
CH2CH2CH3), 0.85 (9H, s, SiC(CH3)3 (major)), 0.81 (9H, s, SiC(CH3)3 (minor)), 0.01 (3H, s, SiCH3 
(major)), –0.03 (3H, s, SiCH3 (minor)), –0.03 (3H, s, SiCH3 (major)), –0.08 (3H, s, SiCH3 (minor)); 
δC (101 MHz, CDCl3) 164.7 (CO2), 151.9 (ipso-Tris (major)). 151.8 (ipso-Tris (minor)), 149.2 (ipso-
Ph (minor)), 149.1 (ipso-Ph (major)), 137.5 (p-Tris), 136.2 (C═CH (major)), 135.5 (C═CH (minor)), 
134.5 (p-Ph (minor)), 134.4 (p-Ph (major)), 131.9 (o-Tris (minor)), 131.7 (o-Tris (major)), 129.8 (m-
Ph (minor)), 129.6 (m-Ph (major)), 129.0 (o-Ph (major)), 129.0 (o-Ph (minor)), 128.2 (C═CH 
(major)), 127.9 (C═CH (minor)), 123.4 (m-Tris (minor)), 123.3 (m-Tris (major)), 71.1 (CO2CH2 
(major)), 71.1 (CO2CH2 (minor)), 69.9 (CHOTBS (major)), 69.8 (SCHCO2 (minor)), 69.3 (SCHCO2 
(major)), 69.2 (CHOTBS (minor)), 37.6 (CH(OTBS)CH2CH2CH2 (major)), 36.5 
(CH(OTBS)CH2CH2CH2 (minor)), 34.6 (SCHCH2 (major)), 34.1 (para-CH(CH3)2), 33.0 (SCHCH2 
(minor)), 31.7 (CH(OTBS)CH2CH2CH2 (minor)), 31.7 (CH(OTBS)CH2CH2CH2 (major)), 29.3 
(ortho-CH(CH3)2 (minor)), 29.3 (ortho-CH(CH3)2 (major)), 29.2 (ortho-CH(CH3)2), 25.9 (SiC(CH3)3 
(major)), 25.8 (SiC(CH3)3 (minor)), 25.6 (CO2CH2C(═CH)CH2 (minor)), 25.0 (CO2CH2C(═CH)CH2 
(major)), 24.8 (para-CH(CH3)2 (major)), 24.8 (para-CH(CH3)2 (minor)), 24.7 (ortho-CH(CH3)2 
(minor)), 24.7 (ortho-CH(CH3)2 (major)), 24.5 (C═CHCH2), 23.6 (CO2CH2C(═CH)CH2CH2), 22.6 
(CH(OTBS)CH2CH2CH2 (minor)), 22.5 (CH(OTBS)CH2CH2CH2 (major)), 22.3 (C═CHCH2CH2), 
22.0 (CH2CH2CH3 (minor)), 21.9 (CH2CH2CH3 (major)), 21.0 (CH2CH2CH3), 18.0 (SiC(CH3)3 
(major)), 17.9 (SiC(CH3)3 (minor)), 14.2 (CH2CH2CH3 (major)), 14.0 (CH2CH2CH3 (minor)), –4.2 
(SiCH3 (major)), –4.7 (SiCH3 (minor)), –4.8 (SiCH3 (minor)), –4.9 (SiCH3 (major)); νmax (film/cm
-1
) 
2955, 2929, 2858, 1737 (C═O), 1600, 1462, 1448, 1363 (SO2), 1319, 1250 (S═N), 1150 (SO2), 1092 
(S═N), 1053, 998 (S═N), 934, 907, 881, 836, 775, 737, 684, 663, 568, 531, 505; m/z (ESI) [M+H]+ 
for C44H71NO6S2Si req. 802.4570, found 802.4580. 
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tert-Butyldimethyl((1R,3S)-1-((R)-2-methylenecyclohexyl)-1-((S)-(N-(2,4,6-
triisopropylphenylsulfonyl)phenylsulfonimidoyl)nonan-3-yloxy)silane (499) 
 
BSA (3.50 mL, 14.32 mmol, 6 equiv) was added to a stirring solution of ester 498 (1.91 g, 2.39 mmol, 
1 equiv) and KOAc (23 mg, 0.239 mmol, 0.1 equiv) in DMF (4.47 mL) in a pre-dried microwave vial. 
The mixture was subjected to 4 x 5 min pulses at 120 °C in the microwave, when TLC (2 % acetone 
in PhMe) indicated complete consumption of starting material. The reaction was diluted with EtOAc 
(20 mL) and transferred to a separating funnel. The organic layer was washed alternately with brine 
(3 x 40 mL) and water (3 x 40 mL). The organic layer was dried over Na2SO4, filtered and 
concentrated under reduced pressure. The crude oil was purified by silica gel chromatography 
(03 % EtOAc in petroleum ether) to afford methylenecyclohexane 499 as a pale yellow oil (817 
mg, 45 %, mixture of 3 observable diastereomers in a 5:2:1 ratio (A:B:C)).  
Characteristic spectral data: [α]D
20
 –4.2 (c 0.01, CHCl3); δH (500 MHz, CDCl3) 8.04-7.97 (2H, m, 
o-Ph (diastereomers B and C)), 7.93 (2H, dd, J 8.5, 1.0, o-Ph (diastereomer A)), 7.70-7.62 (1H, p-Ph), 
7.59-7.51 (2H, m, m-Ph), 7.11-7.06 (2H, m, m-Tris), 4.91 (1H, s, C═CHAHB (diastereomer C)), 4.78 
(1H, s, C═CHAHB (diastereomer B)), 4.74 (1H, s, C═CHAHB (diastereomer B)), 4.71 (1H, s, 
C═CHAHB (diastereomer A)), 4.64 (1H, s, C═CHAHB (diastereomer C)), 4.58 (1H, s, C═CHAHB 
(diastereomer A)), 4.38-4.24 (2H, m, ortho-CH(CH3)2), 4.03 (1H, dddd, J 9.5, 7.5, 5.0, 2.0, CHOTBS 
/ SCH (diastereomer A)), 3.85-3.81 (1H, m, SCH (diastereomer C)), 3.79-3.72 (1H, m, CHOTBS 
(diastereomer B)), 3.70-3.64 (1H, m, SCH (diastereomer B)), 3.17-3.10 (1H, m, CHOTBS 
(diastereomer C)), 3.07-3.10 (1H, m, H2C═CCH (diastereomers B and C)), 2.92-2.83 (1H, m, 
para-CH(CH3)2), 2.78-2.71 (1H, m, H2C═CCH (diastereomer A)), 2.39-2.31 (1H, m, SCHCHAHB 
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(diastereomer C)), 2.30-2.22 (3H, m, SCHCHAHB (diastereomer C) / TBSOCHCH2 (diastereomer C)), 
2.13-1.98 (4H, m, TBSOCHCH2 (diastereomer A) / SCHCH2 (diastereomer B)), 1.93-1.81 (4H, m, 
SCHCH2 (diastereomer A) / TBSOCHCH2 (diastereomer B)), 1.79-1.61 (2H, m, H2C═CCH2), 
1.60-1.48 (6H, m, TBSOCHCH2CH2CH2 / H2C═CCHCH2), 1.45-1.37 (2H, m, CH2CH2CH3), 
1.36-0.96 (24H, m,  CH2CH2CH3 / H2C═CCH2CH2CH2 / 3 x CH(CH3)2), 0.93-0.67 (12H, m, 
SiC(CH3)3 / CH2CH2CH3), 0.06 (1H, s, SiCH3 (diastereomer A)), 0.04 (1H, s, SiCH3 (diastereomer 
A)), 0.03 (1H, s, SiCH3 (diastereomer C)), 0.01 (1H, s, SiCH3 (diastereomer B)), –0.04 (1H, s, SiCH3 
(diastereomer C)), –0.08 (1H, s, SiCH3 (diastereomer B)); δC (125 MHz, CDCl3) 151.6 (C═CH2), 
149.2 (ipso-Tris (diastereomers B and C)), 149.0 (ipso-Tris (diastereomer A)), 149.0 (ipso-Ph 
(diastereomer A)), 147.2 (ipso-Ph (diastereomers B and C)), 139.2 (o-Tris (diastereomers B and C)), 
137.8 (o-Tris (diastereomer A)), 137.7 (p-Tris (diastereomers B and C)), 137.1 (p-Tris (diastereomer 
A)), 134.0 (p-Ph (diastereomer A)), 134.0 (p-Ph (diastereomers B and C)), 129.5 (m-Ph (diastereomer 
C)), 129.4 (m-Ph (diastereomer B)), 129.3 (o-Ph (diastereomer B)), 129.2 (m-Ph (diastereomer A)), 
129.2 (o-Ph (diastereomer A)), 129.0 (o-Ph (diastereomer C)), 123.2 (m-Tris), 112.0 (C═CH2 
(diastereomer B)), 107.1 (C═CH2 (diastereomer C)), 106.6 (C═CH2 (diastereomer A)), 71.0 
(TBSOCH (diastereomer B)), 70.3 (TBSOCH (diastereomer C)), 70.1 (TBSOCH (diastereomer A)), 
66.0 (SCH (diastereomer B)), 65.9 (SCH (diastereomer C)), 65.6 (SCH (diastereomer A)), 43.7 
(H2C═CCH (diastereomers B and C)), 41.5 (H2C═CCH (diastereomer A)), 38.7 (SCHCH2 
(diastereomers B and C)), 38.3 (TBSOCHCH2 (diastereomers B and C)), 37.0 (SCHCH2 
(diastereomer A)), 36.7 (TBSOCHCH2 (diastereomer A)), 34.1 (para-CH(CH3)2 (diastereomer A)), 
34.1 (para-CH(CH3)2 (diastereomers B and C)), 33.8 (H2C═CCH2 (diastereomer C)), 33.7 
(H2C═CCH2 (diastereomer A)), 33.7 (H2C═CCH2 (diastereomer B)), 31.9 (TBSOCHCH2CH2 
(diastereomer A)), 31.8 (TBSOCHCH2CH2 (diastereomer B)), 31.6 (TBSOCHCH2CH2 (diastereomer 
C)), 29.7 (ortho-CH(CH3)2 (diastereomer B)), 29.4 (ortho-CH(CH3)2 (diastereomer A)), 29.4 (ortho-
CH(CH3)2 (diastereomer C)), 29.3 (ortho-CH(CH3)2 (diastereomer B)), 29.2 (ortho-CH(CH3)2 
(diastereomer A)), 29.1 (ortho-CH(CH3)2 (diastereomer C)), 27.8 (H2C═CCHCH2 (diastereomer A)), 
27.6 (H2C═CCHCH2 (diastereomer B)), 27.6 (H2C═CCHCH2 (diastereomer C)), 26.0 
(H2C═CCH2CH2), 25.9 (TBSOCHCH2CH2CH2 (diastereomer C)), 25.8 (TBSOCHCH2CH2CH2 
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(diastereomer A)), 25.8 (TBSOCHCH2CH2CH2 (diastereomer B)), 25.3 (para-CH(CH3)2 
(diastereomer B)), 24.9 (para-CH(CH3)2 (diastereomer A)), 24.8 (ortho-CH(CH3)2 (diastereomer B)), 
24.7 (para-CH(CH3)2 (diastereomer A)), 24.6 (ortho-CH(CH3)2 (diastereomer C)), 24.2 
(para-CH(CH3)2 (diastereomer C)), 23.7 (H2C═CCH2CH2CH2), 23.7 (CH2CH2CH3), 22.6 
(CH2CH2CH3 (diastereomer A)), 22.6 (CH2CH2CH3 (diastereomers B and C)), 18.0 (SiC(CH3)3 
(diastereomer A)), 18.0 (SiC(CH3)3 (diastereomers B and C)), 14.1 (CH2CH2CH3 (diastereomer A)), 
14.1 (CH2CH2CH3 (diastereomers B and C)), –3.8 (SiCH3 (diastereomer A)), –3.7 (SiCH3 
(diastereomer B)), –4.0 (SiCH3 (diastereomer A)), –4.2 (SiCH3 (diastereomer B)), –4.6 (SiCH3 
(diastereomer C)), –4.6 (SiCH3 (diastereomer C)); νmax (film)/cm
-1
 2954, 2932, 2857, 1688 (C═C), 
1643, 1599, 1461, 1447, 1375, 1362 (SO2), 1314, 1296 (S═N), 1254, 1149 (SO2), 1095 (S═N), 1063, 
1018, 996 (S═N), 937, 895, 736, 775, 744, 686, 593, 578, 564, 536, 510; m/z (ESI) [M+H]+ for 
C43H71NO4S2Si req. 758.4672, found 758.4654. 
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(1R,3S)-1-((R)-2-methylenecyclohexyl)-1-((S)-(N-(2,4,6-
triisopropylphenylsulfonyl)phenylsulfonimidoyl)nonan-3-ol (450) 
 
TBAF•3H2O (46 mg, 0.145 mmol, 2 equiv) was added to a stirring solution of methylenecyclohexane 
499 (55 mg, 0.0726 mmol, 1 equiv) in THF (0.73 mL) at 0 °C. The reaction was allowed to warm 
slowly to rt and stirred for 48 h when TLC (5 % acetone in PhMe) indicated complete consumption of 
starting material. The reaction was poured onto brine (50 mL) and transferred to a separating funnel. 
The aqueous layer was extracted with EtOAc (3 x 50 mL). The combined organic extracts were dried 
over Na2SO4, filtered and concentrated under reduced pressure. The crude product was purified by 
silica gel chromatography (10  20 % EtOAc in petroleum ether) to afford two distinct products as 
colourless oils (450a: 15 mg, 33 %, 85:15 d.r.; 450b: 13 mg, 28 %, 85:15 d.r.). 
Characteristic spectral data (450a): [α]D
20
 –6.5 (c 0.02, CHCl3); δH (400 MHz, CDCl3) 8.02-7.98 (2H, 
m, o-Ph (major)), 7.98-7.94 (2H, m, o-Ph (minor)), 7.73-7.65 (1H, m, p-Ph), 7.59 (2H, t, J 7.5, m-Ph), 
7.11 (2H, s, m-Tris (major)), 7.10 (2H, s, m-Tris (minor)), 4.84 (1H, s, C═CHAHB (minor)), 4.75 (1H, 
s, C═CHAHB (major)), 4.72 (1H, s, C═CHAHB (minor)), 4.55 (1H, s, C═CHAHB (major)), 4.44-4.23 
(3H, m, ortho-CH(CH3)2 / SCH), 3.73 (1H, br s, CHOH (major)), 3.60-3.52 (1H, m, CHOH (minor)), 
2.93-2.80 (2H, m, para-CH(CH3)2 / H2C═CCH), 2.19 (2H, p, J 4.5, H2C═CCHCH2), 2.13-2.02 (2H, 
m, H2C═CCH2), 1.85-1.40 (8H, m, HOCHCH2 / HOCHCH2CH2 / H2C═CCH2CH2), 1.24 (26H, m, 
3 x CH(CH3)2 / HOCHCH2CH2CH2CH2CH2CH3 / H2C═CCH2CH2CH2), 0.89 (3H, t, J 7.0, 
CH2CH2CH3); δC (101 MHz, CDCl3) 151.8 (C═CH2), 149.1 (ipso-Tris), 148.2 (ipso-Ph), 137.7 
(o-Tris), 137.1 (p-Tris), 134.1 (p-Ph), 129.2 (o-Ph / m-Ph), 123.3 (m-Tris), 111.9 (C═CH2), 
68.7 (CHOH (major)), 68.1 (CHOH (minor)), 64.6 (SCH), 44.5 (H2C═CCH), 35.5 (HOCHCH2CHS),  
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34.1 (para-CH(CH3)2), 33.2 (H2C═CCH2), 31.7 (HOCHCH2CH2CH2), 31.6 (H2C═CCHCH2), 
29.3 (ortho-CH(CH3)2), 29.2 (H2C═CCH2CH2), 28.0 (HOCHCH2CH2CH2), 25.5 
(HOCHCH2CH2CH2), 24.8 (ortho-CH(CH3)2), 24.6 (para-CH(CH3)2), 23.6 (H2C═CCH2CH2CH2), 
22.6 (CH2CH2CH3), 21.4 (CH2CH2CH3), 14.1 (CH2CH2CH3); νmax (film)/cm
-1
 3507, 2955, 2927, 
2856, 1646, 1600 (C═C), 1564, 1447, 1424, 1382, 1363 (SO2), 1311, 1295 (S═N), 1255, 1227, 1147 
(SO2), 1095 (S═N), 1054, 1023, 998 (S═N), 940, 880, 844, 765, 750, 726, 688, 666, 581, 564, 538; 
m/z (ESI) [M+H]
+
 for C37H57NO4S2 req. 644.3807, found 644.3811.  
Characteristic spectral data (450b): [α]D
20
 –3.2 (c 0.01, CHCl3); δH (400 MHz, CDCl3) 7.95 (2H, dd, 
J 8.5, 1.0, o-Ph), 7.74-7.63 (1H, m, p-Ph), 7.57 (2H, d, J 8.0, m-Ph (major)), 7.54 (2H, d, J 3.5, m-Ph 
(minor)), 7.10 (2H, s, m-Tris), 4.75 (1H, s, C═CHAHB (minor)), 4.72-4.66 (2H, m, C═CH2 (major)), 
4.61 (1H, s, C═CHAHB (minor)), 4.26 (2H, hept, J 6.5, ortho-CH(CH3)2), 4.14 (1H, ddt, J 8.5, 5.5, 
2.8, SCH), 3.75-3.62 (1H, m, CHOH (major)), 3.39-3.24 (1H, m, CHOH (minor)), 2.89 (1H, hept, 
J 7.0, para-CH(CH3)2), 2.65-2.57 (1H, m, H2C═CCH), 2.32-2.16 (3H, m, HOCHCH2CHS / 
H2C═CCHAHB), 1.94 (1H, ddd, J 15.0, 7.5, 2.5, H2C═CCHCHAHB), 1.88-1.74 (1H, m, 
H2C═CCHAHB), 1.74-1.37 (9H, m, H2C═CCHCHAHB / HOCHCH2CH2CH2 / H2C═CCH2CH2), 
1.36-1.15 (24H, m, 3 x CH(CH3)2 / CH2CH2CH3 / H2C═CCH2CH2CH2), 0.90 (3H, t, J 7.0, 
CH2CH2CH3); δC (101 MHz, CDCl3) 151.8 (C═CH2), 149.1 (ipso-Tris), 148.8 (ipso-Ph), 
137.4 (p-Tris), 136.5 (o-Tris), 134.1 (p-Ph), 129.3 (m-Ph), 129.2 (o-Ph), 123.3 (m-Tris), 106.9 
(C═CH2), 69.5 (CHOH), 65.3 (SCH), 41.6 (H2C═CCH), 36.9 (H2C═CCH2), 34.1 (para-CH(CH3)2), 
32.4 (HOCHCH2CHS), 31.7 (H2C═CCHCH2), 29.7 (HOCHCH2CH2CH2), 29.3 (ortho-CH(CH3)2), 
29.2 (ortho-CH(CH3)2), 29.0 (H2C═CCH2CH2), 27.7 (HOCHCH2CH2CH2), 25.6 
(HOCHCH2CH2CH2), 24.8 (ortho-CH(CH3)2), 24.8 (para-CH(CH3)2), 23.7 (H2C═CCH2CH2CH2), 
23.6 (CH2CH2CH3), 22.6 (CH2CH2CH3), 14.0 (CH2CH2CH3); νmax (film)/cm
-1
 3502, 2928, 2857, 1600 
(C═C), 1460, 1447, 1363 (SO2), 1296 (S═N), 1234, 1148 (SO2), 1094 (S═N), 1054, 998 (S═N), 745, 
688, 529; m/z (ESI) [M+H]
+
 for C37H57NO4S2 req. 644.3807, found 644.3808. 
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tert-Butyldimethyl((S)-1-((S)-2-methylenecyclohexyl)nonan-3-yloxy)silane (500) 
 
Na(Hg) (6 % Na) (420 mg, 5 equiv by mass) was added in one portion to a stirring solution of 
methylenecyclohexane 499 (84 mg, 0.111 mmol, 1 equiv) and NaH2PO4 (52 mg, 0.333 mmol, 
3 equiv) in MeOH (0.95 mL) at rt. The reaction was stirred for 1 h at rt when TLC (petroleum ether) 
indicated complete consumption of starting material. The reaction was diluted with petrol and purified 
immediately by silica gel chromatography (petroleum ether) to afford 500 as a colourless oil (20 mg, 
51 %, 95:5 d.r.). 
Characteristic spectral data: [α]D
16
 –10.8 (c 0.01, CHCl3); δH (400 MHz, CDCl3) 4.69 (1H, s, 
C═CHAHB (minor)), 4.67 (1H, s, C═CHAHB (major)), 4.61 (1H, s, C═CHAHB (minor)), 4.58 (1H, s, 
C═CHAHB (major)), 3.66 (1H, h, J 6.0, CHOTBS), 2.25 (1H, ddp, J 17.5, 13.0, 6.5, H2C═CCHAHB), 
2.01 (2H, ddt, J 21.5, 12.5, 5.5, H2C═CCHAHB / H2C═CH), 1.77 (1H, dq, J 11.0, 3.5, 
H2C═CCH2CHAHB), 1.69 (2H, ddd, J 17.5, 10.0, 5.0, H2C═CCHCH2), 1.63-1.55 (1H, m, 
H2C═CCHCHAHB), 1.56-1.36 (6H, m, H2C═CCH2CHAHB / H2C═CCHCHAHB / TBSOCHCH2 / 
TBSOCHCH2), 1.29 (10H, br s, H2C═CH2CH2CH2 / TBSOCHCH2CH2CH2CH2CH2CH3), 0.91 (12H, 
br s, CH2CH2CH3 / SiC(CH3)3), 0.07 (6H, s, Si(CH3)2); δC (101 MHz, CDCl3) 153.0 (C═CH2), 
105.5 (C═CH2), 72.6 (CHOTBS), 43.4 (H2C═CCH), 37.2 (TBSOCHCH2), 35.0 (TBSOCHCH2), 
34.8 (H2C═CCH2), 34.1 (H2C═CH2CH2), 31.9 (TBSOCHCH2CH2), 29.6 (TBSOCHCH2CH2CH2), 
28.9 (H2C═CCHCH2), 27.8 (H2C═CCHCH2), 26.0 (SiC(CH3)3), 25.3 (H2C═CCH2CH2CH2), 
24.3 (CH2CH2CH3), 22.7 (CH2CH2CH3), 18.2 (SiC(CH3)3), 14.1 (CH2CH2CH3), –4.4 (Si(CH3)2); νmax 
(film)/cm
–1
 2928, 2856, 1721, 1645 (C═C), 1572, 1460, 1376, 1361, 1253, 1065, 1006, 939, 889, 834, 
811, 773, 737, 663, 630, 574, 547; m/z (ESI) [M+H]
+
 for C22H44OSi req. 353.3240, found 353.3234. 
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(S)-1-((S)-2-methylenecyclohexyl)nonan-3-ol (501) 
 
TBAF•3H2O (79 mg, 0.250 mmol, 2 equiv) was added in one portion to a stirring solution of silyl 
ether 500 (44 mg, 0.125 mmol, 1 equiv) in THF (0.30 mL) at 0 °C. The reaction was allowed to warm 
slowly to rt and stirred for 16 h when TLC (10 % EtOAc in petroleum ether) indicated complete 
consumption of starting material. The reaction was poured onto brine (20 mL), transferred to a 
separating funnel and the aqueous layer was extracted with EtOAc (3 x 20 mL). The combined 
organic extracts were dried over Na2SO4, filtered and concentrated under reduced pressure. The crude 
oil was purified by silica gel chromatography (04 % EtOAc in petroleum  ether) to afford alcohol 
501 as a colourless oil (20 mg, 67 %, 95:5 d.r.).  
Characteristic spectral data: [α]D
16
 –12.0 (c 0.01, CHCl3); δH (400 MHz, CDCl3) 4.69 (1H, s, 
C═CHAHB (minor)), 4.66 (1H, s, C═CHAHB (major)), 4.61 (1H, s, C═CHAHB (minor)), 4.59 (1H, s, 
C═CHAHB (major)), 3.65-3.55 (1H, m, CHOH), 2.28-2.18 (1H, m, H2C═CCHAHB), 2.07-1.97 (2H, m, 
H2C═CCHAHB / H2C═CCH), 1.82-1.71 (2H, m, H2C═CCHCH2), 1.67 (1H, ddd, J 11.5, 8.0, 3.5, 
H2C═CHCHAHB), 1.55 (3H, dtd, J 20.0, 8.0, 4.0, H2C═CCHCHAHB / H2C═CH2CH2), 1.50-1.37 (4H, 
m, HOCHCH2 / HOCHCH2), 1.37-1.21 (10H, m, H2C═CCH2CH2CH2 / 
HOCHCH2CH2CH2CH2CH2CH3), 0.90 (3H, t, J 6.5, CH2CH2CH3); δC (101 MHz, CDCl3)  
152.8 (C═CH2 (minor)), 152.7 (C═CH2 (major)), 105.8 (C═CH2 (minor)), 105.6 (C═CH2 (major)), 
72.3 (CHOH (minor)), 72.1 (CHOH (major)), 43.3 (H2C═CCH (minor)), 43.2 (H2C═CCH (major)), 
37.5 (HOCHCH2), 35.4 (HOCHCH2 (minor)), 35.4 (HOCHCH2 (major)), 34.7 (H2C═CCH2 (minor)), 
34.6 (H2C═CCH2 (major)), 34.0 (H2C═CCHCH2 (major)), 33.9 (H2C═CCHCH2 (minor)), 
31.9 (HOCHCH2CH2 (minor)), 31.9 (HOCHCH2CH2 (major)), 29.4 (HOCHCH2CH2CH2), 
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28.8 (H2C═CCHCH2), 28.1 (H2C═CCH2CH2 (minor)), 27.9 (H2C═CCH2CH2 (major)), 
25.6 (CH2CH2CH3), 24.2 (H2C═CCH2CH2CH2 (minor)), 24.1 (H2CCH2CH2CH2 (major)), 
22.7 (CH2CH2CH3 (minor)),  22.6 (CH2CH2CH3 (major)), 14.1 (CH2CH2CH3); νmax (film)/cm
-1
 3359 
(O–H), 3068, 2926, 2855, 1742, 1645 (C═C), 1457, 1446, 1405, 1378, 1253, 1172, 1127, 1069, 940, 
887, 774, 748, 724, 699, 666, 629, 566; m/z (ESI) [M+H]
+
 for C16H30O req. 239.2375, found 
239.2384. 
tert-Butyl tosylcarbamate (527) 
 
Et3N (1.79 mL, 12.85 mmol, 1.1 equiv) was added dropwise to a stirring solution of 
p-toluenesulfonamide (2.00 g, 11.68 mmol, 1 equiv) and DMAP (143 mg, 1.17 mmol, 0.1 equiv) in 
CH2Cl2 (8.7 mL) at rt. Di-tert-butyl dicarbonate (2.93 g, 13.43 mmol, 1.15 equiv) in CH2Cl2 (3 mL) 
was added dropwise at rt. The reaction was stirred for 2 h at rt when TLC (30 % EtOAc in petroleum 
ether) indicated complete consumption of starting material. The reaction was concentrated under 
reduced pressure, the resulting slurry re-dissolved in EtOAc (30 mL) and transferred to a separating 
funnel. The organic layer was washed with 1 M HCl (aq.) (3 x 50 mL), water (3 x 50 mL) and brine 
(2 x 50 mL). The organic layer was dried over Na2SO4, filtered and concentrated under reduced 
pressure. The crude solid was recrystallised from hexane to afford sulfonamide 527 as a white 
crystalline solid (2.98 g, 94 %). 
Characteristic spectral data: mp. 118 – 120 °C; δH (400 MHz, CDCl3) 7.91 (2H, d, J 8.5, o-Ts), 7.35 
(2H, d, J 8.0, m-Ts), 2.46 (3H, s, Ts-CH3), 2.19 (1H, s, NH), 1.39 (9H, s, C(CH3)3); δC (101 MHz, 
CDCl3) 149.4 (C═O), 144.7 (ipso-Ts), 136.0 (p-Ts), 129.5 (m-Ts), 128.2 (o-Ts), 84.0 (CO2C(CH3)3), 
27.9 (CO2C(CH3)3), 21.7 (Ts-CH3); νmax (film)/cm
-1
 3241 (N–H), 2982, 1743 (C═O), 1712, 1598, 
1476, 1433, 1396, 1344 (SO2), 1308, 1234, 1143 (SO2), 1088, 1020, 910, 828, 815, 772, 732, 704, 
671, 660, 587, 572, 547; m/z (ESI) [M–H]– for C12H17NO4S req. 270.0800, found 270.0789. 
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Values in accordance with those found in the literature.
132
 
tert-Butyl (R)-1-((S)-2-methylenecyclohexyl)nonan-3-yl(tosyl)carbamate (528) 
 
DIAD (0.185 mL, 0.942 mmol, 1.2 equiv) was added to a stirring solution of alcohol 501 (187 mg, 
0.785 mmol, 1 equiv), sulfonamide 527 (319 mg, 1.177 mmol, 1.5 equiv) and triphenylphosphine 
(247 mg, 0.942 mmol, 1.2 equiv) in THF (7.85 mL) at 0 °C. The reaction was allowed to warm slowly 
to rt and stirred for 2.5 h when TLC (10 % EtOAc in petroleum ether) indicated complete 
consumption of starting material. The reaction was concentrated under reduced pressure and the crude 
material purified by silica gel chromatography (15 % EtOAc in petroleum ether) to afford tertiary 
amine 528 as a pale yellow oil (250 mg, 65 %, 95:5 d.r.).  
Characteristic spectral data: [α]D
20
 –34.3 (c 0.009, CHCl3); δH (400 MHz, CDCl3) 7.87 (2H, dd, J 8.0, 
3.4, o-Ts), 7.30 (2H, d, J 8.0, m-Ts), 4.67 (1H, s, C═CHAHB), 4.54 (1H, s, C═CHAHB), 4.43-4.27 (1H, 
m, CHN), 2.45 (3H, s, Ts-CH3), 2.29-2.15 (1H, m, H2C═CHAHB), 2.03 (2H, dd, J 11.0, 6.5, 
H2C═CCHAHB / H2C═CCH), 1.95-1.84 (2H, m, H2C═CCHCH2), 1.79-1.43 (6H, m, H2C═CCHCH2 / 
NCHCH2 / NCHCH2), 1.41 (9H, s, CO2C(CH3)3), 1.39-1.19 (12H, m, H2C═CCH2CH2CH2 / 
NCHCH2CH2CH2CH2CH2CH3), 0.90 (3H, t, J 6.5, CH2CH2CH3); δC (101 MHz, CDCl3) 152.7 (C═O), 
151.0 (C═CH2), 143.8 (ipso-Ts), 137.7 (p-Ts), 105.7 (C═CH2), 83.7 (CO2C(CH3)3), 60.7 (NCH), 
43.2 (H2C═CCH (major)), 43.1 (H2C═CCH (minor)), 34.7 (H2C═CCH2), 34.0 (NCHCH2), 
33.8 (H2C═CCHCH2 (major)), 33.5 (H2C═CCHCH2 (minor)), 31.9 (H2C═CCHCH2 (minor)), 
31.7 (H2C═CCHCH2 (major)), 31.6 (NCHCH2), 29.6 (H2C═CCH2CH2), 29.2 (NCHCH2CH2), 
28.8 (CH2CH2CH2CH3), 28.0 (CO2C(CH3)3), 27.1 (H2C═CCH2CH2CH2), 24.2 (CH2CH2CH3), 
22.7 (CH2CH2CH3), 21.6 (Ts-CH3), 14.1 (CH2CH2CH3); νmax (film)/cm
-1
 2925, 2855, 1725 (C═O), 
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1644 (C═C), 1599, 1457, 1395, 1354 (SO2), 1276, 1252, 1151 (SO2), 1088, 1041, 1020, 988, 888, 
843, 812, 769, 725, 705, 668, 583, 548; m/z (ESI) [M+Na]
+ 
for C28H45NO4S req. 514.2967, found 
514.2964. 
4-methyl-N-((R)-1-((S)-2-methylenecyclohexyl)nonan-3-yl)benzenesulfonamide (520) 
 
N-Boc amine 528 (203 mg, 0.413 mmol, 1 equiv) was dissolved in DMF (0.83 mL) in a pre-dried 
microwave vial. The reaction was subjected to 30 min at 210 °C in the microwave, when TLC 
indicated complete consumption of starting material. The reaction was concentrated under reduced 
pressure and residual DMF removed via azeotrope with PhMe. The crude product was purified by 
silica gel chromatography (57.5 % EtOAc in petroleum ether) to afford sulfonamide 520 as a white 
crystalline solid (138 mg, 85 %, single diastereomer).  
Characteristic spectral data: mp. 94 – 96 °C; [α]D
20
 –32.0 (c 0.005, CHCl3); δH (400 MHz, CDCl3) 
7.77 (2H, d, J 8.0, o-Ts), 7.31 (2H, d, J 8.0, m-Ts), 4.60 (1H, s, C═CHAHB), 4.41 (1H, s, C═CHAHB), 
4.22 (1H, d, J 7.5, NH), 3.22 (1H, sext, J 6.5, NCH), 2.44 (3H, s, Ts-CH3), 2.13 (1H, dt, J 12.0, 5.5, 
H2C═CCHAHB), 1.96 (1H, ddd, J 12.5, 8.0, 3.5, H2C═CCHAHB), 1.88-1.79 (1H, m, H2C═CCH), 
1.69-1.46 (4H, m, H2C═CCH2CH2 / NCHCH2CH2), 1.37 (4H, dtd, J 22.0, 10.5, 7.0, H2C═CCHCH2 / 
NCHCH2), 1.30-1.20 (4H, m, NCHCH2 / H2C═CCH2CH2CH2), 1.16 (8H, br s, H2C═CCHCH2 / 
NCHCH2CH2CH2CH2CH2CH3), 0.88 (3H, t, J 7.1, CH2CH2CH3); δC (101 MHz, CDCl3) 152.4 
(C═CH2), 143.1 (p-Ts), 138.5 (ipso-Ts), 129.6 (m-Ts), 127.1 (o-Ts), 105.7 (C═CH2), 54.6 (CHN), 
43.0 (H2C═CCH), 35.4 (NCHCH2), 34.5 (H2C═CCH2), 33.7 (NCHCH2CH2), 33.1 (H2C═CCHCH2), 
31.7 (H2C═CCHCH2), 29.0 (NCHCH2CH2CH2), 28.7 (H2C═CCH2CH2), 27.7 (NCHCH2), 25.2 
(H2C═CCH2CH2CH2), 24.0 (CH2CH2CH3), 22.5 (CH2CH2CH3), 21.5 (Ts-CH3), 14.1 (CH2CH2CH3); 
Chapter 4: Experimental                                                                                                                      279 
 
 
νmax (film)/cm
–1
 3278 (N–H), 2925, 2856, 1642 (C═C), 1597, 1496, 1446, 1425, 1377, 1324 (SO2), 
1288, 1160, 1094, 1043, 990, 885, 843, 816, 723, 707, 667; m/z (ESI) [M+H]
+
 for C23H37NO2S req. 
392.2623, found 392.2636. 
tert-Butyl (R)-1-((S)-2-oxocyclohexyl)nonan-3-yl(tosyl)carbamate (544) 
 
Through a stirred solution of methylenecyclohexane 528 (40 mg, 0.0814 mmol, 1 equiv) in CH2Cl2 
(2 mL) was bubbled O2 (10 min), O3 (10 min, or until the solution turned blue), and O2 (10 min). TLC 
(10 % EtOAc in petroleum ether) indicated complete consumption of starting material. PPh3 (43 mg, 
0.163 mmol, 2 equiv) was added in one portion at –78 °C, the reaction allowed to warm slowly to rt, 
and stirred for 16 h. The reaction was concentrated under reduced pressure and the crude product 
purified by silica gel chromatography (10 % EtOAc in petroleum ether) to afford ketone 544 as a 
colourless oil (37 mg, 92 %, 95:5 d.r.). 
Characteristic spectral data: [α]D
20
 –28.6 (c 0.005, CHCl3); δH (400 MHz, CDCl3) 7.86 (2H, d, J 8.0, 
o-Ts), 7.31 (2H, d, J 8.5, m-Ts), 4.37 (1H, p, J 8.0, 7.0, NCH), 2.45 (3H, s, Ts-CH3), 2.43-2.40 (1H, 
m, O═CCHAHB (minor)), 2.38 (1H, d, J 4.0, O═CCHAHB (major)), 2.34-2.26 (2H, m, O═CCHAHB / 
O═CCH), 2.08 (2H, ddd, J 16.5, 10.5, 4.5, NCHCH2), 1.90-1.80 (4H, m, O═CCH2CHAHB / 
O═CHCHAHB / O═CHCHAHB / NCHCHAHB), 1.78-1.60 (4H, m, O═CCH2CHAHB / O═CCHCHAHB / 
O═CCHCHAHB / NCHCHAHB), 1.39 (9H, s, CO2C(CH3)3), 1.28 (10H, br s, O═CCH2CH2CH2 / 
NCHCH2CH2CH2CH2CH2CH3), 0.89 (3H, t, J 6.5, CH2CH2CH3); δC (101 MHz, CDCl3) 213.0 (C═O 
(minor)), 212.9 (C═O (major)), 151.0 (CO2C(CH3)3), 143.8 (ipso-Ts), 137.6 (p-Ts), 129.0 (m-Ts), 
128.5 (o-Ts), 83.8 (CO2C(CH3)3 (minor)), 83.8 (CO2C(CH3)3 (major)), 60.5 (NCH (major)), 60.2 
(NCH (minor)), 50.6 (O═CCH (major)), 50.4 (O═CCH (minor)), 42.0 (O═CCH2), 34.1 (NCHCH2 
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(minor)), 34.1 (NCHCH2 (major)), 33.6 (O═CCHCH2 (major)), 33.6 (O═CCHCH2 (minor)), 31.9 
(O═CCHCH2 (minor)), 31.7 (O═CCHCH2 (major)), 31.5 (NCHCH2 (major)), 31.3 (NCHCH2 
(minor)), 29.7 (NCHCH2CH2 (major)), 29.7 (NCHCH2CH2 (minor)), 29.4 (NCHCH2CH2CH2 
(minor)), 29.2 (NCHCH2CH2CH2 (major)), 28.0 (CO2C(CH3)3), 27.2 (CH2CH2CH3), 27.0 
(O═CCH2CH2CH2), 24.9 (O═CH2CH2 (major)), 24.8 (O═CCH2CH2 (minor)), 22.7 (CH2CH2CH3 
(minor)), 22.5 (CH2CH2CH3 (major)), 21.6 (Ts-CH3), 14.1 (CH2CH2CH3 (minor)), 14.1 
(CH2CH2CH3); νmax (film)/cm
–1
 2926, 2858, 1724 (C═O), 1713 (C═O), 1598, 1456, 1395, 1353 
(SO2), 1277, 1252, 1151 (SO2), 1087, 1042, 1020, 981, 915, 843, 812, 770, 725, 706, 668, 582, 547; 
m/z (ESI) [M+Na]
+
 for C27H43NO5S req. 516.2760, found 516.2748. 
Allyl tosylcarbamate (537) 
 
Et3N (1.41 mL, 10.14 mmol, 1 equiv) was added to a stirred solution of allyl alcohol (0.69 mL, 10.14 
mmol, 1 equiv) in Et2O (10.1 mL) at 0 °C. p-Toluenesulfonyl isocyanate (2 g, 10.14 mmol, 1 equiv) 
was then added in one portion at 0 °C. The reaction was allowed to warm slowly to rt and stirred for 
48 h, when TLC (50 % EtOAc in petroleum ether) indicated complete consumption of starting 
material. The reaction was diluted with EtOAc (30 mL) and transferred to a separating funnel. The 
organic layer was washed with 2 M HCl (aq.) (3 x 30 mL) and the aqueous extracts back-extracted 
with EtOAc (3 x 20 mL). The combined organic extracts were washed with brine (3 x 20 mL), dried 
over Na2SO4, filtered and concentrated under reduced pressure. The crude product was purified by 
silica gel chromatography (40 % EtOAc in petroleum ether) to afford sulfonamide 537 as a pale 
yellow crystalline solid (1.65 g, 64 %). 
Characteristic spectral data: δH (400 MHz, CDCl3) 8.58 (1H, br s, NH), 7.93 (2H, d, J 8.5, o-Ts), 7.32 
(2H, d, J 8.0, m-Ts), 5.79 (1H, ddt, J 16.5, 11.0, 5.5, CH═CH2), 5.32-5.13 (2H, m, CH═CH2), 4.55 
(2H, d, J 5.5, CH2CH═CH2), 2.42 (3H, s, Ts-CH3); δC (101 MHz, CDCl3) 150.6 (C═O), 
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145.0 (ipso-Ts), 135.5 (p-Ts), 131.0 (CH═CH2), 129.6 (m-Ts), 128.4 (o-Ts), 119.2 (CH═CH2), 
67.3 (CH2CH═CH2), 21.6 (Ts-CH3); νmax (film)/cm
–1
 3235 (N–H), 1749 (C═O), 1649 (C═C), 1598, 
1445, 1420, 1344 (SO2), 1308, 1282, 1221, 1155 (SO2), 1089, 1019, 994, 948, 912, 854, 814, 770, 
731, 704, 662, 571, 545; m/z (ESI) [M–H]– for C11H13NO4S req. 254.0487, found 254.0476. 
Values in accordance with those found in the literature.
133
 
Allyl (R)-1-((S)-2-methylenecyclohexyl)nonan-3-yl(tosyl)carbamate (531) 
 
DIAD (0.053 mL, 0.267 mmol, 1.2 equiv) was added in one portion to a stirring solution of alcohol 
501 (53 mg, 0.222 mmol, 1 equiv), sulfonamide 532 (85 mg, 0.333 mmol, 1.5 equiv) and 
triphenylphosphine (70 mg, 0.267 mmol, 1.2 equiv) in THF (2.22 mL) at 0 °C. The reaction was 
allowed to warm to rt and stirred for 16 h, when TLC (5 % EtOAc in petroleum ether) indicated 
complete consumption of starting material. The reaction was concentrated under reduced pressure and 
the crude material purified by silica gel chromatography (13 % EtOAc in petroleum ether) to afford 
tertiary amine 531 as a colourless oil (62 mg, 59 %, 85:15 d.r.). 
Characteristic spectral data: [α]D
20
 –29.4 (c 0.007, CHCl3); 7.88 (2H, dd, J 8.5, 2.1, o-Ts), 7.31 (2H, d, 
J 8.0, m-Ts), 5.95-5.75 (1H, m, CH═CH2), 5.30 (1H, q, J 1.5, CH═CHAHB), 5.28-5.24 (1H, m, 
CH═CHAHB), 5.23 (1H, d, J 1.0, CH═CHAHB), 4.67 (1H, s, C═CHAHB (major)), 4.65 (1H, s, 
C═CHAHB (minor)), 4.59 (1H, dt, J 6.0, 1.0, CH2CH═CH2), 4.54 (1H, s, C═CHAHB), 4.44 (1H, dtd, 
J 11.5, 9.0, 6.0, CHN), 2.45 (3H, s, Ts-CH3), 2.22 (1H, ddd, J 12.0, 7.0, 4.5, H2C═CCHAHB), 2.03 
(2H, ddd, J 12.5, 8.0, 3.5, H2C═CCHAHB / H2C═CCH), 1.97-1.85 (2H, m, NCHCH2), 1.81-1.55 (4H, 
m, H2C═CCH2CH2 / H2C═CCHCH2), 1.55-1.39 (2H, m, NCHCH2), 1.37-1.16 (12H, m, 
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H2C═CCHCH2CH2 / NCHCH2CH2CH2CH2CH2CH3), 0.96-0.82 (3H, m, CH2CH2CH3); 
δC (101 MHz, CDCl3) 154.2 (C═O), 152.6 (C═CH2), 144.3 (ipso-Ts), 137.0 (p-Ts), 131.2 (CH═CH2), 
129.0 (m-Ts), 128.9 (o-Ts), 119.2 (CH═CH2), 105.8 (C═CH2), 67.2 (CO2CH2CH═CH2), 61.3 (NCH), 
43.1 (H2C═CCH), 34.6 (H2C═CCH2), 33.8 (H2C═CCHCH2), 33.8 (NCHCH2), 31.7 (NCHCH2), 31.5 
(H2C═CHCH2CH2), 29.7 (NCHCH2CH2), 29.6 (H2C═CCH2CH2CH2), 29.2 (H2C═CCH2CH2), 28.8 
(NCHCH2CH2CH2), 24.1 (CH2CH2CH3), 22.6 (CH2CH2CH3), 21.6 (Ts-CH3), 14.1 (CH2CH2CH3); 
νmax (film)/cm
–1
 2928, 2857, 1732 (C═O), 1645 (C═C), 1596, 1452, 1365 (SO2), 1256, 1170 (SO2), 
1089, 991, 934, 888, 813, 763, 665, 589; m/z (ESI) [M+H]
+
 for C27H41NO4S req. 476.2835, found 
476.2827. 
N-allyl-4-methyl-N-((R)-1-((S)-2-methylenecyclohexyl)nonan-3-yl)benzenesulfonamide (538) 
 
Pd(PPh3)4 (2 mg, 0.0019 mmol, 0.02 equiv) was added to a stirring solution of N-Alloc amine 531 
(45 mg, 0.0947 mmol, 1 equiv) in MeCN (0.5 mL) at rt. The reaction was stirred for 3 h at rt when 
TLC (10 % EtOAc in petroleum ether) indicated complete consumption of starting material. The 
reaction was concentrated under reduced pressure and the crude product purified by silica gel 
chromatography (2 % EtOAc in petroleum ether) to afford N-allyl amine 538 as a colourless oil 
(28 mg, 69 %, 85:15 d.r.). 
Characteristic spectral data: [α]D
20
 –30.7 (c 0.015, CHCl3); δH (400 MHz, CDCl3) 7.73 (2H, d, J 8.0, 
o-Ts), 7.28 (2H, d, J 8.0, m-Ts), 5.95-5.84 (1H, m, CH═CH2), 5.20 (1H, d, J 17.0, CH═CHtrans), 5.10 
(1H, d, J 10.0, CH═CHcis), 4.62 (1H, s, C═CHAHB (major)), 4.60 (1H, s, C═CHAHB (minor)), 4.44 
(1H, s, C═CHAHB (major)), 4.43 (1H, s, C═CHAHB (minor)), 3.72 (3H, dq, J 28.0, 7.5, 6.0, NCH / 
NCH2CH═CH2), 2.43 (3H, s, Ts-CH3), 2.16 (1H, dt, J 11.5, 5.5, H2C═CCHAHB), 2.04-1.93 (1H, m, 
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H2C═CCHAHB), 1.90-1.81 (1H, m, H2C═CCH), 1.74-1.47 (6H, m, H2C═CHCH2 / NCHCH2 / 
NCHCH2), 1.45-1.03 (14H, m, H2C═CCH2CH2CH2CH2 / NCHCH2CH2CH2CH2CH2CH3), 0.88 (3H, 
t, J 7.0, CH2CH2CH3); δC (101 MHz, CDCl3) 152.6 (C═CH2 (major)), 152.2 (C═CH2 (minor)), 142.8 
(ipso-Ts (major)), 142.7 (ipso-Ts (minor)), 138.7 (p-Ts), 136.6 (CH═CH2 (major)), 136.5 (CH═CH2 
(minor)), 129.4 (m-Ts (major)), 129.4 (m-Ts (minor)), 127.2 (o-Ts), 116.8 (CH═CH2), 106.0 (C═CH2 
(minor)), 105.7 (C═CH2 (major)), 59.5 (NCH (major)), 59.2 (NCH (minor)), 46.0 (CH2CH═CH2 
(major)), 46.0 (CH2CH═CH2 (minor)), 43.2 (H2C═CCH (major)), 43.1 (H2C═CCH (minor)), 34.5 
(H2C═CCH2), 33.9 (NCHCH2 (minor)), 33.8 (NCHCH2 (major)), 33.7 (H2C═CCH2CH2), 31.9 
(H2C═CHCH2 (minor)), 31.7 (H2C═CHCH2 (major)), 31.5 (H2C═CHCH2 (major)), 31.3 
(H2C═CCHCH2 (minor)), 29.4 (NCHCH2 (minor)), 29.3 (NCHCH2 (major)), 29.1 (NCHCH2CH2 
(major)), 29.0 (NCHCH2CH2 (minor)), 28.7 (NCHCH2CH2CH2 (major)), 28.7 (NCHCH2CH2CH2 
(minor)), 26.7 (H2C═CCH2CH2CH2 (major)), 26.4 (H2C═CCH2CH2CH2 (minor)), 24.0 (CH2CH2CH3 
(major)), 23.6 (CH2CH2CH3 (minor)), 22.7 (CH2CH2CH3 (minor)), 22.6 (CH2CH2CH3 (major)), 21.4 
(Ts-CH3), 14.1 (CH2CH2CH3 (minor)), 14.1 (CH2CH2CH3 (major)); νmax (film)/cm
-1
 2927, 2856, 1644 
(C═C), 1458, 1379, 1336 (SO2), 1247, 1218, 1159 (SO2), 1115, 1080, 1018, 974, 908, 884, 850, 835, 
814, 730, 660, 575, 549, 512; m/z (ESI) [M+H]
+ 
for C26H41NO2S req. 432.2936, found 432.2927. 
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Table 1. Crystal data and structure refinement for 520 
 
Identification code DC1402 
Formula C23 H37 N O2 S 
Formula weight 391.59 
Temperature 173 K 
Diffractometer, wavelength Agilent Xcalibur PX Ultra A, 1.54184 Å 
Crystal system, space group Orthorhombic, P 21 21 21 
Unit cell dimensions a = 5.18884(13) Å  = 90° 
 b = 20.0941(8) Å  = 90° 
 c = 22.3848(9) Å  = 90° 
Volume, Z 2333.96(14) Å3, 4 
Density (calculated) 1.114 Mg/m3 
Absorption coefficient 1.344 mm-1 
F(000) 856 
Crystal colour / morphology Colourless needles 
Crystal size 0.30 x 0.05 x 0.03 mm3 
 range for data collection 2.955 to 73.799° 
Index ranges -6<=h<=6, -24<=k<=23, -27<=l<=24 
Reflns collected / unique 5505 / 3923 [R(int) = 0.0389] 
Reflns observed [F>4(F)] 3334 
Absorption correction Analytical 
Max. and min. transmission 0.966 and 0.781 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 3923 / 1 / 250 
Goodness-of-fit on F2 1.055 
Final R indices [F>4(F)] R1 = 0.0788, wR2 = 0.2015 
R indices (all data) R1 = 0.0902, wR2 = 0.2135 
Absolute structure parameter 0.055(17) 
Largest diff. peak, hole 0.846, -0.491 eÅ-3 
Mean and maximum shift/error 0.000 and 0.000 
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Table 2. Bond lengths [Å] and angles [°] for DC1402. 
 
C(1)-C(2) 1.336(13) 
C(2)-C(7) 1.450(11) 
C(2)-C(3) 1.517(11) 
C(3)-C(4) 1.496(14) 
C(4)-C(5) 1.546(14) 
C(5)-C(6) 1.496(14) 
C(6)-C(7) 1.451(14) 
C(7)-C(8) 1.582(10) 
C(8)-C(9) 1.482(9) 
C(9)-C(10) 1.532(8) 
C(10)-N(17) 1.445(9) 
C(10)-C(11) 1.557(9) 
C(11)-C(12) 1.526(8) 
C(12)-C(13) 1.511(8) 
C(13)-C(14) 1.522(8) 
C(14)-C(15) 1.514(10) 
C(15)-C(16) 1.531(13) 
N(17)-S(18) 1.604(6) 
S(18)-O(20) 1.426(5) 
S(18)-O(19) 1.442(4) 
S(18)-C(21) 1.771(6) 
C(21)-C(26) 1.375(8) 
C(21)-C(22) 1.386(8) 
C(22)-C(23) 1.393(9) 
C(23)-C(24) 1.368(11) 
C(24)-C(25) 1.384(11) 
C(24)-C(27) 1.509(9) 
C(25)-C(26) 1.387(9) 
 
C(1)-C(2)-C(7) 125.6(7) 
C(1)-C(2)-C(3) 120.0(8) 
C(7)-C(2)-C(3) 114.4(8) 
C(4)-C(3)-C(2) 110.3(7) 
C(3)-C(4)-C(5) 107.6(8) 
C(6)-C(5)-C(4) 112.1(9) 
C(7)-C(6)-C(5) 114.6(10) 
C(2)-C(7)-C(6) 108.7(7) 
C(2)-C(7)-C(8) 111.2(7) 
C(6)-C(7)-C(8) 116.5(7) 
C(9)-C(8)-C(7) 112.0(6) 
C(8)-C(9)-C(10) 113.2(6) 
N(17)-C(10)-C(9) 111.4(5) 
N(17)-C(10)-C(11) 108.7(5) 
C(9)-C(10)-C(11) 112.7(6) 
C(12)-C(11)-C(10) 113.9(5) 
C(13)-C(12)-C(11) 112.5(5) 
C(12)-C(13)-C(14) 113.4(6) 
C(15)-C(14)-C(13) 113.5(6) 
C(14)-C(15)-C(16) 111.2(8) 
C(10)-N(17)-S(18) 122.3(4) 
O(20)-S(18)-O(19) 120.8(3) 
O(20)-S(18)-N(17) 106.3(3) 
O(19)-S(18)-N(17) 106.3(3) 
O(20)-S(18)-C(21) 108.3(3) 
O(19)-S(18)-C(21) 106.2(3) 
N(17)-S(18)-C(21) 108.5(3) 
C(26)-C(21)-C(22) 121.4(5) 
C(26)-C(21)-S(18) 117.9(4) 
C(22)-C(21)-S(18) 120.7(5) 
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C(21)-C(22)-C(23) 118.6(6) 
C(24)-C(23)-C(22) 121.4(6) 
C(23)-C(24)-C(25) 118.5(6) 
C(23)-C(24)-C(27) 121.3(8) 
C(25)-C(24)-C(27) 120.3(7) 
C(24)-C(25)-C(26) 121.9(6) 
C(21)-C(26)-C(25) 118.2(6) 
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6.2.0       Appendix II - Relevant NMR Spectra 
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